TW542858B - Method and composition for inhibiting corrosion in aqueous systems - Google Patents

Abstract

A method for controlling corrosion of metals, such as stainless steel, in contact with an aqueous system which comprises introducing into said system at least one tetrazolium compound of the formula: wherein R1, R2 and R3 are selected from the group consisting of lower alkyl, branched lower alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl and heterocyclic substituted aryl, with the proviso that neither R1, R2, or R3 contain more than 14 carbon atoms; and n is 1 or 2, such tetrazolium compound optionally having associated water soluble ionic species if needed to obtain a neutral charge.

Description

五、發明說明（1 ) 相關申請案件之對照參# 本申請案件為登記於1998年8月19日第09/136·884號 之部伤繼續申請案件，登記於1999年5月3日第〇9/3〇3,596 號之部份繼續申請案件，登記於1999年5月3曰第 09/3 04，181號之部份繼續申請案件，及登記於1999年$月口 曰第09/309,564號之部份繼續φ請案件。這些中請案件的 各揭示内容全部加入為參考資料。 金屬廣泛地被使用在含水相系統裝置的結構。“水相 系統”的意思是指任何包含其中含有或經常性接觸水相液 體系統的金屬。以水為主的液體通常是指液體中含有至少 大約50重量比的水，其餘的是固體（懸浮的及/或溶解的） 及/或非水相液體。水相液體一詞是要包括不只以水為主 的液體，同時也是主要非水相，但有足夠的水，至少大約 5重量比的水存在㈣體，使得水溶性處理組成份可以有 效的使心限制錢。這種非水相液體可以是與水互混或 不互混的。 但不限制於，以蒸發得到其冷 一般的水相系統包括 閉回路冷卻系統，鍋爐 置’逆滲透裝置，油品 ’氣體洗滌塔，鼓風爐 卻源的開放式再循環冷卻系統，密 和類似的蒸汽發生系統，熱交換震 生產系統’快速蒸發器，脫鹽工廠 ，紙和紙漿加工裝置，蒸汽發電廠，地熱系統，食物和飲 料加工裝置’魏蒸發器，採礦“，洗«置，土壤授 拌系統’住家或商業用途的密閉回路加熱系統，水相為主 的冷凌系、统，沈降系統，水相切割液體（例如用於 542858 五、發明說明（ 消 礙磨’錢孔，拉肖,|，私处 拉、、、糸，旋轉，切割，縫製，磨床和螺 紋切割加工或非切宝彳士 ’、 口J成形，懸壓，拉絲或壓製加工）， 相打磨系統，水抖r β ， 一醇防/東系統，水/乙二醇水力液體 ，鐵表面預處理，聚合物塗覆系統等等。多種不同形態的 κ可乂使用於&種系統，例如新鮮水，半驗水，海水，食 鹽水，垃圾廢棄物，工業廢水等等。 < 〃可以用本發明組成物處理的水相系統可能含有溶解的 " 可月匕是自周圍空氣吸附氧得到的，或它們可以實質 的或凡王/又有氧。另外，水相系統中可能含有其他溶解的 孔體，如一iU匕碳，硫化氯或氨或可能實質的或完全的沒 有這些氣體。 在水相系統中可能遇到數個不同方式的腐敍。例如水 相系統可能在整個金屬表面均勻地腐姓。水相系統也可能 有局部化的腐敍H點或裂隙賴，只有在金屬表面的 -些位置發現腐蝕。通常’局部化腐蝕的控制可能是延長 金屬裝置在水相线中可料命的關鍵因子。特別是含有 高含量侵略性陰離子的水相系統’如氣化物和硫酸鹽，特 別可能受到-般化和局部化的攻擊。這些侵略性陰離子可 能以可造成問題的含量存在於用於水相系統的水源，或它 們可能在水相“中濃縮為有害的含量，因為它們是蒸發 水系統的一部份，如蒸發性的冷卻系統。 局部化腐蝕可能較一般的腐蝕對系統正常操作造成 大威脅’因為這種腐蝕集中發生於一個位置，可能造成 統攜帶液體流構造的穿孔。明顯的，這些穿孔可#芒成 項 頁 # 更系 漏 6 542858V. Description of the invention (1) References to related application cases # This application case is a case of continuing injury application registered on August 19, 1998 No. 09/136 · 884, and was registered on May 3, 1999. Part of 9 / 3〇3,596 continued to apply for the case, registered on May 3, 1999 No. 09/3 04,181, continued to apply for the case, and was registered in 1999 Yueyuekou No. 09 / 309,564 Part of the case continues. The disclosures of these cases are all incorporated as reference materials. Metals are widely used in the structure of aqueous phase system devices. By "aqueous phase system" is meant any metal that contains or regularly contacts an aqueous phase liquid system. Water-based liquids usually refer to liquids containing at least about 50% by weight of water, with the remainder being solid (suspended and / or dissolved) and / or non-aqueous liquids. The term aqueous phase liquid is intended to include not only water-based liquids, but also the non-aqueous phase, but there is sufficient water, and at least about 5 weight ratio of water is present in the carcass, so that the water-soluble components can effectively use Heart limits money. This non-aqueous liquid can be miscible or immiscible with water. But it is not limited to the common water phase system obtained by evaporation, including closed-loop cooling systems, boilers with 'reverse osmosis devices, oil' gas scrubbing towers, and open recirculation cooling systems from blast furnaces, dense and similar Steam generation system, heat exchange shock production system 'rapid evaporator, desalination plant, paper and pulp processing plant, steam power plant, geothermal system, food and beverage processing plant' Wei evaporator, mining ', washing «set up, soil mixing System 'Closed loop heating system for home or commercial use, water-based cooling systems, systems, sedimentation systems, water-phase cutting liquids (eg, for use in 542858 V. Description of the invention (In order to prevent grinding of money holes, Lashaw, |, Private parts, drawing, sewing, rotating, cutting, sewing, grinding and thread cutting processing or non-cutting jewelers', mouth J forming, suspension pressing, wire drawing or pressing processing), phase grinding system, water shaking r β, Mono alcohol / East system, water / glycol hydraulic liquid, iron surface pretreatment, polymer coating system, etc. Many different forms of κ can be used in & systems, for example Fresh water, semi-tested water, seawater, salt water, garbage waste, industrial wastewater, etc. <; The aqueous system that can be treated with the composition of the present invention may contain dissolved " Obtained, or they can be substantial or king / aerobic. In addition, the aqueous system may contain other dissolved pores, such as iU carbon, chlorine sulfide or ammonia or may be substantially or completely free of these gases. There may be several different types of corruption in the water phase system. For example, the water phase system may uniformly rot on the entire metal surface. The water phase system may also have localized corrosion points H or cracks, only in the metal Corrosion found at some locations on the surface. Often 'control of localized corrosion may be a key factor in extending the life expectancy of metal installations in the aqueous phase line. Especially aqueous systems containing high levels of aggressive anions' such as gaseous and sulfuric acid Salts are particularly likely to be attacked by generalization and localization. These aggressive anions may be present in problematic amounts in water sources used in aqueous systems, or they Can be concentrated in the water phase to harmful levels because they are part of an evaporative water system, such as an evaporative cooling system. Localized corrosion may pose a greater threat to the normal operation of the system than ordinary corrosion. 'Because of this corrosion Concentrations occur in one location, and may cause perforations that carry liquid flow structures. Obviously, these perforations can be # 芒 成 项 页 # More systematic leakage 6 542858

經濟部智慧財產局員工消費合作社印製 而要關掉整個水相系統才能夠整修。事實上，腐餘問 題常常造成巨大的維護費用，以及裝置損壞結果的費用。 口此水相系統中金屬腐蝕的抑制是重要的。 在下面的說明中，我們使用寡聚物，聚合物，共募聚 矛/、χΚ物這些詞彙。寡聚物的意思是指單一單體聚合 反應得到的物料，其中加人產物之單體單元的數目是在2 矛大、、勺10之間。$合物的意思、是指單一單體聚合反應得到 的=^有限制加人產物之單體單元的數目。共寡聚物 、^ ^疋扼夕於一種單體（包括2，3，4個等不同的單體） 水合反應得到的物料，加人產物之單體單元的總數目在2 矛大、力10之間。共聚物的意思是指多於一種的單體（包括2 ，3，4個等不同的單體）聚合反應得到的物料，沒有限制 加入產物之單體單元的數目。 在水相系統中，金屬，如鋼，發生下面的腐姓反應： Fe〇Fe2++2e- Fe(〇H)2+ 〇HOFe(OH)3+e· 當使用氧化還原電位高於腐蝕金屬或合金的四唑鏘化 。物，四唑鑰分子很快地在金屬，如鋼或不銹鋼，的表面 上發生還原作用，形成不可溶的物料而避免鋼再繼續腐蝕 〇 本發明方法包含用下面化學通式的四唑繙鹽處理工業 水： /、 裝— (請先閱讀背面之注意事項再填寫本頁) . ;線· 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） -I I I- 1 542858 五 經濟部智慧財產局員工消費合作社印製Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, and the entire water phase system must be turned off for refurbishment. In fact, the problem of corrosion often results in huge maintenance costs and the cost of equipment damage. The suppression of metal corrosion in this aqueous phase system is important. In the following description, we use the terms oligomer, polymer, co-aggregation spear / χκ. The oligomer refers to the material obtained by the polymerization of a single monomer. The number of monomer units added to the product is between 2 and 10. The meaning of the $ compound means that the number of monomer units added to the product is limited by the polymerization of a single monomer. Co-oligomers, ^ ^ 疋 Condensed on a single monomer (including 2, 3, 4 and other different monomers) The material obtained by the hydration reaction, the total number of monomer units added to the product is 2 Between 10. Copolymer means the material obtained by polymerization of more than one monomer (including 2, 3, 4 and other different monomers). There is no limit to the number of monomer units added to the product. In aqueous systems, metals such as steel undergo the following scumming reactions: Fe〇Fe2 ++ 2e- Fe (〇H) 2+ 〇HOFe (OH) 3 + e · When the oxidation-reduction potential is higher than that of corrosive metals Or the tetrazole of the alloy. The tetrazolium molecule quickly reduces on the surface of metal, such as steel or stainless steel, to form insoluble materials to prevent the steel from continuing to corrode. The method of the present invention includes using a tetrazolium salt of the chemical formula Treatment of industrial water: / 、 Loading — (Please read the precautions on the back before filling this page).; Line · This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) -II I- 1 542858 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs

發明說明（Invention Description (

其中Κ’ΙΜΑ可以是各種不同的有機的和無機的取代基 ，如由較低級録，芳基，Μ基，和雜環取代的芳基所 組成之族者’但是必須R|，R2stR3都不含有多於14個碳原 子’及η可以是1或2。 化合物中可含有正的或負的平衡離子來平衡上面構造 的電荷。這種化合物化學或電化學還原得到四唑啉和甲臢 ’很快地吸附於金屬表面’提供腐蝕保護的薄膜。 本發明者也發現一些下面化學通式的四唑鏘化合物： Ν=/ Ν R3 ^ η 其中R1 ’ R；2和R;可以是各種不同的有機的和無機的取代基 ’如由較低級烷基，分枝的較低級烷基，芳基，取代的芳 基，烷芳基，取代的烷芳基和雜環取代的芳基所組成之族 者，但是必須Ri，R2或R3都不含有多於14個碳原子，及 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） I ---I l· I I I ^ . I I--I I I « (請先閱讀背面之;i意事頊存填寫本頁) 542858 A7 五、發明說明（ 經濟部智慧財產局員工消費合作社印製 可以是1或2,協同地與多種化合物合併，提供水相系統中 金屬一般和局部化腐蝕有效的保護。如果選擇要與四唑鏘 化合物合併的組成份也是水垢及/或沈積抑制劑，該組合 也會提供這些水相系統的水垢及/或沈積抑制。 陰離子及/或陽離子可以伴隨上面的構造來平衡決定 於使用的取代物的電荷。如果Ri，有都是中性的 ，則顯示於上面的化學式的構造會是正電荷的，就需要陰 離子種系。 用於平衡的陰離子及/或陽離子可以是任何如鹵基， 确酸根，亞石肖酸根，碳酸根，石炭酸氣根，硫酸根，鱗酸根 ，和過渡金屬含氧酸的陰離子及/或陽離子。 陰離子及/或陽離子可以伴隨上面的構造來平衡決定 於使用取代物的電荷。如果Ri，Μ%所有的都是中性的 ，然後顯示於上面化學式的構造會是正的電荷，就會需要 陰離子種系。例如如本發明的四唑鑽化合物是中性的。在 最簡單的情況下，如果所有的R!，心和心都是中性的，當 卜則需要一個單一負電荷的陰離子，如，的平衡離 子來平衡電荷。當n=2，則需要二個陰離子，各帶一個單 一負電荷或一個雙負電荷的陰離子，如SCV2，來平衡電 何。此外，例如伴隨Ri，&和&的電荷不是中性的，例如 如果這基團包括磺酸基，羧基及/或四級氮，必須存在有 伴卩远的平衡離子提供四唾|翁化合物的中性電荷。因此， 如如果n=2，Ri以一個單一羧基團（c〇〇·)取代，則該四 鏘化合物可以是一個氯化鋅鹽，其中Zn+2中和二個羧基電 例 口坐Wherein K′ΙΜΑ can be a variety of organic and inorganic substituents, such as those consisting of lower-order, aryl, M, and heterocyclic substituted aryl 'but must be R |, R2stR3 Not containing more than 14 carbon atoms' and η may be 1 or 2. Compounds can contain positive or negative counterions to balance the charge on the structure above. This compound is chemically or electrochemically reduced to obtain a thin film of tetrazoline and formazan which is quickly adsorbed on the metal surface to provide corrosion protection. The present inventors have also discovered some tetrazolium compounds of the general chemical formula: Ν = / Ν R3 ^ η where R1 'R; 2 and R; can be a variety of different organic and inorganic substituents' such as by lower Alkyl, branched lower alkyl, aryl, substituted aryl, alkaryl, substituted alkaryl, and heterocyclic substituted aryl groups, but all must be Ri, R2, or R3 Does not contain more than 14 carbon atoms, and this paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) I --- I l · III ^. I I--III «(Please read the back first (I intend to fill in this page) 542858 A7 V. Description of the invention (printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs can be 1 or 2, which can be combined with a variety of compounds to provide general and local metal in the water phase system Effective protection against chemical corrosion. If the components chosen to be combined with the tetrazolium compound are also scale and / or deposition inhibitors, this combination will also provide scale and / or deposition inhibition for these aqueous systems. Anions and / or cations can With the above structure, the balance depends on the usage. If Ri is neutral, the structure of the chemical formula shown above will be positively charged, and an anion species is required. The anion and / or cation used for the balance can be any such as halo, indeed Anions and / or cations of acid, shoshate, carbonate, carbolic acid, sulfate, phosphonate, and transition metal oxo acids. Anions and / or cations can be balanced with the above structure depending on the use of substituents If all of Ri and M% are neutral, then the structure shown in the above chemical formula will be a positive charge, and an anion germline will be required. For example, the tetrazole diamond compound of the present invention is neutral. In the simplest case, if all R !, the heart and the heart are neutral, then a single negatively charged anion, such as the counter ion, is needed to balance the charge. When n = 2, two are needed Anions, each with a single negative charge or a double negative charge, such as SCV2, to balance the electric charge. In addition, for example, the charges accompanying Ri, & and & are not neutral, such as If this group includes a sulfonic group, a carboxyl group, and / or a quaternary nitrogen, there must be a counter ion with a distant counter ion to provide a neutral charge of the tetrasalene compound. Therefore, if n = 2, Ri has a single carboxyl group (C〇 ··) substitution, the tetrafluorene compound may be a zinc chloride salt, in which Zn + 2 neutralizes two carboxyl groups.

--------------裝--- (請先閱讀背面之注意事項再填寫本頁) 訂 線· 542858 A7 B7 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 五、發明說明（6 ) 荷，而cr中和二個環氮的正電荷。 這種可以如本發明使用的四唑鏘化合物的實施例包括 硝基藍四唑鏘氯化物（3,3，-(3,3，-二甲氧基-4,4M申聯苯基）-雙-[2-對-硝苯基-5-苯基-2H-四唑鏺氯化物])，此後稱之為 NBT，二苯乙烯基硝基藍四唑鏘氯化物（2,2，_二-對-硝苯 基-5,5 - 一本乙婦基-3，3’-[3，3’-二曱氧基-4,4’-伸聯笨基]二 四嗤鍇氯化物），此後稱之為DNBT，四硝基藍四唑鏘氯化 物（3,3’-(3,3’_二甲氧基-4,4，-伸聯苯基雙-[2,5-對-硝苯基 四唾鏘氯化物])，此後稱之為TNBT，及碘硝基四唑鐵氣 化物（2-(4-碘苯基）-3-(4-硝苯基）_5·苯基四唑繙氣化物）， 此後稱之為INT。 水相系統中的金屬可以是任何可以避免腐蝕及/或長 水垢的金屬。例如這些金屬可以是非鐵金屬，如銅，鋁或 鐵金屬，如鐵，鋼，例如低碳鋼，和不銹鋼，例如鐵以為 主’含有絡為主要合金元素的合金，如含有大約m3〇% 之間Cr的鋼，它對許多環境有極佳的腐蝕抗性。 本發明甚至沒有添加入其他物料，包括其他抗腐钱及 /或水垢避免組成份’當單獨使用时鐵化合物時，也可 以用低濃度的四咕鐵化合物提供特別有利的結果。这特別 是當四唾鑕化合物使用的水相系統，在氧存在下’處理系統的pH為大約6或更大的情況，如冷卻水系統 汽發生系統’氣體洗嶋統，和紙毁和紙製造㈣： 本發明四唾錄化合物可較佳地以範圍自大如 約5…的活性處理含量加到水相系統 約至 蒸 大 (請先閱讀背面之注意事項再填寫本頁) · I--------^---------. t ® ® (cns)a4 (210 五 、發明說明（7) 25 ppm的處理含量是特別佳的。 一個較佳的觀點，本發 不銹鋼腐蝕的方法，1 曰。上制接觸水相系 、 7万居，其中包含引入該系 學式的四唾鑽化合物·· 夕一個下面化-------------- Install --- (Please read the precautions on the back before filling out this page) Threading · 542858 A7 B7 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Note (6), and cr neutralizes the positive charge of the two ring nitrogens. Examples of such tetrazolidine compounds that can be used in accordance with the present invention include nitroblue tetrazolium chloride (3,3,-(3,3, -dimethoxy-4,4M biphenyl)- Bis- [2-p-nitrophenyl-5-phenyl-2H-tetrazolium chloride]), hereinafter referred to as NBT, distyrylnitro blue tetrazolium chloride (2,2, _ Di-p-nitrophenyl-5,5-one ethynyl-3,3 '-[3,3'-dioxo-4,4'-extendylbenzyl] tetrakinium chloride ), Hereinafter referred to as DNBT, tetranitroblue tetrazolium chloride (3,3 '-(3,3'_dimethoxy-4,4, -extendylphenylbis- [2,5- P-Nitrophenyltetrasaline chloride]), hereinafter referred to as TNBT, and iodonitrotetrazole iron gaseous compound (2- (4-iodophenyl) -3- (4-nitrophenyl) _5 · Phenyltetrazole vaporizer), hereafter referred to as INT. The metal in the aqueous system can be any metal that can avoid corrosion and / or scale. For example, these metals can be non-ferrous metals such as copper, aluminum or iron. , Such as iron, steel, such as low-carbon steel, and stainless steel, such as iron-based alloys containing iron as the main alloying element, such as steel containing about Cr between about m3% It has excellent corrosion resistance to many environments. The invention does not even add other materials, including other anti-corrosion money and / or scale avoidance components. When used alone, iron compounds can also be used at low concentrations of four Curry compounds provide particularly favorable results. This is especially the case when the tetrasial compounds are used in an aqueous system where the pH of the treatment system is about 6 or greater in the presence of oxygen, such as a cooling water system steam generation system ' Washing system, and paper destruction and paper manufacturing: The four salivary compounds of the present invention can be preferably added to the water phase system with an active treatment content ranging from as large as about 5 ... to steaming (please read the precautions on the back first) (Fill in this page) · I -------- ^ ---------. T ® ® (cns) a4 (210 V. Description of the invention (7) 25 ppm is particularly good. A better point of view, the method of stainless steel corrosion in the present invention, is 1. The upper system is in contact with the water phase system, 70,000 residences, which includes the introduction of the tetra-sialite compound of the system formula ...

這 經濟部智慧財產局員工消費合作社印製 之 美」其3係擇自由較低級院基，分枝的較低級院 二取代的芳基’㈣基’取代的院芳基和雜環取 方土組成之族者，但是必須R|，〜或〜都不含有多於 14個碳原子；及η為…，如果需要，這種四唾鏘化合物 任擇地含有伴隨的水溶性離子種系以得到中性電荷。 本水相系統Τ包括至少-個其它的水相系、统處理物料 一迖擇要使得泫物料不會實質的還原四唑鐯化合物。 種物料可以與四唑鏘化合物一起或分別地加入。 其他水相系統處理物料係擇自由下面化合物所組成〜 才矢者·無機磷酸鹽，硼酸鹽，亞硝酸鹽，在水中釋放金屬 陰離子的化合物，2,3-二羥基苯酸，ι,ι〇-啡啉，聚羧酸酯 ’煙基聚羧酸酯，烷基羥基羧酸，胺基羥基琥珀酸，羧基 胺’聚環氧琥珀酸，修飾的聚環氧琥珀酸，單膦酸，二 酸’膦酸基羧酸，羥基膦酸基羧酸，胺基膦酸，膦酸基 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 11 542858 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明（8 ) 基胺氧化物’聚合的胺氧化物’聚峻聚胺基亞曱基鱗酸g旨 ，聚醚聚胺基-亞甲基鱗酸酯N-氧化物，亞胺基亞甲基鱗 酸，肌胺酸之長鏈脂肪酸衍生物；調聚的，共調聚的，聚 合的或共聚合的含碳羧酸酯，鹼金屬矽酸鹽，單氣填酸鹽 ’胺’ 一胺’烧醇胺胺’脂肪胺和二胺，四級化胺， 氧烷基化胺，烷基吡啶，四唑，咪唑啉和取代的味0坐,林， 酸胺胺’聚胺’聚伸烧基聚胺’苯續酸之院基衍生物，苯 酸鹽和取代的苯酸鹽，胺基苯酸鹽，水揚酸鹽，二聚酸_ 三聚酸，石油氧化物，硼葡萄糖酸鹽；木質素，木質石黃酸 鹽’鞣酸，直鏈C5-Cn單魏酸酷和C4-C15 α，ω-二叛酸g旨； 羧酸和氫硫基羧酸之胺鹽，胺基酸，聚胺基酸，羥基醚酸 和相關的内酯化合物，N-醯基亞胺基二乙酸；三以喷二_ 和三-魏酸，織·和填酸酯類；及單氟鱗酸鹽；它們的水溶 性鹽，及它們的混合物。 此外’如上面的說明，當本發明與其他化合物合併使 用時也提供有利的結果，如揭示於登記於1 998年8月19日 的第09/136,884號，登記於1999年5月3日的第09/303,596 號，登記於1999年5月3日的第09/304，181號，和登記於1999 年5月12曰的第09/309,564號等美國專利申請案件的化合 物，這些揭示内容在此加入作為參考資料。 可以與四唑鏘化合物合併，協同地提供改良的腐蝕保 護的化合物的實施例包括：無機磷酸鹽，如正磷酸鹽或聚 石粦酸鹽，硼酸鹽，亞硝酸鹽，和在水中釋放金屬陰離子的 化合物，其中該金屬陰離子係擇自由鉬酸根，鎢酸根，飢 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） -------- I--l·--I β — II--I I I I I π (請先閱讀背面之注意事項再填寫本頁) 12 542858 Α7 Β7 經濟部智慧財產局員工消費合作社印製 五、發明說明（9 ) 酸根’偏鈒酸根，鉻酸根所組成之族者或其混合物。 無機碟酸鹽可包括正碟酸鹽，聚碟酸鹽，其水溶性鹽 和其混合物，如正磷酸和焦磷酸之混合物或其水溶性鹽， 如其納鹽和鉀鹽。 蝴酸鹽可包含各種不同的硼酸鹽，如擇自四硼酸鹽， 偏硼酸鹽，及/或正硼酸鹽，如四硼酸鈉或四硼酸鈉水合 物的水溶性硼酸鹽。 _ 硝酸鹽可包括亞琐酸鹽，如亞硝酸鈉。 可以與四唾鏘化合物合併的附加物料包括聚丙烯酸或 聚順·丁烯二酸，如揭示於上面說明的登記於丨999年5月3 曰的美國申請案件第〇9/304·1 81號者。特別佳的聚丙烯酸 和聚順-丁婦二酸的分子量為大約8,〇〇〇或更少。 可以與四°坐鐵化合物合併的附加物料包括聚羧酸酯。 這些聚羧酸酯可以是簡單的脂肪化合物，脂肪鍵含有在4 個和大約20個之間的碳原子，該脂肪鏈以羧基基團多取代 _ (如CVCy α，ω—二羧酸酯或如化合物12,3，^ 丁烷四羧酸） 或其水溶性鹽或可以是聚合的化合物。聚合的聚羧酸酯可 以是含有羧基基團的乙烯不飽和單體的均聚物或共聚物( 包括二I物’四聚合物等）。這些聚致酸醋可包含一個得 自二個或更多個不同的乙烯不飽和單體聚合反應的共聚物 ，各單體含有一個或更多個羧基基團。這種聚合聚羧酸酯 的實施例包括聚丙烯酸，聚順-丁烯二酸，和聚順-丁烯二 酸酐，及其水溶性鹽。另外，聚羧酸酯可以是烴基聚羧酸 酯，如揭示於美國專利案件第4,957,704號者，在此加入 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） -------------裝-----：----訂---------線 (請先閱讀背面之注意事項再填寫本頁) 13 經濟部智慧財產局員工消費合作社印製 542858 A7 ___ B7 五、發明說明（10) 作為參考資料。 可以與本發明四唑鏘化合物合併的附加物料包括具有 下面化學式的烷基羥基羧酸或這種烷基羥基羧酸的混合物： HOOC_(RB 1 )a_(RB2)b-(RB3)c-RB4 其中a，b，和c為0到6的整數，（a+b+c)>0，其中rb1，rB2 ，Rb3包含〇〇或CYZ，其中Y和Z分別擇自基團Η，OH， CHO，COOH，CH3，CH2(OH)，CH(OH)2，CH2(COOH)， CH(OH)CO〇H，CH2(CHO)和CH(OH)CHO，其選擇要使當 該分子寫為完全水合物的形式時，它最少有一個〇H基團 ，及Rw為Η或COOH，包括這些酸各種不同的立體異構物 和化學相當的環狀，脫水，和水合物形態，及在水中形成 上面化合物的可水解的酯類和縮醛，或這種烷基羥基羧酸 的水溶性鹽。這種羥基羧酸的實施例包括酒石酸，中酒石 酸，檸檬酸，葡萄糖酸，葡萄糖庚糖酸，丙酮二酸和糖質 酸，及其水溶性鹽。 可以與四唑鏘化合物合併的附加物料包括胺基羥基琥 拍酸化合物（或這種胺基羥基琥珀酸化合物的混合物），如 揭示於美國專利案件第5，183,590號者，在此加入作為參 考資料。適合的胺基羥基琥珀酸包括擇自由下面化學通式 化合物所組成之族者： |^C!This is the beauty printed by the employees ’cooperatives of the Intellectual Property Bureau of the Ministry of Economics. The third is to choose free lower-level courtyards, branched lower-level courtyards, and substituted aryl groups. People of soil composition, but must not have R |, ~ or ~ that do not contain more than 14 carbon atoms; and η is ..., if desired, this tetrasialyl compound optionally contains the accompanying water-soluble ion species to Get a neutral charge. The present aqueous phase system T includes at least one other aqueous phase system, which processes the materials one by one so that the materials do not substantially reduce the tetrazolium compound. This material can be added together or separately with the tetrazolium compound. Other water-phase system processing materials are composed of the following compounds ~ Talents · Inorganic phosphate, borate, nitrite, compounds that release metal anions in water, 2,3-dihydroxybenzoic acid, ι, ι〇 -Phenanthroline, polycarboxylates 'nicotinic polycarboxylates, alkyl hydroxycarboxylic acids, aminohydroxysuccinic acids, carboxyamines' polyepoxysuccinic acids, modified polyepoxysuccinic acids, monophosphonic acids, di Acid 'phosphonic acid carboxylic acid, hydroxyphosphonic acid carboxylic acid, aminophosphonic acid, basic phosphonic acid paper standard applicable to China National Standard (CNS) A4 (210 X 297 mm) 11 542858 A7 B7 Intellectual Property Bureau Printed by the staff consumer cooperative V. Description of the invention (8) Polyamine polyamine-methylene phosphonate N- Oxides, iminomethylene linoleic acid, long-chain fatty acid derivatives of sarcosinic acid; telomerized, co-telomerized, polymerized or copolymerized carbon-containing carboxylic acid esters, alkali metal silicates, mono Gas-filled salt 'amine' Monoamine 'Alcoholamine' Fatty and diamines, quaternary amines, oxyalkyl groups Amines, alkylpyridines, tetrazoles, imidazolines and substituted odorants, lin, acid amines, 'polyamines', polyalkylene polyamines, benzoic acid derivatives, benzoates and substituted benzenes Acid salt, amine benzoate salt, salicylate salt, dimer acid_trimer acid, petroleum oxide, borate gluconate; lignin, lignin xanthanate, tannic acid, linear C5-Cn mono-Wei Acid acid and C4-C15 α, ω-diamino acid g; amine salts of carboxylic and hydrothiocarboxylic acids, amino acids, polyamino acids, hydroxy ether acids and related lactone compounds, N-fluorene Diimino diacetic acid; tri- and di-weilic acid, weaving, and filling esters; and monofluorophosphoric acid salts; their water-soluble salts, and mixtures thereof. In addition, 'as explained above, the present invention also provides favorable results when used in combination with other compounds, such as disclosed in No. 09 / 136,884, registered on August 19, 1998, and registered on May 3, 1999. Compounds registered in U.S. Patent Application No. 09 / 303,596, No. 09 / 304,181 on May 3, 1999, and No. 09 / 309,564, dated May 12, 1999. These disclosures are in This is added as a reference. Examples of compounds that can be combined with tetrazolium compounds to provide improved corrosion protection synergistically include: inorganic phosphates, such as orthophosphate or polycarboxylate, borate, nitrite, and release of metal anions in water Compounds, in which the metal anion is selected from free molybdate, tungstate, and paper sizes. Applicable to China National Standard (CNS) A4 (210 X 297). -------- I--l ·- -I β — II--IIIII π (Please read the precautions on the back before filling out this page) 12 542858 Α7 Β7 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economy A family or mixture of acid radicals. The inorganic dish salt may include ortho dish, poly dish salt, a water-soluble salt thereof, and a mixture thereof, such as a mixture of orthophosphoric acid and pyrophosphate, or a water-soluble salt thereof, such as a sodium salt and a potassium salt thereof. Phenates can include various borate salts, such as water-soluble borate salts selected from tetraborate, metaborate, and / or orthoborate, such as sodium tetraborate or sodium tetraborate hydrate. _ Nitrate can include phosphonates, such as sodium nitrite. Additional materials that can be combined with tetrasialyl compounds include polyacrylic acid or polycis-butenedioic acid, as disclosed in the above-mentioned U.S. Application No. 09/304 · 1 81, May 3, 999 By. Particularly preferred polyacrylic acid and polymaleic acid have a molecular weight of about 8,000 or less. Additional materials that can be combined with the four degree iron compound include polycarboxylates. These polycarboxylic acid esters can be simple fatty compounds with fatty bonds containing between 4 and about 20 carbon atoms. The fatty chains are more substituted with carboxyl groups (such as CVCy α, ω-dicarboxylic acid esters or Such as compound 12,3, butane tetracarboxylic acid) or a water-soluble salt thereof or may be a polymerized compound. The polymerized polycarboxylic acid ester may be a homopolymer or a copolymer (including a dimer, a tetramer, etc.) of an ethylenically unsaturated monomer containing a carboxyl group. These polyacids may comprise a copolymer derived from the polymerization of two or more different ethylenically unsaturated monomers, each monomer containing one or more carboxyl groups. Examples of such polymerized polycarboxylic acid esters include polyacrylic acid, polymaleic acid, and polymaleic anhydride, and water-soluble salts thereof. In addition, the polycarboxylic acid ester may be a hydrocarbon-based polycarboxylic acid ester, such as disclosed in US Patent Case No. 4,957,704, which is added to this paper standard applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 public love) --- ---------- Install -----: ---- Order --------- line (Please read the precautions on the back before filling this page) 13 Intellectual Property of the Ministry of Economic Affairs Printed by the Bureau's Consumer Cooperatives 542858 A7 ___ B7 V. Description of Invention (10) is for reference. Additional materials that can be combined with the tetrazolium compound of the present invention include an alkylhydroxycarboxylic acid having the following chemical formula or a mixture of such alkylhydroxycarboxylic acids: HOOC_ (RB 1) a_ (RB2) b- (RB3) c-RB4 Where a, b, and c are integers from 0 to 6, (a + b + c) > 0, where rb1, rB2, Rb3 contains 〇〇 or CYZ, where Y and Z are selected from the groups Η, OH, respectively, CHO, COOH, CH3, CH2 (OH), CH (OH) 2, CH2 (COOH), CH (OH) COOH, CH2 (CHO), and CH (OH) CHO are selected so that when the molecule is written as When fully hydrated, it has at least one OH group, and Rw is fluorene or COOH, including various stereoisomers of these acids and chemically equivalent cyclic, dehydrated, and hydrated forms, and in water Hydrolysable esters and acetals of the above compounds are formed, or water-soluble salts of such alkylhydroxycarboxylic acids. Examples of such hydroxycarboxylic acids include tartaric acid, middle tartaric acid, citric acid, gluconic acid, glucoheptonic acid, pyruvate, and glyconic acid, and water-soluble salts thereof. Additional materials that can be combined with tetrazolium compounds include aminohydroxysuccinic acid compounds (or mixtures of such aminohydroxysuccinic compounds), as disclosed in U.S. Patent Case No. 5,183,590, incorporated herein by reference data. Suitable aminohydroxysuccinic acids include those selected from the group consisting of compounds of the general chemical formula: | ^ C!

RC2~N h〇/^co2h 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） -------L---1------- •--N請先閱讀背面之注意事項再填寫本頁} 訂---------· 14 542858 A7 B7 五、發明說明（11 其中RC1為Η或，任擇地以_〇H，-c〇2H，-S03H或笨基取 代的(^至匸4烷基，任擇地以-OH4-C〇2H取代的匕至匕環 烷基或苯基，及RC2為H，任擇地以_〇H4-C〇2H (特別是 包括-CH(C〇2H)CH(OH)(C〇2H)部份者）取代的Cl至c6烷基 ;及 ^C2RC2 ~ N h〇 / ^ co2h This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) ------- L --- 1 ------- • --N Please read the notes on the back before filling out this page} Order --------- · 14 542858 A7 B7 V. Description of the invention (11 where RC1 is Η or, optionally _〇H, -c〇 2H, -S03H or benzyl substituted (^ to 匸 4 alkyl, optionally substituted with -OH4-CO2H to d-cycloalkyl or phenyl, and RC2 is H, optionally with- H4-C〇2H (especially those including -CH (C〇2H) CH (OH) (C〇2H) moiety) substituted Cl to c6 alkyl; and ^ C2

H02CH02C

VV

^C2 I _ Zc-N C02H^ C2 I _ Zc-N C02H

HO〆 \〇HHO〆 \ 〇H

HO C02H 其中Rq為如上述者，及Zc係擇自由下面基團所組成之族 者：i)(CH2)k-其中 k是一個 2至 10的整數，ii)-(CH2)2-Xc-(CH2)2-其中 Xc為 _〇_，-S-，-NRcr 其中 rC3係擇自由 Η，Ci 至c：6烧基，羥基院基，羧基烧基，醯基， 成之族者’其中RC4係擇自由匕至匕烷基或苯甲基所組成 之族者，和下面化學通式的殘基： 裝-----=---^訂---------線 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製HO C02H where Rq is as described above, and Zc is a group consisting of the following groups: i) (CH2) k- where k is an integer from 2 to 10, ii)-(CH2) 2-Xc- (CH2) 2-where Xc is _〇_, -S-, -NRcr where rC3 is selected from free fluorene, Ci to c: 6 alkynyl, hydroxyalkyl, carboxyl alkynyl, fluorenyl, adult group 'where RC4 is selected from the group consisting of free alkyl to benzyl or benzyl, and residues of the following general chemical formula: ----- = --- ^ Order --------- line (Please read the notes on the back before filling out this page) Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs

其中R(：2為如上述者， iii)含下面化學通式的殘基： 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 15 542858Where R (: 2 is as above, iii) residues with the following general chemical formula: This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 15 542858

五、發明說明（12) 經濟部智慧財產局員工消費合作社印製 (CH2) — 其中Y為H’ Cl至C6烷基，烷氧基，鹵基，-CO，H，-S〇3H ’ m係獨立地為0或卜及p為1或2 ’及 (iv)含下面化學通式的殘基： (CH2)q/Q)S 一 (CRC5Rc6)t —、 (CH2)r^(CRc5RC6)t一 /、中Rc>rC6係獨立地為烧基，〇為9或^至^ 烷基，s為0, 1或2，喺獨立地為〇, 卜 2或3，及r為1或2或其水溶性鹽。這種胺基羥基琥珀酸化 口物較佳的貫施例包括亞胺基二（2_羥基琥珀酸），N，N，-雙 (2-羥基琥珀基}-1，6-己烷二胺，和n，n、雙（2_羥基琥珀基）_ 間-伸二甲笨二胺或其水溶性鹽。較佳的是使用正磷酸或 其水溶性鹽與至少一個胺基羥基琥珀酸的混合物。 可以與四唑鏘化合物合併的附加物料包括羧基胺化合 物’該化合為羧基化劑，如環氧琥珀酸，與包含多重氮原 子的胺’如聚乙烯聚胺，之反應產物，如揭示於國際專利 申請案件W0 96/33953者，在此加入作為參考資料。 可以與四化合物合併的附加物料包括下面化學通式的 聚環氧琥珀酸（此後稱之為PESAs): 本紙張尺度適用中國國家標準（cns)A4規格（210 X 297公釐） 16 -----：----1------- (請先閱讀背面之注意事項再填寫本頁) 一石、·1111111 542858 A7 五、發明說明（η)V. Description of the invention (12) Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs (CH2) — where Y is H'Cl to C6 alkyl, alkoxy, halo, -CO, H, -S〇3H 'm Are independently 0 or B and p is 1 or 2 'and (iv) residues containing the following general formula: (CH2) q / Q) S-(CRC5Rc6) t —, (CH2) r ^ (CRc5RC6) t- /, Rc > rC6 is independently alkynyl, 0 is 9 or ^ to ^ alkyl, s is 0, 1 or 2, 〇 is independently 0, bu 2 or 3, and r is 1 or 2 Or a water-soluble salt thereof. Preferred examples of such aminohydroxysuccinates include iminobis (2-hydroxysuccinic acid), N, N, -bis (2-hydroxysuccinyl) -1,6-hexanediamine , And n, n, bis (2-hydroxysuccinyl) _- m-dimethylbenzidinediamine or a water-soluble salt thereof. It is preferable to use a mixture of orthophosphoric acid or a water-soluble salt thereof with at least one aminohydroxysuccinic acid. Additional materials that can be combined with the tetrazolium compound include carboxyamine compounds 'which are combined into carboxylating agents, such as epoxysuccinic acid, and amines containing multiple nitrogen atoms,' such as polyethylene polyamines, as disclosed in International patent application case WO 96/33953 is hereby incorporated by reference. Additional materials that can be combined with the four compounds include polyepoxysuccinic acids of the following general formula (hereafter referred to as PESAs): This paper standard applies to China Standard (cns) A4 specification (210 X 297 mm) 16 -----: ---- 1 ------- (Please read the notes on the back before filling this page) One stone, · 1111111 542858 A7 V. Description of the invention (η)

HOHO

Rt c -Rt c-

Rt c-Rt c-

•H mto2c co2mt 其中1的範圍自大約2至大約50，較佳地2至25 ; MT為氫或 一個水溶性陽離子，如Na+，NH4+或K+，及RT為氫，CV4烧 基或取代的c“4烷基（較佳地1為氫）。較佳地Rt為氫，及: 的範圍自大約2至大約1 〇或自大約4至大約7。使用PESA5 於處理水相系統的方法已經揭示於美國專利案件第 5,062,962號和5,344,590號，各在此加入作為參考資料。 使用正墙酸鹽，聚環氧琥珀酸，丙烯酸/烯丙基羥基丙基 磺酸聚合物，和唑類組合作為腐蝕抑制方法已經被揭示於 美國專利案件第5,256，332號，在此加入作為參考資料。 車父佳的混合物包括正碟酸及/或其水溶性鹽和聚環氧琥珀 酸的混合物。 下面化學通式的修飾的聚環氧琥珀酸也可能有效的與 本發明化合物四唾鏘合併： ------------------：----訂---------線 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製• H mto2c co2mt where 1 ranges from about 2 to about 50, preferably 2 to 25; MT is hydrogen or a water-soluble cation, such as Na +, NH4 + or K +, and RT is hydrogen, CV4 alkyl or substituted c "4-alkyl (preferably 1 is hydrogen). Preferably Rt is hydrogen, and: ranges from about 2 to about 10 or from about 4 to about 7. Methods for treating aqueous phase systems using PESA5 have been disclosed In U.S. Patent Nos. 5,062,962 and 5,344,590, each of which is incorporated herein by reference. Orthowall acid salt, polyepoxysuccinic acid, acrylic / allylhydroxypropylsulfonic acid polymer, and azole combination are used as corrosion Inhibition methods have been disclosed in U.S. Patent Case No. 5,256,332, which is hereby incorporated by reference. The mixture of Chevron includes a mixture of orthoic acid and / or its water-soluble salt and polyepoxysuccinic acid. The modified polyepoxysuccinic acid of the formula may also be effectively combined with the compound tetrasialyl of the present invention: ------------------: ---- order ---- ----- line (Please read the notes on the back before filling out this page) Employees ’Cooperatives, Intellectual Property Bureau, Ministry of Economic Affairs System

Zd-Zd-

lD2 R c D3 C-〇-j-h mdo2c co2md 其中Rdi ’當有存在’為H，取代的或未取代的烷基或芳 基部份’其碳鏈高達失去水相溶液溶解度的長度或乙稀不 飽和化合物聚合反應後得到的重複單元；RD2和RD3，各獨 本紙張尺度適用中國國家標準（CNS)A4規格（2〗0 X 297公爱） 17 經濟部智慧財產局員工消費合作社印製 542858 A7 ^___ _BT^ 五、發明說明（I4) 自立地為H，ci至C4烷基或取代的（^至匕烷基；20為0，S ，NH或NRD1，其中rdi為如上面說明者，u是一個大於1的 正整數；f是一個正的整數；及MD為Η，水溶性陽離子（如 ΝΗ4+ ’驗金屬）或未取代的1至3個碳原子較低級烷基基團 ’（當RD1不存在，ZD可以是md03S，其中MD為如上面說明 者）°使用這種化合物的方法已經被揭示於美國專利案件 第5,871，691號和5,489,666號，在此加入作為參考資料。 這種修飾的聚環氧琥珀酸的實施例包括如上面化學式的衍 生物’其中RD1為間-CH2_C6ivCH2-(間-伸二甲苯），心為· NH-，和RD3二者都是H，f為2，及]^為他或Η。實際 實施例通常是範圍為u的個別分子的混合物，此後稱之為 間-伸二甲苯二胺/PESA衍生物。 可以與四唑鐵化合物合併的附加化合物包括2,3-二羥 基苯酸和1，1 〇-啡σ林。 可以與四°坐鏺化合物合併的附加化合物包括下面化學 通式的單膦酸：lD2 R c D3 C-〇-jh mdo2c co2md where Rdi is' when present 'is H, a substituted or unsubstituted alkyl or aryl moiety' whose carbon chain is as long as it loses the solubility of the aqueous solution or ethene Repeated units obtained after polymerization of saturated compounds; RD2 and RD3, each unique paper size applies Chinese National Standard (CNS) A4 specifications (2〗 0 X 297 public love) 17 Printed by the Intellectual Property Bureau of the Ministry of Economic Affairs and Consumer Cooperatives 542858 A7 ^ ___ _BT ^ V. Description of the invention (I4) is independently H, ci to C4 alkyl or substituted (^ to alkyl; 20 is 0, S, NH or NRD1, where rdi is as described above, u Is a positive integer greater than 1; f is a positive integer; and MD is Η, a water-soluble cation (such as NΗ4 + 'metal test) or an unsubstituted lower alkyl group of 1 to 3 carbon atoms' (when RD1 does not exist, ZD can be md03S, where MD is as described above) ° The method of using this compound has been disclosed in US Patent Case Nos. 5,871,691 and 5,489,666, which are incorporated herein by reference. Examples of polyepoxysuccinic acids include Derivatives of the formula 'where RD1 is m-CH2_C6ivCH2- (m-xylene), the heart is · NH-, and both RD3 are H, f is 2, and] ^ is he or Η. Actual examples are usually Is a mixture of individual molecules in the range u, hereafter referred to as m-xylene diamine / PESA derivatives. Additional compounds that can be combined with tetrazolium iron compounds include 2,3-dihydroxybenzoic acid and 1,10- B. sigma. Additional compounds that can be combined with the four-degree sitting compound include monophosphonic acids of the following general formula:

p f/0Hp f / 0H

Rf—P、0H 其中rf是一個c^c!2直鏈或支鏈烷基殘基，C2至Ci2直鏈 或支鏈烴烯基殘基，q至C12環烷基殘基，匕至匕。芳基殘 基或（^至C!2芳烷基殘基，其中RF可另外獨立地以擇自羥 基’胺基或i基的基團單一或多重取代；該二膦酸化合物 的化學通式為： 本紙張尺度適用中國國家標準（CNS)A4規格（210 x 297公釐） -----I ——— (請先閱讀背面之注意事項再填寫本頁) 訂---------. 18 542858 A7 B7 五、發明說明（15) H0, 0 〇Rf—P, 0H where rf is a c ^ c! 2 straight or branched chain alkyl residue, C2 to Ci2 straight or branched chain alkenyl residue, q to C12 cycloalkyl residue, d to d . Aryl residues or (^ to C! 2 aralkyl residues, where RF may additionally be independently single or multiple substituted with a group selected from a hydroxyl 'amine or i group; the general chemical formula of the diphosphonic acid compound For: This paper size applies Chinese National Standard (CNS) A4 specification (210 x 297 mm) ----- I ——— (Please read the precautions on the back before filling this page) Order ------ ---. 18 542858 A7 B7 V. Description of the invention (15) H0, 0 〇

0H0H

•P HO〆• P HO〆

、0H 其中RK是一個(：1至（：12直鏈或支鏈伸烷基殘基，（：2至(：：1，直 鏈或支鏈伸烯基殘基，〇5至<:12伸環烷基殘基，（：6至(：：1〇伸 芳基殘基或(1：7至C〗2伸芳烧基殘基，其中可另外獨立地 以擇自經基，胺基或_基的基團單一或多重取代，或其水 溶性鹽。一個這種二膦酸較佳的實施例為丨_羥基乙烷 二膦酸（HEDP)或其水溶性鹽。 可以與四唑鏘化合物合併的附加物料包括膦酸基羧酸 (或這種膦酸基魏酸的混合物），如揭示於美國專利案件第 及 經濟部智慧財產局員工消費合作社印製 3,886,204s虎 ’ 3,886,205 號 ’ 3,923,876 號，3,933,427 號， 4,020，101號和4,246，103號者，所有都在此加入作為參考 資料。較佳的是以下面化學通式定義之膦酸基羧酸： 0 Rhi I H0\ll \p- / —C-COOH I HO 1 CH2— COOH 0 H H0, H0/, 0H where RK is a (: 1 to (: 12 straight or branched chain alkylene residue, (: 2 to (:: 1, straight or branched chain alkylene residue, 05 to <: 12 cycloalkyl residues, (: 6 to (:: 10) aryl residues or (1: 7 to C) 2 arylene residues, which may additionally independently A single or multiple substitution of a radical or a radical, or a water-soluble salt thereof. A preferred embodiment of such a diphosphonic acid is _hydroxyethanediphosphonic acid (HEDP) or a water-soluble salt thereof. The additional materials incorporated in the oxazonium compound include a phosphonic acid (or a mixture of such phosphonic acid), as disclosed in U.S. Patent Case No. 3 and the Intellectual Property Office of the Department of Economics and Consumer Cooperatives, Tiger's No. 3,886,205 'Nos. 3,923,876, 3,933,427, 4,020,101 and 4,246,103, all of which are hereby incorporated by reference. Preferred phosphonate carboxylic acids defined by the following general formula: 0 Rhi I H0 \ ll \ p- / —C-COOH I HO 1 CH2— COOH 0 H H0, H0 /

——X—C ——COOH CHr—COOH 其中RH!為H ’ 1至4個碳原子的烧基，烴稀基或炔基 基，環烷基或芳烷基或擇自下面化學式的基團者： 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） ----------^---------^ (請先閱讀背面之注意事項再填寫本頁) 19 542858 A7 B7 五、發明說明（16) RH2 CH-CH5COOH 及 _ CH-——X—C ——COOH CHr—COOH where RH! Is an alkyl group of H ′ 1 to 4 carbon atoms, a dilute hydrocarbon group or an alkynyl group, a cycloalkyl group or an aralkyl group or a group selected from the following chemical formula By: This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ---------- ^ --------- ^ (Please read the notes on the back first (Fill in this page again) 19 542858 A7 B7 V. Description of the invention (16) RH2 CH-CH5COOH and _ CH-

CH——COOH 其中RH2為H，1至4個碳原子的烷基或羧基；及XH係擇自 下面化學式的基團者：CH——COOH where RH2 is H, an alkyl or carboxyl group of 1 to 4 carbon atoms; and XH is selected from the group of the following formula:

COOHCOOH

COOHCOOH

COOH 一CH—' -CH- •c—，及 c- ch3 ch3 其中·Ρ〇3Η2基團為下面的膦酸基基團?/0Η—ρ\ \〇Η 或其水溶性鹽。一個這種較佳的膦酸基羧酸的實施例為3_ 膦酸基丁烷·1，2,4-三羧酸或其水溶性鹽。 可以與四。坐鏘化合物合併的附加物料包括羥基膦酸基 叛酸（或這種羥基膦酸基羧基化合物的混合物），如揭示於 美國專利案件第4,689,200號和4,847,017號者，二者在此 都加入作為參考資料。適合的羥基膦酸基羧酸包括含下面 化學通式者： -----J----L-------：----訂---------· (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 Η0, ΗΟ〆 0 Re -C-XrCOOH—CH —'- CH— • c—, and c—ch3 ch3 where the · P03Η2 group is the following phosphonic acid group? / 0Η—ρ \ \ 〇Η or its water-soluble salt. An example of such a preferred phosphonic carboxylic acid is 3-phosphonic butane · 1,2,4-tricarboxylic acid or a water-soluble salt thereof. Can be with four. The additional materials incorporated in the perylene compound include hydroxyphosphonic acid (or a mixture of such hydroxyphosphonic acid carboxyl compounds), such as those disclosed in US Patent Nos. 4,689,200 and 4,847,017, both of which are incorporated herein by reference data. Suitable hydroxyphosphonocarboxylic acids include those containing the following general formula: ----- J ---- L -------: ---- Order --------- · (Please read the notes on the back before filling out this page) Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Η0, ΗΟ〆0 Re -C-Xr

-COOH-COOH

OH 其中RE為H’ Ci至C!2直鏈或支鏈烷基殘基，（：2至(：】2直鏈 或支鏈烴烯基殘基，^至匕2環烷基殘基，C0sCiq芳基殘 基或C?至C12芳烷基殘基，XE是一個任擇的基團，當有存OH where RE is H 'Ci to C! 2 linear or branched alkyl residues, (: 2 to (:) 2 straight or branched chain alkenyl residues, ^ to 2 cycloalkyl residues C0sCiq aryl residue or C? To C12 aralkyl residue, XE is an optional group, when there is

542858 A7 B7 五、發明說明（17) 在，是一個(^至(21()直鏈或支鏈伸烷基殘基，C2sc1()直鏈 或支鏈伸烯基殘基或c6至C1G伸芳基殘基或其水溶性鹽。 一個這種羥基膦酸基羧酸較佳的實施例為2_羥基-膦酸基 乙酸或其水溶性鹽。 可以與四唑鏘化合物合併的附加物料包括胺基膦酸如 揭示於美國專利案件第3,619,427號，3,723·347號， 3,816,333 號，4,029,696 號，4,033,896 號，4,079,006 號， 4，163,733 號 ’ 4,307,038 號，4,308，147 號和 4,617，129 號者 ’所有都在此加入作為參考資料。適合的胺基膦酸包括含 下面化學通式者： \ ϊ/0Η542858 A7 B7 V. Description of the invention (17) is a (^ to (21 () straight or branched alkylene residue, C2sc1 () straight or branched alkylene residue or c6 to C1G extension An aryl residue or a water-soluble salt thereof. A preferred example of such a hydroxyphosphonic acid is 2-hydroxy-phosphonic acid or a water-soluble salt thereof. Additional materials that can be combined with the tetrazolium compound include Aminophosphonic acids are disclosed in U.S. Patent Nos. 3,619,427, 3,723.347, 3,816,333, 4,029,696, 4,033,896, 4,079,006, 4,163,733 '4,307,038, 4,308,147, and 4,617,129' All are added here for reference. Suitable aminophosphonic acids include those containing the following general formula: \ ϊ / 0Η

<4 OH 其中Rq是含大約一個至大約四個碳原子的較低級伸烷基 ，或胺，羥基或鹵基取代的較低級伸烷基；為RQ_p〇3H2 ，η，OH，胺基，取代的胺基或心為如前面定義者； 為Rgs或以下面化學通式代表的基團： I---I --I I l· I--^ · I I I---I I (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製< 4 OH where Rq is a lower alkylene group containing about one to about four carbon atoms, or a lower alkylene group substituted with an amine, a hydroxyl group or a halogen group; RQ_p03H2, η, OH, amine Group, substituted amine group or group is as defined above; is Rgs or a group represented by the following chemical formula: I --- I --II l · I-^ · II I --- II (Please (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs

其中RG5和RG6係各自獨立地擇自H，0H，胺基，取代的胺 基或如前面定義之Rf ;、為RG5，RG6或基團RG2-p〇3H2， 本紙張尺度適用中國國豕4示準（CNS)A4規格（210 χ 297公爱） ..... ^ - 21 - 542858 五、 發明說明（I8) 而…為如前面定義纟；V是一個i至大約15的整數；及 w疋一船到大約14的整數或其水溶性鹽。-個這種胺基 膦3夂的’、〜例為二乙三胺五（亞甲基膦酸）或其水溶性鹽。 可以與四。坐鏘化合物合併的附加物料包括水溶性鹏酸 基甲基胺氧化物(或這種水溶性膦酸基甲基胺氧化物的混 合物）如揭示於美國專利案件第5,〇51，532號，5娜別號 ’和5’167,866號者’所有都在此加入作為參考資料。適 合的膦酸基甲基胺氧化物包括含下面化學通式者·· Rai \2 —CF^POjH^ 經濟部智慧財產局員工消費合作社印製 其中RA1係擇自由烴基，和羥基取代的，烷氧基取代的， 羧基取代的和磺醯基取代的烴基所組成之族者；及係 擇自由烴基，和羥基取代的，烷氧基取代的，羧基取代的 和磺醯基取代的烴基，-CH2p〇3H2，及 0 ▲ —N ( C^P〇3^) 2 ； 所組成之族者，或ra !和Rm共同形成一個環上含3至5個碳 原子的脂肪環或該膦酸基甲基胺氧化物的水溶性鹽。烴基 包括不使胺氧化物非水溶性的烷基，芳基，和烷芳基基團 。一個這種膦酸基甲基胺氧化物較佳的實施例為Ν,Ν—雙_ 膦酸基甲基乙醇胺N-氧化物，此後稱之為EBO或其水溶性 5^ 〇Among them, RG5 and RG6 are independently selected from H, 0H, amine, substituted amine or Rf as defined above; RG5, RG6 or group RG2-p03H2, this paper standard applies to China National Standard 4 Specification (CNS) A4 (210 χ 297 public love) ..... ^-21-542858 V. Description of the invention (I8) And ... is as defined above; V is an integer from i to about 15; and w疋 One boat to an integer of about 14 or its water-soluble salt. An example of such an amine phosphine 3 夂 is diethylenetriaminepenta (methylenephosphonic acid) or a water-soluble salt thereof. Can be with four. The additional materials combined with the perylene compound include a water-soluble pentoic acid methylamine oxide (or a mixture of such water-soluble phosphonomethylamine oxides) as disclosed in U.S. Patent No. 5,051,532, All 5 Nabe 'and 5'167,866' are included here for reference. Suitable phosphonomethylamine oxides include those containing the following general formula: Rai \ 2 —CF ^ POjH ^ Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, where RA1 is a free hydrocarbon group, and a hydroxy-substituted, alkane A group consisting of oxy-substituted, carboxy-substituted and sulfofluorenyl-substituted hydrocarbon groups; and selected from free hydrocarbon groups, and hydroxy-substituted, alkoxy-substituted, carboxy-substituted and sulfonyl-substituted hydrocarbon groups,- CH2p〇3H2, and 0 ▲ —N (C ^ P〇3 ^) 2; the group of members, or ra! And Rm together form an aliphatic ring containing 3 to 5 carbon atoms on the ring or the phosphonic acid group Water-soluble salt of methylamine oxide. Hydrocarbyl groups include alkyl, aryl, and alkaryl groups that do not render the amine oxide water-insoluble. A preferred example of such a phosphonomethylamine oxide is N, N-bis-phosphonomethylethanolamine N-oxide, hereinafter referred to as EBO or its water-soluble 5 ^.

本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） A7 B7This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) A7 B7

542858 五、發明說明（19) 可以與四唑鐵化合物合併的附加物料包括聚合的胺氧 化物，如說明於美國專利案件第5,629,385號者，在此加 入作為參考資料，聚醚聚胺基亞甲基膦酸酯和聚醚聚胺基 亞甲基膦酸酯N·氧化物，如分別說明於美國專利案件第 5,338,477號和5,322,636號者，二者在此加入作為參考資 料，及亞胺基伸烷基膦酸，如說明於美國專利案件第 5,788,857號者，在此加入作為參考資料。 可以與四唑鏘化合物合併的附加物料包括含磷羧酸酯 物料（此後稱為P-羧酸鹽），這些物料為調聚的，共調聚的 ，聚合的或共聚合的化合物，包括至少一個有機磷基團和 多個羧酸酯基團。任擇地，當羧酸鹽得自含有非羧酸酯 取代基的單體，這些物料也可能包括其他取代基基團。磷 可以存在為一個終端基團。在該情況下，它可以是一個膦 酸基或終端型膦基形態的部份或可以加入化合物作為膦基 部份，其中磷直接結合於二個碳原子，這是一種有時候稱 為‘二烷基”膦基部份的組態。這些可能性圖式地顯示下面。 ^----------^---------^ (請先閱讀背面之注意事項再填寫本頁) Y—0—542858 V. Description of the invention (19) Additional materials that can be combined with tetrazolium iron compounds include polymerized amine oxides, such as those described in US Patent No. 5,629,385, which is hereby incorporated by reference, polyether polyaminomethylene Phosphonates and polyether polyaminomethylene phosphonate N · oxides, as described in U.S. Patent Nos. 5,338,477 and 5,322,636, respectively, both of which are incorporated herein by reference, and imine alkylene Phosphonic acid, as described in US Patent No. 5,788,857, is hereby incorporated by reference. Additional materials that can be combined with tetrazolium compounds include phosphorus-containing carboxylic acid ester materials (hereinafter referred to as P-carboxylates) that are telomerized, co-telomerized, polymerized, or copolymerized compounds, including at least One organophosphorus group and multiple carboxylate groups. Alternatively, when the carboxylate is obtained from a monomer containing non-carboxylic acid ester substituents, these materials may also include other substituent groups. Phosphorus may be present as a terminal group. In this case, it can be a phosphonate or terminal phosphine moiety or a compound can be added as a phosphine moiety where the phosphorus is directly bound to two carbon atoms, which is a type sometimes called 'di Configuration of "alkyl" phosphine. These possibilities are shown diagrammatically below. ^ ---------- ^ --------- ^ (Please read the notes on the back first (Fill in this page again) Y—0—

〇 I〇 I

C Η一C Η 一

0 I c ο 經濟部智慧財產局員工消費合作社印製 0 χ 膦酸基0 I c ο Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs 0 χ Phosphonic acid group

XX

0 II-卜 0 I X 終端型膦基 垸基形態膦基 X可以是氫或一個陽離子種系，如鹼金屬離子，銨離 子或四級化胺基團。γ可以與X相同或可另外為一個取 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） 23 經濟部智慧財產局員工消費合作社印製 542858 A7 一·· - 五、發明說明（20) " '' 的或未取代的烧基，芳基或貌芳基殘基，其中的取代物可 能含有或可能不含有缓酸醋。¥必須是要選擇使維持化合 物在水中足夠的溶解度。顯示的破原子是調聚物，共調聚 物’聚合物或共聚物石炭骨架％ 一部份，&骨架含有至少二 個羧基基團，任擇地有其他磷加入物和任擇地有其他非I 基取代物。 P_羧酸鹽的平均分子量數較佳的少於1〇,〇〇〇，特別佳 的是低平均分子量數的募聚的或聚合的h羧酸鹽，如2,000 或更少，特別是1，000或更少。特別佳的是2個或更多個羧 酸酯取代於線形烷基殘基，較優先的是以丨,2气鄰接的）或 1，3-取代物的安排。p-羧酸鹽可能含有磷取代物或主要或 全部為膦酸基種系，主要或全部為終端型膦基種系，主要 或全部為二烧基膦基種系的取代物或含有這些取代形態的 混合物於個別分子上及/或於以特別製備方法產生的分子 的混合物。用於P-羧酸鹽的各種不同製備方法也可能產生 各種不同的無機碟種系作為合成的方法的一部份。當這種 P-魏酸鹽和伴隨的無機礙種系混合物與四唾鏘化合物合併 也被認為是在本發明範圍内。 適合用於本發明的P-羧酸鹽的製備方法及其單獨和與 其他水處理試劑組合在水相系統中作為腐蝕及/或水垢控 制劑之用法非限制的實施例揭示於美國專利案件第 2,957,93 1 號，4,046,707 號，4,088,678 號，4，105,55 1 號， 4,127,483 號，4，159,946 號，4,207,405 號，4,239,648 號， 4,563,284 號，4,621,127 號，4,681，686 號，5,023,000 號， 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 24 ----------Γ — ----l·---訂--------- (請先閱讀背面之注意事項再填寫本頁) 542858 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明（21) 5,073,299 號，5,077,361 號，5,085,794 號，5，160,630 號， 5,216,099 號，5,229,030 號，5,256,302 號，5,256,746 號， 5,294,687 號，5,360,550 號，5,376,731 號，5,386,038 號， 5,409,571 號，5,606,105 號，5,647,995 號，5,681，479 號， 和5,783,728號及歐洲專利案件第283191A2號，360746B1 號，569731A2號，681995A3號，786018A1 號，792890A1 號，807635A1 號，807654A2號，和 861846A2號，所有的0 II-Bu 0 I X Terminal-type phosphinyl phosphonium phosphonium group X can be hydrogen or a cationic species, such as alkali metal ion, ammonium ion or quaternary amine group. γ can be the same as X or it can be another one. This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 public love). 23 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs. 542858 A7. Note (20) " '' unsubstituted or unsubstituted alkyl, aryl or aryl residues, the substitutions of which may or may not contain bitten vinegar. ¥ must be chosen to maintain sufficient solubility of the compound in water. The broken atom shown is a part of the telomer, co-telomer 'polymer or copolymer charcoal skeleton, & the skeleton contains at least two carboxyl groups, optionally with other phosphorus additions and optionally with Other non-I substituents. The average molecular weight of the P_carboxylate is preferably less than 10,000, particularly preferred is the agglomerated or polymerized h carboxylate having a low average molecular weight, such as 2,000 or less, especially 1 10,000 or less. Particularly preferred is the arrangement of 2 or more carboxylic acid esters substituted with linear alkyl residues, more preferably adjacent by 2 or 2 gas) or 1,3-substituents. p-carboxylates may contain phosphorus substituents or are predominantly or entirely phosphonic acid-based species, mainly or wholly terminal phosphine-based species, mainly or wholly di-alkyl phosphine-based species, or contain these substitutions A mixture of morphologies on individual molecules and / or a mixture of molecules produced by a special preparation method. Various preparation methods for P-carboxylates may also produce a variety of inorganic dish species as part of the synthetic method. It is also considered to be within the scope of this invention when this P-weilate and the accompanying inorganic interfering germline mixture is combined with a tetrasialyl compound. A non-limiting example of a method for preparing a P-carboxylate suitable for use in the present invention and its use alone and in combination with other water treatment reagents as a corrosion and / or scale control agent in an aqueous system is disclosed in U.S. Patent Case No. 2,957,93 No. 1, 4,046,707, 4,088,678, 4,105,55 No. 1, 4,127,483, 4,159,946, 4,207,405, 4,239,648, 4,563,284, 4,621,127, 4,681,686, 5,023,000, this paper The scale is applicable to China National Standard (CNS) A4 (210 X 297 mm) 24 ---------- Γ----- l · --- order --------- ( Please read the notes on the back before filling this page) 542858 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (21) 5,073,299, 5,077,361, 5,085,794, 5,160,630, 5,216,099, 5,229,030 No. 5,256,302, 5,256,746, 5,294,687, 5,360,550, 5,376,731, 5,386,038, 5,409,571, 5,606,105, 5,647,995, 5,681,479, and 5,783,728 and European Patent Case No. 283191A2, 360746B1 No. 569731A2, No. 681995A3, No. 786018A1, No. 792890A1, No. 807635A1, No. 807654A2, and No. 861846A2, all

I 在此都加入作為參考資料。檢視這些專利案件中較好的， 有多種製造適用於本發明P-羧酸鹽的製備方法。本發明的 目標不是要限定任何特別製程或方法來製造適用於本發明 的P羧酸酯。一般而言，它們可以用一個含磷物料與一個 或更多個可聚合的單體反應得到，至少其中一個含有羧基 基團或以另外如水解’氧化等等的反應，在最後化合物可 以產生羧基的基團（聚合反應步驟之後），這種單體在此後 稱之為羧基單體。揭示於文獻的方法通常包含將含碟的物 _ 料與一個或更多個不飽和單體反應，至少其中一個為叛基 單體，以產生P羧酸酯寡聚物或聚合物。適合的羧基單體 的實施例包括丙烯酸，順-丁烯二酸，順-丁烯二酸酐，甲 基丙烯酸’分解烏頭酸，巴豆酸，乙烯乙酸，反-丁稀二 酸，檸康酸，甲基-反·丁烯二酸，丙烯腈，甲基丙稀睛， α-亞甲基戊二酸，環己烯二羧酸，順-1，2,3,6-四氫酞酸酐 ’ 3,6·環氧-1，2,3,6·四氫酞酸酐，5 -降冰片烯-2,3-二叛酸 酐，雙環[2·2·2]-5-辛稀-2,3-二叛酸酐，3-曱基_1，2,6_四氫 酞酸酐，及2-曱基1，3,6·四氫酞酸酐。較佳的羧基單體為 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） -----^----^--------- (請先閱讀背面之注意事項再填寫本頁) 25 經濟部智慧財產局員工消費合作社印製 542858 A7 B7 五、發明說明（22) 丙烯酸，順-丁烯二酸，分解烏頭酸，和順-丁烯二酸酐。 雖然較佳的是P-羧酸鹽物料含有一個攜帶羧基團殘基 的主要部份’較佳的可以使用一個共寡聚的或共聚合的P 羧酸酯’該P羧酸酯含有衍生自至少一個羧基單體的殘基 和一個次要部份（少於總產品50重量百分比），得自至少另 一個非羧基單體的單體的殘基。有多種適合的非羧基單體 ’包括’例如2-丙稀酿胺-2_甲基丙烧石黃酸（Lubrizol Corporation以AMPSTMi市出售），2-羥基-3-(2-丙烯氧基) 丙烷磺酸，2-甲基-2-丙烯基-1-磺酸，烯丙基磺酸，烯丙 氧基苯績酸，苯乙稀石黃酸，乙稀石黃酸，烯丙基膦酸，乙稀 膦酸，異丙烯基膦酸，磷乙基甲基丙烯酸酯，丙烯酸或甲 基丙烯酸的羥基烷基和CrC4烷基酯類，丙烯醯胺，烯丙 基取代的丙稀醯胺，稀丙基醇，2-乙稀σ比唆，4-乙烯σ比。定 ，Ν-乙烯吡咯酮，Ν-乙烯甲醯胺，Ν-乙烯咪唑，乙烯乙 酸酯，水解的乙烯乙酸酯，和苯乙烯。 特別包括於Ρ_羧酸鹽類的是下面化學通式的膦聚合物 ?严I have included it here as a reference. Examining these patent cases, it is preferable that there are various methods for preparing P-carboxylates suitable for use in the present invention. The object of the present invention is not to limit any particular process or method for making P carboxylic acid esters suitable for use in the present invention. In general, they can be obtained by reacting a phosphorus-containing material with one or more polymerizable monomers, at least one of which contains a carboxyl group or by another reaction such as hydrolysis' oxidation, etc., and the final compound can generate a carboxyl group. Group (after the polymerization step), this monomer is hereinafter referred to as a carboxyl monomer. The methods disclosed in the literature generally involve reacting a dish-containing material with one or more unsaturated monomers, at least one of which is a tether monomer, to produce a Pcarboxylate oligomer or polymer. Examples of suitable carboxyl monomers include acrylic acid, maleic acid, maleic anhydride, methacrylic acid's decomposed aconitic acid, crotonic acid, ethylene acetate, trans-succinic acid, citraconic acid, Methyl-trans-butenedioic acid, acrylonitrile, methyl acrylic, α-methyleneglutaric acid, cyclohexene dicarboxylic acid, cis-1,2,3,6-tetrahydrophthalic anhydride ' 3,6 · epoxy-1,2,3,6 · tetrahydrophthalic anhydride, 5-norbornene-2,3-dibenzyl anhydride, bicyclo [2 · 2 · 2] -5-octane-2, 3-diamino acid anhydride, 3-fluorenyl1,2,6_tetrahydrophthalic anhydride, and 2-fluorenyl 1,3,6 · tetrahydrophthalic anhydride. The better carboxyl monomer is based on Chinese paper standard (CNS) A4 specification (210 X 297 public love) ----- ^ ---- ^ --------- (Please read first Note on the back, please fill in this page again) 25 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 542858 A7 B7 V. Description of the invention . Although it is preferred that the P-carboxylate material contains a major portion carrying a carboxyl group residue, 'preferably a co-oligomeric or copolymerized P-carboxylic acid ester can be used' which contains The residue of at least one carboxyl monomer and a minor portion (less than 50 weight percent of the total product) are derived from the residue of at least one other non-carboxyl monomer. There are a variety of suitable non-carboxyl monomers 'including', such as 2-propenamine-2_methylpropanesulfuric acid (sold by the Lubrizol Corporation as AMPSTMi), 2-hydroxy-3- (2-propenyloxy) Propanesulfonic acid, 2-methyl-2-propenyl-1-sulfonic acid, allylsulfonic acid, allyloxybenzoic acid, phenethelite, ethionite, allylphosphine Acids, ethylene phosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate, hydroxyalkyl and CrC4 alkyl esters of acrylic or methacrylic acid, allylamine, allyl-substituted allylamine , Dilute propyl alcohol, 2-ethene σ ratio 唆, 4-ethene σ ratio. N-vinylpyrrolidone, N-vinylformamide, N-vinylimidazole, ethylene acetate, hydrolyzed ethylene acetate, and styrene. Particularly included in the P_carboxylates are phosphine polymers of the following general formula:

rj1~pC ΟΧ； 其中乂3為11，鹼金屬原子，鹼土金屬原子或銨或胺殘基； 及R』2是一個下面包含二個不同殘基的共聚物殘基 + CH2CH(RJ2)七 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） ---------------- (請先閱讀背面之注意事項再填寫本頁) 訂---------· 26 542858rj1 ~ pC OX; where 乂 3 is 11, alkali metal atom, alkaline earth metal atom or ammonium or amine residue; and R′2 is a copolymer residue containing two different residues below + CH2CH (RJ2) seven Paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) ---------------- (Please read the precautions on the back before filling this page) Order- ------- · 26 542858

經濟部智慧財產局員工消費合作社印製 五、發明說明（23) 其中z是一個範圍自2至1〇〇的整數，其中第一殘基中的Rj 2 為-COOH，第二殘基中的Rj2 為-CONHC^CHACI^SOaXj， 其中Χ』為如之前定義者。 適合的用於本發明P-羧酸鹽物料非限制的實施例包括 Belsperse 161，Belclene 400，Belclene 494，Belclene 500 ( 所有都是FMC corporation上市產品），膦酸基琥珀酸，和 _ Brieorr 288(Albright and Wilson的一種產品）。Bricorr 288 被說明為一種組成物，基本上由一個高達5〇%重量比的膦 酸基琥ίό酸’以組成物重量計，一個膦酸化鹼金屬順-丁 稀一酸酯二聚物，重量不多於次要部份，以二聚物重量計 ’較高膦酸化順-丁烯二酸酯寡聚物組成；及組成物大約 0.5至大約5%重量比的驗金屬罐酸鹽。 可以與四。坐鏘化合物合併的附加物料包括肌胺酸的長 鏈脂肪酸衍生物（或這種肌胺酸脂肪酸衍生物的混合物）或 其水溶性鹽。一個這種衍生物的實施例是Ν-月桂醯基肌 k 胺酸。 本發明四唾鐳化合物也可能與水溶性驗金屬石夕酸鹽， 如偏矽酸鈉合併。這種矽酸鹽是已知於文獻中當作鐵金屬 和铭腐蝕抑制劑的，二者都是在液體中主要是水的系統以 及以二醇為主的水相系統，這些系統通常用於内燃機引擎 作為防凍冷凍劑。矽酸鈉鹽可用一般的化學式 Na2〇*SiO，yH2〇代表，其中X是在大約1至大約3·5的範圍 。可以使用市面的矽酸鈉溶液，其中的矽對驗的莫耳比是 大約3.3。Si〇2:Na2〇莫耳比低至大約ι:ι的更多鹼溶液或 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 裝-----·_----訂---------線 (請先閱讀背面之注意事項再填寫本頁) 27 542858 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明（24)Printed by the Employees' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs V. Invention Description (23) where z is an integer ranging from 2 to 100, where Rj 2 in the first residue is -COOH, and in the second residue Rj2 is -CONHC ^ CHACI ^ SOaXj, where X ′ is as defined before. Non-limiting examples of suitable P-carboxylate materials for use in the present invention include Belsperse 161, Belclene 400, Belclene 494, Belclene 500 (all of which are marketed by the FMC corporation), phosphonic succinic acid, and Brieorr 288 ( A product of Albright and Wilson). Bricorr 288 is illustrated as a composition consisting essentially of a phosphonic succinic acid of up to 50% by weight, based on the weight of the composition, a phosphonated alkali metal cis-butyric acid dimer, weight Not more than minor parts, a 'higher phosphonated maleic acid oligomer composition by weight of the dimer; and a composition of about 0.5 to about 5% by weight of a metallurgical pot salt. Can be with four. The additional materials combined with the sitting compound include a long-chain fatty acid derivative of sarcosinate (or a mixture of such sarcosinic fatty acid derivatives) or a water-soluble salt thereof. An example of one of these derivatives is N-lauric acid. The tetrasalium compounds of the present invention may also be combined with water-soluble metallolithic acid salts, such as sodium metasilicate. This silicate is known in the literature as an iron metal and corrosion inhibitor, both of which are mainly water systems in liquids and glycol-based water phase systems. These systems are commonly used in The internal combustion engine acts as an antifreeze refrigerant. The sodium silicate can be represented by the general chemical formula Na2 * SiO, yH2O, where X is in the range of about 1 to about 3.5. A commercially available sodium silicate solution can be used, in which the silicon mole ratio is approximately 3.3. Si〇2: Na2〇 More than alkaline solution as low as about ι: ι or this paper size applies Chinese National Standard (CNS) A4 specifications (210 X 297 mm) Packing ----- · _-- --Order --------- line (please read the precautions on the back before filling this page) 27 542858 A7 B7 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs V. Invention Description (24)

Si〇2:Na20莫耳比高達大約3.5:1的更少鹼溶液也可以使用 。其他鹼金屬矽酸鹽，特別是矽酸鉀鹽也可以使用。當使 用水溶性鹼金屬矽酸鹽於本發明實例，合併矽酸鹽與其他 抑制劑及/或矽安定劑可能是有利的。這種適合的組合的 實施例揭示於美國專利案件第3,711,246號，4,085,063號 ，4,404,114號，5，137,657號，5,262,078號，5,578,246號 ，和5,589，106號，所有在此都加入作為參考資料。 本發明四峻纟翁化合物也可與水溶性單碳酸鹽合併。 使用這種鹽作為金屬表面腐蝕抑制劑已經被揭示於美國專 利案件第4，132,572號和4,613,450號，二者在此都加入作 為參考資料。如揭示於美國專利案件第5，182,028號者， 在此加入作為參考資料，這種鹽也有碳酸鈣水垢控制及鐵 和錳安定的用途。 多種適合與本發明四唑鏘物料組合的附加水相系統腐 蝕抑制劑是已知於文獻的。這種抑制劑非限制的實施例可 以在下面文獻找到：Corrosion Inhibitors，C.C. Nathan, ed·， NACE， 1973 ; I.L. Rozenfeld， Corrosion Inhibitors，Less alkaline solutions of SiO2: Na20 molar ratios up to about 3.5: 1 can also be used. Other alkali metal silicates, especially potassium silicates, can also be used. When using water-soluble alkali metal silicates in the examples of the present invention, it may be advantageous to combine silicates with other inhibitors and / or silicon stabilizers. Examples of such suitable combinations are disclosed in U.S. Patent Nos. 3,711,246, 4,085,063, 4,404,114, 5,137,657, 5,262,078, 5,578,246, and 5,589,106, all of which are incorporated herein by reference. The quaternium compound of the present invention can also be combined with a water-soluble monocarbonate. The use of this salt as a metal surface corrosion inhibitor has been disclosed in U.S. Patent Nos. 4,132,572 and 4,613,450, both of which are incorporated herein by reference. As disclosed in U.S. Patent No. 5,182,028, which is incorporated herein by reference, this salt also has calcium carbonate scale control and iron and manganese stabilization applications. A variety of additional aqueous phase system corrosion inhibitors suitable for use in combination with the tetrazolidine materials of the present invention are known in the literature. Non-limiting examples of such inhibitors can be found in the following documents: Corrosion Inhibitors, C.C. Nathan, ed., NACE, 1973; I.L. Rozenfeld, Corrosion Inhibitors,

McGraw-Hill, 1981 ； Metals Handbook, 9th Ed., Vol. 13 -Corrosion，pp. 478-497 ； Corrosion Inhibitors for Corrosion Control, B.G. Clubley, ed.5 The Royal Society of Chemistry, 1990 ; Corrosion Inhibitors, European Federation ofMcGraw-Hill, 1981; Metals Handbook, 9th Ed., Vol. 13 -Corrosion, pp. 478-497; Corrosion Inhibitors for Corrosion Control, BG Clubley, ed. 5 The Royal Society of Chemistry, 1990; Corrosion Inhibitors, European Federation of

Corrosion Publications Number 11, The Institute of Materials, 1994 ； Corrosion, Vol. 2 - Corrosion Control, L.L. Sheir, R.A. Jarman, and G.T. Burstein, eds·，Butterworth- 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） ---------1 ——----l·---訂--------- (請先閱讀背面之注意事項再填寫本頁) 28 經濟部智慧財產局員工消費合作社印製 542858 A7 __________ B7 五、發明說明（25)Corrosion Publications Number 11, The Institute of Materials, 1994; Corrosion, Vol. 2-Corrosion Control, LL Sheir, RA Jarman, and GT Burstein, eds ·, Butterworth- This paper standard applies to China National Standard (CNS) A4 (210 X 297 mm) --------- 1 -------- l · --- Order --------- (Please read the precautions on the back before filling this page) 28 Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs 542858 A7 __________ B7 V. Description of Invention (25)

Heinemann, 1994? pp. 17:10-17:39 ； Y.I. Kuznetsov. OrganicHeinemann, 1994? Pp. 17: 10-17: 39; Y.I. Kuznetsov. Organic

Inhibitors of Corrosion of Metals，Plenum，1996 ;及VS Sastri，Corrosion Inhibitors: Principles and Applications·Inhibitors of Corrosion of Metals, Plenum, 1996; and VS Sastri, Corrosion Inhibitors: Principles and Applications ·

Wiley，1998。這種抑制劑包括胺（如嗎福啉，環己基胺， 苯甲基胺），烷醇胺，醚胺，二胺，脂肪胺和二胺，四級 化胺’氧院基化胺，烧基σ比咬；四唾類，如揭示於美國專 I 利案件弟5，744，069號者，在此加入作為參考資料；味σ坐 啉和取代的咪唑啉，醯胺胺’聚胺，包括聚伸烷基聚胺， 如揭示於美國專利案件第5,275,744號者，在此加入作為 參考資料，苯磺酸，苯酸鹽和取代的苯酸鹽的烷基衍生物 (如對-二級-丁基苯酸，如揭示於美國專利案件第5，2 7 5，7 4 4 號者’在此加入作為參考資料）’胺基苯酸鹽，水楊酸鹽 ，二聚酸-三聚酸，石油氧化物，硼葡萄糖鹽；木質素， 鞣酸，和其礦酸化及/或羧酸化衍生物（如木質確酸鹽）； 直鏈C^-Ch單羧酸酯，羧酸和氫硫基羧酸胺鹽，如揭示於 丨美國專利案件第5，7 7 9，9 3 8號者，在此加入作為參考資料 ，胺基酸，聚胺基酸，及其衍生物，如揭示於美國專利案 件第 4,971，724 號，5,531，934 號，5,616,544 號，5,75〇,〇7〇 號，和5,785,896號者，在此加入作為參考資料；羥基醚 酸和相關的内酯化合物，如揭示於美國專利案件第 5,055,230號者，在此加入作為參考資料，N•醯基肌胺酸 ，N-醯基亞胺基二乙酸；三吖畊二_和三_羧酸，如揭示於 美國專利案件第4,402,907號者，在此加入作為參考資料 ，及磷·和磷酸酯類（如乙氧化醇），如揭示於美國專利 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） ^ „----^--------- (請先閱讀背面之注意事項再填寫本頁) 29 542858 A7 B7 五、發明說明（26) h 5,611.991 件第 3,873,465 號，3,932,3〇3 號，4,〇66,398 號 號者，在此加入作為參考資料。 在本發明的實例中，以使用附加試劑加強或加入本發 明組合另外的功能性可能是有利的。適合的附加試劑包括 分散劑，銅腐蝕抑制劑，鋁腐蝕抑制劑，水溶性金屬鹽及 其螯合物’水垢和沈積控制劑，多價螯合劑，防珠劑，氧 化性和非氧化性生物制劑，非離子的和離子的冷凌溫度抑 制劑，PH調節劑，惰性和活性示蹤劑，非水溶性的和水 溶性的潤滑劑，表面活性劑，辦硬度調節冑，和呈色劑。 當水相系統含有懸浮的顆粒化物質，通常需要用分散 劑來維持系統的澄清度。多種可用於本發明實例聚合的和 非聚合的分散劑是已知於文獻的。較佳的是a)得自一個或 更多個乙烯不飽和單體聚合反應的水溶性石黃酸化聚合物或 共聚物，單體中至少一個含有石黃酸化功能性，或其水溶性 鹽，或b)分子量<10,〇〇〇的二異丁烯和順-丁烯二酸酐的共 聚物’或其水溶性鹽。特別佳的是大約3:1重量比的丙烯 酉文和稀丙基沒基丙基續酸酯驗共聚物或其水溶性鹽。 可與本發明四唑鏘化合物合併的附加試劑包括銅腐蝕 抑制劑，包括雜環形態的銅抑制劑，如唑類化合物。如已 知於文獻的，唑類通常用於提供以銅為主的合金之腐蝕保 護。然而，也如文獻已知的，在一些系統内，唑類和類似 的雜環形態的銅抑制劑另外再提供以鐵為主的金屬及/或 鋁的腐蝕保護，使用這種物料於這些目的被認為是在本發 明範圍内。因為一個熟悉文獻者可以很快地瞭解，使用銅 本紙張尺度適用中國國家標準（CNS)A4 #見格⑽X 297公爱 542858Wiley, 1998. Such inhibitors include amines (such as morpholine, cyclohexylamine, benzylamine), alkanolamines, etheramines, diamines, fatty amines and diamines, quaternary amines, oxygenated amines, and Basic sigma bite; Tetrasaloids, such as those disclosed in US Patent No. 5,744,069, are hereby incorporated as reference materials; sigma oxoline and substituted imidazoline, amidoamine 'polyamine, Including polyalkylene polyamines, as disclosed in U.S. Patent No. 5,275,744, incorporated herein by reference, benzenesulfonic acid, benzoate and substituted benzoate alkyl derivatives (such as para-secondary -Butyl benzoic acid, as disclosed in U.S. Patent Case Nos. 5, 2 7 5, 7 4 4 'Add here for reference)' Aminobenzoate, salicylate, dimer acid-trimer Acids, petroleum oxides, boron glucose salts; lignin, tannic acid, and its mineralized and / or carboxylated derivatives (such as ligninates); linear C ^ -Ch monocarboxylic acid esters, carboxylic acids and hydrogen Thiocarboxylic acid amine salts, as disclosed in US Patent Case No. 5, 7 7 9, 9 3 8 are added here as reference materials, amino acids, polyamino acids And its derivatives, such as those disclosed in U.S. Patent Nos. 4,971,724, 5,531,934, 5,616,544, 5,75,007, and 5,785,896, are incorporated herein by reference; hydroxy ethers Acids and related lactone compounds, such as those disclosed in U.S. Patent Case No. 5,055,230, are hereby incorporated by reference, N • fluorenylsarcosinic acid, N-fluorenimine diacetic acid; triazine di_ and Tri-carboxylic acids, such as those disclosed in U.S. Patent No. 4,402,907, are hereby incorporated by reference, and phosphorus and phosphate esters (such as ethoxylated alcohols), as disclosed in the US patent. CNS) A4 specifications (210 X 297 public love) ^ -------- ^ --------- (Please read the notes on the back before filling out this page) 29 542858 A7 B7 V. Description of the invention (26 ) h 5,611.991 pieces 3,873,465, 3,932,30, 3, 4,66,398, which are hereby incorporated by reference. In the examples of the present invention, additional functions are used to enhance or add additional functions of the combination of the present invention. Sex may be advantageous. Suitable additional reagents include Powders, copper corrosion inhibitors, aluminum corrosion inhibitors, water-soluble metal salts and their chelates' scale and sedimentation control agents, sequestering agents, anti-bead agents, oxidizing and non-oxidizing biological agents, non-ionic and Ionic cold temperature inhibitors, pH regulators, inert and active tracers, water-insoluble and water-soluble lubricants, surfactants, hardness regulators, and colorants. When aqueous systems contain suspensions Dispersants are usually required to maintain the clarity of the system. A variety of polymeric and non-polymeric dispersants that can be used in the examples of this invention are known in the literature. It is preferred that a) the water-soluble luteinized polymer or copolymer obtained from the polymerization of one or more ethylene unsaturated monomers, at least one of the monomers contains a lutein-functionalizing function, or a water-soluble salt thereof, Or b) a copolymer of diisobutylene and maleic anhydride with a molecular weight < 10,000, or a water-soluble salt thereof. Particularly preferred is an acrylic copolymer and a diisopropyl propyl dibasic acid ester copolymer or a water-soluble salt thereof in a weight ratio of about 3: 1. Additional agents that can be combined with the tetrazolium compound of the present invention include copper corrosion inhibitors, including copper inhibitors in heterocyclic forms, such as azole compounds. As known in the literature, azoles are often used to provide corrosion protection for copper-based alloys. However, as is known in the literature, in some systems, azoles and similar heterocyclic copper inhibitors additionally provide corrosion protection for iron-based metals and / or aluminum. Use this material for these purposes It is considered to be within the scope of the present invention. Because a person familiar with the literature can quickly understand that the copper paper size is applicable to the Chinese National Standard (CNS) A4 #See Grid X 297 Public Love 542858

五、發明說明（2*7) 經濟部智慧財產局員工消費合作社印製 抑制劑於本發明實例可能加強本發明組成物保護特別金屬 系統的性能及/或可能延伸到多金屬系統的應用性。 適合的唑類化合物包括***，四唑，吡唑，σ米唑，異 h唑，哼唑，異噻唑，和噻唑，所有都任擇地以烷基，芳 基，芳烷基，烷基醇，和烴烯基基團取代，包括揭示於美 國專利案件第2,6185608號，2,742,369號，和2,941，953號 和摘述於美國專利案件第4，1〇1，441號者，所有在此都加 入作為參考資料。適合的唑類和相關雜環化合物的實施例 包括苯并***，甲苯***，烷基或烷氧基取代的苯并*** ，其中該取代發生於苯環的4或5位置，2_氫硫基苯并噻唑 ’ 2·氫硫基笨并***，丨，^·***，4_苯基-ns·***，I,〕· 奈并二唾，4-硝基笨并三唾，σ比唾，6-叾肖基引唾，4-笨甲 基°比唾，4,5-二甲基。比唾，3·烯丙基a比嗤，咪唑，腺嗓呤 ’鳥嗓呤，苯并咪唑，5_曱基苯并咪唑，2_苯基咪唑，2一 苯甲基咪唑，4-烯丙基咪唑，4-(β-羥基乙基）咪唑，嗓吟 ’ 4-甲基咪唑，黃嘌呤，次黃嘌呤，2-甲基咪唑，異1。坐 ，苯并異哼唑，3-氫硫基苯并異哼唑，哼唑，2_氫硫基哼 唾’ 2-氫硫基苯并哼唑，異噻唑，弘氫硫基異噻唑，2_氫 硫基苯并異噻唑，苯并異噻唑，噻唑，2,5-二氫硫基噻二 0坐’ 2，5-二氫硫基苯并三σ坐，5,5，-亞甲基•雙-苯并三嗤， 及4,5，6,7-四氫苯并三σ坐。另外適合的。坐類包括揭示於美 國專利案件第 3,985,503 號，4,298,568 號，4,734,257 號， 4,744,950 號，4,874,579 號，5,217,686 號，和 5,236,626 號 者在此加入作為參考資料’和揭不於美國專利案件第 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐）V. Description of the invention (2 * 7) The inhibitor printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs on the examples of the present invention may enhance the performance of the composition of the present invention to protect special metal systems and / or may extend to the applicability of multi-metal systems. Suitable azole compounds include triazole, tetrazole, pyrazole, sigmazole, isohazole, humazole, isothiazole, and thiazole, all of which are optionally alkyl, aryl, aralkyl, alkyl Alcohol, and alkenyl group substitutions, including those disclosed in U.S. Patent Nos. 2,6185608, 2,742,369, and 2,941,953, and those summarized in U.S. Patent Nos. 4,101,441, all in This is added as a reference. Examples of suitable azoles and related heterocyclic compounds include benzotriazole, toltriazole, alkyl or alkoxy substituted benzotriazole, where the substitution occurs at the 4 or 5 position of the benzene ring, 2_ Hydrosulfanylbenzothiazole '2. Hydrosulfanylbenzotriazole, 丨, ^ · triazole, 4-phenyl-ns · triazole, I,] · Nenobisalan, 4-nitrobenzotriazole Saliva, σ is better than saliva, 6- 叾 Shokyloin, salivary, 4-benzylmethyl ° saliva, 4,5-dimethyl. Bisal, 3, allyl a than fluorene, imidazole, adenine's guanine, benzimidazole, 5-fluorenyl benzimidazole, 2-phenylimidazole, 2-benzylimidazole, 4-ene Propylimidazole, 4- (β-hydroxyethyl) imidazole, groan '4-methylimidazole, xanthine, hypoxanthine, 2-methylimidazole, iso-1. Sitting, benzoisohumazole, 3-hydrothiobenzoisohumazole, humazole, 2_hydrothiobenzyl '2-hydrothiobenzoxazole, isothiazole, hydrothiothioisothiazole, 2-Hydroxythiobenzoisothiazole, benzoisothiazole, thiazole, 2,5-dihydrothiothiodioxo '2,5-dihydrothiobenzotrisigma, 5,5, -sub Methyl-bis-benzotrifluorene, and 4,5,6,7-tetrahydrobenzotrisigma. Also suitable. The categories include those disclosed in U.S. Patent Cases Nos. 3,985,503, 4,298,568, 4,734,257, 4,744,950, 4,874,579, 5,217,686, and 5,236,626, which are hereby incorporated by reference 'and disclosed in the U.S. Patent Case, which is applicable to the paper standard. China National Standard (CNS) A4 specification (210 X 297 mm)

-I 裝----------訂---------線 (請先閱讀背面之注意事項再填寫本頁) 31 542858 經濟部智慧財產局員工消費合作社印製 A7 五、發明說明（28 ) 5，156,769號的i•笨基_5_氫硫基四&，在此加人作為參考 資料。適合的唾類包括混合的組成物，如包括至少㈣， 以重量計，5_甲基苯并三唾異構物的甲苯三吐組成物，如 揭不於美國專利案件第5,503,775號者，在此加入作為參 考資料。當水㈣統使用“素為主的氧化性生物制劑（ 如氯)時’特別適合的是耐鹵素唑類，提供改良的腐蝕性 能，沒有不良氣味’減少生物制劑的消耗。這種耐自素唑 類非限制的實施例揭示於美國專利案件第5,772,919號， M63,463號和5,863,464號，在此加入作為參考資料，盆 中包括氣-甲笨三唾’漠-甲苯三唾，單齒基苯并三峻，二 画基苯并三唾，和單自基和n笨并三錢合物。 較佳的唑類為甲苯***，笨并***和耐鹵素唑，特別 是氣·甲笨三。坐。 可以與本發明四唑鐯化合物合併的附加試劑包括鋁腐 蝕抑制齊卜較佳的是水溶性硝酸鹽，肖別是硝酸納，确酸 鹽與驗金屬石夕酸鹽的組合。 可以與本發明四唑鏘化合物合併的附加試劑包括擇自 鋅錳，鋁，錫，鎳，釔，和稀土金屬（原子序57至71)之 族的金屬的水溶性金屬鹽及/或這種金屬的有機金屬螯合 物，其中該有機螯合物要選擇可提供金屬離子需要量的水 溶解度。如文獻已知的’這種金屬鹽和螯合物可以使用來 提供另外的腐蝕保護。 使用鋅離子作為腐蝕抑制劑是已知於文獻的，特別是 與其他水處理試劑組合，如磷酸鹽，膦酸鹽，卜羧酸鹽， 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） ----- (請先閱讀背面之注意事項再填寫本頁) ----訂--------- 32 542858-I Pack ---------- Order --------- Line (Please read the notes on the back before filling this page) 31 542858 Printed by A7, Consumer Cooperatives, Intellectual Property Bureau, Ministry of Economic Affairs V. Description of the invention (28) No. 5,156,769 i • benzyl_5_hydrosulfanyl tetra & Suitable salivas include mixed compositions, such as toluene triturate compositions that include at least pyrene, by weight, 5-methylbenzotrisialyl isomers, as disclosed in U.S. Patent No. 5,503,775, in This is added as a reference. When the water system uses "peptide-based oxidizing biological agents (such as chlorine)", it is particularly suitable for halogenated azoles that provide improved corrosion performance and no unpleasant odors. "Reduces the consumption of biological agents. Non-limiting examples of azoles are disclosed in U.S. Patent Cases Nos. 5,772,919, M63,463 and 5,863,464, which are incorporated herein by reference, and the basin includes qi-methylbenzyl salivary 'mo-toluene trisial, monodentate Benzotriazine, dimethylbenzotrisalyl, and monobenzyl and n-benzyltriestate. The preferred azoles are tolutriazole, benzotriazole, and halogen-resistant azole, especially chloroform Stupid. Sit. The additional reagents that can be combined with the tetrazolium compound of the present invention include aluminum corrosion inhibition, preferably water-soluble nitrate, and sodium nitrate, as well as a combination of salt and metal oxalate. Additional reagents that can be combined with the tetrazolium compound of the present invention include water-soluble metal salts selected from the group consisting of zinc manganese, aluminum, tin, nickel, yttrium, and rare earth metals (atomic numbers 57 to 71) and / or Organometallic chelate of a metal, wherein the organic chelate The compound is selected to provide the water solubility required for the metal ions. As known in the literature, 'this metal salt and chelate can be used to provide additional corrosion protection. The use of zinc ions as corrosion inhibitors is known in the literature. , Especially in combination with other water treatment reagents, such as phosphates, phosphonates, and carboxylates, this paper size applies to China National Standard (CNS) A4 specifications (210 X 297 public love) ----- (please first Read the notes on the back and fill out this page) ---- Order --------- 32 542858

發明說明（29) 經濟部智慧財產局員工消費合作社印製 叛馱鹽和羥基羧酸鹽。較佳的鋅離子源是硫酸，氣，乙酸 或肖的鋅鹽和氧化鋅溶解於驗得到的鋅酸離子。特別佳 的是硫酸鹽和氯鹽和鋅酸離子。 錳離子與胺基膦酸酯和與P-羧酸鹽組合使用於水處理 已經分別被揭示於美國專利案件第4,64〇,818號和歐洲專 利案件第283 191A2號，二者在此都加入作為參考資料。 在水相系統中使用釔和原子序57至71鑭系金屬陽離子及/ 或其有機的螯合物作為腐蝕抑制已經被揭示於美國專利案 件第4,749,550號和5，130,052號，二者在此都加入作為參 考資料較仏的鑭鹽為鑭，镨，和敍者，及含有其混合物 的上市物料。 本發明可以與四唑鏘化合物合併的附加試劑包括水垢 和沈積控制劑。雖然許多前面說明的本發明組合同時提供 腐餘和水垢及/或沈積控制（特別對碳酸妈水垢），也可能 有B守候必須使用附加試劑來控制特別種系（如硫酸鋇或草 酸鈣）的長水垢及/或沈積。適合用於控制各種這種種系的 試劑是已知於文獻的。 可以與本發明四唑鏘化合物合併的附加試劑包括多價 螯合劑。這種試劑需要用以避免金屬（如鐵，銅）或鹼土離 子堵塞水相系統或干擾系統中腐蝕抑制劑或其他試劑適當 的功能。這種多價螯合劑是已知於文獻的，在一些情況下 ’可以可選擇有效於特定離子者。適合的多價螯合劑非限 制的貫施例包括乙二胺四（乙酸）氮基三乙酸，和n，n_:(2_ 每基乙基）甘胺酸或其水溶性鹽。 --------------裝·---L----訂---------線 f ,清先閱讀背面之注意事項再填寫本頁}Description of the Invention (29) Betrayal salts and hydroxycarboxylates are printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs. Preferred sources of zinc ions are sulfuric acid, gaseous, acetic or zinc salts of zinc and zinc oxide dissolved in the detected zinc acid ions. Particularly preferred are sulfate and chloride salts and zincate ions. The use of manganese ions in combination with aminophosphonates and P-carboxylates in water treatment has been disclosed in U.S. Patent No. 4,64,818 and European Patent Case No. 283 191A2, both of which are here Add as reference. The use of yttrium and atomic numbers 57 to 71 lanthanide metal cations and / or their organic chelates as corrosion inhibitors in aqueous systems has been disclosed in U.S. Patent Nos. 4,749,550 and 5,130,052, both of which are here The lanthanum salts that are added as reference materials are lanthanum, osmium, and Syria, and listed materials containing their mixtures. Additional agents that can be combined with the tetrazolium compound of the present invention include scale and deposition control agents. Although many of the previously described combinations of the present invention provide both rot and scale and / or deposition control (especially for carbonate carbonate scales), there may also be B-waiting that additional reagents must be used to control specific species (such as barium sulfate or calcium oxalate) Long scale and / or deposits. Suitable reagents for controlling a variety of such germlines are known in the literature. Additional agents that can be combined with the tetrazolium compound of the invention include sequestering agents. This reagent needs to be used to prevent metals (such as iron, copper) or alkaline earth ions from blocking the aqueous system or interfering with the proper function of corrosion inhibitors or other reagents in the system. Such sequestrants are known in the literature, and in some cases may be selected to be effective on specific ions. Non-limiting examples of suitable sequestrants include ethylenediamine tetra (acetic acid) nitrotriacetic acid, and n, n _ :( 2_perylethyl) glycine or a water-soluble salt thereof. -------------- Installation --- L ---- Order --------- line f, please read the notes on the back before filling this page}

542858 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明（30) 可以與本發明四。坐鐵化合物合併的附加試劑包括防沐 劑。適合的防沫劑的實施例包括矽酮（如聚二 ，二硬脂基癸二酿胺，二硬脂基己二醯胺和衍；·自；7乙) 燒或環氧丙炫縮合作用的相關產物，及脂肪醇，如癸酿醇 和其環氧乙烷縮合物。 可以與本發明四唑鏘化合物合併的附加試劑包括生物 制劑。可能必須在水相系統和本發明組成物進料源使用生 物制劑以控制微生物生長。氧化性和非氧化性生物制劑都 可以使用於這些目的。適合的氧化性生物制劑包括至少一 個下面化合物：氣，次氯酸鹽，溴，次溴酸鹽，氣及/或 提供溴化合物（如溴氯乙内醯脲），過乙酸，無機過氧化物 和過氧化物產生物，二氧化氣，和臭氧。適合的非氧化性 生物制劑包括至少一個下面化合物：胺，四級銨化合物（ 如N-烷基二甲基苯甲基銨氣化物），2_溴_2_硝基丙烷-^ 二醇’ β-溴硝基笨乙烯，十二烷基胍氫氣酸鹽，2,2-二漠_ 3 -氮基丙fe胺，戊二酿，氯盼，含硫化合物如楓，亞甲基 雙硫氰酸酯和胺基甲酸酯，異噻唑酮，溴化丙醯胺，三叮 併（例如terbuthylazine，和三吖啡衍生物，如揭示於美國 專利案件第5,534,624號者，在此加入作為參考資料），鱗 化合物，有機金屬化合物，如三丁基錫氧化物，和這種生 物制劑的混合物。一個較佳的非氧化性生物制劑是一個混 合物，其中包含（a)2-溴-2-硝基丙烷-1，3-二醇（BNPD)和（b) 一個大約75% 5-氯-2-甲基-4-異噻唑-3-酮和大約25% 2-甲 基-4-異噻唑-3-酮的混合物，該BNPD(a)對該混合物（b)重 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） -----j----訂--------- (請先閱讀背面之注意事項再填寫本頁) 34 542858542858 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs A7 B7 V. Description of Invention (30) It can be related to the present invention. Additional reagents that incorporate iron compounds include anti-foam agents. Examples of suitable anti-foaming agents include silicones (such as polybis, distearyl sebacamide, distearyl adipamide, and derivatives; · from; 7B) fired or propylene oxide Related products, and fatty alcohols, such as decanol and its ethylene oxide condensate. Additional agents that can be combined with the tetrazolium compound of the present invention include biological agents. It may be necessary to use biologics in the aqueous system and the feed of the composition of the invention to control microbial growth. Both oxidizing and non-oxidizing biological agents can be used for these purposes. Suitable oxidative biological agents include at least one of the following compounds: gas, hypochlorite, bromine, hypobromite, gas and / or the supply of bromine compounds (such as bromochlorohydantoin), peracetic acid, inorganic peroxides And peroxides, dioxide, and ozone. Suitable non-oxidizing biological agents include at least one of the following compounds: amines, quaternary ammonium compounds (such as N-alkyldimethylbenzyl ammonium vapors), 2-bromo_2_nitropropane- ^ diol ' β-bromonitrobenzyl ethylene, dodecylguanidine hydrochloride, 2,2-diamo_3-aminopropylamine, glutaric acid, chloropan, sulfur compounds such as maple, methylene disulfide Cyanate esters and carbamates, isothiazolones, propylammonium bromide, tributyl (such as terbuthylazine, and triacrine derivatives, as disclosed in U.S. Patent No. 5,534,624, incorporated herein by reference Information), scale compounds, organometallic compounds such as tributyltin oxide, and mixtures of this biological agent. A preferred non-oxidizing biological agent is a mixture containing (a) 2-bromo-2-nitropropane-1,3-diol (BNPD) and (b) an approximately 75% 5-chloro-2 -A mixture of methyl-4-isothiazol-3-one and about 25% 2-methyl-4-isothiazol-3-one, the BNPD (a) to this mixture (b) the weight of the paper applies to the country of China Standard (CNS) A4 specification (210 X 297 mm) ----- j ---- Order --------- (Please read the precautions on the back before filling this page) 34 542858

五、發明說明（31) 置比為大約16:1至大約1:1 ’如揭示於美國專利案件第 4,732,905號者，在此加入作為參考資料。 可以與本發明四讀化合物合併的附加試劑包括冷;東 溫度抑制劑。這種試劑需要用於如冷;東，除濕，和内燃機 引擎的冷m统的水相系統。此抑制劑本質上可以是離 子的或非離子的。適合_子試劑非限制的實施例包括氯 化好氯化鈉，漢化鐘，和氯化鐘。適合的非離子試劑的 實施例為水溶性醇’如乙二醇，丙二醇，乙醇，甘油，丙 醇，甲醇，及其混合物。 可以與本發明四唑鏘化合物合併的附加試劑包括pH 調節劑。適合的試劑非限制的實施例包括氫氧化鈉，氫氧 化鉀，氫氧化鋰，鹽酸，硫酸，硝酸，二氧化碳，氨，有 機&L如草I，驗金屬碳酸鹽，和驗金屬碳酸氫鹽。 备本發明組成物用於包含在表面和金屬之間移動接觸 的水相系、、充（如3有幫浦裝置系統或包含金屬切割或成形 應用遇到者），該系統可能需要使用潤滑劑來改善切割操 作性能或減少接觸及/或金屬表面的磨損。這種潤滑劑可 以是水浴性或非水溶性的。適合的非水溶性的有機潤滑劑 如天然油或合成油，包括揭示於美國專利第5,7丨6,9丨7號 者’在此加入作為參考資料。適合的水溶性潤滑劑包括揭 不於美國專利案件第3,720,695號，4,053,436號，4,289,636 號，4,402,839 號，4,425,248 號，4,636,321 號，4,758,359 號 ’ 4,895,668 號，5,401，428 號，5,547,595 號，5,616,544 號，和5,6 5 3,6 9 5號者，在此加入作為參考資料。一些潤 本紙張尺度適用中國國家標準（CNS)A4規格（21〇 x 297公爱） I - I I (請先閱讀背面之注意事項再填寫本頁) ·. -丨線- 經濟部智慧財產局員工消費合作社印製 35 542858 五、發明說明（π) 滑劑（如揭示於美國專利案件第4,405,426號和5·4〇丨，428號 者，所有在此都加入作為參考資料）可能對本發明組成物 另外供改良的腐敍抑制性能。 在含有本發明組成份混合物安定產品的配方内或本發 明組成物應用到特別水相系統（特別是系統中存在明顯比 例的非水相液體者）時，另外使用表面活性劑是有利的。 這種表面活性劑本質上可以是陰離子的，陽離子的，兩性 的或非離子的，匕們是已知於文獻的。這種試劑可以加到 本务明組成物作為多種功能（如作為乳化劑，分散劑，水 合劑，防沫劑，潤滑劑，腐蝕抑制劑）。為達到特定目的 使用特定的適當表面活性劑的方法是已知於熟悉文獻者。 當使用有限水溶解度的添加物於本發明組成物時，使用表 面活性劑疋特別需要的（如當使用非水溶性的有機潤滑劑 或以微；;容的物料為主的附加腐姓抑制齊j，如月旨肪酸衍生物） 4 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 可以與本發明四唾鏘化合物合併的附加試劑包括妈硬 度調節劑。文獻中已經知道，許多水相系統腐餘抑制劑， 特別是-般用於處理開放式再循環冷卻系統者的效率決定 於二水中小！的溶解妈的存在。雖然本發明組成物的效 =比較不受溶_的影響’在本發明實例中系統中增加溶 解舞的濃度是有利的。適合的鹤硬度調節劑非限制的實施 例包括碳酸氫舞，碳_，氣㈣，硫_，和乙酸㈣ 及氫氧化鈣和氧化辦。 可以與本發明四嗤鏘化合物合併的附加試劑包括呈色 本紙張尺ϋ家標準各⑵〇 X 297立 36 542858 A7 B7 五、發明說明（33 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製V. Description of the invention (31) The ratio is about 16: 1 to about 1: 1 ′ As disclosed in US Patent No. 4,732,905, it is incorporated herein by reference. Additional reagents that can be combined with the fourth reading compounds of the invention include cold; east temperature inhibitors. This reagent needs to be used in cold water systems such as cold, dehumidifier, and cold engine systems of internal combustion engines. This inhibitor may be ionic or non-ionic in nature. Non-limiting examples of suitable reagents include sodium chloride, sodium chloride, and bell chloride. Examples of suitable non-ionic agents are water-soluble alcohols such as ethylene glycol, propylene glycol, ethanol, glycerol, propanol, methanol, and mixtures thereof. Additional agents that can be combined with the tetrazolium compound of the present invention include pH adjusters. Non-limiting examples of suitable reagents include sodium hydroxide, potassium hydroxide, lithium hydroxide, hydrochloric acid, sulfuric acid, nitric acid, carbon dioxide, ammonia, organic & ascorbic acid I, metal carbonate, and metal carbonate . The composition of the present invention is used for the aqueous phase system, including the mobile contact between the surface and the metal (such as a 3 pump system or a metal cutting or forming application encountered), the system may require the use of lubricants To improve cutting performance or reduce contact and / or metal surface wear. This lubricant may be water-bathable or water-insoluble. Suitable water-insoluble organic lubricants, such as natural oils or synthetic oils, including those disclosed in U.S. Patent Nos. 5,7, 6,9, and 7, are incorporated herein by reference. Suitable water-soluble lubricants include U.S. Patent Nos. 3,720,695, 4,053,436, 4,289,636, 4,402,839, 4,425,248, 4,636,321, 4,758,359 '4,895,668, 5,401,428, 5,547,595, and 5,616,544, and 5,6 5 3,6 9 No. 5 are hereby incorporated as reference materials. Some paper sizes are subject to the Chinese National Standard (CNS) A4 (21 × 297 Public Love) I-II (Please read the precautions on the back before filling this page) ·.-Line-Employees of Intellectual Property Bureau, Ministry of Economic Affairs Printed by a consumer cooperative 35 542858 V. Description of the invention (π) Lubricants (such as those disclosed in US Patent Nos. 4,405,426 and 5.40, 428, all of which are incorporated herein as reference materials) may affect the composition of the present invention In addition for improved rot suppression performance. It is advantageous to additionally use a surfactant in a formulation containing a stable product of the component mixture of the present invention or when the composition of the present invention is applied to a special aqueous phase system (especially a non-aqueous phase liquid in a significant proportion of the system). Such surfactants can be anionic, cationic, amphoteric or nonionic in nature, and knives are known in the literature. This reagent can be added to this composition for various functions (e.g. as emulsifier, dispersant, hydrating agent, anti-foaming agent, lubricant, corrosion inhibitor). Methods for using specific suitable surfactants for specific purposes are known to those familiar with the literature. When using additives with limited water solubility in the composition of the present invention, the use of surfactants is particularly needed (such as when using water-insoluble organic lubricants or micro-; j, such as a fatty acid derivative of the month) 4 Additional reagents printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs that can be combined with the tetrasialyl compound of the present invention include a hardness regulator. It is known in the literature that the efficiency of many water phase system residue inhibitors, especially those used to treat open recirculation cooling systems, is determined by the small amount of secondary water! The presence of the dissolved mother. Although the effect of the composition of the present invention is relatively unaffected by dissolution, it is advantageous to increase the concentration of dissolution dance in the system of the example of the present invention. Non-limiting examples of suitable crane hardness modifiers include bicarbonate, carbon, tritium, sulfur, and thallium acetate and calcium hydroxide and oxidizing agents. Additional reagents that can be combined with the tetrazine compounds of the present invention include coloring papers, paper standards, house standards, 297, 297, 36, 542,858, A7, and B7. V. Description of the invention

77 J這種°式A彳的用法非限制的實施例包括改善產品外觀， 黧助產品確認，和作為使用比色法可以控制的自動進料控 制系統的添加物。這種試劑非限制的實施例包括水溶性染 料。 令人驚許的，本發明者發現四唑鏘化合物協同地與多 種已·^的水垢及/或腐餘抑制劑合併提供大大增加一般的 腐蝕和凹點腐蝕的性能。本組合有效於大的鈣硬度和pH 犯圍，包括低硬度水。在一些情況下，當使用本組合與沒 有使用四唑鏘化合物的處理方法比較，甚至當維持總活性 處理含量一定時，也得到減少一個或更多個級次量的腐蝕 率〇 本發明四唑鑽化合物是已知為可還原的種系。雖然反 應機制細節還沒有被深入研究，還不完全被瞭解，一般相 信一個本發明新穎的組成物腐蝕抑制效應的要素是可溶的 四唑鎩化合物在腐蝕金屬表面還原成為一個較不可溶的和 保護性的薄膜。這個還原作用可以是多步驟方法，保護性 的薄膜可能含有數個中間還原產物。很可能的，一些這種 中間還原產物可能不是保護性的薄膜的一部份，但仍然7 能可以再進一步還原，形成抑制腐蝕薄膜。這種四唑鏘 合物抑制腐蝕的中間還原產物也被認為在範圍本發明= 四唑鏘化合物保護性的作用加上附加水處理劑的保 性作用提供有效的水相系統腐蝕控制。在許多情況下 加水處理劑也提供對抗水形成水垢和沈積的保護，在這 情況下，本發明組合是有效於控制腐蝕和長水垢/沈S 訂 線 化 護 附 4b 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） 542858 A7 五、發明說明（Μ) 經濟部智慧財產局員工消費合作社印製 附加水處理劑可能提供組成物其他需要的性質（如分散顆 粒化物質的能力）。然而，一些水處理劑（如脫氧劑）可能 使四唑鎩化合物直接在溶液中還原，使四唑鏘化合物本$ 或強力抑制腐蝕中間還原產物不能在金屬表面形成保護性 的薄膜。因此，在水相溶液中，特別使用條件下，實質還 原四唑鏘化合物的水處理劑不適合與本發明使用。使用條 件包括這種考量作為四唾鐳化合物和還原四唾鐵水處理劑 相對比例（如使用不實質還原存在的四唑鏺化合物量的減 少水處理劑的量的用法仍然在本發明範圍内）。使用的條 件也包括四唑鏘化合物和其他種系的絕對濃度，溫度， 間，改變四唑纟翁化合物和還原四唑鐳水處理試劑之間交 作用的附加氧化劑及/或還原劑或其他化合物的存在或 存在，催化性表面（如金屬表面）的存在或不存在等等。 悉文獻者可很快地測定在使用條件下是否特別試劑實質的 還原四唑鏘化合物。因為四唑鏘化合物還原產物通常是較 冰色的，而原始物料則否，得到此測定的簡單方法包括 視覺觀察和比色法。 延伸上面的說明，水相系統不含有影響四唑鏘化合 腐蝕抑制性，使得四唑鑕化合物不抑制腐蝕的物料。因〜 ，該四唑鑕化合物不被物料實質的還原而使四唑鑽化合物 不此抑制腐蝕。此外，任何使四唑鏘化合物及/或附加物 料不能腐蝕抑制及/或預防長水垢的物料較佳地不包括於 水相系統中，或較佳地包含不影響使四唑鏘化合物達到腐 餘抑制及/或避免長水垢的量。 時 不 熟 的 物 此77 J. Examples of non-limiting uses of the formula A 彳 include improved product appearance, assisted product identification, and additions as an automatic feed control system that can be controlled using a colorimetric method. Non-limiting examples of such agents include water-soluble dyes. Surprisingly, the present inventors have discovered that the tetrazolium compound synergistically combines with various scale and / or residue inhibitors to provide properties that greatly increase general corrosion and pitting corrosion. This combination is effective for large calcium hardness and pH violations, including low hardness water. In some cases, when this combination is compared with a treatment method without using a tetrazolium compound, even when the total active treatment content is maintained, a corrosion rate of one or more orders of magnitude is reduced. The tetrazole of the present invention Drilling compounds are known as reducible germlines. Although the details of the reaction mechanism have not been thoroughly studied and are not fully understood, it is generally believed that an element of the corrosion inhibitory effect of the novel composition of the present invention is the reduction of a soluble tetrazolium compound on a corroded metal surface to a more insoluble and Protective film. This reduction can be a multi-step process, and the protective film may contain several intermediate reduction products. It is possible that some of these intermediate reduction products may not be part of a protective film, but still can be further reduced to form a corrosion-resistant film. This intermediate reduction product of the tetrazolium compound for inhibiting corrosion is also considered to be within the scope of the present invention = the protective effect of the tetrazolium compound plus the protective effect of the additional water treatment agent provides effective corrosion control of the aqueous system. In many cases, the water treatment agent also provides protection against water formation of scale and sedimentation. In this case, the combination of the present invention is effective in controlling corrosion and long scale / sinking. Threading protection 4b This paper standard applies to Chinese national standards (CNS) A4 specification (210 X 297 public love) 542858 A7 V. Description of the invention (M) Additional water treatment agent printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs may provide other required properties of the composition (such as the ability). However, some water treatment agents (such as deoxidants) may reduce the tetrazolium compound directly in the solution, making the tetrazolium compound costly or strongly inhibit the corrosion. The intermediate reduction products cannot form a protective film on the metal surface. Therefore, in an aqueous solution, a water treatment agent that substantially reduces a tetrazolium compound is not suitable for use in the present invention under special use conditions. The conditions of use include such considerations as the relative ratio of the tetrasialide compound and the reduced tetrasialide water treatment agent. . The conditions used also include the absolute concentration, temperature, and temperature of the tetrazolium compound and other germline, additional oxidants and / or reducing agents or other compounds that change the interaction between the tetrazolium compound and the reduced tetrazolium water treatment reagent. The presence or absence of, the presence or absence of catalytic surfaces (such as metal surfaces), and so on. Those familiar with the literature can quickly determine whether the reagent is a substantial reduction of the tetrazolium compound under the conditions of use. Because the reduced product of the tetrazolium compound is usually ice-colored, and the original material is not, simple methods for obtaining this determination include visual observation and colorimetry. Extending the above description, the aqueous system does not contain materials that affect the corrosion inhibitory properties of the tetrazolium compound, so that the tetrazolium compound does not inhibit corrosion. Because ~, the tetrazolium compound is not substantially reduced by the material, so that the tetrazolium compound does not inhibit corrosion. In addition, any material that prevents the tetrazolium compound and / or additional materials from corrosion inhibition and / or the prevention of scale formation is preferably not included in the aqueous system, or preferably does not affect the tetrazolium compound's ability to achieve decay. Suppress and / or avoid the amount of scale. Unfamiliar

本紙張尺度翻巾關家鮮（CNS)A4規格⑵〇 x 297公釐） -----------—Γ—訂--------- (請先閱讀背面之注意事項再填寫本頁) 542858 經濟部智慧財產局員工消費合作社印製 A7 r-----Ε__ 五、發明說明（35) 们車乂仏的本發明實例中，大約0.5至10,000 ppm 白勺四唾鐵化合物和水相系統處理物料的組合加到需要處理 的火相系、、先，大約10至1000PPm的該組合是特別佳的。其 h才系、洗處理物料與四唾鐵化合物的重量比較佳地是大 、勺100,1到丨·20，而重量比大約20:1到1:1是特別佳的。 本备明組成物可以應用的水相系統pH範圍自大約5至 _ 大、力12 pH較佳地在大約6至大約丨〇的範圍内。 本毛明組成份可在填充系統時，用有效濃度以泥漿進 料^ ^ ”水相〆夜體混合投予水相系統。當在系統（如開放 式冷部系統）内用於處理水相系統的一個或更多個處理組 成份從系統排出或由於化學的或物理的方法而消耗，則需 要補充來、准持處理效率，本發明組成物可以用連續的方式 用門、貝的方式或用兩種方式的組合（如使用連續的低量 進料’需要時以泥漿進料補充）進料到系統。決定於應用 K車乂好的疋合併本發明組成物從一個進料供應源一起 ^ 一次處理進料，或，另外，將組成份分為二個或更多個處 、原各源獨立地用足以維持系統内濃度需要的速率連續 的或間‘的進料到系統。各處理源可以使用單一或多進料 點進入水相系統。 處理進料的時效和速率可以用多種已知於文獻的方法 控制。-個適合的方法是使用計量幫浦或其他進料系統裝 置匕們可以用各種不同的組態，以固定速率，以一定時 私表’、以其他系統組件，如補充幫浦或增壓幫浦產生的訊 5虎或以*員比為主或以電腦為主進料控制系統產生的訊號 t @ S ^#iT(CNS)A4 (21〇Τ297 ^ )----- “免 -39 - ^----------^---------^ (請先閱讀背面之注意事項再填寫本頁) 542858 A7 經濟部智慧財產局員工消費合作社印製 水 實 ,153 五、發明說明（3〇 連續進料。適合的進㈣統非限制的實施例已經揭示於美 國專利案件第 4,648,043 號，4,659·459 號，4,897,797 號， 5,〇56,036號，5.G92J39號和5,695,〇92號。進料控制系統 可使用下面相關的訊號：一個或更多個處理組成份的濃度 ’-個或更多個加到處理的惰性或活性示縱劑物料的濃度 ，一個或更多個系統性能測定值（如得自腐蝕率計，水^ 價測器，熱移轉偵測裝置，檢測水中腐織物量的分析裝 置，如總鐵或溶解鐵或其他金屬組成份等等的數值），二 個或更多個系統的物理特性數值（如溫度，流動率，導電 性）’ -個或更多個系統的化學特性數值（如阳，辦硬度， 氧化還原電位，驗度）或這些訊號的組合，來進料並維持 足夠在特別水相系統中有效性能的處理含量。另外，最好 在一些系、统中使用控㈣釋放(此後也稱之為$漸釋放或 時效釋放）輸送系統於一些或所有本發明化合物。在這種 控制的釋放系統中’要進料的物料灌輸進人或另外加到控 制釋放系統填充料内。適合的控制釋放輸送系統包括將填 充料暴露於水相系統中的液體者或液體流進料到水相系統 ’而處理組成份以各種不同的方法的動作逐漸地釋放入系 統（如擴散’溶解’滲透壓差異），它可另外設計改變釋放 率，來配合水相液體的特性，如溫度，流動率，pH， 硬度，導電性等等。這種控制的釋放輸❹統非限制的 施例已經被揭示於美國專利案件第3,985,298號，4,22〇， 號 ’ 5,3 16,774號，5,364,627號，和 5,391，369號。 ---------^---------. (請先閱讀背面之注意事項再填寫本頁) 當使用的進料系統利用處理或示縱劑組成份的測定漢The size of this paper is turned over (CNS) A4 size ⑵〇x 297 mm) ------------- Γ-order --------- (Please read the back Note: Please fill in this page again) 542858 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs A7 r ----- Ε__ 5. Description of the invention (35) In the example of the invention of our car, about 0.5 to 10,000 ppm The combination of a tetrasial compound and the material processed in the aqueous phase system is particularly preferred when it is added to the fire phase system to be processed. First, about 10 to 1000 PPm. Its weight is relatively large, the weight of the washing treatment material and the tetrasialo compound is relatively large, the spoon is 100,1 to 丨 · 20, and the weight ratio of about 20: 1 to 1: 1 is particularly good. The pH of the aqueous phase system to which the composition of the present invention can be applied ranges from about 5 to _large, and the pH of the force 12 is preferably in the range of about 6 to about 〇. This Maoming composition can be fed to the water phase system with an effective concentration of ^ ^ "water phase and nocturnal body" when filling the system. When used in the system (such as an open cold section system) to treat the water phase One or more processing components of the system are discharged from the system or consumed due to chemical or physical methods, and need to be supplemented to maintain the processing efficiency. The composition of the present invention can be used in a continuous manner using a door, shell or Feed the system in a combination of two methods (such as using a continuous low-volume feed, supplemented with mud feed when needed). It is determined by the use of a K-car, which combines the composition of the present invention from one feed supply source together ^ Process the feed at one time, or, in addition, divide the components into two or more locations, each source independently using a continuous or intermittent feed to the system at a rate sufficient to maintain the concentration in the system. Each process The source can enter the aqueous system using single or multiple feed points. The time and rate of processing the feed can be controlled using a variety of methods known in the literature. A suitable method is to use a metering pump or other feed system device Daggers can use a variety of different configurations, at a fixed rate, at a certain time, to private watches', to other system components, such as supplementary or booster pumps produced by the 5th Tiger, or to the main staff ratio or computer The signal generated by the main feed control system t @ S ^ # iT (CNS) A4 (21〇Τ297 ^) ----- "FREE -39-^ ---------- ^ --- ------ ^ (Please read the notes on the back before filling out this page) 542858 A7 Printed by the Consumers ’Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, 153 V. Description of the invention (30 continuous feed. Suitable feed Non-limiting examples of the system have been disclosed in U.S. Patent Cases Nos. 4,648,043, 4,659.459, 4,897,797, 5, 〇56,036, 5.G92J39, and 5,695, 〇92. The feed control system can use the following related Signal: Concentration of one or more processing components'-One or more concentration of inert or active peptizer material added to the process, one or more system performance measurements (if obtained from a corrosion rate meter , Water valence detector, thermal transfer detection device, analysis device to detect the amount of rotten fabric in water, such as total iron or dissolved iron or other metals Values of components, etc.), physical property values of two or more systems (eg temperature, flow rate, conductivity) '-chemical property values of one or more systems (eg, yang, hardness, redox potential) , Test) or a combination of these signals to feed and maintain a sufficient processing performance in a particular aqueous system. In addition, it is best to use controlled release (also referred to as $ gradual hereinafter) in some systems and systems Release or aging release) delivery system to some or all of the compounds of the invention. In this controlled release system, the 'material to be fed is infused into a person or otherwise added to the filler of a controlled release system. Suitable controlled release delivery systems include The filler is exposed to the liquid in the aqueous system or the liquid stream is fed into the aqueous system 'and the processing components are gradually released into the system in a variety of different actions (such as diffusing' dissolving 'the osmotic pressure difference). It can be designed to change the release rate to match the characteristics of the aqueous liquid, such as temperature, flow rate, pH, hardness, conductivity, etc. Non-limiting examples of such controlled release systems have been disclosed in U.S. Patent Cases Nos. 3,985,298, 4,220, '5,3,774, 5,364,627, and 5,391,369. --------- ^ ---------. (Please read the precautions on the back before filling out this page) When using the feed system, use the processing or measuring agent composition

542858542858

度，14些濃度可以用連續的，半連續的或批次形態的分析 技術測定，包括光譜法方法（uv，可見光放射，可見光吸 收，1R’Raman’榮光’鱗光等），電化學的方法（包括PH ’ ORP，和離子特定電極測定法），層析法（Gc，Lc)，決 定於抗體結合或釋放的方法，以化學為主的分析/比色方 法，如the Hach Company上市者等等。一個適合的光譜儀 法說明於美國專利案件第5,242,6〇2號，在此加入作為參 考貧料。一個適合用於調節水處理試劑系統内濃度的方法 揭示於美國專利案件第5,411，889號。美國專利案件第 5,855,791號，纟此加人作為參考㈣，這些案件揭示適 a的方法以些性此偵測器和系統特性為主，用於測定 腐姓和堵塞抑制劑進料率。 可能任擇地使用的示蹤劑化合物可以是不作為特別處 理功能的化合物，此後稱之為惰性示蹤劑，或可以是也很 快地被偵測的水處理化合物，這種處理化合物此後稱之為 活性示蹤劑。適合的示蹤劑包括可溶的鋰鹽，如氣化鋰， 過渡金屬，如說明於美國專利案件第4,966,7u號者，在 此加入作為參考資料，和螢光惰性示蹤劑，如說明於美國 專利案件第4,783,3 14號者，在此加入作為參考資料。適 合的螢光惰性示蹤劑包括單-，二·，和三磺酸化萘（如萘 石黃酸或萘二磺酸的水溶性鹽）。適合的活性示蹤劑包括螢 光標記的聚合物，如說明於美國專利案件第5,丨7丨，45〇號 者，在此加入作為參考資料，和含有光惰性，隱藏的可檢 測部份的聚合物，當與光活化劑接觸會吸收光線，如說 本紙張尺度適用中國國家標準（CNS)A4規格（21G X 297公爱） ^ — (請先閱讀背面之注意事項再填寫本頁) . •線· 經濟部智慧財產局員工消費合作社印製 41 542858 A7 五、發明說明（38 ) 於美國專利案件第5·654，198號者，在此加入作為參考資 料，及以唑類為主的銅腐蝕抑制劑，如曱苯***，和水、、容 性鉬酸鹽和鎢酸鹽。 雖然許多與四唑鏘化合物合併的化合物是已知的腐蝕 抑制劑，它們通常被認為只在特別的鈣硬度和ρΗ條件下 有效。例如一些膦酸基羧酸酯，如2-膦酸基丁烷-:1,2,4一三 羧酸（PBTC)通常只在pH超過8和水中含有一定量的鈣硬度 (如> 200 mg/卜以CaC〇3計）有效的作為腐蝕抑制劑。如下 面的證實，PBTC與四唑鏘化合物的組合在pH 76，只含 有1〇〇 mg/丨鈣，以CaC〇3計，的水中是很有效的。類似= 結果也在其他組合看到。最好在許多水相系統有“耐受，，水 PH和硬度的處理，也就是在大範圍的這些條件下可以 行得很好。 使用四唑鏘化合物可明顯的減少需要的總處理劑量， 有效地限制水相系統中的腐蝕。四唑鏘化合物的組合許多 是與主要或特定使用為水垢及/或沈積抑制劑的物料。然 而’這些組合有效地同時用於長水垢/沈積和腐触的控制 項 進 訂 4 濟 部 智 慧 財 員 工 消 費 印 測試方法知條件 本發明處理的腐姓抑制活性用燒杯腐姓測試儀器 (町A)評估。BCTA由_個2公升燒杯，上面m空 乱/C〇2授動器，！〇〗〇低碳鋼（LCS)測試管，—個LCS 電化學碳針，和磁授拌棒組成。測試溶液的體積紅9公 升。在測試期間空氣/⑶此㈣« 1以得到電化學腐 本紙張尺5顧中_緖i^Ns)A4祕（細χ撕公爱 542858 五、發明說明（39) 钱測定的參考資料電極和對電極是以⑽如一⑶架構。 燒杯沈浸於水浴中以控制溫度。在測試期間，以極化電 技術定期地從碳針取得電化學的腐减據。所有的測試都 ^120〇F進行，使用4〇〇 RpM攪拌率。除非另外說明，測 忒期間為18小時。各測試報告二個數值；ec(_是在測 心間測疋的電化學腐姓率的平均數值，而ec(i8小時）是 在測4終點腐㈣的數值。後項數值更被認為是預期長期 腐钱率的指標。 在所有的測。式中，沈浸於燒杯中的測試管在測試期間 都被拍下片。對於—些測試，測試管上的凹點深度以顧 微鏡技術測定（參考ASTM G 4694，5·2 4)。這些凹 點測定測試’使用二個測試管，每—測試管測定高達胸 凹點（每一邊高達10個）。 除非另外特別說明，測試水含有1〇〇mg/l Ca (以CaC〇3 計），50 mg/丨Mg (以CaC_)，刚mg/丨氣化物，和⑽邮 4S文鹽。使用這種水在86，7·6，和68的pH進行測試。 14些阳值相對的“M”驗度為川，32，和4 mg/ι (所有的都 疋以C a C Ο 3計）。 經濟部智慧財產局員工消費合作社印製 較困難在這種測試水控制鐵金屬腐蝕。相對較低的鈣 硬度使依賴料抑制劑難以有效地作用。相對較高的硫酸 鹽和氣化物含量（對肖定約含量）使得水對鐵金屬具有侵略 性’特別是對於凹點腐蝕。 為了避免在測試期間發生碳酸鈣及/或磷酸鈣沈積， δ午多測试在測試水加入5 mg/卜聚合反應度為大約5的 (210 x 297 公釐） 本紙張尺度適用中國國家標準（CNS)A4規;fi 542858 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明（40) 環氧號ίό酸（PES A)，和5 mg/1活性的丙稀酸和稀丙基經基 丙基磺酸酯醚鈉鹽共聚物（AA/AHPSE)來進行。對一些測 試只用5 mg/1的AA/AHPSE共聚物。 同時進行添加和取代（固定抑制劑含量）測試。在前面 的測試形態，一個低含量的四唑鏘化合物（2至5 mg/Ι)加到 一個第二組成物。在後項測試，第二組成物減少一個特定 量（2至5 mg/1)，而以相同量的四唑鏘化合物取代。 性能實施例 實施例# 1 在pH 8.6進行測試的BCTA結果顯示於表1。使用於這 些測試的四唑繙化合物為NBT。Belcor 575是FMC出售的 說基膦酸基乙酸。Bricorr 288是Albright and Wilson出售 的一個膦酸基琥珀酸，膦酸化順-丁烯二酸二聚物，磷酸 ’和一個以重量計次要部份的較高膦酸化的順·丁烯二酸 券水物的混合物。Dequest 2060為Monsanto出售的二乙三 胺五（亞曱基膦酸）。Bayhibit AM為Bayer出售的2-膦酸基 丁烷-1，2,4-三羧酸。Goodrite κ·752 是一個 b F Goodrich 出售的聚丙烯酸酯。 如從表1可看到的，在所有的情況，除了 Bricorr 288 ，添加或取代低含量的NBT協同地改善腐蝕性能。這種如 特別測试條件的因素可能使Bricorr 288得到這種情況。 本紙張尺度適用中國國豕標準（CNS)A4規格（210 X 297公爱 -----：--------l·---訂--------- (請先閱讀背面之注意事項再填寫本頁) 542858 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明（41) 表1 pH 8.6Degree, 14 concentrations can be measured by continuous, semi-continuous or batch morphological analysis techniques, including spectroscopic methods (uv, visible light emission, visible light absorption, 1R'Raman 'glory' scale light, etc.), electrochemical methods (Including PH 'ORP, and ion-specific electrode assays), chromatography (Gc, Lc), methods that depend on antibody binding or release, chemical-based analysis / colorimetric methods, such as the marketer of the Hach Company, etc. Wait. A suitable spectrometer method is described in U.S. Patent Case No. 5,242,602, which is hereby incorporated by reference. A suitable method for adjusting the concentration in a water treatment reagent system is disclosed in U.S. Patent No. 5,411,889. U.S. Patent Case No. 5,855,791, which is hereby incorporated by reference, reveals that the appropriate method is based on the characteristics of this detector and system, and is used to determine the feed rate of rotten and clogging inhibitors. A tracer compound that may be optionally used may be a compound that does not function as a special treatment, hereinafter referred to as an inert tracer, or may be a water treatment compound that is also detected quickly, and such a treatment compound is hereinafter referred to as Is an active tracer. Suitable tracers include soluble lithium salts, such as lithium gaseous, transition metals, as described in U.S. Patent Case No. 4,966,7u, incorporated herein by reference, and fluorescent inert tracers, as described In U.S. Patent Case No. 4,783,3, 14 is hereby incorporated by reference. Suitable fluorescently inert tracers include mono-, di-, and trisulfonated naphthalenes (such as the water-soluble salts of naphthalene flavonic acid or naphthalenedisulfonic acid). Suitable active tracers include fluorescently labeled polymers, such as those described in U.S. Patent Case No. 5, 丨 7 丨, No. 45, incorporated herein by reference, and containing photo-inert, hidden detectable portions The polymer will absorb light when in contact with the photoactivator. For example, the paper size applies the Chinese National Standard (CNS) A4 (21G X 297 public love) ^ — (Please read the precautions on the back before filling this page) • Line · Printed by the Intellectual Property Bureau of the Ministry of Economic Affairs' Consumer Cooperatives 41 542858 A7 V. Description of Invention (38) In the US Patent Case No. 5.654,198, here are incorporated as reference materials, and mainly azoles Copper corrosion inhibitors, such as benzotriazole, and water, capacitive molybdate and tungstate. Although many compounds combined with tetrazolium compounds are known corrosion inhibitors, they are generally considered to be effective only under exceptional calcium hardness and pH conditions. For example, some phosphonate carboxylic acid esters, such as 2-phosphonobutane-: 1,2,4 monotricarboxylic acid (PBTC), usually contain only a certain amount of calcium hardness (such as > 200) in pH over 8 and water mg / bu as CaC03) effective as a corrosion inhibitor. It was confirmed as follows that the combination of PBTC and tetrazolium compound was very effective in water at pH 76, containing only 100 mg / calcium in terms of CaCO3. Similar = results are also seen in other combinations. It is best to have "tolerance," water pH and hardness treatment in many aqueous systems, that is, it can work well under a wide range of these conditions. The use of tetrazolium compounds can significantly reduce the total treatment dose required, Effectively limits corrosion in aqueous systems. Many combinations of tetrazolium compounds are with materials that are primarily or specifically used as scale and / or deposition inhibitors. However, 'these combinations are effective for both scale / deposition and rust contact simultaneously The control items of the Ministry of Education of Jibei Smart Wealth Co., Ltd. Consumer Test Method Known Conditions The inhibitory activity of the rotten surname treated by the present invention was evaluated with a beaker rotten surname tester (machi A). Co2 actuator, 〇〗 〇 Low carbon steel (LCS) test tube, an LCS electrochemical carbon needle, and a magnetic stir bar. The volume of the test solution is 9 liters red. ㈣ «1 to get electrochemical rot paper ruler 5 Gu Zhong _ 绪 i ^ Ns) A4 secret (fine χ tear public love 542858 V. Description of the invention (39) reference for the determination of the electrode and counter electrode are as follows: Architecture. Beaker immersed in water bath In order to control the temperature. During the test, the electrochemical corrosion reduction data was obtained periodically from the carbon needle by polarized electric technology. All tests were performed at 120 ° F, using a stirring rate of 400 RpM. Unless otherwise stated, the measurement The duration of the radon is 18 hours. Two values are reported for each test; ec (_ is the average value of the electrochemical survivorship rate measured in the test heart, and ec (i8 hours) is the value at the end of the test. The value of the term is considered as an indicator of the expected long-term rate of rotten money. In all measurements, the test tube immersed in the beaker was photographed during the test. For some tests, the depth of the pit on the test tube Quantitative micro-mirror techniques (refer to ASTM G 4694, May 24). These pit test tests use two test tubes, each measuring up to chest pits (up to 10 on each side). Unless otherwise specified Note that the test water contained 100 mg / l Ca (calculated as CaC03), 50 mg / 丨 Mg (calculated as CaC_), just mg / 丨 gas, and 4S sodium salt. Using this water at 86 , PH of 6,6, and 68. 14 The relative "M" test for positive values is Sichuan, 32, and 4 mg / (All are calculated as C a C 0 3). It is more difficult for employees of the Intellectual Property Bureau of the Ministry of Economic Affairs to print consumer cooperatives in this test to control the corrosion of ferrous metals in this test water. The relatively low calcium hardness makes it difficult to effectively rely on material inhibitors. Effect. Relatively high sulfate and gaseous content (content of Schrodinger) makes water aggressive to ferrous metals, especially for pitting corrosion. In order to avoid calcium carbonate and / or calcium phosphate deposition during the test, δ Noon test is added in test water with 5 mg / Bu polymerization reaction degree of about 5 (210 x 297 mm) This paper size applies to Chinese National Standard (CNS) A4 regulations; fi 542858 A7 B7 Employees ’intellectual property bureau consumption Printed by the cooperative V. Description of the invention (40) Epoxy resin (PES A), and 5 mg / 1 active acrylic acid and dipropyl propyl sulfonate ether sodium salt copolymer (AA / AHPSE ) To proceed. For some tests only 5 mg / 1 AA / AHPSE copolymer was used. Simultaneous addition and substitution (fixed inhibitor content) tests. In the previous test form, a low content of a tetrazolium compound (2 to 5 mg / 1) was added to a second composition. In the latter test, the second composition was reduced by a specific amount (2 to 5 mg / 1) and replaced with the same amount of tetrazolium compound. Performance Examples Example # 1 The results of BCTA tested at pH 8.6 are shown in Table 1. The tetrazole compound used in these tests was NBT. Belcor 575 is a monophosphonic acid sold by FMC. Bricorr 288 is a phosphonic succinic acid, phosphonated maleic-butenedioic acid dimer sold by Albright and Wilson, Phosphoric Acid 'and a higher phosphonized maleic acid, a minor portion by weight Water mixture of coupons. Dequest 2060 is diethylenetriaminepenta (phosphoranylidenephosphonic acid) sold by Monsanto. Bayhibit AM is a 2-phosphonic acid butane-1,2,4-tricarboxylic acid sold by Bayer. Goodrite κ · 752 is a polyacrylate sold by b F Goodrich. As can be seen from Table 1, in all cases, except for Bricorr 288, the addition or replacement of low levels of NBT synergistically improved the corrosion performance. Such factors as special test conditions may cause this situation to Bricorr 288. This paper size applies to China National Standard (CNS) A4 specification (210 X 297 public love -----: -------- l · --- order --------- (please (Please read the notes on the back before filling out this page) 542858 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs A7 B7 V. Description of Invention (41) Table 1 pH 8.6

含有 5 mg/1 活性PESA和5 mg/1 活性AA/AHPSE mg/1 抑制劑 mg/1 EC EC (所有都是活性劑） NET avg 18 0 - 0 58 50 0 - 2 24 24 0 - 5 7.7 5.5 20 L-酒石酸 0 6.2 8.5 20 L-酒石酸 2 2.6 3.2 20 L-酒石酸 5 2.7 2.7 15 HEDP 0 2.5 2.0 10 HEDP 0 3.0 2.1 7 HEDP 3 2.2 2.2 15 Belcor 575 0 3.8 2.8 10 Belcor 575 0 5.6 4.6 7 Belcor 575 3 1.7 1.2 15 Bricorr 288 0 3.8 2.9 10 Bricorr 288 0 4.7 4.0 7 Bricorr 288 3 6.2 4.4 15 Goodrite K-752 0 25 53 12 Goodrite K-752 3 8.8 17 15 Dequest 2060 0 4.0 3.2 10 Dequest 2060 0 7.3 8.8 7 Dequest 2060 3 3.6 2.7 15 Bayhibit AM 0 6.1 5.7 10 Bayhibit AM 0 8.1 9.1 7 Bayhibit AM 3 3.3 3.0 實施例#2 在pH 7.6，含有AA/AHPSE和PESA的情況下進行測試 的腐蝕結果顯示於表2。只含AA/AHPSE的結果顯示於表3 (請先閱讀背面之注意事項再填寫本頁) 裝 訂 線 45 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 542858Contains 5 mg / 1 active PESA and 5 mg / 1 active AA / AHPSE mg / 1 inhibitor mg / 1 EC EC (all are active agents) NET avg 18 0-0 58 50 0-2 24 24 0-5 7.7 5.5 20 L-tartaric acid 0 6.2 8.5 20 L-tartaric acid 2 2.6 3.2 20 L-tartaric acid 5 2.7 2.7 15 HEDP 0 2.5 2.0 10 HEDP 0 3.0 2.1 7 HEDP 3 2.2 2.2 15 Belcor 575 0 3.8 2.8 10 Belcor 575 0 5.6 4.6 7 Belcor 575 3 1.7 1.2 15 Bricorr 288 0 3.8 2.9 10 Bricorr 288 0 4.7 4.0 7 Bricorr 288 3 6.2 4.4 15 Goodrite K-752 0 25 53 12 Goodrite K-752 3 8.8 17 15 Dequest 2060 0 4.0 3.2 10 Dequest 2060 0 7.3 8.8 7 Dequest 2060 3 3.6 2.7 15 Bayhibit AM 0 6.1 5.7 10 Bayhibit AM 0 8.1 9.1 7 Bayhibit AM 3 3.3 3.0 Example # 2 The corrosion results of tests performed at pH 7.6 with AA / AHPSE and PESA are shown in the table 2. The results with AA / AHPSE only are shown in Table 3 (Please read the notes on the back before filling this page) Binding Line 45 This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 542858

。在這些水中，8)為3 mpy或更少者被認為 工業應用是可接受的腐料。在—些㈣於表㈣情^ 存在有时錯化合物的腐解是不可接受的。’然而，第— 組成份與四唑鏘化合物的組合協同的改善情況是明顯的， -個熟悉文獻者可很快地敎需要的有效抑制劑總量以及 四唾鏘化合物和其他組成份用以得到目標應用需要的腐姓 保護需要的相對比例。 这個上面說明的在pH 86結果的趨勢也在pH以看到 ’ B£ic.T：L._288的測試結果以圖式顯示於1，更清楚地說 明使用四㈣化合物NET與此物料組合得到的協同改善。 實施例#3 在pH 6.8進行測試的腐蝕結果顯示於下 — I ---------訂------- (請先閱讀背面之注咅？事項再填寫本頁) !壽！ 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公爱） 46 542858 A7 B7 五、發明說明（43) 經濟部智慧財產局員工消費合作社印製 表2 pH 7.6，含有 5 mg/1 活性PESA和 5 mg/1 活性AA/AHPSE 抑制劑 mg/1 EC EC mg/ (所有都是活性劑） NBT avg 18 0 - 0 67 87 0 - 2 65 73 0 - 5 28 32 0 - 5 40 36 10 Goodrite K-752 0 19 37 10 Goodrite K-752 2 27 38 10 Goodrite K-752 5 11 12 20 Goodrite K-752 0 11 11 20 Goodrite K-752 2 7.4 6.9 20 Goodrite K-752 5 1.3 0.7 20 Goodrite K-732 0 14 23 25 Goodrite K-732 0 7.4 8.0 20 Goodrite K-732 2 6.4 5.6 20 Goodrite K-732 5 0.9 0.4 20 Goodrite K-752和 K-732以50:50混合 0 12 18 20 Goodrite K-752和 K-732以50:50混合 2 7.8 8.8 20 Goodrite K-752和 K-732以50:50混合 5 1.3 0.6 25 A 0 15 17 20 A 5 1.8 1.1 25 B 0 9.4 7.7 20 B 5 2.0 1.0 25 C 0 19 19 20 C 5 1.1 0.5 5 0-P04 0 4.1 3.0 5 0-P04 2 0.9 0.3 5 o-po4 5 0.8 0.4 20 Bricorr 288 0 5.3 4.6 15 Bricorr 288 5 1.1 0.4 20 Bayhibit AM 0 12 8.7 15 Bayhibit AM 5 2.0 0.5 A : N，N’-雙(2-羥基琥珀基)-6,6-己烷二胺鈉鹽 B :亞胺基二(2-羥基琥珀酸)鈉鹽 C : N，N’-雙(2-羥基琥珀基)-間-二曱苯二胺鈉鹽 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 47 •-------------裝--- (請先閱讀背面之注意事項再填寫本頁) 訂： .線. 542858 A7 B7 五、發明說明（44 ) 經濟部智慧財產局員工消費合作社印製 表3 pH 7.6，含有 5 mg/1 活性AA/AHPSE 抑制劑 mg/1 EC EC mg/1 (所有都是活性劑） NBT avg 18 0 - 3 56 63 0 - 5 59 58 0 - 10 33 19 0 - 15 16 11 0 - 20 10 5 20 Bricorr 288 0 5.6 5.5 17 Bricorr 288 3 1.8 0.4 15 Bricorr 288 5 1.6 0.3 10 Bricorr 288 10 0.7 0.2 5 Bricorr 288 15 5.8 3.2 10 Bricorr 288 5 1.9 0.7 5 Bricorr 288 5 20 16 25 PESA 0 13 18 30 PESA 0 11 13 10 PESA 5 13 12 20 PESA 5 1.8 0.8 30 PESA 5 1.0 1.0 25 檸檬酸 0 14 13 30 檸檬酸 0 12 14 10 檸檬酸 5 21 16 20 檸檬酸 5 2.3 0.9 30 擰檬酸 5 1.3 0.4 30 Goodrite K-732 0 6.1 6 10 Goodrite K-732 5 9.7 10 20 Goodrite K-732 5 0.8 0.5 30 Goodrite K-732 5 0.7 0.3 25 Belclene 200 0 14 13 30 Belclene 200 0 14 12 10 Belclene 200 5 6.8 6.3 20 Belclene 200 5 1.3 0.7 30 Belclene 200 5 1.2 0.7 25 2,3-二羥基苯酸 0 7.7 7.0 20 2,3-二羥基苯酸 5 0.97 0.49 25 1,2,3,4-丁烷四羧酸 0 12 23 20 1，2,3,4-丁烷四羧酸 5 9.3 7.5 75 四蝴酸納（Borax) 0 64 77 70 四蝴酸納（Borax) 5 58 51 30 亞硝酸鹽（亞硝酸鈉） 0 59 62 25 亞硝酸鹽（亞硝酸鈉） 5 36 45 60 亞硝酸鹽（亞硝鈉酸） 0 25 41 55 亞硝酸鹽（亞硝酸鈉） 5 11 14 ------------—=—訂--------- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 48 542858 A7 B7 五、發明說明（45) 經濟部智慧財產局員工消費合作社印製 表3-續. In these waters, 8) of 3 mpy or less is considered an acceptable humus for industrial applications. In some cases, it is unacceptable that the decay of the wrong compound sometimes exists. 'However, the synergistic improvement of the combination of the first component and the tetrazolium compound is obvious. A person familiar with the literature can quickly determine the total amount of effective inhibitors that are needed, as well as the tetrasial compound and other components. Get the relative proportions of rotten name protection needed for the target application. The above-mentioned trend at pH 86 results is also seen at pH to see 'B £ ic.T: L._288. The test results are shown graphically at 1, which more clearly illustrates the use of the tetrafluorene compound NET with this material combination Get synergistic improvements. Example # 3 The corrosion results tested at pH 6.8 are shown below — I --------- Order ------- (Please read the note on the back? Matters before filling out this page)! life! Printed by the Intellectual Property Bureau of the Ministry of Economic Affairs of the Consumer Cooperatives This paper is printed in accordance with the Chinese National Standard (CNS) A4 (210 X 297 public love) 46 542858 A7 B7 V. Description of the invention (43) Printed by the Employees Cooperative of the Intellectual Property Bureau of the Ministry of Economics Table 2 pH 7.6 with 5 mg / 1 active PESA and 5 mg / 1 active AA / AHPSE inhibitor mg / 1 EC EC mg / (all are active agents) NBT avg 18 0-0 67 87 0-2 65 73 0-5 28 32 0-5 40 36 10 Goodrite K-752 0 19 37 10 Goodrite K-752 2 27 38 10 Goodrite K-752 5 11 12 20 Goodrite K-752 0 11 11 20 Goodrite K-752 2 7.4 6.9 20 Goodrite K-752 5 1.3 0.7 20 Goodrite K-732 0 14 23 25 Goodrite K-732 0 7.4 8.0 20 Goodrite K-732 2 6.4 5.6 20 Goodrite K-732 5 0.9 0.4 20 Goodrite K-752 and K-732 to 50:50 mix 0 12 18 20 Goodrite K-752 and K-732 mix 50:50 2 7.8 8.8 20 Goodrite K-752 and K-732 mix 50:50 5 1.3 0.6 25 A 0 15 17 20 A 5 1.8 1.1 25 B 0 9.4 7.7 20 B 5 2.0 1.0 25 C 0 19 19 20 C 5 1.1 0.5 5 0-P04 0 4.1 3.0 5 0-P04 2 0.9 0.3 5 o-po4 5 0.8 0.4 20 Bricorr 288 0 5.3 4.6 15 Bricorr 288 5 1.1 0.4 20 Bayhibit AM 0 12 8.7 15 Bayhibit AM 5 2.0 0.5 A: N, N'-bis (2-hydroxysuccinyl) -6,6-hexanediamine sodium salt B: Sub Aminobis (2-hydroxysuccinic acid) sodium salt C: N, N'-bis (2-hydroxysuccinyl) -m-diphenylenediamine sodium salt This paper is in accordance with China National Standard (CNS) A4 specifications ( 210 X 297 mm) 47 • ------------- Install --- (Please read the precautions on the back before filling this page) Order: .line. 542858 A7 B7 V. Description of the invention (44) Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, Table 3, pH 7.6, containing 5 mg / 1 active AA / AHPSE inhibitor mg / 1 EC EC mg / 1 (all active agents) NBT avg 18 0-3 56 63 0-5 59 58 0-10 33 19 0-15 16 11 0-20 10 5 20 Bricorr 288 0 5.6 5.5 17 Bricorr 288 3 1.8 0.4 15 Bricorr 288 5 1.6 0.3 10 Bricorr 288 10 0.7 0.2 5 Bricorr 288 15 5.8 3.2 10 Bricorr 288 5 1.9 0.7 5 Bricorr 288 5 20 16 25 PESA 0 13 18 30 PESA 0 11 13 10 PESA 5 13 12 20 PESA 5 1.8 0.8 30 PESA 5 1.0 1.0 25 Citric acid 0 14 13 30 Citric acid 0 12 14 10 Citric acid 5 21 16 20 Citric acid 5 2.3 0.9 30 Citric acid 5 1.3 0.4 30 Goodrite K-732 0 6.1 6 10 Goodrite K-732 5 9.7 10 20 Goodrite K-732 5 0.8 0.5 30 Goodrite K-732 5 0.7 0.3 25 Belclene 200 0 14 13 30 Belclene 200 0 14 12 10 Belclene 200 5 6.8 6.3 20 Belclene 200 5 1.3 0.7 30 Belclene 200 5 1.2 0.7 25 2,3-dihydroxybenzoic acid 0 7.7 7.0 20 2,3-dihydroxybenzene Acid 5 0.97 0.49 25 1,2,3,4-butanetetracarboxylic acid 0 12 23 20 1,2,3,4-butanetetracarboxylic acid 5 9.3 7.5 75 Borax 0 64 77 70 Borax 5 58 51 30 Nitrite (sodium nitrite) 0 59 62 25 Nitrite (sodium nitrite) 5 36 45 60 Nitrite (sodium nitrite) 0 25 41 55 Nitrite Salt (Sodium Nitrite) 5 11 14 ------------— = — Order --------- (Please read the precautions on the back before filling this page) The paper size Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 48 542858 A7 B7 V. Description of invention (45) Printed by the Consumer Cooperatives of Intellectual Property Bureau of the Ministry of Economic Affairs 3-Continue

pH 7.6，含有 5 mg/1 活性AA/AHPSE mg/1 抑制劑 (所有都是活性劑） mg/1 NBT EC avg EC 18 25 中酒石酸 0 9.4 7.7 20 中酒石酸 5 1.7 0.93 30 葡萄糖酸 5 3.6 2.2 20 N-月桂醯基肌胺酸 0 46 73 15 N-月桂醯基肌胺酸 5 30 30 25 1，1〇-啡啉 0 59 66 20 1,10-啡啉 5 40 25 30 Belsperse 161(含膦基基團之寡聚PAA) 0 5.2 4.4 25 Belsperse 161(含膦基基團之寡聚PAA) 5 1.1 0.31 30 低分子量聚丙烯酸(PAA)，含膦酸終端基 團，鈉鹽 0 6.6 7.1 25 低分子量(PAA)，含膦酸終端基團，鈉鹽 5 1.7 0.84 30 Belclene 500 (含膦基基團的寡聚PAA) 0 14 17 25 Belclene 500 (含膦基基團的寡聚PAA) 5 2.5 0.93 30 Belclene 400 (AA : AMPS含次膦酸鹽） 0 11 10 25 Belclene 400 (AA : AMPS含次膦酸鹽） 5 3.3 1.2 30 Belclene 494 (AA : AMPS含終端膦酸酯） 0 8.3 7.7 25 Belclene 494 (AA : AMPS含終端膦酸酉旨） 5 7.2 7.2 聚丙烯酸酯 25 Goodrite K-732 5 1.1 0.35 20 Goodrite K-732 5 1.5 0.65 30 Goodrite K-732 5 0.96 0.43 修飾的聚環氧琥珀酸 25 間-伸二曱苯二胺/PESA衍生物鈉鹽# 1 5 0.98 0.48 25 間-伸二曱苯二胺/PESA衍生物鈉鹽#2 5 1.7 0.62 25 間-伸二曱苯二胺/PESA衍生物鈉鹽# 3 5 1.7 0.72 25 間-伸二曱苯二胺/PESA衍生物鈉鹽# 4 5 1.8 0.73 ----------------- (請先閱讀背面之注意事項再填寫本頁) --線- 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 49 542858 A7 B7 五、發明說明（46) 經濟部智慧財產局員工消費合作社印制衣 表4 pH 6.8 含有 5 mg/1 活性PESA和 5 mg/1 活性AA/AHPSE mg/1 抑制劑 (所有都是作為活性劑） mg/1 ΝΒΤ EC avg EC 18 0 - 0 71 80 0 - 5 67 67 25 A 0 20 20 20 A 0 3.7 1.5 25 B 0 13 14 20 B 5 2.0 0.6 25 C 0 21 19 20 C 5 2.7 2.1 25 丙酮二酸 0 6.2 5.3 20 丙嗣二酸 5 2.3 1.9 25 L-酒石酸 0 17 17 20 L-酒石酸 5 4.3 2.0 25 糖質酸 0 13 12 20 糖質酸 5 2.2 0.9 7 0-P04 0 4.5 4.1 7 0-P04 2 1.4 1.0 7 0-P04 5 1.0 0.6 20 Bricorr 288 0 5.0 6.2 15 Bricorr 288 5 1.3 0.5 20 HEDP 0 7.3 5.9 15 HEDP 5 1.0 0.6 20 Belcor 575 0 5.7 8.5 15 Belcor 575 5 0.7 0.6 20 鉬酸鹽，Mo04 0 15 33 15 鉬酸鹽，Mo04 5 11 12 30 鉬酸鹽，Mo04 0 8.1 11 25 鉬酸鹽，Mo04 5 2.8 3.1 25 Goodrite K-732 0 8.8 8.4 20 Goodrite Κ-732 5 3.8 1.8 ----------------：----訂--------- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 50 542858pH 7.6 with 5 mg / 1 active AA / AHPSE mg / 1 inhibitor (all are active agents) mg / 1 NBT EC avg EC 18 25 medium tartaric acid 0 9.4 7.7 20 medium tartaric acid 5 1.7 0.93 30 gluconic acid 5 3.6 2.2 20 N-lauric acid sarcosinate 0 46 73 15 N-lauric acid sarcosinate 5 30 30 25 1,10-morpholine 0 59 66 20 1,10-morpholine 5 40 25 30 Belsperse 161 (including Phosphine-based oligomeric PAA) 0 5.2 4.4 25 Belsperse 161 (phosphine-based oligomeric PAA) 5 1.1 0.31 30 Low molecular weight polyacrylic acid (PAA), containing phosphonic acid terminal groups, sodium salt 0 6.6 7.1 25 Low molecular weight (PAA), phosphonic acid-containing terminal group, sodium salt 5 1.7 0.84 30 Belclene 500 (oligomeric PAA with phosphine group) 0 14 17 25 Belclene 500 (oligomeric PAA with phosphine group) 5 2.5 0.93 30 Belclene 400 (AA: AMPS with phosphinate) 0 11 10 25 Belclene 400 (AA: AMPS with phosphinate) 5 3.3 1.2 30 Belclene 494 (AA: AMPS with terminal phosphonate) 0 8.3 7.7 25 Belclene 494 (AA: AMPS with terminal phosphonic acid) 5 7.2 7.2 Polyacrylate 25 Goodrite K-732 5 1.1 0.35 20 Goodrite K-732 5 1.5 0.65 30 Goodr ite K-732 5 0.96 0.43 Modified polyepoxysuccinic acid 25 meta-diphenylene diamine / PESA derivative sodium salt # 1 5 0.98 0.48 25 meta-diphenylene diamine / PESA derivative sodium salt # 2 5 1.7 0.62 25 meta-diphenylene diamine / PESA derivative sodium salt # 3 5 1.7 0.72 25 meta-diphenylene diamine / PESA derivative sodium salt # 4 5 1.8 0.73 ---------- ------- (Please read the precautions on the back before filling this page) --Line- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 49 542858 A7 B7 V. Invention Instructions (46) Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs Table 4 pH 6.8 Contains 5 mg / 1 active PESA and 5 mg / 1 active AA / AHPSE mg / 1 inhibitor (all as active agents) mg / 1 ΝΒΤ EC avg EC 18 0-0 71 80 0-5 67 67 25 A 0 20 20 20 A 0 3.7 1.5 25 B 0 13 14 20 B 5 2.0 0.6 25 C 0 21 19 20 C 5 2.7 2.1 25 Pyruvate 0 6.2 5.3 20 Malonic acid 5 2.3 1.9 25 L-tartaric acid 0 17 17 20 L-tartaric acid 5 4.3 2.0 25 Sugar acid 0 13 12 20 Sugar acid 5 2.2 0.9 7 0-P04 0 4.5 4.1 7 0-P04 2 1.4 1.0 7 0-P04 5 1. 0 0.6 20 Bricorr 288 0 5.0 6.2 15 Bricorr 288 5 1.3 0.5 20 HEDP 0 7.3 5.9 15 HEDP 5 1.0 0.6 20 Belcor 575 0 5.7 8.5 15 Belcor 575 5 0.7 0.6 20 Molybdate, Mo04 0 15 33 15 Molybdate, Mo04 5 11 12 30 Molybdate, Mo04 0 8.1 11 25 Molybdate, Mo04 5 2.8 3.1 25 Goodrite K-732 0 8.8 8.4 20 Goodrite Κ-732 5 3.8 1.8 ------------ ----: ---- Order --------- (Please read the precautions on the back before filling this page) This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ) 50 542858

A7 B7 五、發明說明（47) 抑制凹點生長效率A7 B7 V. Description of the invention (47) Inhibit pit growth efficiency

在pH 8.6以酒石酸測試不同暴露次數的凹點深度結^ 顯不於表5。如結果顯示，添加入NBT是很有效於限制Q 點的生長。凹點是非碟抑制劑，如酒石酸的特別問題。 表5 凹點深度對沈浸時間的函數20 mg/1酒石酸， pH8.6含有5rngパ活性PESA和5mg/l活性AA/AHPSE 的測試凹點深度，微米；表列的數值為平均值 添加物 沈浸時間 無 2 mg/1 NBT 5 mg/1 NBT _ 18 56 34 18 42 89 23 21 66 130 30 30 90 134 44 30 貫施例# 5 在PH 7.6，正-磷酸鹽測試的凹點深度和凹點數的數 據顯示於表6。這些結果顯示NBT是有效於減少凹點深度 和凹點密度。 表6 -------------裝-----：----訂. (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 凹點深度和數目7 mg/1 0-P04，pH 7.6，18小時 測試含有 5 mg^mPESA和 5 mg/1 活性 AA/AHPSE 凹點深度，微米；表列的數值為平均值 添加物 無 2mg/l NBT 5 mg/1 NBT —!度 22 11 9 凹點數目 80* 39 18 *有更多凹點，但總沒得到凹點數目 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 51 mg/1 抑制劑 (作為活性劑） mg/1 NBT EC (avg) EC (18) 總 凹點數 Max PD Avg PD Min PD 10 HEDP 0 3.0 2.1 8 48 42 40 7 HEDP 3 2.2 2.2 20 23 14 8 10 Bayhibit AM 0 8.1 9.1 11 82 58 38 7 Bayhibit AM 3 3.4 3.0 20 68 30 7 542858 A7 B7 五、發明說明（48) 實施例# 6 顯示於表7是在10 mg/1總加入抑制劑得到的凹點數據 ’该結果再證實NBT的凹點成長抑制性質。雖然凹點密度 高於含有NBT的處理，但是凹點深度明顯地降低。在 Bayhibit AM的情況可清楚地看到NBT明顯的對一般腐蝕 率的控制。 A1 PH 8.6之結果The depth of the pits tested with tartaric acid at pH 8.6 for different exposure times is not as significant as shown in Table 5. As the results show, the addition of NBT is very effective in limiting Q-point growth. Dimples are a particular problem with non-dish inhibitors such as tartaric acid. Table 5 Depth of pits as a function of immersion time 20 mg / 1 tartaric acid, pH 8.6 Test pit depths containing 5rng パ active PESA and 5mg / l active AA / AHPSE, micrometers; the values in the table are average addition immersion No time 2 mg / 1 NBT 5 mg / 1 NBT _ 18 56 34 18 42 89 23 21 66 130 30 30 90 134 44 30 Example # 5 At pH 7.6, the pit depth and pit of the ortho-phosphate test The data of the numbers are shown in Table 6. These results show that NBT is effective in reducing pit depth and pit density. Table 6 ------------- Installation -----: ---- Order. (Please read the precautions on the back before filling out this page) Depth and number of pits 7 mg / 1 0-P04, pH 7.6, 18 hours test contains 5 mg ^ mPESA and 5 mg / 1 active AA / AHPSE pit depth, micron; the values in the table are average values 2mg / l NBT 5 mg / 1 NBT —! Degree 22 11 9 Number of pits 80 * 39 18 * There are more pits, but the number of pits is not always obtained X 297 mm) 51 mg / 1 Inhibitor (as active agent) mg / 1 NBT EC (avg) EC (18) Total number of pits Max PD Avg PD Min PD 10 HEDP 0 3.0 2.1 8 48 42 40 7 HEDP 3 2.2 2.2 20 23 14 8 10 Bayhibit AM 0 8.1 9.1 11 82 58 38 7 Bayhibit AM 3 3.4 3.0 20 68 30 7 542858 A7 B7 V. Description of the invention (48) Example # 6 is shown in Table 7 at 10 mg / 1 Pit data obtained by total addition of inhibitors' This result confirms the pit growth inhibitory properties of NBT. Although the pit density was higher than that of the NBT-containing treatment, the pit depth was significantly reduced. In the case of Bayhibit AM, it is clear that NBT clearly controls the general corrosion rate. Results of A1 PH 8.6

含有5 mg/1丙稀酸/1-稀丙氧基經基丙烧石黃酸的 共聚物和5 mg/1 PESA PD=$測試終點測試管測定的凹點深度，微米 _最大深度，Avg=平均深度，Min=最小深度Contains 5 mg / 1 acrylic acid / 1-dilute propoxy copolymer of propylene propionite flavonic acid and 5 mg / 1 PESA PD = $ end point of the test tube, micron_maximum depth, Avg = Average depth, Min = minimum depth

Olij實施例-其他測試水 水相系統’如冷卻塔等等，中水的硬度和pH可能有 很大的變化。能有效的作用於廣大的硬度範圍和pH範圍 而同時抑制腐蝕和沈積的抑制劑配方是大大有利的。另外 最好在一些必須使用未循環水的系統，這種系統通常含低 鈣（<100 mg/1 Ca ’ 以 CaC〇3計）和相對中性的 ρΗ(6.5-7·5), 使用的抑制劑需要不依賴鹼性pH，高硬度條件來有效地 作用，如許多目前使用的處理情況。這種系統的實施例為 密閉回路冷卻系、統，單循環的冷卻***，熱水加熱系統等 等。下面的實施例再確認含有四唑鐳化合物的抑制劑配方 -----^----訂--------- (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製Olij Example-Other Test Waters Aqueous phase systems' such as cooling towers, etc. The hardness and pH of the reclaimed water may vary greatly. Inhibitor formulations that are effective in a wide range of hardness and pH ranges while inhibiting corrosion and sedimentation are greatly advantageous. In addition, it is best to use uncirculated water in such systems, which usually contain low calcium (< 100 mg / 1 Ca 'based on CaC03) and relatively neutral ρΗ (6.5-7 · 5) Inhibitors need to be independent of alkaline pH, high hardness conditions to function effectively, as in many currently used processing situations. Examples of such systems are closed loop cooling systems, systems, single cycle cooling systems, hot water heating systems, and the like. The following examples reconfirm the inhibitor formula containing tetrazolium and radium compounds ----- ^ ---- Order --------- (Please read the precautions on the back before filling this page) Ministry of Economy Printed by the Intellectual Property Bureau Staff Consumer Cooperative

52 542858 A7 B7 五、發明說明（49) 的廣泛效率，當以本揭示說明的四唑鏘化合物與其他組成 份合併使用，得到的改善超過已知於文獻的物料。 實施例#7 低pH，低硬度 表8顯示水中含有15 mg/1 Ca，以CaC03計，7.6 mg/1 Mg ，以 CaC〇3計，71 mg/1 Cl，48 mg/1 S04，力口入 5 mg/1 活性 AA/AHPSE，在pH 7.0的結果。當加入5 mg/1 NBT，腐钱 ) 率明顯的減少。 --------------裝—— (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 表8 mg/1 處理劑 mg/1 NBT EC avg EC (18) 10 0-P04 0 12 9.7 10 0-P04 5 1.2 0 67 20 Bricorr 288 0 10 9.2 20 Bricorr 288 5 0.96 0.21 20 HEDP 0 9.1 9.0 20 HEDP 5 0.89 0.13 20 Belcor 575 0 5.9 5.8 20 Belcor 575 5 0.51 0.21 15 EBO 0 14 15 15 EBO 5 1.1 0.55 30 Goodrite K-732 0 6.1 6.4 30 Goodrite K-732 5 0.48 0.12 60 L-酒石酸 0 13 12 60 L·酒石酸 5 2.4 1.2 20 丙酮二酸 0 5.3 6.3 20 丙酮二酸 5 1.1 0.70 20 糖質酸 5 2.1 1.1 〇-P〇4 :正填酸鹽 HEDP :羥基亞乙基二膦酸 · 線' 53 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） 542858 A7 五 發明說明（50) 較低pH，較高硬度 在阳 6·8’ 水中含有 500 mg/l Ca，以 CaC03 計，250 mg/l Mg ’以 CaC〇3計 ’ 7 mg/1 MAlk，以 CaC03計，354 mg/1 氣 化物’和500 mg/丨硫酸鹽進行bCTA測試的結果顯示於表9 所有測试都含有5 mg/1活性aa/AHPSE。這種條件通常 在開放式再循環冷卻系統遇到，該系統中的來源水（補充 水）因為洛發而被濃縮數倍，並加入硫酸維持較低的pH。 在k些’収系列中’各對比較（含有和不含NBT)的總抑制 劑濃度維持-定或接近—定。在各情況下，取代部份抑制 劑或抑制劑與耐混合得到明顯改善的腐祕能。如前面 的說明’不是所有與时鐵化合物的組合提供可接受的腐 但在所有情況的組合都有改善性能。熟悉文獻者^特別的水相系統中得到滿意性能需要的適當含I和比率。 --------I--I ----(請先閱讀背面之注意事項再填寫本頁) I I ·11!111 經濟部智慧財產局員工消費合作社印製52 542858 A7 B7 V. Extensive efficiency of invention description (49). When the tetrazolium compound described in this disclosure is used in combination with other components, the improvement is more than that of materials known in the literature. Example # 7 Low pH, low hardness Table 8 shows that water contains 15 mg / 1 Ca, calculated as CaC03, 7.6 mg / 1 Mg, calculated as CaC03, 71 mg / 1 Cl, 48 mg / 1 S04, Likou Add 5 mg / 1 active AA / AHPSE, results at pH 7.0. When 5 mg / 1 NBT was added, the rate of corruption was significantly reduced. -------------- Packing—— (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 8 mg / 1 Processing agent mg / 1 NBT EC avg EC (18) 10 0-P04 0 12 9.7 10 0-P04 5 1.2 0 67 20 Bricorr 288 0 10 9.2 20 Bricorr 288 5 0.96 0.21 20 HEDP 0 9.1 9.0 20 HEDP 5 0.89 0.13 20 Belcor 575 0 5.9 5.8 20 Belcor 575 5 0.51 0.21 15 EBO 0 14 15 15 EBO 5 1.1 0.55 30 Goodrite K-732 0 6.1 6.4 30 Goodrite K-732 5 0.48 0.12 60 L-tartaric acid 0 13 12 60 L · tartaric acid 5 2.4 1.2 20 pyruvate 0 5.3 6.3 20 Pyruvate 5 1.1 0.70 20 Glycosylic acid 5 2.1 1.1 〇-P〇4: Ortho-acid salt HEDP: Hydroxyethylene diphosphonic acid · Line '53 This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 542858 A7 Fifth invention description (50) Lower pH, higher hardness Contains 500 mg / l Ca in 6.8 ′ water, as CaC03, 250 mg / l Mg 'in CaC 〇3 count '7 mg / 1 MAlk, calculated as CaC03, 354 mg / 1 gaseous matter' and 500 mg / 丨 sulfate bCTA test results are shown in Table 9 All tests Containing 5 mg / 1 active aa / AHPSE. This condition is often encountered in open recirculation cooling systems where the source water (make-up water) is concentrated several times due to Lovat and sulfuric acid is added to maintain a lower pH. The total inhibitor concentration of each pair of comparisons (with and without NBT) in the 'collection series' is maintained-fixed or near-fixed. In each case, the substitution of some inhibitors or inhibitors with significantly improved corrosion resistance was achieved. As stated earlier, not all combinations with iron compounds provide acceptable decay, but in all cases the combination has improved performance. Those familiar with the literature ^ appropriate I and ratios required for satisfactory performance in particular aqueous systems. -------- I--I ---- (Please read the notes on the back before filling out this page) I I · 11! 111 Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs

本紙張尺度適用中國國家標準（CNS)A4規格（21〇 297公釐） 54 542858 A7 B7 i、發明說明（51) 表9 mg/1 處理#1 mg/1 處理#2 mg/1 NBT EC (avg) EC (18) 10 0-P〇4 - - 0 7.5 5^0^ 5 o-p〇4 - - 5 2.3 Γό ^ 7 0-P〇4 3.0 Pyro-P04 0 2.9 _ 1.2 5.5 0-P04 2.5 Pyro-P04 3 0.99 037 ^ 4 0-P04 2.0 Pyro-P04 3 1.6 —----- 〇·77 20 Bricorr 288 - - 0 31 49 15 Bricorr 288 - - 5 13 13^ 16 Bricorr 288 4 0-P〇4 0 2.6 1.6^ 12 Bricorr 288 3 0-P04 5 1.5 0^92^ 25 糖質 - - 0 34 ~ 60^ 20 糖質 - - 5 13 lT^ 15 糖質 4 0-P〇4 0 7.9 -- 8.2 12 糖質 3 0-P〇4 5 2.1 1.3 16 D 4 〇-P〇4 0 12 ------ 7.7 12 D 3 0-P04 5 1.9 〇~89^ D :亞胺基-二(2-羥基琥珀酸)鈉鹽 --------------裝--- f請先閱讀背面之注咅？事項再填寫本頁}This paper size applies the Chinese National Standard (CNS) A4 specification (21〇297 mm) 54 542858 A7 B7 i. Description of the invention (51) Table 9 mg / 1 treatment # 1 mg / 1 treatment # 2 mg / 1 NBT EC ( avg) EC (18) 10 0-P〇4--0 7.5 5 ^ 0 ^ 5 op〇4--5 2.3 Γό ^ 7 0-P〇4 3.0 Pyro-P04 0 2.9 _ 1.2 5.5 0-P04 2.5 Pyro -P04 3 0.99 037 ^ 4 0-P04 2.0 Pyro-P04 3 1.6 ------- 〇 77 20 Bricorr 288--0 31 49 15 Bricorr 288--5 13 13 ^ 16 Bricorr 288 4 0-P〇 4 0 2.6 1.6 ^ 12 Bricorr 288 3 0-P04 5 1.5 0 ^ 92 ^ 25 Glycan--0 34 ~ 60 ^ 20 Glycan--5 13 lT ^ 15 Glycan 4 0-P〇4 0 7.9- 8.2 12 Glycan 3 0-P〇4 5 2.1 1.3 16 D 4 0-P〇4 0 12 ------ 7.7 12 D 3 0-P04 5 1.9 0 ~ 89 ^ D: imino-bis ( 2-Hydroxysuccinic acid) sodium salt -------------- pack --- f Please read the note on the back first? Matters refill this page}

經濟部智慧財產局員工消費合作社印製 實施例#9 高pH，中硬度的水 表 10顯示 pH 8.6，含有 360 mg/1 Ca，以 CaC03計，18〇 mg/1 Mg，以 CaC03計，255 mg/1 α，220 mg/1 S04，和 3〇〇Printed by Example # 9 Employee Consumer Cooperative of the Bureau of Intellectual Property, Ministry of Economic Affairs, Water meter 10 with high pH and medium hardness shows pH 8.6, contains 360 mg / 1 Ca, calculated as CaC03, 180 mg / 1 Mg, calculated as CaC03, 255 mg / 1 α, 220 mg / 1 S04, and 3〇〇

mg/1 Malk，以CaC〇3計，的測試水得到的結果。所有測試 都含有5 mg/1活性AA/AHPSE。這種條件通常在開放式再 循環冷卻系統遇到，該系統中的來源水（補充水）由於蒸發 ，已經被濃縮數倍，而pH被控制於中等的pH 8範圍使其 較容易控制鐵的腐餘。從這些結果明顯看到在這些條件下 添加入四嗤鐵化合物的效率Q 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） --線· 55 542858 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明（52) 表10 mg/1 處理#1 mg/1 處理#2 mg/1 NBT EC (avg) EC (18) 10 PESA - - 0 11 15 5 PESA - - 5 6.7 20 PESA - - 0 7.6 7.0 10 PESA - - 5 4.5 2.7 20 PESA - - 5 2.5 1.7 10 PESA 10 L-酒石酸 0 7.3 4.3 10 PESA 10 L-酒石酸 5 2.5 1.9 10 Acumer™ 4210 - - 0 11 7.8 10 Acumer™ 4210 - - 5 3.7 1.6 20 Acumer™ 4210 - - 0 6.4 4.1 20 Acumer™ 4210 - - 5 2.2 2.0 10 Acumer™ 4210 10 PESA 0 6.4 4.3 10 Acumer™ 4210 10 PESA 5 2.6 2.0 10 Acumer™ 4210 10 L-酒石酸 0 5.4 3.5 10 Acumer™ 4210 10 L-酒石酸 5 1.9 1.6mg / 1 Malk, as CaCO3, in test water. All tests contained 5 mg / 1 active AA / AHPSE. This condition is usually encountered in open recirculation cooling systems, where the source water (make-up water) has been concentrated several times due to evaporation, and the pH is controlled to a medium pH 8 range making it easier to control iron. Corruption. It is clear from these results that the efficiency of adding the tetramium iron compound under these conditions Q The paper size is applicable to the Chinese National Standard (CNS) A4 (210 X 297 mm)-line · 55 542858 A7 B7 Intellectual Property Printed by the Bureau ’s Consumer Cooperatives 5. Description of the invention (52) Table 10 mg / 1 Processing # 1 mg / 1 Processing # 2 mg / 1 NBT EC (avg) EC (18) 10 PESA--0 11 15 5 PESA-- 5 6.7 20 PESA--0 7.6 7.0 10 PESA--5 4.5 2.7 20 PESA--5 2.5 1.7 10 PESA 10 L-tartaric acid 0 7.3 4.3 10 PESA 10 L-tartaric acid 5 2.5 1.9 10 Acumer ™ 4210--0 11 7.8 10 Acumer ™ 4210--5 3.7 1.6 20 Acumer ™ 4210--0 6.4 4.1 20 Acumer ™ 4210--5 2.2 2.0 10 Acumer ™ 4210 10 PESA 0 6.4 4.3 10 Acumer ™ 4210 10 PESA 5 2.6 2.0 10 Acumer ™ 4210 10 L-tartaric acid 0 5.4 3.5 10 Acumer ™ 4210 10 L-tartaric acid 5 1.9 1.6

Acumer4210 :聚順-丁烯二酸，由Rohm&Haas供應 實施例#10 另外的四σ坐鐳化合物 以ΝΒΤ和三個另外的四唑鏘化合物：二苯乙烯基硝基 藍四唑鏘氣化物（DNBT)，四硝基藍四唑鐯氣化物（ΤΝΒΤ) ，和2-(4-碘苯基）-3-(4-硝苯基）-5-苯基四唑鐯氣化物（ΙΝΤ) ，在pH 7.6得到的數據顯示於表11。測試水與實施例2相 同。和DNBT與Belclene 200的組合不同，揭示於本發明四 唑鏘化合物與其他物料組合的協同交互作用是很明顯的。 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐） ---------Γ — ----l·---訂--------- (請先閱讀背面之注意事項再填寫本頁) 56 542858 A7 B7 五、發明說明（53) 表11 抑制劑 (所有都是逢性劑） mg/1 四°坐錯化合物 mg/1 EC avg EC 18 - - DNBT 25 15 13 - - TNBT 25 12 9.0 - - INT 25 9.0 5.7 - - NBT 20 10 5 Bricorr 288 25 - - 4.4 4.2 Bricorr 288 20 DNBT 5 1.5 0.9 Bricorr 288 20 TNBT 5 1.1 0.8 Bricorr 288 20 INT 5 4.0 3.7 Bricorr 288 15 NET 5 1.6 0.4 Belclene 200 25 - - 15 13 Belclene 200 20 DNBT 5 21 22 Belclene 200 20 TNBT 5 5.5 5.2 Belclene 200 20 INT 5 6.7 11 Belclene 200 20 NET 5 1.3 0.7 ---------------裝—— (請先閱讀背面之注意事項再填寫本頁) 線· 本發明已經以其特別的實例作為說明，明顯的，本發 明許多其他的形態和修飾對熟悉文獻者是很清楚的。附隨 的申請專利範圍和本發明通常要涵蓋所有在本發明真正的 精神和範圍内的這種明顯的形態和修飾。 經濟部智慧財產局員工消費合作社印製 57 本紙張尺度適用中國國家標準（CNS)A4規格（210 X 297公釐）Acumer4210: polycis-butenedioic acid, supplied by Rohm & Haas Example # 10 Additional tetrasigmadium compound with NTB and three additional tetrazolium compounds: distyrylnitroblue tetrazolium gas (DNBT), tetranitroblue tetrazolium hydrazone (TNBT), and 2- (4-iodophenyl) -3- (4-nitrophenyl) -5-phenyltetrazolium hydride (ILT) The data obtained at pH 7.6 are shown in Table 11. The test water was the same as in Example 2. Unlike the combination of DNBT and Belclene 200, the synergistic interactions of the tetrazolium compound disclosed in the present invention with other material combinations are obvious. This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) --------- Γ — ---- l · --- Order --------- ( Please read the precautions on the back before filling out this page) 56 542858 A7 B7 V. Description of the invention (53) Table 11 Inhibitors (all of which are potent agents) mg / 1 Four ° misplacement compound mg / 1 EC avg EC 18 --DNBT 25 15 13--TNBT 25 12 9.0--INT 25 9.0 5.7--NBT 20 10 5 Bricorr 288 25--4.4 4.2 Bricorr 288 20 DNBT 5 1.5 0.9 Bricorr 288 20 TNBT 5 1.1 0.8 Bricorr 288 20 INT 5 4.0 3.7 Bricorr 288 15 NET 5 1.6 0.4 Belclene 200 25--15 13 Belclene 200 20 DNBT 5 21 22 Belclene 200 20 TNBT 5 5.5 5.2 Belclene 200 20 INT 5 6.7 11 Belclene 200 20 NET 5 1.3 0.7 ------ --------- Equipment—— (Please read the notes on the back before filling this page) Thread · The present invention has been described with its specific examples. Obviously, many other forms and modifications Those familiar with the literature are clear. The scope of the accompanying patent application and the present invention should generally cover all such obvious forms and modifications within the true spirit and scope of the present invention. Printed by the Employees ’Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs

Claims (1)

542858 A8 佴8 申請專利範圍 L. ir ψ ίΕ , 補充本⑽9曰丨 ，省,明六-本食修正後是否變更原實質&lt;0 第89108329號專利申請案申請專利範圍修正本 修正曰期：90年12月 1 · 一種用於控制接觸水相系統的金屬之腐钱的組成物 ’其中包含下述的組合： 0)下式的四唑鏺化合物：542858 A8 佴 8 Scope of patent application L. ir ψ ίΕ, supplement to this ⑽9, province, Mingliu-whether to change the original substance after the revision of this food &lt; 0 No. 89108329 Patent Application Application Patent Scope Amendment Date of this amendment: December 90, 1990 · A composition for controlling spoilage of metals in contact with an aqueous phase system ', which contains the following combination: 0) A tetrazolium compound of the formula: 2. R3 -y η 其中Ri，R2和R3係擇自於由較低級烷基，分枝的較低 級烷基，芳基，取代的芳基，烷芳基，取代的烷芳基 和雜環取代的芳基所組成之族者，但是必須Ri，反2或 I都不含有多於14個碳原子；及11為1或2，如果需要， 這種四唑鏘化合物任擇地含有伴隨的水溶性離子種系 ’以得到中性電荷，及 (b)至少另一個水相系統處理物料，其選擇要使得 該物料不實質的還原四唑鍇化合物。 如申請專利範圍第1項之組成物，其中該其他水相 統處理物料係擇自於由下述化合物所組成之族者： 機磷酸鹽，硼酸鹽，亞硝酸鹽，在水中釋放金屬陰 子的化合物，2,3-二羥基苯酸，1，10_啡啉，聚羧酸 ，烷基羥基羧酸，胺基羥基琥珀酸，羧基胺，聚環 系 離 酯 氧 (請先閲讀背面之注意事項再填寫本頁)2. R3 -y η where Ri, R2 and R3 are selected from lower alkyl, branched lower alkyl, aryl, substituted aryl, alkaryl, substituted alkaryl and A group consisting of heterocyclic substituted aryl groups, but must be Ri, neither trans 2 or I contain more than 14 carbon atoms; and 11 is 1 or 2, if necessary, this tetrazolium compound optionally contains Accompanying water-soluble ionic species' to obtain a neutral charge, and (b) at least another aqueous phase system processing material, which is selected so that the material does not substantially reduce the tetrazolium compound. For example, the composition of the scope of application for patent No. 1 wherein the other water-phase treatment materials are selected from the group consisting of the following compounds: organic phosphate, borate, nitrite, release metal cations in water Compounds, 2,3-dihydroxybenzoic acid, 1,10-morpholine, polycarboxylic acids, alkylhydroxycarboxylic acids, aminohydroxysuccinic acids, carboxyamines, polycyclic esterifying oxygen (please read the (Please fill in this page again) 58 542858 A8 B8 C8 D8 申請專利範圍 琥珀酸，經改質的聚環氧琥珀酸，單膦酸，二膦酸， 膦酸基魏酸，羥基膦酸基魏酸，胺基膦酸，膦酸基甲 基胺氧化物，聚合胺氧化物，聚醚聚胺基亞甲基膦酸 酯，聚醚聚胺基-亞曱基膦酸酯N-氧化物，亞胺基伸烷 基膦酸，肌胺酸之長鏈脂肪酸衍生物；調聚的，共調 聚的，聚合的或共聚合的含磷羧酸酯，鹼金屬矽酸鹽 ，單氟磷酸鹽’胺，二胺，烷醇胺，醚胺，脂肪胺和 二胺，四級化胺，氧烷基化胺，烷基-吡啶，四唑，咪 唑啉和取代的咪唑啉，醯胺胺，聚胺，聚伸烷基聚胺 ，苯磺酸，苯酸鹽和取代的苯酸鹽的烷基衍生物，胺 基苯酸鹽，水楊酸鹽，二聚酸-三聚酸，石油氧化物， 硼葡萄糖酸鹽；木質素，木質磺酸鹽，鞣酸；直鏈c5_Cll 單羧酸酯和（^-Cb α，ω-二羧酸酯；羧酸和氫硫基羧酸 的胺鹽，胺基酸，聚胺基酸，經基趟酸和相關的内酯 化合物’ Ν-酿基亞胺基二乙酸；三”丫 σ井二_和三_叛酸 ’磷-和磷酸鹽類；及單氟磷酸鹽；它們的水溶性鹽.， 及它們的混合物。 如申請專利範圍第1項之組成物，其中該四唑鏘化合 物係擇自於由硝基藍四唑鏘（2,2、二-對·硝苯基-5,5，-二苯乙烯基-3,3’-[3,3’-二甲氧基-4,4，_伸聯苯基]二四 坐麵）’ 一本乙婦基硝基藍四α坐鐵（2，2’-二-對-石肖苯基 -5,5’-二苯乙烯基-3,3’-[3,3’-二甲氧基_4,4、伸聯苯基] 二四嗤鏺），四硝基藍四唑鏺（3,3，-(3,3，_二甲氧基_4,4，-伸聯苯基）雙-[2,5-對-硝苯基-2Η-四唑鐵]及埃确基四58 542858 A8 B8 C8 D8 Scope of patent application Succinic acid, modified polyepoxysuccinic acid, monophosphonic acid, bisphosphonic acid, phosphonic acid, hydroxyphosphonoic acid, aminophosphonic acid, phosphonic acid Methylamine oxide, polymeric amine oxide, polyether polyaminomethylene phosphonate, polyether polyamino-amidino phosphonate N-oxide, imino alkylene phosphonic acid, muscle Long-chain fatty acid derivatives of amino acids; telomerized, co-telomerized, polymerized or copolymerized phosphorus-containing carboxylic acid esters, alkali metal silicates, monofluorophosphate'amines, diamines, alkanolamines, Ether amines, fatty amines and diamines, quaternized amines, oxyalkylated amines, alkyl-pyridines, tetrazoles, imidazolines and substituted imidazolines, amidoamines, polyamines, polyalkylene polyamines, Benzenesulfonic acid, alkyl derivatives of benzoate and substituted benzoate, aminobenzoate, salicylate, dimer-trimer acid, petroleum oxide, borogluconate; lignin, Lignosulfonate, tannic acid; linear c5_Cll monocarboxylic acid esters and (^ -Cb α, ω-dicarboxylic acid esters; amine salts of carboxylic acids and hydrothiocarboxylic acids, amino acids, polyamino acids Glycolic acid and related lactone compounds 'N-aminoimino-diacetic acid; three "γσ well di- and tri-acid' phosphorus-and phosphates; and monofluorophosphates; their Water-soluble salts, and mixtures thereof. The composition of item 1 in the scope of patent application, wherein the tetrazolium compound is selected from nitro blue tetrazolium (2,2, di-p-nitrophenyl) -5,5, -styrenyl-3,3 '-[3,3'-dimethoxy-4,4, _biphenyl] seated facet)' one ethynyl nitro group Blue tetra alpha sitting iron (2,2'-bis-p-stone phenylphenyl-5,5'-distyryl-3,3 '-[3,3'-dimethoxy_4,4, Diphenylene] tetrakistriazolium), tetranitro blue tetrazolium hydrazone (3,3,-(3,3, _dimethoxy_4,4, -diphenylene) bis- [2, 5-p-nitrophenyl-2'-tetrazolium] and ezetyl tetra (請先閲讀背面之注意事項再填窝本頁)(Please read the notes on the back before filling in this page) 59 542858 A8 B8 C8 D8 、申請專利範圍 唑鏘（2-(4_碘苯基）-3-(4-硝笨_基）-5-苯基四唑鏘）之水 溶性鹽所組成之族者。 如申請專利範圍第2項之組成物，其中該四唑鏺化合 物係擇自於由硝基藍四唑鍇（2,2，_二_對_硝苯基_5,5，_ 二苯乙烯基-3,3，_[3,3，-二甲氧基-4,4，-伸聯苯基]二四 坐鑷）一本乙烯基硝基藍四σ坐錯（2,2’_二-對_硝苯基 -5,5’-二苯乙烯基-3,3、[3,3、二甲氧基_4,4，_伸聯苯基] 二四唑繙），四硝基藍四唑鏘（3,3，_(3,3，_二曱氧基_4,4、 伸聯苯基）-雙_[2,5-對-确苯基-2Η-四唑鑕]及碘硝基四 唑鑕（2气4-碘苯基）-3-(4-硝苯基）-5-苯基四唑鏘）之水 溶性鹽所組成之族者。 如申請專利範圍第1項之組成物，其中該水溶性離子 種系係擇自於由鹵基，硝酸根，亞硝酸根，碳酸根， 碳酸氫根，硫酸根’磷酸根，及過渡金屬含氧酸根之 陰離子所組成之族者。 如申請專利範圍第5項之組成物，其中該函基係擇自 於由氣’氟，溴和峨所組成之族者。 如申請專利範圍第6項之組成物，其中該鹵基係氯。 如申請專利範圍第5項之組成物，其中該過渡金屬含 氧酸根係擇自於由鉬酸根，鉻酸根，和鎢酸根所組成 之族者。 如申請專利範圍第8項之組成物，其中該過渡金屬含 氧酸根係翻酸根。 10_如申請專利範圍第2項之組成物，其中該無機磷酸鹽 4. 5. 6. 8. 9. 本紙張尺度適用中國國家標準（CNs) A4規格（210X297公爱） ..... .............裝------------------、可.................線. (請先閲讀背面之注意事項再填窝本頁) 60 542858 A8 B8 C8 ----------^____ 六、申請專利範圍 為正磷酸鹽，聚磷酸鹽，其水溶性鹽^其混合物。 11.如申請專利範圍第2項之組成物，其中該無機磷酸鹽 是一個正磷酸和焦磷酸或其水溶性鹽的混合物。 12·如申請專利範圍第2項之組成物，其中該硼酸鹽是一 個擇自,於由四獨酸鹽，偏蝴酸鹽，及正娜酸鹽之水溶 性硼酸鹽所組成之族者。 13·如申請專利範圍第12項之組成物，其中該水溶性硼酸 鹽為四删酸納或四獨酸納之水合物。 14.如申請專利範圍第2項之組成物，其中該亞硝酸鹽係 亞硝酸鈉。 15·如申請專利範圍第2項之組成物，其中該金屬陰離子 釋放化合物係擇自於由鉬酸鹽，鐵酸鹽，鈒酸鹽，偏 釩酸鹽，及鉻酸鹽之水溶性鹽所組成之族者。 16·如申請專利範圍第15項之組成物，其中該鉬酸鹽之水 溶性鹽為鉬酸鈉或鉬酸鈉之水合物。 17. 如申請專利範圍第2項之組成物，其中該聚羧酸酯包 含含有4個和20個之間碳原子的脂肪化合物，該化合 物以敌酸S旨基團或其水溶性鹽多重取代。 18. 如申請專利範圍第17項之組成物，其中該聚羧酸酯係 1，2,3,4-丁烷四羧酸。 19·如申請專利範圍第2項之組成物，其中該聚羧酸酯是 一個得自含有一個或更多個羧基基團的乙烯不飽和 單體聚合反應的均聚物。 20.如申請專利範圍第19項之組成物，其中該均聚物為聚 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁) •訂丨 f -61 - 其中该均聚物為聚 其中該均聚物為聚 其中該聚羧酸酯是 542858 六、申請專利範圍 丙烯酸或其水溶性鹽。 21·如申請專利範圍第19項之組成物 川貝-丁稀二酸或其水溶性鹽。 22.如申凊專利範圍第19項之組成物 川貝-丁稀二酸gf或其水溶性鹽。 23·如申請專利範圍第2項之組成物 一個得自二個或更多個不同的乙烯不飽和單體聚合 反應的共聚物，該單體各含有一個或更多個羧基基團 24·如申請專利範圍第2項之組成物，其中該烷基羥基羧 酸的化學通式為 HOOC-(RB1)a-(RB2)b_(RB3)c_RB4 其中a，b ,和c為0至6的整數，（a+b+c)&gt;0 ,其中rb1 ，rb2 , Rb3包含C=Q或CYZ，其中Y和Z分別擇自包含 Η ’ OH ’ CHO，COOH，CH3，CH2(OH)，CH(OH)2 ’ CH2(COOH)，CH(OH)COOH，CH2(CHO)和 CH(OH)CHO的基團，其選擇要使該分子最少有一個 0H基團，當寫為其完全水合物的形式，及1^4為11或 COOH，包括這些酸各種不同的立體異構物和化學相 ¥的環狀’脫水’和水合物形態，及在水中形成上面 化合物的可水解的酯類和縮醛，或這種烷基羥基羧酸 的水溶性鹽。 25·如申請專利範圍第24項之組成物，其中該烷基羥基羧 酸係擇自於由酒石酸，中酒石酸，檸檬酸，葡萄糖酸 本紙張尺度適用中國國家標準（CNs) A4規格（210X297公釐） ------------------------裝·：： (請先閲讀背面之注意事項再填寫本頁) 訂丨 •線丨 62 542858 A8 B8 ^ C8 D8 六、申請專利範圍 ，葡萄糖庚糖酸，丙朗二酸，糖質酸及其水溶性鹽所 組成之族者。 (請先閲讀背面之注意事項再填寫本頁) 26.如申請專利範圍第2項之組成物，其中該其他水相系 統處理物料是一個正填酸或其水溶性鹽和至少一個 化學通式為 HO〇C-(RBl)a-(RB2)b-(RB3)c_RB4 的烧基經 基羧酸之混合物，其中a，b，和c為0至6的整數，及 (a+b+c)&gt;0，其中 RB1，RB2，RB3 包含 C=0 或 CYZ，其中 Y和Z分別擇自於由H，OH，CHO，COOH，CH3，CH2(OH) ，CH(OH)2，CH2(COOH)，CH(OH)COOH，CH2(CHO) 和CH(OH)CHO的基團所組成之族者，其選擇要使該分 子最少有一個0H基團，當寫為其完全水合物的形式， 及RB4為Η或COOH，包括這些酸各種不同的立體異構 物和化學相當的環狀，脫水，和水合物的形態和在水 中形成上面化合物的可水解的酯類和縮經或這種烧 基羥基羧酸的水溶性鹽，及其水溶性鹽。 27·如申請專利範圍第26項之組成物，其中該羥基羧酸係 擇自於由酒石酸，中酒石酸，檸檬酸，葡萄糖酸，葡 萄糖庚糖酸，丙酮二酸，糖質酸及其水溶性鹽所組成 之族者。 28·如申請專利範圍第2項之組成物，其中該胺基羥基琥 珀酸的化學通式為 63 本紙張尺度適用中國國家標準（CNS) Α4規格（210X297公釐） 542858 A8 B8 C8 D8 、申請專利範圍 H〇’ \C02H 其中RC^H或，任擇地以-OH，-C02H，-S03H或苯基 取代的CiSC4烷基，任擇地以-OH或-C02H取代的c4 至c7環烷基或苯基，尺口為！！，任擇地以-OH或-C02H ( 特別是包括-ch(co2h)ch(co2h)ch(oh)(co2h)的部 份者）取代的(^至(:6烷基；及 (請先閲讀背面之注意事項再填窝本頁) ^C2 1 ^C2 H〇2C\ N— / -Zc——N ] /C02H H02c/ OH a HO \ co2h •訂· ;線丨 其中RC2為如上述者，及zc係擇自於由下面基團所組成 之族者 i) -(CH2)k-其中k是一個2至10的整數， ii) -(CH2)2-Xc-(CH2)2-其中 Xc為-0-，-S-，-NRC3-，其中RC3係擇自於由Η，^至仏烷基，羥基烷基，羧 基烷基，醯基，-C(0)0RC4所組成之族者，其中Rc4係 擇自於由(^至^烷基或苯曱基和一個下面化學通式的 殘基： 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 64 542858 (CRC5RC6)t59 542858 A8 B8 C8 D8, a family consisting of water-soluble salts of oxazonium (2- (4_iodophenyl) -3- (4-nitrobenzyl) -5-phenyltetrazolium) By. For example, the composition of claim 2 in the patent application scope, wherein the tetrazolium compound is selected from nitroblue tetrazolium (2,2, _di_p-nitrophenyl_5,5, _stilbene -3,3, _ [3,3, -dimethoxy-4,4, -extendylphenyl] two-four sitting tweezers) one vinyl nitro blue four-sigma sitting wrong (2,2'_ Di-p-nitrophenyl-5,5'-distyryl-3,3, [3,3, dimethoxy_4,4, _dienylphenyl] tetrazolidine), tetranitrile Cyanotetrazolium (3,3, _ (3,3, _dioxo-4,4, phenylene) -bis_ [2,5-p-chlorophenyl-2Η-tetrazolidine ] And water-soluble salts of iodonitrotetrazolium (2 gas 4-iodophenyl) -3- (4-nitrophenyl) -5-phenyltetrazolium). For example, the composition of the scope of patent application, wherein the water-soluble ionic species is selected from the group consisting of halide, nitrate, nitrite, carbonate, bicarbonate, sulfate'phosphate, and transition metal. A family of oxyacid anions. For example, the composition of the scope of application for the patent No. 5 wherein the letter is selected from the group consisting of gas' fluorine, bromine and e. For example, the composition of claim 6 in the patent application scope, wherein the halogen group is chlorine. For example, the composition according to item 5 of the patent application range, wherein the transition metal oxo acid group is selected from the group consisting of molybdate, chromate, and tungstate. For example, the composition according to item 8 of the patent application scope, wherein the transition metal oxyacid is pivalate. 10_ If the composition of the scope of application for the second item of the patent, wherein the inorganic phosphate 4. 5. 6. 8. 9. This paper size applies Chinese National Standards (CNs) A4 specifications (210X297 public love) ..... ............. install ------------------, but ... . Line. (Please read the precautions on the back before filling this page) 60 542858 A8 B8 C8 ---------- ^ ____ 6. The scope of patent application is orthophosphate, polyphosphate, which is soluble in water Sex salt ^ its mixture. 11. The composition of claim 2 in which the inorganic phosphate is a mixture of orthophosphoric acid and pyrophosphoric acid or a water-soluble salt thereof. 12. The composition according to item 2 of the scope of patent application, wherein the borate is a member selected from the group consisting of water-soluble borate of tetra-mono-, meta-, and n-natrate. 13. The composition according to item 12 of the application, wherein the water-soluble borate is a sodium tetrodeate or a sodium tetrasodium hydrate. 14. The composition according to item 2 of the patent application, wherein the nitrite is sodium nitrite. 15. The composition according to item 2 of the patent application range, wherein the metal anion-releasing compound is selected from water-soluble salts of molybdate, ferrite, osmate, metavanadate, and chromate. Composed of the clan. 16. The composition according to item 15 of the application, wherein the water-soluble salt of the molybdate is sodium molybdate or sodium molybdate hydrate. 17. The composition according to item 2 of the scope of patent application, wherein the polycarboxylic acid ester contains an aliphatic compound containing 4 to 20 carbon atoms, and the compound is substituted by an S-group or a water-soluble salt thereof. . 18. The composition of claim 17 in which the polycarboxylic acid ester is 1,2,3,4-butanetetracarboxylic acid. 19. The composition of claim 2 in which the polycarboxylic acid ester is a homopolymer obtained from the polymerization of an ethylenically unsaturated monomer containing one or more carboxyl groups. 20. If the composition of the scope of application for item 19 of the patent, where the homopolymer is a polymer paper, the Chinese National Standard (CNS) A4 specification (210X297 mm) is applicable (please read the precautions on the back before filling this page) • Order f-61-where the homopolymer is poly where the homopolymer is poly where the polycarboxylate is 542858 6. Patent application scope acrylic acid or its water-soluble salt. 21. The composition according to item 19 of the scope of patent application, Chuanbei-succinic acid or its water-soluble salt. 22. The composition as claimed in claim 19 of the patent scope Chuanbei-succinic acid gf or its water-soluble salt. 23. If the composition of item 2 of the patent application is a copolymer obtained from the polymerization of two or more different ethylene unsaturated monomers, each of which contains one or more carboxyl groups. 24. Such as The composition of the scope of patent application, wherein the chemical formula of the alkyl hydroxycarboxylic acid is HOOC- (RB1) a- (RB2) b_ (RB3) c_RB4 where a, b, and c are integers from 0 to 6. (A + b + c) &gt; 0, where rb1, rb2, and Rb3 contain C = Q or CYZ, where Y and Z are selected from the group consisting of Η 'OH' CHO, COOH, CH3, CH2 (OH), CH ( OH) 2 'CH2 (COOH), CH (OH) COOH, CH2 (CHO) and CH (OH) CHO groups, the choice is to make the molecule have at least one 0H group, when written as its completely hydrated Form, and 1 ^ 4 is 11 or COOH, including the cyclic 'dehydration' and hydrate forms of the various stereoisomers and chemical phases of these acids, and the hydrolyzable esters and condensations of the above compounds in water. An aldehyde, or a water-soluble salt of this alkylhydroxycarboxylic acid. 25. The composition according to item 24 of the patent application, wherein the alkyl hydroxycarboxylic acid is selected from tartaric acid, middle tartaric acid, citric acid, and gluconic acid. (Li) ------------------------ Installation :: (Please read the precautions on the back before filling in this page) Order 丨 • Line 丨 62 542858 A8 B8 ^ C8 D8 6. Scope of patent application, a family consisting of glucose heptonic acid, malonic acid, glyconic acid and its water-soluble salts. (Please read the precautions on the back before filling this page) 26. If the composition of the scope of patent application No. 2 wherein the other water phase system processing material is a positive filling acid or its water-soluble salt and at least one chemical formula Is a mixture of alkyl carboxylic acids of HOOC- (RB1) a- (RB2) b- (RB3) c_RB4, where a, b, and c are integers from 0 to 6, and (a + b + c ) &gt; 0, where RB1, RB2, RB3 contains C = 0 or CYZ, where Y and Z are selected from H, OH, CHO, COOH, CH3, CH2 (OH), CH (OH) 2, CH2 ( COOH), CH (OH) COOH, CH2 (CHO) and CH (OH) CHO, the group of members is chosen so that the molecule has at least one 0H group, when written as its fully hydrated form , And RB4 is hydrazone or COOH, including various stereoisomers and chemically equivalent cyclic, dehydrated, and hydrated forms of these acids and hydrolyzable esters and condensations that form the above compounds in water or such Water-soluble salts of alkanoyl hydroxycarboxylic acids, and water-soluble salts thereof. 27. The composition according to item 26 of the application, wherein the hydroxycarboxylic acid is selected from the group consisting of tartaric acid, middle tartaric acid, citric acid, gluconic acid, glucoheptanoic acid, pyruvate, glyconic acid and its water solubility Family of salt. 28. If the composition of the scope of the application for the second item of the patent application, wherein the chemical formula of the amino hydroxysuccinic acid is 63, the paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 542858 A8 B8 C8 D8, application Patent range H〇 '\ C02H where RC ^ H or, CiSC4 alkyl optionally substituted with -OH, -C02H, -S03H or phenyl, c4 to c7 cycloalkane optionally substituted with -OH or -C02H Or phenyl, the ruler is! !! , Optionally substituted with -OH or -C02H (especially those including -ch (co2h) ch (co2h) ch (oh) (co2h)) (^ to (: 6 alkyl; and (please first Read the notes on the back and fill in this page) ^ C2 1 ^ C2 H〇2C \ N— / -Zc——N] / C02H H02c / OH a HO \ co2h , And zc are selected from the group consisting of i)-(CH2) k- where k is an integer from 2 to 10, and ii)-(CH2) 2-Xc- (CH2) 2-where Xc is -0-, -S-, -NRC3-, where RC3 is selected from the group consisting of Η, ^ to 仏 alkyl, hydroxyalkyl, carboxyalkyl, fluorenyl, -C (0) 0RC4 Among them, Rc4 is selected from (^ to ^ alkyl or phenyl amidino and a residue of the following general chemical formula: This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 64 542858 (CRC5RC6 ) t A8 B8 C8 D8 申請專利範圍 —ch2ch2~Nv/c〇2h hcT^c〇2h 其中Rc2為如上述者所組成之族者， iii)含下列化學通式之殘基 (CHA (CH^ — 其中Y為Η，CdC6烷基，烷氧基，鹵基，_C〇2h，-S03H ，m係獨立地為〇或1，及p為1或2，以及 iv)含下列化學通式之殘基： (Q)s (CH2V^(CRe5RC6)t 其中Res和R&lt;：6係獨立地為H或CiSC6烷基，Q為HSG 至C6烷基，s為Ο，1或2，t係獨立地為〇，1，2或3，q 為Ο，1，2或3，及r為1或2或其水溶性鹽。 29·如申請專利範圍第28項之組成物，其中該胺基羥基琥 珀酸係擇自於由亞胺基二（2-羥基琥珀酸），n，N，-雙（2-羥基琥轴基）-1，6-己烷二胺，N，N，_雙（2-羥基琥珀基）· 間-伸二甲苯二胺所組成之族者或其水溶性鹽。 30.如申請專利範圍第2項之組成物，其中該其他水相系 統處理物料是一個正填酸或其水溶性鹽和至少一個 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） (請先閲讀背面之注意事項再填窝本頁)A8 B8 C8 D8 Patent application scope—ch2ch2 ~ Nv / c〇2h hcT ^ c〇2h where Rc2 is a family composed of the above, iii) residues containing the following general formula (CHA (CH ^ — where Y Is fluorene, CdC6 alkyl, alkoxy, halo, -CO2h, -S03H, m is independently 0 or 1, and p is 1 or 2, and iv) residues containing the following general formula: ( Q) s (CH2V ^ (CRe5RC6) t where Res and R &lt;: 6 are independently H or CiSC6 alkyl, Q is HSG to C6 alkyl, s is 0, 1 or 2, and t is independently 0, 1, 2, or 3, q is 0, 1, 2, or 3, and r is 1 or 2 or a water-soluble salt thereof. 29. The composition according to item 28 of the scope of patent application, wherein the aminohydroxysuccinic acid is selected From iminobis (2-hydroxysuccinic acid), n, N, -bis (2-hydroxysuccinyl) -1,6-hexanediamine, N, N, _bis (2-hydroxysuccinic acid) Group) or a group consisting of m-xylylenediamine or its water-soluble salt. 30. The composition of item 2 in the scope of patent application, wherein the other water-phase system processing material is a positive filling acid or its water-solubility Salt and at least one paper size apply Chinese national standards ( CNS) A4 size (210X297 mm) (Please read the precautions on the back before filling this page) 65 542858 A8 B8 C8 D8 、申請專利範圍 胺基羥基琥珀酸的混合物，其中該胺基羥基琥珀酸的 化學通式為 ^C2 一 CH2CH2—N、/C〇2H 其中RC^H或任擇地以-OH，-C02H，-S03H或苯基取 代的（^至口烷基，任擇地以-〇H或-C02H取代的C4至 C7環烷基或苯基，RC2為Η，任擇地以-OH或-C02H(特 別是包括-CH(C02H)CH(0H)(C02H)部份者）取代的q 至〇6烷基；及 (請先閲讀背面之注意事項再填寫本頁) ~zc /C02H η/ \ co2h 訂— :線丨 其中RC2為如上述者，及zc係擇自於由下面基團所組成 之族者 i) -(CH2)k-其中k是一個2至10的整數， ii) -(CH2)2-Xc-(CH2)2-其中 Xc 為-〇-，-S-，NRC3-’其中Res係擇自於由Η，（^至(：6烷基，羥基烷基，羧 基烧基，醯基，-C(0)0RC4所組成之族者，其中尺以係 擇自於由（^至匕烷基或苯甲基和含下面化學通式的殘 基所組成之族者： 本紙張尺度適用中國國家標準（CNS) M規格（21〇Χ297公釐） 66 54285865 542858 A8 B8 C8 D8, a mixture of amino hydroxysuccinic acid in the scope of patent application, wherein the chemical formula of the amino hydroxysuccinic acid is ^ C2 -CH2CH2-N, / C〇2H where RC ^ H or optionally -OH, -C02H, -S03H or phenyl substituted (^ to alkalkyl, optionally substituted with -0H or -C02H C4 to C7 cycloalkyl or phenyl, RC2 is Η, optionally with -OH or -C02H (especially those including -CH (C02H) CH (0H) (C02H)) substituted q to 〇6 alkyl; and (Please read the precautions on the back before filling this page) ~ zc / C02H η / \ co2h order —: line 丨 where RC2 is as described above, and zc is selected from the group consisting of the following groups i)-(CH2) k-where k is an integer from 2 to 10 , Ii)-(CH2) 2-Xc- (CH2) 2- where Xc is -〇-, -S-, NRC3- 'where Res is selected from Η, (^ to (: 6 alkyl, hydroxyalkane A group consisting of alkyl, carboxyl, fluorenyl, and -C (0) 0RC4, in which the rule is selected from the group consisting of (^ to alkyl or benzyl and a residue containing the following general chemical formula Family: This paper size applies to Chinese National Standard (CNS) M specifications (21 Χ297 mm) 66 542 858 签況虱基，_基，-co2h，-so3h ，m係獨立地為〇或卜及或2,以及 iv)含下列化學通式的殘基： HCj^cOjH 其中Re：2為如上述者， Hi)含下列化學通式的殘基 其中Y為Η，（^至C6燒基，炫氧宜 (CH2)q&gt;&lt;/(Q)s —(CRC5RC6)t —/ (cH2)f^\(CRC5RC6)l— 其中Res和Res係獨立地為H或Cl至C6烷基，Q為Η*。 至C6烷基，s為0，；!或2，t係獨立地為〇，}，2或3，q 為〇，1，2或3，及]：為1或2或其水溶性鹽。 3 1 ·如申請專利範圍第3〇項之組成物，其中該胺基羥基琥 珀酸係擇自於由亞胺基二（2-羥基琥拍酸），n，n，i(2_ 經基珑ίέ基）-1，6·己烷二胺，N，N，-雙（2-羥基琥珀基）· 間-伸一甲本二胺所組成之族者或其水溶性鹽。 32·如申請專利範圍第2項之組成物，其中該聚環氧號拍 酸的化學通式為 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） (請先閲讀背面之注意事項再填寫本頁)Indicate lice group, _ group, -co2h, -so3h, m is independently 0 or 2 or 2, and iv) residues containing the following general chemical formula: HCj ^ cOjH where Re: 2 is as described above, Hi) Residues containing the following general chemical formulas in which Y is Η, (^ to C6 alkyl, oxo should be (CH2) q> &lt; / (Q) s — (CRC5RC6) t — / (cH2) f ^ \ (CRC5RC6 ) l— where Res and Res are independently H or Cl to C6 alkyl, and Q is Η *. To C6 alkyl, s is 0,; or 2, t is independently 0,}, 2 or 3 , Q is 0, 1, 2 or 3, and]: 1 or 2 or a water-soluble salt thereof. 3 1 · The composition according to item 30 of the patent application scope, wherein the aminohydroxysuccinic acid is selected from From iminobis (2-hydroxysuccinic acid), n, n, i (2_ mesityl) -1,6 · hexanediamine, N, N, -bis (2-hydroxysuccinyl) · The group consisting of meta-methylene dibenzyl diamine or its water-soluble salt. 32. For example, the composition of the scope of patent application No. 2, wherein the chemical formula of the polyepoxy acid is applicable to the paper size of China National Standard (CNS) A4 Specification (210X297 mm) (Please read the notes on the back before filling in this page) 67 542858 A8 B8 C8 D8 、申請專利範圍 R丁 R丁 H067 542858 A8 B8 C8 D8, patent application scope R D R D H 0 C C—〇- Η mto2c C02Mt 其中1的範圍自2至50，Μτ為氫或一個水溶性陽離子， 如Na ’ NH/或1^+及1^為氫，Cl_4烷基或取代的Cw烷 基或其水溶性鹽。 33·如申請專利範圍第32項之組成物，其中該Rt為氫，及 1的範圍自2至1 〇。 34·如申請專利範圍第32項之組成物，其中該RT為氫，及 1為自4至7。 35·如申睛專利範圍第2項之組成物，其中該其他水相系 統處理物料是一個正磷酸或其水溶性鹽和一個含下 面化學通式的聚環氧琥珀酸的混合物 R丁 R丁 HOCC—〇- Η mto2c C02Mt where 1 ranges from 2 to 50, Mτ is hydrogen or a water-soluble cation, such as Na′NH / or 1 ^ + and 1 ^ is hydrogen, Cl_4 alkyl or substituted Cw alkyl or Its water-soluble salt. 33. The composition of claim 32 in the scope of patent application, wherein the Rt is hydrogen, and 1 ranges from 2 to 10. 34. The composition of claim 32, wherein the RT is hydrogen, and 1 is from 4 to 7. 35. The composition of item 2 in the scope of the patent application, wherein the other water phase system processing material is a mixture of orthophosphoric acid or a water-soluble salt thereof and a polyepoxysuccinic acid containing the following general formula: HO C C 〇- Η 较------------------、一叮------------------緩. (請先閲讀背面之注意事项再填寫本頁J Mt02C C02Mt -4 其中1的範圍自2至50，Μτ為氫或一個水溶性陽離子 如Na+，NH4+或K+，及R為氫，Cl_4烷基或取代的c 烧基或其水溶性鹽。 36.如申請專利範圍第35項之組成物，其中該聚環氧琥珀 酸的Rt為氫及1為自2至10。 37·如申請專利範圍第35項之組成物，其中該聚環氧琥珀 本紙張尺度顧巾關家標準（⑽）A4規格⑵QX297公楚） 68 六、中請專利範圍 酸的RT為氫及1為自4至7。 38· 如申請專利範圍第2項之組成物， 環氧琥珀酸的化學通式為 其中該經改質的聚CC 〇- 缓 Slower than ------------------, Yiding ------------------. (Please read first Note on the back page, please fill in this page again J Mt02C C02Mt -4 where 1 ranges from 2 to 50, Mτ is hydrogen or a water-soluble cation such as Na +, NH4 + or K +, and R is hydrogen, Cl_4 alkyl or substituted Or a water-soluble salt thereof. 36. The composition according to item 35 of the patent application, wherein Rt of the polyepoxysuccinic acid is hydrogen and 1 is from 2 to 10. 37. The composition according to item 35 of the patent application The standard of the polyepoxy amber paper (Guoguanjia standard (⑽) A4 size (QX297)) 68. The patent claims that the range of the acid's RT is hydrogen and 1 is from 4 to 7. 38. If the composition of the scope of application for item 2 of the patent, the chemical formula of epoxy succinic acid is 义 D2 ^D3Meaning D2 ^ D3 Md02C C02Md f 39. 40. 其中RD1，當有存在，為Η，取代的或未取代的院基或 芳基部份，其碳鏈長度高達使失去水相溶液中的溶解 度者或一個乙烯不飽和化合物聚合反應得到的重複單 凡，Rd2和Rd3係各自獨立地為Η，（^至匕烷基或取代 WCjC4烧基；ZD為〇，s，ΝΗ或NRD1，其中Rm為如 上面說明者，η是一個大於i的正整數，f是一個正的整 數；MD為Η，水溶性陽離子（如NH/，鹼金屬）或含i 個至3個碳原子的未取代的較低級烷基基團（當R⑴不 存在，ZD可以是MD〇3S，其中MD為如上面說明者）。 如申請專利範圍第38項之組成物，其中該rd1為間_伸 二甲苯部份（間-CH2-C6H4-CH2-)，RD2和 RD3都是Η，ZD 為-NH ’ MD為Na或Η，及f=2，u是一個大於1的正整數 如申請專利範圍第2項之組成物，其中該單膦酸的化 學通式為 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 69 542858 A8 B8 C8 D8 申叫專利範圍 Ο OH D 11/ F—P\〇H 其中《^為^至匸〗2直鏈或支鏈烷基殘基，c2sc12直鏈 或支鍵煙烯基殘基，（：5至(：12環烷基殘基，c6sc1〇芳 基殘基或(^至匕2芳烷基殘基，其中知可另外以獨立地 擇自經基，胺基或鹵基或其水溶性鹽的基團單一或多 重取代。 1 ·如申睛專利範圍第2項敘述之組成物，其中該二膦酸 的化學通式為 0HOvl! —] 〇 OH (請先閲讀背面之注意事項再填寫本頁} .裝， -P 訂· Η0/ 、0H .•線- 其中Rk為(^至(：12直鏈或支鏈伸烷基殘基，（：：2至(：12直 鍵或支鏈伸烯基殘基，c5sc12伸環烷基殘基，〇6至&lt;：：10 伸芳基殘基或C7至c12伸芳烷基殘基，其中1?^可另外以 獨立地擇自羥基，胺基或鹵基或其水溶性鹽的基團單 一或多重取代。 42. 如申請專利範圍第41項敘述之組成物，其中該二膦酸 為1-羥基乙烷-1，1-二膦酸或其水溶性鹽。 43. 如申請專利範圍第2項敘述之組成物，其中該膦酸基 羧酸的化學通式為 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 70 542858 8 8 8 8 A B c D 六、申請專利範圍 及 Ho HO, :p 0 HI R COOH -COOH Η Ρ X—C——COOH CH，一 COOH (請先閲讀背面之注意事項再填窝本頁) 其中尺則為！！，含有1個至4個碳原子的烷基，烴烯基或 炔基，芳基，環烷基或芳烷基基團或擇自下面的基團 者： ^•H2 Rh2 。严3 I ^ I ——CH——0¾—COOH及——CH——CH——COOH 其中RH2為H，1個至4個碳原子的烷基基團或羧基基團 :及XH係擇自下面基團者： COOH COOH P03H, ——CH—，- —c——，及- ch3 —c— ch3 COOH CH—CHf 其中-P03H2基團為下面的膦酸基基團 ?/0H —p\ \〇H 或其水溶性鹽。 本紙張尺度適用中國國家標準（CNS) Μ規格（210X297公釐） 71 542858 45 H0, A8 B8 C8 D8 、申睛專利範圍 44·如申請i利範圍第43項敘述之組成物，其中該膦酸基 幾酸為2-膦酸基丁烷-；ι，2,4-三羧酸或其水溶性鹽。 如申請專利範圍第2項敘述之組成物，其中該經基膦 酸基羧酸的化學通式為 0 R. P—C—XE—COOH HO〆 OH 其中RE為Η，（^至(：12直鏈或支鏈烷基殘基，〇2至(：12 直鏈或支鏈烴烯基殘基，C5至C12環烷基殘基，（：6至（：1() 方基殘基或C7至Ci2方烧基殘基，χΕ是一個任擇的基團 ，當有存在，是一個（^至(:1()直鏈或支鏈伸烷基殘基， 匸2至〔1()直鏈或支鏈伸烯基殘基或C6sc1G伸芳基殘基 或其水溶性鹽。， 46·如申請專利範圍第45項敘述之組成物，其中該羥基膦 酸基羧酸為2-羥基-膦酸基乙酸或水溶性鹽。 47.如申請專利範圍第2項敘述之組成物，其中該胺基膦 酸的化學通式為 裝----------------訂------------------線 (請先閱讀背面之注意事項再填寫本頁) 0 J!/ OH 、OH 其中Rg2為含有一個至四個碳原子的較低級伸烷基或 胺’經基或鹵基取代的較低級伸烷基；Rg3為rg2_P〇3H2 ，Η ’ OH，胺基，取代的胺基或心，其中r^c^ci2 直鏈或支鏈烷基殘基，（^至!：〗2直鏈或支鏈烴烯基殘基 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 72 V /N—CH,P〇3^ 542858 A8 B8 C8 D8 5'、申請專利範圍 * ’ C5至Cl2環烧基殘基，C6至C10芳基殘基或&lt;：7至（：12芳 烷基殘基，其中RF可另外以獨立地擇自羥基，胺基或 鹵基的基團單一或多重取代，尺以為尺⑺或以下面化學 通式代表的基團：Md02C C02Md f 39. 40. Where RD1, when present, is fluorene, substituted or unsubstituted nosyl or aryl moiety, whose carbon chain length is as high as to make it lose its solubility in aqueous solution or an ethylene unsaturated Repeated monomers obtained from the polymerization of compounds, Rd2 and Rd3 are each independently Η, (^ to alkyl or substituted WCjC4 alkyl; ZD is 0, s, NΗ or NRD1, where Rm is as described above, η Is a positive integer greater than i, f is a positive integer; MD is Η, water-soluble cations (such as NH /, alkali metal) or unsubstituted lower alkyl groups containing i to 3 carbon atoms (When R⑴ does not exist, ZD can be MD03S, where MD is as described above.) For the composition of the 38th scope of the patent application, where rd1 is the meta-xylene part (meta-CH2-C6H4- CH2-), RD2 and RD3 are all europium, ZD is -NH ', MD is Na or europium, and f = 2, u is a positive integer greater than 1 as in the composition of the scope of patent application item 2, wherein the monophosphine The chemical formula of the acid is based on the paper size. Applicable to China National Standard (CNS) A4 (210X297 mm) 69 542858 A8 B 8 C8 D8 claims a patent scope of 0 OH D 11 / F-P \ 〇H where ^ is ^ to 匸 2 straight or branched alkyl residues, c2sc12 straight or branched nicotinyl residues, ( : 5 to (: 12 cycloalkyl residues, c6sc1 0 aryl residues, or (2 to 2 aralkyl residues), in which it is known that it can be independently selected from the group consisting of a mesityl group, an amine group or a halogen group or a water-soluble group thereof. Single or multiple substitution of the group of the salt. 1. The composition described in item 2 of the patent scope of Shenyan, where the chemical formula of the diphosphonic acid is 0HOvl! —] 〇OH (Please read the precautions on the back before Fill out this page}. Pack, -P order · Η0 /, 0H. • line-where Rk is (^ to (: 12 straight or branched chain alkylene residues, (:: 2 to (: 12 straight bonds or Branched chain alkenyl residues, c5sc12 cycloalkyl residues, 〇6 to &lt; :: 10 aryl residues or C7 to c12 alkylene residues, of which 1 to ^ may additionally be independently selected Single or multiple substitutions from hydroxy, amine or halo groups or their water-soluble salts. 42. The composition as described in item 41 of the application, wherein the diphosphonic acid is 1-hydroxyethane-1,1 -Bisphosphonic acid or its water-soluble salt 43. The composition described in item 2 of the scope of the patent application, in which the chemical formula of the phosphonic acid is based on the paper standard applicable to China National Standard (CNS) A4 (210X297 mm) 70 542858 8 8 8 8 AB c D VI. Application scope and Ho HO,: p 0 HI R COOH -COOH Ρ Ρ X—C——COOH CH, a COOH (Please read the precautions on the back before filling in the page) The ruler is! !! , Alkyl, alkenyl or alkynyl, aryl, cycloalkyl or aralkyl groups containing 1 to 4 carbon atoms or selected from the group consisting of: ^ • H2 Rh2. Yan 3 I ^ I ——CH——0¾—COOH and ——CH——CH——COOH where RH2 is H, an alkyl group or carboxyl group of 1 to 4 carbon atoms: and XH is selected from The following groups are: COOH COOH P03H, ——CH—, — —c——, and — ch3 —c— ch3 COOH CH—CHf where the -P03H2 group is the following phosphonic acid group? / 0H —p \ \ 〇H or its water-soluble salt. This paper size applies Chinese National Standard (CNS) M specification (210X297 mm) 71 542858 45 H0, A8 B8 C8 D8, Shenyan patent scope 44. The composition described in item 43 of the scope of application, where the phosphonic acid Hexanoic acid is 2-phosphonobutane-; 1,2,4-tricarboxylic acid or a water-soluble salt thereof. The composition described in item 2 of the scope of patent application, wherein the chemical formula of the phosphonophosphonic acid is 0 R. P—C—XE—COOH HO〆OH where RE is Η, (^ to (: 12 Linear or branched alkyl residues, 02 to (: 12 linear or branched hydrocarbon alkenyl residues, C5 to C12 cycloalkyl residues, (: 6 to (: 1 () square residues or C7 to Ci2 square alkyl residues, χΕ is an optional group, when present, is a (^ to (: 1 () straight or branched alkylene residue, 匸 2 to [1 () Straight chain or branched chain alkenyl residue or C6sc1G arylene residue or its water-soluble salt. 46. The composition as described in item 45 of the scope of patent application, wherein the hydroxyphosphonic acid is 2-hydroxy -Phosphonic acid or water-soluble salt 47. The composition as described in item 2 of the scope of the patent application, wherein the chemical formula of the aminophosphonic acid is -------------- --Order ------------------ line (please read the notes on the back before filling in this page) 0 J! / OH, OH where Rg2 contains one to four Lower alkylene or amine of carbon atom substituted with lower alkylene or halo; Rg3 is rg2_P〇3H 2, Η 'OH, amine, substituted amine or heart, where r ^ c ^ ci2 straight or branched alkyl residues, (^ to!: 〖2 straight or branched alkylene residues basic paper Standards are applicable to China National Standard (CNS) A4 specifications (210X297 mm) 72 V / N—CH, P0 ^^ 542858 A8 B8 C8 D8 5 ', patent application scope *' C5 to Cl2 cycloalkyl residues, C6 to C10 aryl residues or &lt;: 7 to (: 12 aralkyl residues, where RF may additionally be single or multiple substituted with groups independently selected from hydroxyl, amine or halo groups, and the rule is ⑺ or less Groups represented by the general chemical formula: 其中RG5和RG0係各自獨立地擇自H，〇H，胺基，取代 的胺基。或如前面定義之RF; (^為尺⑺，RG6或基團 Rg2 PO3H2 ’其RG2為如刖面定義者；V是一個1至15的 整數；W是一個丨至14的整數或其水溶性鹽。 48.如申請專利範圍第47項敘述之組成物，其中該胺基膦 酸為一乙二胺五（亞甲基膦酸）或其水溶性鹽。 49·如申請專利範圍第2項敘述之組成物，其中該膦酸基 甲基胺氧化物的化學通式為 Rai fcA2 其中化^係擇自於由烴基，和羥基取代的，烷氧基取代 的，羧基取代的和磺醯基取代的烴基所組成之族者； 及Ra2係擇自於由烴基，和羥基取代的，烷氧基取代的Among them, RG5 and RG0 are each independently selected from H, 0H, amine, and substituted amine. Or RF as defined above; (^ is the ruler, RG6 or the group Rg2 PO3H2 ', where RG2 is as defined by 刖; V is an integer from 1 to 15; W is an integer from 1 to 14 or its water solubility 48. The composition described in item 47 of the scope of patent application, wherein the aminophosphonic acid is monoethylenediaminepenta (methylenephosphonic acid) or a water-soluble salt thereof. The composition of the description, wherein the chemical formula of the phosphonomethylamine oxide is Rai fcA2, wherein the ^ is selected from the group consisting of hydrocarbyl, and hydroxy substituted, alkoxy substituted, carboxy substituted, and sulfonyl. A group consisting of a substituted hydrocarbon group; and Ra2 is selected from the group consisting of a hydrocarbon group, a hydroxy group, and an alkoxy group. (請先閲讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page) 542858 A8 B8 C8 D8 申請專利範圍 ’羧基取代的和磺醯基取代的烴基，-CH2P〇3H2，及 0 ▲ ——明N (即明)2; 所組成之族者，或ra1和ra2共同形成一個環内含有3 個至5個碳原子的脂肪環或該膦酸基甲基胺氧化物的 水溶性鹽’烴基包括不使該胺氧化物不可溶於水的烷 基，芳基，和烷芳基基團。 50.如申請專利範圍第49項敘述之組成物，其中該膦酸基 甲基胺氧化物為N，N-雙-膦酸基甲基乙醇胺N-氧化物 或其水溶性鹽。 5 1 ·如申請專利範圍第2項敘述之組成物，其中該含磷羧 酸酯是一個得自一個或更多個不飽和單體，在含磷化 合物存在下聚合反應的寡聚物，聚合物，共寡聚物或 共聚物，該單體含有一個或更多個羧基基團或含有一 個或更多個聚合反應後轉型為羧基基團之基團，其中 得到的含磷羧酸酯含有主要或全部存在為終端型膦 基種系或其水溶性鹽的礙加入物。 52.如申請專利範圍第2項敘述之組成物，其中該含磷羧 酸醋是一個得自一個或更多個不飽和單體，在含填化 合物存在下聚合反應的募聚物，聚合物，共寡聚物或 共聚物，該單體含有一個或更多個羧基基團或含有一 個或更多個聚合反應後轉型為羧基基團之基團，其中 得到的含鱗羧酸酯含有主要或全部存在為膦酸基種 系或其水溶性鹽的填加入物。 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） (請先閲讀背面之注意事項再填窝本頁) •訂— :線丨 74 542858 A8 B8 C8 D8 六、申請專利範圍 5 3.如申明專利乾圍苐2項敘述之組成物，其中該含鱗叛 酸_疋一個得自一個或更多個不飽和單體，在含鱗化 合物存在下聚合反應的寡聚物，聚合物，共寡聚物或 共聚物，該單體含有一個或更多個羧基基團或含有一 個或更多個聚合反應後轉型為羧基基團之基團，其中 得到的含磷羧酸酯含有主要或全部存在為二烷基膦 基種系或其水溶性鹽的磷加入物。 54.如申請專利範圍第2項敘述之組成物，其中該含磷羧 酸酯是一個得自一個或更多個不飽和單體，在含磷化 合物存在下聚合反應的寡聚物，聚合物，共寡聚物或 共聚物，該單體含有一個或更多個羧基基團或含有一 個或更多個聚合反應後轉型為羧基基團之基團，其中 得到的含磷羧酸酯含有存在為膦酸基，終端型膦基， 和一烧基膦基種系混合或其水溶性鹽的填加入物。 55·如申請專利範圍第51項敘述之組成物，其中該不飽和 單體係擇自於由丙烯酸，順-丁烯二酸，順-丁烯二酸 酐，甲基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸， 反-丁烯二酸，檸康酸，曱基-反-丁烯二酸，丙烯腈， 甲基丙烯腈，α-亞曱基戊二酸，環己烯二羧酸，順 -1，2,3,6·四氫酞酸酐，3,6-環氧-1，2,3,6-四氫欧酸酐， 5-降冰片烯-2,3-二羧酸酐，雙環[2·2·2]-5-辛烯-3,3-二 羧酸酐，3-甲基-1，2,6_四氫酞酸酐，和2_甲基-1，3,6-四氫酞酸酐所組成之族者。 56.如申請專利範圍第51項敘述之組成物，其中該丙烯酸 本紙張尺度適用中國國家標準（CNS) Α4規格（210X297公釐） 75 (請先閱讀背面之注意事項再填寫本頁) 訂丨 542858 A8 B8 C8 D8 、申請專利範圍 是唯一的不飽和單體。 57·如申請專利範圍第51項敘述之組成物，其中該唯一的 不飽和單體係擇自於由順-丁烯二酸酸，分解烏頭酸， 和順-丁烯二酸酐所組成之族者。 如申請專利範圍第51項敘述之組成物，其中一個不飽 和單體為丙烯酸及另一個不飽和單體係擇自於由順_ 丁烯二酸，分解烏頭酸，和順_丁烯二酸酐所組成之族 者。 59·如申請專利範圍第52項敘述之組成物，其中該不飽和 單體係擇自於由丙烯酸，順_ 丁烯二酸，順-丁烯二酸 酐，甲基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸， 反-丁烯二酸，檸康酸，甲基_反_丁烯二酸，丙烯腈， 甲基丙稀腈，α-亞甲基戊二酸，環己烯二羧酸，別 -1，2,3,6-四氫酞酸酐，3,6-環氧_ι，2,3,6-四氫酞酸酐， 5_降冰片烯-2,3-二羧基酸酐，雙環[2·2·2]-5-辛烯-2,3 二羧酸酐，3-甲基-1，2,6-四氫酞酸酐，和孓甲基-；1，3 四氫酞酸酐所組成之族者。 60. 如申請專利範圍第52項敘述之組成物，其中該丙稀 係唯一的不飽和單體。 61. 如申請專利範圍第52項敘述之組成物，其中該唯一 不飽和單體係擇自於由順_丁烯二酸，分解烏頭酸， 順-丁烯二酸酐所組成之族者。 62. 如申請專利範圍第52項敘述之組成物，其中該一個 飽和單體係丙烯酸及另一個不飽和單體係擇自於 58 6- 酸 的 和 不 由 (請先閲讀背面之注意事項再填寫本頁) :線丨 本紙張尺度適用中國國家標準（CNs) A4規格（210X297公釐） 76 542858 A8 B8 C8 D8 申請專利範圍 順-丁烯二酸，分解烏頭酸，和順-丁烯二酸酐所組成 之族者。 63·如申請專利範圍第53項敘述之組成物，其中該不飽和 單體係擇自於由丙烯酸，順-丁烯二酸，順·丁烯二酸 酐，甲基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸， 反-丁烯二酸，檸康酸，甲基_反-丁烯二酸，丙烯腈， 甲基丙稀腈，α-亞甲基戊二酸，環己晞二羧酸，順 -1，2,3,6-四氫酞酸酐，3,6-環氧-^允卜四氫酞酸酐， 5-降冰片烯-2,3-二羧酸酐，雙環0么2]巧_辛烯-2,3-二 叛酸酐’ 3曱基-1，2,6-四氫醜酸酐，和2_甲基四 氫口酸酐所組成之族者。 64·如申請專利範圍第53項敘述之組成物，其中該丙烯酸 係唯一的不飽和單體。 65.如申請專利範圍第53項敘述之組成物，其中該唯一的 不飽和單體係擇自於由順-丁晞二酸，分解烏頭酸，和 順-丁烯二酸酐所組成之族者。 如申請專利範圍第53項敘述之組成物，其中該一個不 飽和單體係丙稀酸及另一個不餘和單體係擇自於由 順-丁烯二酸，分解烏頭酸，和順_ 丁烯二酸酐所組成 之族者。 67.如申請專利範圍第54項敘述之組成物，其中該不飽和 單體係擇自於由丙烯酸，順-丁烯二酸，順_丁烯二酸 奸’甲基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸， 反-丁稀二酸，檸康酸，甲基·反-丁烯二酸。丙烯腈， (請先閲讀背面之注意事項再填寫本頁) .訂丨542858 A8 B8 C8 D8 Patent application scope 'Carboxyl-substituted and sulfonyl-substituted hydrocarbon groups, -CH2P〇3H2, and 0 ▲-Ming N (ie Ming) 2; the group of members, or ra1 and ra2 together An aliphatic ring containing 3 to 5 carbon atoms in one ring or a water-soluble salt of the phosphonic acid methylamine oxide, a hydrocarbyl group includes an alkyl group, an aryl group, and an alkyl group which do not make the amine oxide water-insoluble. Aryl group. 50. The composition as described in item 49 of the scope of the patent application, wherein the phosphonomethylamine oxide is N, N-bis-phosphonomethylethanolamine N-oxide or a water-soluble salt thereof. 5 1 · The composition described in item 2 of the scope of the patent application, wherein the phosphorus-containing carboxylic acid ester is an oligomer obtained from one or more unsaturated monomers and polymerized in the presence of a phosphorus-containing compound. Polymer, co-oligomer or copolymer, the monomer containing one or more carboxyl groups or containing one or more groups converted into carboxyl groups after polymerization reaction, wherein the obtained phosphorus-containing carboxylic acid ester contains Additives are predominantly or wholly present as terminal phosphine-based species or their water-soluble salts. 52. The composition described in item 2 of the scope of the patent application, wherein the phosphorus-containing carboxylic acid vinegar is an agglomerate obtained from one or more unsaturated monomers and polymerized in the presence of a filler compound, a polymer Co-oligomer or copolymer, the monomer contains one or more carboxyl groups or contains one or more groups converted into carboxyl groups after polymerization reaction, wherein the obtained scale-containing carboxylic acid ester contains mainly Or all of the fillers are present as phosphonic acid-based species or their water-soluble salts. This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling in this page) • Order —: Line 丨 74 542858 A8 B8 C8 D8 VI. Application scope 5 3 As stated in the patent claim 2 of the composition described in the above description, wherein the squamous acid-containing one is derived from one or more unsaturated monomers, polymerized in the presence of a squamous compound, an oligomer, a polymer Co-oligomer or copolymer, the monomer contains one or more carboxyl groups or contains one or more groups converted into carboxyl groups after polymerization, wherein the obtained phosphorus-containing carboxylic acid ester contains mainly Or all phosphorus additions are present as dialkylphosphine-based species or their water-soluble salts. 54. The composition described in item 2 of the scope of the patent application, wherein the phosphorus-containing carboxylic acid ester is an oligomer or polymer obtained from one or more unsaturated monomers and polymerized in the presence of a phosphorus-containing compound. Co-oligomer or copolymer, the monomer contains one or more carboxyl groups or contains one or more groups converted into carboxyl groups after polymerization, wherein the obtained phosphorus-containing carboxylic acid ester contains It is a filler of a phosphonic acid group, a terminal phosphine group, and a monoalkylphosphine-based species mixture or a water-soluble salt thereof. 55. The composition as described in claim 51 of the scope of patent application, wherein the unsaturated monosystem is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid, decomposed aconitic acid, and croton Acid, ethylene acetic acid, trans-butenedioic acid, citraconic acid, fluorenyl-trans-butenedioic acid, acrylonitrile, methacrylonitrile, α-fluorenylglutaric acid, cyclohexene dicarboxylic acid, Cis-1,2,3,6 · tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclic [2 · 2 · 2] -5-octene-3,3-dicarboxylic anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-tetrahydro A family of hydrophthalic anhydride. 56. If the composition described in item 51 of the scope of patent application, the acrylic paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 75 (Please read the precautions on the back before filling this page) Order 丨542858 A8 B8 C8 D8, the scope of patent application is the only unsaturated monomer. 57. The composition described in item 51 of the scope of patent application, wherein the only unsaturated monosystem is selected from the group consisting of maleic acid, decomposed aconitic acid, and maleic anhydride By. For example, the composition described in item 51 of the scope of patent application, in which one unsaturated monomer is acrylic acid and the other unsaturated monosystem is selected from maleic acid, decomposed aconitic acid, and maleic anhydride The group of people. 59. The composition as described in claim 52 in the scope of the patent application, wherein the unsaturated monosystem is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid, decomposed aconitic acid, and croton Acid, ethylene acetic acid, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, methylacrylonitrile, α-methylene glutaric acid, cyclohexene dicarboxylic acid , Bie-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy, 2,3,6-tetrahydrophthalic anhydride, 5-norbornene-2,3-dicarboxylic anhydride, Bicyclic [2 · 2 · 2] -5-octene-2,3 dicarboxylic anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and fluorenylmethyl-; 1,3 tetrahydrophthalic anhydride The group of people. 60. The composition as described in item 52 of the scope of patent application, wherein the acrylic is the only unsaturated monomer. 61. The composition described in item 52 of the scope of patent application, wherein the unique unsaturated monosystem is selected from the group consisting of maleic acid, decomposing aconitic acid, and maleic anhydride. 62. For the composition described in item 52 of the scope of patent application, the one saturated mono-system acrylic acid and the other unsaturated mono-system are selected from 58 6- acid and involuntary (please read the notes on the back before filling (This page): Line 丨 This paper size applies to Chinese National Standards (CNs) A4 specifications (210X297 mm) 76 542858 A8 B8 C8 D8 Application scope of patents Maleic acid, decomposed aconitic acid, and maleic acid anhydride The group of people. 63. The composition as described in claim 53 in the scope of patent application, wherein the unsaturated monosystem is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid, decomposed aconitic acid, and croton Acid, ethylene acetic acid, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, methacrylonitrile, α-methyleneglutaric acid, cyclohexanedicarboxylic acid , Cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy- ^ allow tetrahydrophthalic anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclic 0? 2] A group consisting of octene-2,3-dihydroanhydride '3 fluorenyl-1,2,6-tetrahydroanhydride, and 2-methyltetrahydroanhydride. 64. The composition as described in claim 53 in the scope of patent application, wherein the acrylic acid is the only unsaturated monomer. 65. The composition as described in claim 53 in the scope of patent application, wherein the only unsaturated monosystem is selected from the group consisting of maleic acid, decomposed aconitic acid, and maleic anhydride . For example, the composition described in item 53 of the scope of patent application, in which one unsaturated mono system acrylic acid and the other surplus and mono system are selected from cis-butenedioic acid, decomposing aconitic acid, and cis_ A family of butadiene anhydride. 67. The composition as described in claim 54 in the scope of patent application, wherein the unsaturated monosystem is selected from the group consisting of acrylic acid, maleic acid, maleic acid, methacrylic acid, and decomposing aconitic acid, Crotonic acid, ethylene acetic acid, trans-succinic acid, citraconic acid, methyl-trans-butenedioic acid. Acrylonitrile, (Please read the notes on the back before filling this page). Order 丨 77 542858 A8 B8 C8 D8 六、申請專利範圍 -甲基丙稀-腈，α-亞甲基戊二酸，環己烯二羧酸，順 -1，2,3,6-四氫酞酸酐，3,6-環氧四氫酞酸酐， 5-降冰片烯-2,3-二羧酸酐，雙環[2.2.2]-5_辛烯_2,3-二 魏酸酐，3 -甲基-1，2,6-四氫酜酸酐，和曱基β1，3,6· 四氫酞酸酐所組成之族者。 68·如申請專利範圍第54項敘述之組成物，其中該丙烯酸 係唯一的不飽和單體。 69. 如申请專利範圍第54項敘述之組成物，其中該唯一的 不飽和單體係擇自於由順-丁烯二酸，分解烏頭酸，和 順-丁婦—酸野所組成之族者。 70. 如申請專利範圍第54項敘述之組成物，其中該一個不 飽和單體係丙烯酸及另一個不飽和單體係擇自於由 順-丁烯二酸，分解烏頭酸，和順-丁烯二酸酐所組成 之族者。 71 ·如申請專利範圍第2項敘述之組成物，其中該含填魏 酸酯是一個得自二個或更多個不飽和單體，在含磷化 合物存在下聚合反應的共寡聚物或共聚物，含填羧酸 酉曰殘基的主要部份（多於50%，以重量計）為衍生自含 有一個或更多個羧基基團或含有一個或更多個聚合 反應後轉型為羧基基團之基團的羧基單體，其餘的殘 基係得自非羧基單體，其中得到的含磷羧酸酯含有主 要或全部存在為終端型鱗基種系或其水溶性鹽的礙 加入物。 72·如申請專利範圍第71項敘述之組成物，其中該非羧基 本紙張尺度適用中國國家標準（CNS) Α4規格（210X297公釐） -----------------------裝..................-ΙΤ................線. (請先閲讀背面之注意事項再填寫本頁) 78 542858 A8 D8 六、申請專利範圍 一單體係擇自於由2-丙烯醯胺-2-甲基丙烷磺酸，2-羥基 -3-(2-丙烯氧基）丙烷磺酸，2-甲基-2-丙烯基-1-磺酸， 烯丙基磺酸，烯丙氧基苯磺酸，苯乙烯磺酸，乙烯磺 酸，烯丙基膦酸，乙烯膦酸，異丙烯基膦酸，磷乙基 曱基丙烯酸酯，丙烯酸或甲基丙烯酸的羥基烧基和 Ci-C4烧基酯類，丙烯酿胺，烧基取代的丙烯隨胺，稀 丙基酵’ 2 -乙婦σ比淀’ 4 -乙稀σ比淀，N -乙稀°比σ坐綱， Ν-乙烯甲醯胺，Ν-乙烯咪唑，乙烯乙酸酯，水解的乙 稀乙酸酯，和苯乙稀所組成之族者。 73.如申請專利範圍第71項敘述之組成物，其中該羧基單 體係擇自於由丙烯酸，順-丁烯二酸，順-丁烯二酸酐 ’曱基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反 -丁烯二酸，檸康酸，甲基_反_丁烯二酸，丙烯腈，甲 基丙烯腈，α-亞甲基戊二酸，環己烯二羧酸，順 -1，2,3,6-四氫酞酸酐，3,6_環氧-ι，2,3,6-四氫酞酸酐， 5-降冰片烯-2,3-二羧酸酐，雙環[2·2·2]-5_辛烯_2,3_二 羧酸酐，3-甲基-1，2,6_四氫酜酸酐，和2_甲基β1，3,6-四氫酞酸酐所組成之族者。 74·如申請專利範圍第73項敘述之組成物，其中該羧基單 體係擇自於由丙烯酸’順-丁烯二酸，分解烏頭酸，和 順-丁烯二酸酐所組成之族者。 75·如申請專利範圍第2項敘述之組成物，其中該含磷羧 酸醋是-個得自二個或更多個不飽和單體，在含鱗化 合物存在下聚合反應的共募聚物或共聚物，含麟叛酸 家標準⑽）M規格（2歌297么---- (請先閲讀背面之注意事項再填寫本頁) •、可丨 79 542858 A8 B8 C8 D8 、申清專利範圍 S旨殘基的主要部份（多於50%，以重量計）是衍生自含 有一個或更多個羧基基團或含有一個或更多個聚合 反應後轉型為羧基基團之基團的羧基單體，其餘的殘 基是得自非羧基單體，其中得到的含填羧酸酯含有主 要或全部存在為膦酸基種系或其水溶性鹽的鱗力σ入 物。 76.如申請專利範圍第乃項敘述之組成物，其中該非羧基 單體係擇自於由2-丙烯醯胺-2-甲基丙烷磺酸，2-羥基 -3-(2-丙婦氧基）丙烧石黃酸，2-甲基_2-丙稀基-1-石黃酸， 烯丙基磺酸，烯丙氧基苯磺酸，苯乙烯磺酸，乙烯磺 酸’烯丙基膦酸，乙烯膦酸，異丙烯基膦酸，磷乙基 甲基丙烯酸酯，丙烯酸或甲基丙烯酸的羥基烷基和 CrC4烷基酯類，’丙烯醯胺，烷基取代的丙烯醯胺，烯 丙基醇，2-乙辦^比唆，4-乙稀σ比咬，N-乙烯吨洛酮， 乙烯甲醯胺，Ν-乙烯咪唑，乙烯乙酸酯，水解的乙 烯乙酸酯，和苯乙烯所組成之族者。 77·如申請專利範圍第75項敘述之組成物，其中該羧基單 體係擇自於由丙稀酸，順-丁稀二酸，順-丁稀二酸酐 ’甲基丙稀酸，分解烏頭酸，巴豆酸，乙稀乙酸，反 -丁烯二酸，檸康酸，甲基-反-丁烯二酸，丙烯腈，甲 基丙烯腈，α-亞曱基戊二酸，環己烯二羧酸，順 -1，2,3,6-四氫酜酸酐，3,6-環氧-1，2,3,6-四氫欧酸酐， 降冰片烯-2,3-二羧酸酐，雙環[2·2·2]-5_辛烯-2,3_二 羧酸酐，3-曱基-1，2,6-四氫酞酸酐，和2-曱基]，3,6- 本紙張尺度適用中國國家標準（CNS) Α4規格（210X297公釐） ------------------------裝—— (請先閲讀背面之注意事項再填窝本頁) 訂丨 :線- 542858 申叫專利範圍 ♦ 四氫酞酸酐所組成之族者。 如申印專利範圍第77項敘述之組成物，其中該竣基單 體係擇自於由丙烯酸，順-丁烯二酸，分解烏頭酸，和 順-丁烯二酸酐所組成之族者。 ?9·如申請專利範圍第2項敘述之組成物，其中該含磷羧 酸酷是一個得自二個或更多個不飽和單體，在含磷化 合物存在下聚合反應的共寡聚物或共聚物，含碟羧酸 酿中，以整個化合物重量計，多於5〇〇/〇比例的殘基， 是衍生自含有一個或更多個羧基基團或含有一個或 更多個聚合反應後轉型為幾基基團之基團的單體，其 餘的殘基是得自不含有羧基基團或聚合反應後轉型 為叛基基團之基團的單體或非叛基單體，其中得到的 含罐羧酸酯含有主要或全部存在為二烷基膦基種系 或其水溶性鹽的罐加入物。 8〇·如申請專利範圍第79項敘述之組成物，其中該非羧基 單體係擇自於由2-两烯醯胺-2-甲基丙烷磺酸，2-羥基 -3-(2丙烯氧基）丙烷磺酸，2-甲基-2-丙烯基-1-磺酸， 烯丙基磺酸，烯丙氧基苯磺酸，苯乙烯磺酸，乙烯磺 酸，烯丙膦酸，乙烯膦酸，異丙烯基膦酸，磷乙基甲 基丙烯酸酯，丙烯酸或甲基丙烯酸的羥基烷基和&lt;^-(：4 烷基酯類，丙烯醯胺，烷基取代的丙烯醯胺，烯丙基 醇，2-乙烯°比咬，4-乙烯°比唆，N-乙稀。比洛酮，N-乙 烯甲醯胺，N-乙稀咪唾，乙稀乙酸酯，水解的乙稀乙 酸醋，和苯乙稀所組成之族者。 本紙張尺度適用中國國家標準（06) A4規格（210X297公釐） 81 (請先閲讀背面之注意事項再填寫本頁) 訂丨 542858 A8 B8 C8 D8 申請專利範圍 81·如申請專利範圍第79項敘述之組成物，其中該緣基單 體係擇自於由丙烯酸，順-丁烯二酸，順_ 丁婦二酸針 ，甲基丙烯酸，分解烏頭酸，巴豆酸，乙埽乙酸，反 -丁烯二酸，檸康酸，甲基_反_丁烯二酸，丙烯胯，甲 基丙烯腈，α-亞★甲基戊二酸，環己烯二幾酸，順 -1，2,3,6-四氫酞酸酐，3,6-環氧-1，2,3,6-四氳酞酸酐， 5-降冰片烯-2,3·二羧酸酐，雙環[2·2·2]-5-辛烯_2 二 羧酸酐，3-甲基-1，2,6-四氫酞酸酐，和2_甲基q 3 6-四氫酞酸酐所組成之族者。 82. 如申請專利範圍第81項敘述之組成物，其中該幾基單 體係擇自於由丙烯酸，順-丁烯二酸，分解烏頭酸，和 順-丁烯二酸酐所組成之族者。 83. 如申請專利範圍，第2項敘述之組成物，其中該含填魏 酸醋是一個得自二個或更多個不飽和單體，在含填化 合物存在下聚合反應的共寡聚物或共聚物，含碟叛酸 8旨殘基的主要部份（多於50%，以重量計）是衍生自含 有一個或更多個羧基基團或含有一個或更多個聚合 反應後轉型為叛基基團之基團的敌基單體，其餘的殘 基是得自非羧基單體，其中得到的含磷羧酸酯含有存 在為膦酸基，終端型膦基，和二烷基膦基種系混合物 或其水溶性鹽的磷加入物。 84. 如申請專利範圍第83項敘述之組成物，其中該非羧基 單體係擇自於由2-丙烯醯胺-2-甲基丙烷磺酸，2-羥基 -3-(2丙烯氧基）丙烷磺酸，2_甲基丙烯基磺酸， 本紙張尺度適用中國國家標準（⑽）A4規格（21〇χ297公釐） (請先閲讀背面之注意事項再填寫本頁) .、?Ti •線丨 82 542858 A8 B8 C8 D8 六、申請專利範圍 烯丙基磺酸，烯丙氧基苯磺酸，苯【烯磺酸，乙烯磺 酸，烯丙基膦酸，乙嫦膦酸，異丙稀基膦酸，填乙基 曱基丙烯酸酯，丙烯酸或甲基丙烯酸的羥基烷基酯類 ，丙烯酸或甲基丙烯酸的烧基酯類，丙烯酸胺， 烧基取代的丙烯醯胺，烯丙基醇，2-乙烯吡啶，.4-乙 烯吡啶，N-乙烯吡咯酮，N-乙烯甲醯胺，N-乙烯咪唑 ，乙烯乙酸酯，水解的乙烯乙酸酯，和苯乙烯所組成 之族者。 85·如申請專利範圍第83項敘述之組成物，其中該魏基單 體係擇自於由丙烯酸，順-丁烯二酸，順-丁稀二酸酐 ，甲基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反 -丁烯二酸，檸康酸，甲基_反_丁烯二酸，丙烯腈，甲 基丙烯腈，α-亞甲基戊二酸，環己烯二羧酸，順 -1，2,3,6-四氫酜酸酐，3,6-環氧-1，2,3,6-四氫酜酸酐，5 降冰片烯-2,3-二羧酸酐，雙環[2·2·2]-5-辛烯-2,3-二羧 酸酐，3-甲基_1，2,6-四氫酞酸酐，和2-甲基-1，3,6-四氫 酞酸酐所組成之族者。 86·如申凊專利範圍第85項敘述之組成物，其中該叛基單 體係擇自於由丙烯酸，順-丁烯二酸，分解烏頭酸，和 順-丁烯二酸酐所組成之族者。 87·如申凊專利範圍第2項敘述之組成物，其中該含填羧 酸醋是一個含下面化學通式的膦聚合物 本紙張尺度適财關家標準（⑽）Μ規格⑽χ297公楚) (請先閲讀背面之注意事項再填寫本頁)77 542858 A8 B8 C8 D8 6. Scope of patent application-methyl propylene-nitrile, α-methylene glutaric acid, cyclohexene dicarboxylic acid, cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxytetrahydrophthalic anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclo [2.2.2] -5_octene_2,3-diweilenic anhydride, 3-methyl- A family consisting of 1,2,6-tetrahydrofluoric anhydride and fluorenyl β1,3,6 · tetrahydrophthalic anhydride. 68. The composition as described in claim 54 in the scope of patent application, wherein the acrylic acid is the only unsaturated monomer. 69. The composition described in item 54 of the scope of patent application, wherein the only unsaturated monosystem is selected from the group consisting of maleic acid, decomposing aconitic acid, and maleic acid By. 70. The composition described in item 54 of the scope of patent application, wherein the one unsaturated monoacrylic acid and the other unsaturated monosystem are selected from maleic acid, decomposing aconitic acid, and maleic acid A family of oxalic anhydride. 71. The composition described in item 2 of the scope of the patent application, wherein the filler-containing westerate is a co-oligomer obtained from two or more unsaturated monomers and polymerized in the presence of a phosphorus-containing compound or Copolymers containing a major proportion of carboxylic acid residues (more than 50% by weight) derived from one or more carboxyl groups or converted to carboxyl groups after one or more polymerization reactions The carboxyl monomer of the group, and the remaining residues are derived from non-carboxyl monomers. The phosphorous carboxylic acid esters contained therein contain mainly or all of the terminal scale-based species or their water-soluble salts. Thing. 72. If the composition described in item 71 of the scope of patent application, the non-carboxyl paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) ---------------- ------- Installation ........- ΙΤ ...... line. (Please read first Note on the back, please fill out this page again) 78 542858 A8 D8 VI. Application scope of patents-A single system is selected from 2-propenylamine-2-methylpropanesulfonic acid, 2-hydroxy-3- (2-propene (Oxy) propanesulfonic acid, 2-methyl-2-propenyl-1-sulfonic acid, allylsulfonic acid, allyloxybenzenesulfonic acid, styrenesulfonic acid, ethylenesulfonic acid, allylphosphonic acid , Vinylphosphonic acid, isopropenylphosphonic acid, phosphoethylfluorenyl acrylate, hydroxyalkyl and Ci-C4 alkyl esters of acrylic or methacrylic acid, propylene amines, propylene substituted with amines, dilute Propyl ferment '2-acetic acid σ yodo' 4-acetic acid σ yodo, N-ethene ° σ succino, N-vinylformamide, N-vinylimidazole, ethylene acetate, hydrolyzed ethyl A family of dilute acetate and styrene. 73. The composition described in item 71 of the scope of patent application, wherein the carboxyl mono system is selected from the group consisting of acrylic acid, maleic acid, maleic anhydride, amidinoacrylic acid, decomposing aconitic acid, and crotonic acid. , Ethylene acetate, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, methacrylonitrile, α-methyleneglutaric acid, cyclohexene dicarboxylic acid, cis -1,2,3,6-tetrahydrophthalic anhydride, 3,6_epoxy-ι, 2,3,6-tetrahydrophthalic anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclic [ 2 · 2 · 2] -5_octene_2,3_dicarboxylic anhydride, 3-methyl-1,2,6_tetrahydrofluoric anhydride, and 2-methylβ1,3,6-tetrahydrophthalide Family of acid anhydrides. 74. The composition as described in item 73 of the patent application range, wherein the carboxyl mono system is selected from the group consisting of acrylic acid &apos; maleic acid, decomposed aconitic acid, and maleic anhydride. 75. The composition described in item 2 of the scope of the patent application, wherein the phosphorous carboxylic acid vinegar is a co-aggregate polymer obtained from two or more unsaturated monomers and polymerized in the presence of a scale-containing compound. Or copolymer, containing Linjia acid standard ⑽) M specifications (2 songs 297? ---- (Please read the precautions on the back before filling in this page) •, can 丨 79 542858 A8 B8 C8 D8, apply for a patent The major part of residues in range S (more than 50% by weight) are derived from groups containing one or more carboxyl groups or containing one or more carboxyl groups after polymerization. Carboxyl monomers, the remaining residues are derived from non-carboxyl monomers, and the resulting filled carboxylic acid esters contain the scaly sigma species mainly or entirely present as phosphonic acid-based species or their water-soluble salts. 76. Such as The composition described in the scope of the patent application is the item described in the item, wherein the non-carboxyl monosystem is selected from the group consisting of 2-propenylamine-2-methylpropanesulfonic acid, 2-hydroxy-3- (2-propoxymethyl) propane Burnt lutein acid, 2-methyl_2-propen-1- lutein acid, allylsulfonic acid, allyloxybenzenesulfonic acid, styrenesulfonic acid , Ethylenesulfonic acid 'allylphosphonic acid, vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate, hydroxyalkyl and CrC4 alkyl esters of acrylic or methacrylic acid,' acrylamidine, Alkyl substituted acrylamide, allyl alcohol, 2-ethyl acetone, 4-ethyl sigma specific ratio, N-vinyltoxanthone, ethylene formamide, N-ethylene imidazole, ethylene acetate , Hydrolyzed vinyl acetate, and styrene. 77. The composition described in item 75 of the scope of patent application, wherein the carboxylic mono system is selected from acrylic acid, cis-butane Acid, cis-succinic anhydride, methyl acryl, decomposing aconitic acid, crotonic acid, acetic acid, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, Methacrylonitrile, alpha-fluorenylglutaric acid, cyclohexene dicarboxylic acid, cis-1, 2, 3, 6-tetrahydrofluoric anhydride, 3, 6-epoxy-1, 2, 3, 6 -Tetrahydrouric anhydride, norbornene-2,3-dicarboxylic anhydride, bicyclic [2 · 2 · 2] -5_octene-2,3-dicarboxylic anhydride, 3-fluorenyl-1,2,6 -Tetrahydrophthalic anhydride, and 2-fluorenyl], 3,6- This paper size applies to Chinese national standards (C NS) Α4 specification (210X297 mm) ------------------------ Packing-(Please read the precautions on the back before filling this page) Order 丨: Line-542858 The scope of patent application ♦ The family of tetrahydrophthalic anhydride. For example, the composition described in item 77 of the scope of the patent application for India, where the single-unit system is selected from acrylic acid, cis-butyl A group consisting of oxalic acid, decomposed aconitic acid, and maleic anhydride.? 9. The composition described in item 2 of the scope of patent application, wherein the phosphorous carboxylic acid is one obtained from two or More unsaturated monomers, co-oligomers or copolymers polymerized in the presence of phosphorus-containing compounds, and carboxylic acid-containing brewers, more than 500/0 residues based on the weight of the entire compound, Is a monomer derived from a group containing one or more carboxyl groups or containing one or more groups that are transformed into several groups after polymerization. The remaining residues are derived from the absence of carboxyl groups or polymerization Monomers or non-rebel monomers which are later converted into sedyl groups, wherein the resulting canned carboxylic acid esters contain mainly or all of them as dioxane Or a phosphonic group can germline water-soluble salts thereof is added. 80. The composition as described in item 79 of the scope of the patent application, wherein the non-carboxyl monosystem is selected from 2-dienepyramine-2-methylpropanesulfonic acid, 2-hydroxy-3- (2propenyloxy Group) propanesulfonic acid, 2-methyl-2-propenyl-1-sulfonic acid, allylsulfonic acid, allyloxybenzenesulfonic acid, styrenesulfonic acid, ethylenesulfonic acid, allylphosphonic acid, ethylene Phosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate, hydroxyalkyl of acrylic or methacrylic acid, and <^-(: 4 alkyl esters, acrylamide, alkyl substituted acrylamide , Allyl alcohol, 2-ethylene ° specific bite, 4-ethylene ° specific bite, N-ethene. Biloxazone, N-ethenemethoxamine, N-ethene, salicyl acetate, hydrolysis The family of acetic acid acetic acid and styrene. This paper size applies to the Chinese national standard (06) A4 size (210X297 mm) 81 (Please read the precautions on the back before filling this page) Order 丨 542858 A8 B8 C8 D8 Patent application scope 81. The composition described in item 79 of the patent application scope, in which the radical system is selected from acrylic acid, cis-butenedioic acid, and cis-butadiene Needle, methacrylic acid, decomposed aconitic acid, crotonic acid, acetic acid, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylamide, methacrylonitrile, α-sub Methyl glutaric acid, cyclohexenedioic acid, cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic anhydride, 5- Norbornene-2,3 · dicarboxylic anhydride, bicyclo [2 · 2 · 2] -5-octene_2 dicarboxylic anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2_ The family consisting of methyl q 3 6-tetrahydrophthalic anhydride. 82. The composition described in item 81 of the scope of application for patent, wherein the monobasic system is selected from acrylic acid, maleic acid, Decomposition of aconitic acid and maleic anhydride. 83. If the scope of the patent application, the composition described in item 2, wherein the fulvic acid vinegar is obtained from two or more Saturated monomers, co-oligomers or copolymers that polymerize in the presence of a filler compound, containing a major portion (more than 50% by weight) of the 8-residue residues of the discrete acid are derived from a compound containing one or more Multiple carboxyl groups or after one or more polymerization reactions Enemy monomers of the type tertiary groups, the remaining residues are derived from non-carboxyl monomers, and the resulting phosphorous carboxylic acid esters contain phosphonate groups, terminal phosphine groups, and dioxane. Phosphine based phosphine-based germline mixture or a water-soluble salt thereof. 84. The composition as described in claim 83, wherein the non-carboxyl monosystem is selected from 2-propenylamine-2-methyl Propanesulfonic acid, 2-hydroxy-3- (2propenyloxy) propanesulfonic acid, 2-methacrylsulfonic acid, this paper size applies to Chinese national standard (⑽) A4 specification (21 × 297 mm) (please (Please read the notes on the back before filling in this page).,? Ti • Line 丨 82 542858 A8 B8 C8 D8 VI. Application for patent scope Allylsulfonic acid, allyloxybenzenesulfonic acid, benzene [enesulfonic acid, ethylene Sulfonic acid, allylphosphonic acid, acetophosphonic acid, isopropylphosphonic acid, ethylethyl acrylate, hydroxyalkyl esters of acrylic or methacrylic acid, and alkyl esters of acrylic or methacrylic acid Class, amine acrylate, alkyl substituted acrylamide, allyl alcohol, 2-vinylpyridine, .4-vinylpyridine, N- A family of vinylpyrrolidone, N-vinylformamide, N-vinylimidazole, ethylene acetate, hydrolyzed ethylene acetate, and styrene. 85. The composition as described in claim 83 in the scope of patent application, wherein the Weiji mono system is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid, decomposed aconitic acid, and croton Acid, ethylene acetic acid, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, methacrylonitrile, α-methyleneglutaric acid, cyclohexene dicarboxylic acid, Cis-1,2,3,6-tetrahydrofluoric anhydride, 3,6-epoxy-1,2,3,6-tetrahydrofluoric anhydride, 5 norbornene-2,3-dicarboxylic anhydride, bicyclic [ 2 · 2 · 2] -5-octene-2,3-dicarboxylic anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-tetrahydro Family of phthalic anhydride. 86. The composition described in the scope of claim 85 of the patent application, wherein the monobasic system is selected from the group consisting of acrylic acid, maleic acid, decomposed aconitic acid, and maleic anhydride By. 87. The composition described in item 2 of the patent scope, wherein the carboxylic acid-containing vinegar is a phosphine polymer containing the following general chemical formula. The paper size is suitable for family standards (⑽M specifications (⑽297)). (Please read the notes on the back before filling this page) 83 542858 A8 B8 C8 D8 、申請專利範圍 〇 Rji _ί/ oxr soxT 其中Xj為H ’鹼金屬原子’鹼土金屬原子或銨或胺殘 基；及R;i是一個包含二個不同的下面殘基的共聚物殘 基 + CH2 CH (RJ2)七 其中z疋一個範圍自2至100的整數，盆中，第 一個殘基的R;2為-COOH，第二個殘基的Rj2為 -CONHC(CH3)2CH2S〇3Xj ’其中Xj為如前面定義者。 8 8 ·如申清專利範圍第2項欽述之組成物，其中該水相系 統處理物料是一個組成物，包含高達50%重量比，以 組成物重量計，的膦酸基琥珀酸，膦酸化鹼金屬順_ 丁烯二酸酯二聚物，不多於次要重量比部份，以二聚 物重量計，的較高膦酸化的順-丁烯二酸酯寡聚物；和 0.5至5%組成物重量比的鹼金屬磷酸鹽。 89.如申請專利範圍第2項敘述之組成物，其中該肌胺酸 之長鏈脂肪酸衍生物係選擇為N-月桂醯基肌胺酸或 其水溶性鹽。 90·如申請專利範圍第1項敘述之組成物，其中該組成物 包括水。 91 ·如申請專利範圍第2項敘述之組成物，其中該組成物 另外包括水。 本紙張尺度適用中國國家標準（CNS) A4規格（21〇χ297公釐） (請先閲讀背面之注意事項再填寫本頁) •、可| -線丨 84 542858 A8 B8 C8 . D8 六、申請專利範圍 (請先閲讀背面之注意事項再填寫本頁) 92·一如申請專利範圍第2項敘述之組成物，其中該組成物 另外含有至少一個擇自於由下面基團所組成之族的 添加物： i) 一個或更多個分散劑 ii) 一個或更多個銅腐姓抑制劑 iii) 一個或更多個鋁腐蝕抑制劑 iv) 一個或更多個擇自於由鋅，錳，鋁，錫，鎳 ，在乙，和稀土金屬所組成之族的金屬的水溶性金屬鹽 v) 一個或更多個擇自於由鋅，錳，鋁，錫，鎳 ，釔，和稀土金屬所組成之族的金屬離子的水溶性的 有機金屬螯合物’其中選擇的有機螯合物要提供金屬 離子需要的水溶解度 vi) —個或更多個水垢控制劑 vii) —個或更多個多價螯合劑 viii) —個或更多個防珠劑 ix) 一個或更多個氧化性生物制劑 X) 一個或更多個非氧化性生物制劑 xi) 一個或更多個可以降低水相系統冷凍溫 的水溶性醇 xii) 一個或更多個離子的冷凍溫度抑制劑 xiii) 一個或更多個pH調節劑 xiv) 一個或更多個惰性示縱劑 XV) 一個或更多個活性示縱劑 xvi) 一個或更多個非水溶性的有機潤滑劑 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 85 542858 A8 B8 C8 D8 六、申請專利範圍 xvii) —個或更多個水溶性潤滑劑 xviii) —個或更多個表面活性劑 xix) —個或更多個鈣硬度調節劑 XX) 一個或更多個呈色劑 93 ·如申請專利範圍第92項敘述之組成物，其中該組成物 另外包括水。83 542858 A8 B8 C8 D8, patent application scope 〇 Rji _ί / oxr soxT where Xj is H 'alkali metal atom' alkaline earth metal atom or ammonium or amine residue; and R; i is a compound containing two different lower residues Copolymer residue + CH2 CH (RJ2), where z 疋 is an integer ranging from 2 to 100. In the basin, R of the first residue; 2 is -COOH, and Rj2 of the second residue is -CONHC ( CH3) 2CH2SO3Xj 'where Xj is as defined previously. 8 8 · According to the composition described in item 2 of the scope of the patent application, wherein the material treated in the aqueous phase system is a composition containing up to 50% by weight of the phosphonic acid succinic acid and phosphine based on the weight of the composition Acidified alkali metal cis-butadiene dimer, not more than minor weight ratio, based on the weight of the dimer, a higher phosphonized cis-butenedioate oligomer; and 0.5 Alkali metal phosphate to 5% by weight of the composition. 89. The composition described in item 2 of the scope of the patent application, wherein the long-chain fatty acid derivative of the sarcosinic acid is selected from N-laurate sarcosinic acid or a water-soluble salt thereof. 90. The composition as described in item 1 of the scope of patent application, wherein the composition includes water. 91. The composition described in item 2 of the scope of patent application, wherein the composition additionally includes water. This paper size applies to Chinese National Standard (CNS) A4 specification (21 × 297 mm) (Please read the precautions on the back before filling this page) •, OK | -line 丨 84 542858 A8 B8 C8. D8 VI. Patent Application Scope (please read the precautions on the back before filling this page) 92. As described in the second paragraph of the scope of the patent application, the composition additionally contains at least one addition selected from the group consisting of the following groups Materials: i) one or more dispersants ii) one or more copper corrosion inhibitors iii) one or more aluminum corrosion inhibitors iv) one or more selected from zinc, manganese, aluminum , Tin, nickel, water-soluble metal salts of metals of the group consisting of B, and rare earth metals v) One or more selected from the group consisting of zinc, manganese, aluminum, tin, nickel, yttrium, and rare earth metals Group of metal ions, water-soluble organometallic chelates' wherein the organic chelates are selected to provide the water solubility required for metal ions vi)-one or more scale control agents vii)-one or more Chelates viii)-one or more Anti-bead agents ix) One or more oxidizing biological agents X) One or more non-oxidizing biological agents xi) One or more water-soluble alcohols that can lower the freezing temperature of the aqueous phase system xii) One or more Freezing temperature inhibitors for each ion xiii) one or more pH adjusters xiv) one or more inert scissors XV) one or more active scissors xvi) one or more water-insoluble Organic Lubricants The size of this paper applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) 85 542858 A8 B8 C8 D8 VI. Patent application scope xvii) — One or more water-soluble lubricants xviii) — One or more Surfactant xix)-one or more calcium hardness modifiers XX) one or more coloring agents 93 · The composition as described in item 92 of the patent application scope, wherein the composition additionally includes water. 94·如申请專利範圍第92項欽述之組成物，其中該分散劑 疋'個侍自一^固或更多個乙稀不飽和單體聚合反靡 的水溶性磺酸化聚合物或共聚物。 95·如申請專利範圍第94項敘述之組成物，其中該水溶性 石κ酸化共聚物是3:1重量比的丙婦酸和埽丙基經基丙 基磺酸鹽醚或其水溶性鹽的共聚物。 96·如申請專利範圍第92項敘述之組成物，其中該分散劑 疋一個分子量&lt;10,000的二異丁烯和順·丁烯二酸酐的 共聚物，或其水溶性鹽。 97.如申請專利範圍第92項敘述之組成物，其中該銅腐蝕 抑制劑為甲苯***。 98·如申請專利範圍第92項敘述之組成物，其中該鋼腐蝕 抑制劑是一個混合的甲苯***組成物，包括至少“％ 重量比的5-甲基苯并***異構物。 99.如申請專利範圍第92項敘述之組成物，其中該銅腐餘 抑制劑為苯并***。 如中請專職圍第92項敘述之組成物，其中該鋼腐韻 抑制劑為氫硫基苯并噻唑。 本紙張尺度翻巾_家標準（⑽）A4規格⑵〇χ297公爱) 542858 鹽 A8 B8 C8 D8 、申請專利範圍 如申明專利範圍第92項敘述之組成物，其中該銅腐钱 抑制劑是一個烷基或烷氧基取代的苯并三唾，其中該 取代發生於苯環的4或5位置。 102.如申請專利範圍第1〇1項敘述之組成物，其中該取代 基係擇自於由正-丁基和己氧基所組成之族春。 103·如申請專利範圍第92項敘述之組成物，其中該銅腐蝕 抑制劑為1-苯基_5-氫硫基四唑。 104·如申凊專利範圍第92項敘述之組成物，其中該銅腐餘 抑制劑是一個耐函素σ坐類。 105·如申請專利範圍第1〇4項敘述之組成物，其中該耐鹵 素唑類為氣-甲苯***。 106·如申請專利範圍第92項敘述之組成物，其中談鋁腐蝕 抑制劑是一個水溶性硝酸鹽。 107.如申請專利範圍第1〇6項敘述之組成物，其中該水溶 性硝酸鹽為硝酸鈉。 108·如申請專利範圍第92項敘述之組成物，其中該水溶性 金屬鹽是得自鋅。 109·如申請專利範圍第1〇8項敘述之組成物，其中該鋅鹽 是硫酸鹽，氯化物或硝酸鹽。 110·如申請專利範圍第92項敘述之組成物，其中該水溶性 金屬鹽是得自+2氧化態的猛。 111·如申請專利範圍第110項敘述之組成物，其中該+2氧 化態猛鹽為硫酸鹽，氯化物，乙酸鹽或硝酸鹽。 112.如申請專利範圍第92項敘述之組成物，其中該金屬 本紙張尺度適用中國國家標準（CNs) Α4規格（210X297公釐） (請先閲讀背面之注意事項再填窝本頁) 、可| 87 542858 A8 B8 C8 D8 申請專利範圍 。是得自鑭或包含鑭的稀土金展的混合物。 113·如申請專利範圍第112項敘述之組成物，其中該鑭鹽或 包含的稀土金屬鹽的混合物係獨立地擇自硫酸鹽 氣化物’乙酸鹽或石肖酸鹽。 114. 如申請專利範圍第92項敘述之組成物，其中該多價螯 合劑係擇自於由乙二胺四（乙酸）氮基三乙酸，和n，n_ 二（2-羥乙基）甘胺酸或其水溶性鹽所組成之族者。 115. 如申請專利範圍第2項敘述之組成物，其中該鹼金屬 矽酸鹽為偏矽酸鈉。 116. 如申凊專利範圍第％項敘述之組成物，其中該防沫劑 係擇自於由矽酮，聚二甲基矽氧烷，二硬脂基癸二醯 胺’二硬脂基己二醯胺，脂肪醇’和脂肪醇之環氧乙 烷縮合物所組成之族者。 117. 如申請專利範圍第92項敘述之組成物，其中該氧化性 生物制劑係擇自於由氣，次氯酸鹽，溴，次溴酸鹽， 提供氣之化合物，提供溴之化合物，過乙酸，無機的 過氧化物和過氧化物產生物，二氧化氣，臭氧和其混 合物所組成之族者。 118·如申請專利範圍第92項敘述之組成物，其中該非氧化 性生物制劑係擇自於由胺，四級銨化合物，2-溴-2-硝 基丙烧-1，3 - 一酵’ β-&gt;臭石肖基苯乙婦’十二烧基脈氮乳 酸鹽，2,2-二溴-3-氮基丙醯胺，戊二醛，氯酚，楓， 亞曱基雙硫氰酸酯，亞甲基雙胺基甲酸酯，異噻唑酮 ，溴化丙醯胺，三吖啡，鱗化合物，有機金屬化合物 本紙張尺度適用中國國家標準（CNS) Α4規格（210X297公釐） ....... 裝 訂------------------線 (請先閲讀背面之注意事项再填窝本頁) 542858 A8 B8 C8 ____D8 六、申請專利範圍 和其混合物所組成之族者。 _ 119·如申請專利範圍第92項敘述之組成物，其中該非氧化 性生物制劑是一個混合物，包含0)2-溴_2-硝基丙烷 -1，3-二醇（BNPD)和（b)75% 5-氯 _2_ 甲基-4-異噻唑-3-酮和25% 2-甲基-4-異噻唑-3-酮混合物，該BNPD(a)與 該混合物（b)的重量比為16:1到1:;1。 120. 如申請專利範圍第92項敘述之組成物，其中該水溶性 醇冷凍溫度抑制劑係擇自於由乙二醇，丙二醇，乙醇 ，甘油，丙醇，和甲醇或其混合物所組成之族者。 121. 如申請專利範圍第92項敘述之組成物，其中該離子的 冷凍溫度抑制劑係擇自於由氯化鈣，氣化鈉，溴化鋰 ，和氣化鋰所組成之族者。 122·如申請專利範圍第92項敘述之組成物，其中該？{^調節 劑係擇自於由氫氧化鈉，氫氧化鉀，氫氧化鋰，鹽酸 ，硫酸，硝酸，二氧化碳，氨，有機酸，如草酸，鹼 金屬碳酸鹽，和鹼金屬碳酸氫鹽所組成之族者。 123·如申請專利範圍第％項敘述之組成物，其中該惰性示 蹤劑係擇自於由可溶的鋰鹽，過渡金屬，和螢光物料 所組成之族者。 124.如申請專利範圍第92項敘述之組成物，其中該活性示 蹤劑係擇自於由螢光標記的聚合物，含有光惰性，隱 藏的可檢測部份的聚合物，水溶性鉬酸鹽，和以唾類 為主的銅腐餘抑制劑所組成之族者。 125·如申請專利範圍第92項敘述之組成物，其中該非水溶 本紙張尺度適用中國國家標準（OIS) A4規格（21〇&gt;&lt;297公釐） (請先閲讀背面之注意事項再填寫本頁) •訂丨 89 542858 A8 B8 C8 D8 其中該表面活 兩性的，和非 其中該鈣硬度 、申請專利範圍 」生有機潤滑劑係擇自於由天然油和合成油所組成之 族者。 126·如申請專利範圍第”項敘述之組成物 性劑係擇自於由陰離子的，陽離子的 離子的表面活性劑所組成之族者。 127·如申請專利範圍第92項敘述之組成物 凋節劑係擇自於由躬的碳酸氫鹽，碳酸鹽，氯化物 硫駿鹽，和乙酸鹽，氫氧化鈣和氧化鈣所組成之族者 128·如申明專利範圍第92項敘述之組成物，其中該呈色劑 是一個水溶性染料。 129·如申凊專利範圍第2項敘述之組成物，其中該單氟填 酸鹽為單氟磷酸鈉。 130.種用於控制接觸水相系統之金屬的腐姓的方法，其 中包含引入該系統下面的組合： (a)下面化學式的四唑鏘化合物： (請先閲讀背面之注意事項再填寫本頁) 訂| :線·94. The composition recited in item 92 in the scope of the application for a patent, wherein the dispersant is a water-soluble sulfonated polymer or copolymer that is polymerized by one or more ethylenically unsaturated monomers. . 95. The composition described in item 94 of the scope of application for a patent, wherein the water-soluble stone kappa acid copolymer is 3: 1 by weight of acetic acid and acetopropylpropylsulfonate ether or a water-soluble salt thereof. Copolymer. 96. A composition as described in claim 92 in the scope of the patent application, wherein the dispersant is a copolymer of diisobutylene and maleic anhydride with a molecular weight of <10,000, or a water-soluble salt thereof. 97. The composition as described in claim 92 in the scope of patent application, wherein the copper corrosion inhibitor is toltriazole. 98. The composition described in item 92 of the scope of the patent application, wherein the steel corrosion inhibitor is a mixed toltriazole composition including at least "% by weight of 5-methylbenzotriazole isomers. 99 . For example, the composition described in item 92 of the scope of patent application, wherein the copper residue inhibitor is benzotriazole. As the composition described in item 92 of the full-time application, wherein the steel corrosion inhibitor is hydrogen sulfur group Benzothiazole. This paper size towel _ home standard (⑽) A4 size ⑵〇297297 public love) 542858 salt A8 B8 C8 D8, the composition of the scope of patent application such as stated in the scope of the patent statement stated in item 92, where the copper rot money The inhibitor is an alkyl or alkoxy substituted benzotrisalyl, wherein the substitution occurs at the 4 or 5 position of the benzene ring. 102. The composition as described in claim 101 of the patent application scope, wherein the substituent is It is selected from the family consisting of n-butyl and hexyloxy. 103. The composition as described in item 92 of the application, wherein the copper corrosion inhibitor is 1-phenyl_5-hydrosulfanyl Azole 104. Composition as described in item 92 of the patent application Wherein the copper residue inhibitor is a functional group sigma. 105. The composition described in item 104 of the scope of patent application, wherein the halogen-resistant azole is gas-tolutriazole. 106 · If a patent is applied The composition described in item 92 of the scope, wherein the aluminum corrosion inhibitor is a water-soluble nitrate. 107. The composition described in item 106 of the application scope, wherein the water-soluble nitrate is sodium nitrate. 108 · The composition described in item 92 of the scope of patent application, wherein the water-soluble metal salt is obtained from zinc. 109. The composition described in item 108 of the scope of patent application, wherein the zinc salt is sulfate, chloride or Nitrate. 110. The composition as described in item 92 of the patent application, wherein the water-soluble metal salt is obtained from the oxidation state of +2. 111. The composition as described in item 110 of the patent application, wherein the + 2 The oxidized salt is sulfate, chloride, acetate or nitrate. 112. The composition described in item 92 of the scope of patent application, in which the paper size of the metal applies to Chinese National Standards (CNs) A4 (210X297) Cents) ( Read the precautions on the back before filling in this page), may | 87 542858 A8 B8 C8 D8 patent application scope. It is a mixture of lanthanum or rare earth gold exhibition containing lanthanum. 113 · As described in the 112th patent application scope A composition, wherein the lanthanum salt or a mixture of rare earth metal salts contained therein is independently selected from a sulfate gaseous salt of 'acetate or petrosalate. 114. The composition described in item 92 of the scope of patent application, wherein the multiple The valence chelating agent is selected from the group consisting of ethylenediamine tetra (acetic acid) nitrotriacetic acid, and n, n-bis (2-hydroxyethyl) glycine or a water-soluble salt thereof. 115. The composition described in item 2 of the scope of the patent application, wherein the alkali metal silicate is sodium metasilicate. 116. The composition as described in the item% of the patent application, wherein the antifoaming agent is selected from the group consisting of silicone, polydimethylsiloxane, distearyl sebacamide and distearyl Diamine, a family of fatty alcohols and ethylene oxide condensates of fatty alcohols. 117. The composition described in item 92 of the scope of patent application, wherein the oxidizing biological agent is selected from the group consisting of gas, hypochlorite, bromine, hypobromite, a compound providing gas, a compound providing bromine, and A family of acetic acid, inorganic peroxides and peroxides, dioxide, ozone and mixtures thereof. 118. The composition as described in item 92 of the scope of patent application, wherein the non-oxidizing biological agent is selected from the group consisting of amines, quaternary ammonium compounds, 2-bromo-2-nitropropane-1,3-monoferment ' β- &gt; Scent of stilbene acetophenone's dodecayl vein vein lactate, 2,2-dibromo-3-aziridine, glutaraldehyde, chlorophenol, maple, fluorenyl dithiocyanate Ester, methylene biscarbamate, isothiazolone, propylammonium bromide, triazine, scale compounds, organometallic compounds. The paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm). ...... Binding ------------------ line (please read the precautions on the back before filling the nest page) 542858 A8 B8 C8 ____D8 VI. Scope of patent application And its mixture. _119. The composition as described in claim 92 in the scope of patent application, wherein the non-oxidizing biological agent is a mixture containing 0) 2-bromo_2-nitropropane-1,3-diol (BNPD) and (b ) 75% 5-chloro_2_methyl-4-isothiazol-3-one and 25% 2-methyl-4-isothiazol-3-one mixture, the weight of the BNPD (a) and the mixture (b) The ratio is from 16: 1 to 1:; 1. 120. The composition as described in claim 92, wherein the water-soluble alcohol freezing temperature inhibitor is selected from the group consisting of ethylene glycol, propylene glycol, ethanol, glycerol, propanol, and methanol or a mixture thereof By. 121. The composition described in item 92 of the application, wherein the freezing temperature inhibitor of the ion is selected from the group consisting of calcium chloride, sodium gas, lithium bromide, and lithium gas. 122. If the composition described in item 92 of the scope of patent application, where? {^ Regulators are selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide, hydrochloric acid, sulfuric acid, nitric acid, carbon dioxide, ammonia, organic acids such as oxalic acid, alkali metal carbonates, and alkali metal bicarbonates Family. 123. The composition as described in item% of the patent application scope, wherein the inert tracer is selected from the group consisting of a soluble lithium salt, a transition metal, and a fluorescent material. 124. The composition described in item 92 of the scope of patent application, wherein the active tracer is selected from a polymer labeled with fluorescence, a polymer containing a photo-inert, hidden detectable portion, and a water-soluble molybdic acid A family of salt and saliva-based copper residue inhibitors. 125 · If the composition described in item 92 of the scope of patent application, the non-water-soluble paper size applies the Chinese National Standard (OIS) A4 specification (21〇 &gt; &lt; 297 mm) (Please read the precautions on the back before filling (This page) • Order 丨 89 542858 A8 B8 C8 D8 The surface is amphoteric, and the calcium hardness, which is not in the scope of patent application. Raw organic lubricants are selected from the family consisting of natural oils and synthetic oils. 126. The composition properties described in item "Scope of the patent application" are selected from the group consisting of anionic and cationic ionic surfactants. 127. The composition described in item 92 of the patent application scope is withered The agent is selected from the group consisting of bicarbonate, carbonate, chloride, and acetate, calcium hydroxide, and calcium oxide. The coloring agent is a water-soluble dye. 129. The composition described in the second item of the patent scope of Shen Shen, wherein the monofluoro salt is sodium monofluorophosphate. 130. It is used for controlling contact with the aqueous phase system. The method of metal surname, which includes the following combinations introduced into the system: (a) Tetrazolium compound of the following chemical formula: (Please read the precautions on the back before filling this page) Order |: Line · 其中Ri，R#R3係擇自於由較低級烷基，分枝的較低 級烧基，芳基，取代的芳基，烷芳基，取代的烷芳基 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公楚） 90 -和雜環取代的芳基所組成之族者，但是必須R1,M R3都不含有多於14個碳原子;η為1或2,如果需要，這 種四唾鐵化合物任擇地含有伴隨的水溶性離子種系以 得到中性電荷，及 (b)至J/另一個水相系統處理物料，其選擇要使得 •該物料不實質的還原四唑鏘化合物。 ⑶.如中請專利範圍第13G項之方法，其中該其他水相系 統處理物料係擇自於由下面化合物所組成之族者：無 機鱗酸鹽，复鹽，亞硝酸冑，在水中釋放金屬陰離 子的化合物，2,3-二羥基苯酸，u…啡啉，聚羧酸酯 ，烴基聚羧酸酯，烷基羥基羧酸，胺基羥基琥珀酸， 羧基胺，聚環氧琥珀酸，經改質的聚環氧琥珀酸，單 膦酸，一膦酸，膦酸基羧酸，羥基膦酸基羧酸，胺基 膦酸，膦酸基甲基胺氧化物，聚合的胺氧化物，聚醚 聚胺基亞甲基膦酸酯，聚醚聚胺基_亞甲基膦酸酯N-氧化物’亞胺基伸烧基膦酸，肌胺酸之長鏈脂肪酸衍 生物；調聚的，共調聚的，聚合的或共聚合的含構叛 酸酯，鹼金屬矽酸鹽，單氟磷酸鹽，胺，二胺，烷醇 胺，醚胺，脂肪胺和二胺，四級化胺，氧烧基化胺， 烷基σ比啶，四唑，咪唑琳和取代的咪唑琳，醯胺胺， 聚胺，聚伸烷基聚膦，苯磺酸，苯酸鹽和取代的苯酸 鹽之烷基衍生物，胺基苯酸鹽，水楊酸鹽，二聚酸-三聚酸，石油氧化物，观葡萄糖酸鹽；木質素，木質 磺酸鹽，鞣酸；直鏈C5-Cn單羧酸酯和C4-C15 α，ω-二 91 本紙張尺度適用中國國家標準（°^) Α4規格（210 X 297公楚） 542858 A8 B8 C8 D8 申請專利範圍 „羧酸酯；羧酸和氫硫基羧酸胺鹽，胺基酸，聚胺基酸 ，羥基醚酸和相關的内酯化合物，N—醯基亞胺基二乙 酸，二吖啩二-和三-羧酸，磷和磷酸酯類；及單氟磷 酉文鹽，它們的水溶性鹽，和它們的混合物。Among them, Ri and R # R3 are selected from lower alkyl, branched lower alkyl, aryl, substituted aryl, alkaryl, and substituted alkaryl. The basic paper size applies Chinese national standards ( CNS) A4 specification (210X297) Chu 90- and heterocyclic substituted aryl group, but must be R1, M R3 does not contain more than 14 carbon atoms; η is 1 or 2, if necessary, this The four sialon compounds optionally contain an accompanying water-soluble ionic species to obtain a neutral charge, and (b) to J / another aqueous system treatment material selected so that the material does not substantially reduce tetrazole锵 Compounds. (3) The method of item 13G of the patent scope, wherein the other water-phase system treatment materials are selected from the group consisting of the following compounds: inorganic scale salts, double salts, thallium nitrite, release metals in water Anionic compounds, 2,3-dihydroxybenzoic acid, u ... phenoline, polycarboxylic acid esters, hydrocarbyl polycarboxylic acid esters, alkyl hydroxycarboxylic acids, amino hydroxysuccinic acids, carboxyamines, polyepoxysuccinic acids, Modified polyepoxysuccinic acid, monophosphonic acid, monophosphonic acid, phosphonic acid, hydroxyphosphonic acid, aminophosphonic acid, phosphonic acid methylamine oxide, polymerized amine oxide , Polyether polyaminomethylene phosphonate, polyether polyamino_methylene phosphonate N-oxide 'imino sphingosine phosphonic acid, a long-chain fatty acid derivative of sarcosine; telomerization , Co-telomerized, polymerized or copolymerized conformal acid esters, alkali metal silicates, monofluorophosphates, amines, diamines, alkanolamines, etheramines, fatty amines, and diamines, class 4 Amines, oxyalkylated amines, alkyl σ-pyridines, tetrazoles, imidazolines and substituted imidazolines, amidoamines, polyamines, polyalkylene polyphosphines Benzenesulfonic acid, alkyl derivatives of benzoate and substituted benzoate, aminobenzoate, salicylate, dimer-trimer acid, petroleum oxide, gluconate, lignin, Lignosulphonate, tannic acid; linear C5-Cn monocarboxylic acid esters and C4-C15 α, ω-di 91 This paper size applies to Chinese national standards (° ^) Α4 size (210 X 297) Chu 542858 A8 B8 C8 D8 Patent application scope: carboxylic acid esters; amine salts of carboxylic acids and hydrothiocarboxylic acids, amino acids, polyamino acids, hydroxy ether acids and related lactone compounds, N-fluorenimine diacetic acid, Diazine di- and tri-carboxylic acids, phosphorus and phosphate esters; and monofluorophosphonium phosphonium salts, their water-soluble salts, and mixtures thereof. 132. 如申請專利範圍第130項之方法，其中該四唑鏺化合 物係擇自於由硝基藍四唑鏘硝苯基乃，5，_ 一苯乙烯基-3,3’-[3,3’-二甲氧基_4,4，_伸聯苯基]二四 唑鏘）’二苯乙烯基硝基藍四唑鐵（2,2，·二-對·硝苯基 _5,5’-二苯乙烯基-3,3’_[3,3、二甲氧基_4,4，_伸聯苯基] 二四唑繙），四硝基藍四唑繙（353、（3,3、二曱氧基-4,4、 伸而卩本基）-雙-[2,5-對-确苯基·2Η-四。坐鐵]和硬硝基四 坐I翁（2-(4-埃笨基）-3-(4-石肖苯基）-5-苯基四唾鏘的水溶 性鹽所組成之族者。132. The method of claim 130, wherein the tetrazolium compound is selected from nitroblue tetrazolium nitrophenyl, 5, _- styryl-3,3 '-[3, 3'-dimethoxy-4,4, _biphenyl] bistetrazolium) 'distyrylnitro blue tetrazolium iron (2,2, · di-p-nitrophenyl_5, 5'-distyryl-3,3 '_ [3,3, dimethoxy_4,4, _dienylphenyl] tetrazolidine), tetranitro blue tetrazolidine (353, ( 3,3, dioxo-4,4, stilbene group) -bis- [2,5-p-chlorophenyl · 2。-tetramethylene.] And hard nitro tetrazo 1 -(4-Ebenyl) -3- (4-stone phenyl) -5-phenyl tetrasialyl which is a family of water-soluble salts. 133. 如申請專利範圍第131項之方法，其中該四唑鍇化合 物係擇自於由硝基藍四唑鍇（2,2，-二-對-硝苯基-5,5，_ 二苯乙烯基-3,3，-[3,3，-二甲氧基-4,4，-伸聯苯基]二四 σ坐鑷）’ 一苯乙稀基硝基藍四嗤鏘（2,2’-二_對·硝苯基 _5,5’·二苯乙烯基-3,3，-[3,3，-二甲氧基_3.3、伸聯苯基] 二四唾鏺乃四硝基藍四唑錯^^-^口’-二甲氧基-斗，#，-伸聯苯基）-雙-[2,5-對-罐苯基-2Η-四唑鏺]和碘確基四 唑繙（2-(4-碘苯基）-3-(4-硝苯基）-5-苯基四唑鏘的水溶 性鹽所組成之族者。 134. 如申請專利範圍第13()項之方法，其中該水溶性離子 種系係擇自於由_基，石肖酸根，亞硝酸根，碳酸根， 542858 A8 B8 C8 D8 申請專利範圍 .碳酸氫根，硫酸根，碌酸根，和過渡金屬含氧酸根的 陰離子所組成之族者。 135. 如中請專利範㈣134項之方法，其中㈣基係擇自 於由氣，氟，溴和蛾所組成之族者。 136. 如中請專利範圍第135項之方法，其中該函基為氣。 如中請專利範圍第134項之方法，其中該過渡金屬含 氧酸根係擇自於由翻酸根，路酸根，和鶴酸根所組成 之族者。 138. =中請專利範圍第137項之方法，其中該過渡金屬含 氧酸根為鉬酸根。 139. 如申請專利範圍第131項之方法，其中該無機磷酸 為正磷酸鹽，聚磷酸鹽，其水溶性鹽和其混合物。 140. 如申請專利範圍，第131項之方法，其中該無機磷酸 疋一個正磷酸和焦磷酸或其水溶性鹽的混合物。 141·如申請專利範圍第131項之方法，其中該硼酸鹽是 個擇自於由四觸酸鹽，偏哪酸鹽 性硼酸鹽所組成之族者。 142·如申請專利範圍第141項之方法 鹽為四删酸納或四删酸納水合物 M3.如申請專利範圍第131項之方法 亞硝酸鈉。 144.如申請專利範圍第131項之方法 釋放化合物係擇自於由鉬酸鹽，鎢酸鹽，釩酸鹽 釩酸鹽，和鉻酸鹽之水溶性鹽所組成之族者。 鹽 鹽 和正硼酸鹽的水溶 其中該水溶性硼酸 其中該亞硝酸鹽為 其中該金屬陰離子 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準（CNS) Μ規格（210X297公爱） 93 542858 A8 B8 C8 D8 申請專利範圍 145·如中凊專利範圍第144項之方法2其中該鉑酸鹽之水 溶性鹽為鉬酸鈉或鉬酸鈉之水合物。 M6.如申請專利範圍第131項之方法，其中該聚羧酸醋包 含含有4個和20個之間碳原子的脂肪化合物，該化合 物以羧酸酯基團或其水溶性鹽多重取代。 147·如中請專利範圍第146項之方法，其中該聚叛酸醋為 1’2,3，4 -丁燒^四魏酸。 H8.如申：專利範圍第131項之方法，其中該聚竣酸醋是 一個得自含有一個或更多個羧基基團的乙烯不飽和 單體聚合反應的均聚物。 149·如申請專利範圍第148項之方法 丙烯酸或其水溶性鹽。 150. 如申請專利範圍第ι48項之方法 順-丁稀二酸或其水溶性鹽。 151. 如申請專利範圍第148項之方法 順-丁稀二酸酐或其水溶性鹽。 152. 如申請專利範圍第131項之方法 一個得自二個或更多個不同的乙烯不飽和單體聚合 反應的共聚物，該單體各含有一個或更多個綾基基團 (請先閲讀背面之注意事項再填寫本頁} 裝丨 其中該均聚物為聚 其中該均聚物為聚 其中該均聚物為聚 其中該聚羧酸酯是 153·如申請專利範圍第131項之方法，其中該烷基羥基羧 酸的化學通式為 土 H〇〇C-(RBi)a-(RB2)b-(RB3)c-RB4 其中a ’ b，和c為〇至6的整數，（a+b+c)&gt;〇，其中， 本紙張尺度適用中國國豕標準（CNS) A4規格（210父297公楚） :線丨 94 542858 A8 B8 C8 D8 六、申請專利範圍 (請先閲讀背面之注意事項再填寫本頁) RB2，Rb3包含〇0或GYZ，其中Y和Z分別擇自Η，OH ，CHO，COOH，CH3，CH2(OH)，CH(OH)2，CH2(COOH) ，CH(OH)COOH，CH2(CHO)和 CH(OH)CHO的基團， 其選擇要使該分子最少有一個OH基團，當寫為其完全 水合物的形式，RB4為Η或COOH，包括這些酸各種不 同的立體異構物和化學相當的環狀，脫水，和水合物 的形態及在水中形成上面化合物的可水解的酯類和縮 醛或這種烷基羥基羧酸的水溶性鹽。 154.如申請專利範圍第153項之方法，其中該烷基羥基羧 酸係擇自於由酒石酸，中酒石酸，檸檬酸，葡萄糖酸 ，葡萄糠庚糖酸，丙酮二酸，糖質酸及其水溶性鹽所 組成之族者。 155·如申請專利範圍第131項之方法，其中該其他水相系 統處理物料是一個正磷酸或其水溶性鹽和至少一個 下面化學通式的烷基羥基羧酸的混合物： HOOC-(RB1)a-(RB2)b-(RB3)c-RB4 其中a，b，和c為0至6的整數，（a+b+c)&gt;0，其中RB1， Rb2，Rb3包含〇0或CYZ，其中Y和Z分別擇自Η，OH ，CHO，COOH，CH3，CH2(OH)，CH(OH)2，CH2(COOH) ，CH(OH)COOH，CH2(CHO)和 CH(OH)CHO的基團， 其選擇要使該分子最少有一個OH基團，當寫為其完全 水合物的形式，RB4為Η或COOH，包括這些酸各種不 同的立體異構物和化學相當的環狀，脫水，和水合物 的形態及在水中形成上面化合物的可水解的酯類和縮 本紙張尺度適用中國國家標準（CNS) A4規格（210 X 297公釐） 95 542858 A8 B8 - C8 _ D8申請專利範圍 醛或這種烷基羥基羧酸的水溶性鹽，及其水溶性鹽。 156.如申請專利範圍第155項之方法，其中該羥基羧酸係 擇自於由酒石酸，中酒石酸，檸檬酸，葡萄糖酸，葡 萄糖庚糖酸，丙酮二酸，糖質酸和其水溶性鹽所組成 之族者。 15 7.如申睛專利範圍第13 1項之方法，其中該胺基經基琥 珀酸的化學通式為 -----------------------裝----- (請先閱讀背面之注意事項再填寫本頁) ,CO，H H〇’ \C02H 其中Rci為H或任擇地以-〇H，-C02H，-S03H或苯基取 代的（：丨至C4烷基，任擇地以-〇H或-C02H取代的C4至 C?環烷基或苯基，1^2為η，任擇地以-oh或-C02H ( 特別是包括-CH(C〇2H)CH(OH)(C02H)部份者）取代的 Cl至烧基；及 .、可| ;線— ^C2I I H02c^/N~zc—N, C02H Η〇，σ OH HO C02H 其中Rc2為為如上述者，及zc係擇自於由下面基團所組 成之族者 0 -(CH2)k-其中k是一個2至10的整數， 本紙張尺度適用中國國家標準A4規格（21〇&gt;&lt;297公釐） 96 542858 A8 B8 G8 D8 申請專利範圍 ii) -(CH2)2-Xc-(CH2)2-其中 Xc為-Ο-，_S-，NRC3 ，其中Rc3係擇自於由Η，（^至(：6烷基，羥烷基，羧基 烷基，醯基，-C(0)0RC4所組成之族者，其中RC4係擇 自於由(^至匕烷基或苯曱基和含下面化學通式的殘基 所組成之族者： • CH2CH2- co2h h〇/^co2h 其中Rc2為如上述者，iii)含下面化學通式之殘基 —(CH2)133. The method according to claim 131, wherein the tetrazolium compound is selected from nitroblue tetrazolium (2,2, -di-p-nitrophenyl-5,5, _diphenyl Vinyl-3,3,-[3,3, -dimethoxy-4,4, -extendylphenyl] tetrakisigma tweezers) '-phenylene nitro blue tetrafluorene (2, 2'-di_p-nitrophenyl_5,5 '· distyryl-3,3,-[3,3, -dimethoxy_3.3, phenylene] Nitro blue tetrazolium ^^-^ mouth'-dimethoxy-doxy, #,-extendylphenyl) -bis- [2,5-p-canyl-2'-tetrazolidine] and iodine A family consisting of a water-soluble salt of acyltetrazolidine (2- (4-iodophenyl) -3- (4-nitrophenyl) -5-phenyltetrazolium.) The method of item 13 (), wherein the water-soluble ionic germline is selected from the group consisting of hydrazine, lithianate, nitrite, carbonate, 542858 A8 B8 C8 D8. Patent scope. Bicarbonate, sulfate, and A group consisting of anion and anion of transition metal oxo acid group. 135. For example, please refer to the method of item 134 of the patent, wherein the fluorenyl group is selected from the group consisting of gas, fluorine, bromine and moth. 136. For example, the method of the patent scope of item 135, wherein the function is gas. For example, the method of the patent scope of item 134, wherein the transition metal oxo acid group is selected from free acid and acid. And the group consisting of crane acid. 138. = The method of the scope of patent application No. 137, wherein the transition metal oxoate is molybdate. 139. The method of the scope of patent application No. 131, wherein the inorganic phosphoric acid It is orthophosphate, polyphosphate, its water-soluble salt, and mixtures thereof. 140. The method according to the scope of patent application, item 131, wherein the inorganic phosphoric acid is a mixture of orthophosphoric acid and pyrophosphoric acid or its water-soluble salt. 141 · The method according to the scope of patent application No. 131, wherein the borate is selected from the group consisting of a tetrazate, a metaborate borate. 142 · The method according to scope 141 of the patent application Sodium tetrasodium acid or sodium tetrasodium hydrate M3. Sodium nitrite according to the method of the scope of patent application No. 131. 144. Release method according to the method of the scope of patent application No. 131. The release compound is selected from molybdate, tungsten Vanadate The salt and the water-soluble salt of chromate. Water soluble salt and ortho-borate water-soluble boric acid where the nitrite is the metal anion (Please read the precautions on the back before filling in this Page) This paper size is in accordance with Chinese National Standard (CNS) M specification (210X297 public love) 93 542858 A8 B8 C8 D8 Patent application scope 145 · Method 144 of the scope of the patent scope of Zhongli 2 where the water soluble salt of the platinum salt Sodium molybdate or sodium molybdate hydrate. M6. The method according to claim 131, wherein the polycarboxylic acid vinegar contains an aliphatic compound containing 4 to 20 carbon atoms, and the compound is multiple substituted with a carboxylic acid ester group or a water-soluble salt thereof. 147. The method according to item 146 of the patent application, wherein the polyacid acid vinegar is 1'2,3,4-butane-tetraweilic acid. H8. As claimed: The method according to item 131 of the patent, wherein the poly (vinyl acetate) is a homopolymer obtained from the polymerization of an ethylenically unsaturated monomer containing one or more carboxyl groups. 149. The method according to item 148 of the patent application, acrylic acid or a water-soluble salt thereof. 150. The method according to item 48 of the scope of application for patent maleic acid or a water-soluble salt thereof. 151. The method according to item 148 of the scope of patent application: Maleic anhydride or a water-soluble salt thereof. 152. If the method of patent application No. 131 is a copolymer obtained from the polymerization of two or more different ethylene unsaturated monomers, each of which contains one or more fluorenyl groups (please read first Note on the back, please fill out this page again} Equipment 丨 Where the homopolymer is poly, where the homopolymer is poly, where the homopolymer is poly, and where the polycarboxylate is 153. If the method of applying for the scope of the patent No. 131 Where the chemical formula of the alkyl hydroxycarboxylic acid is HOHC- (RBi) a- (RB2) b- (RB3) c-RB4 where a'b, and c are integers from 0 to 6, ( a + b + c) &gt; 〇, among which, the paper size is in accordance with China National Standard (CNS) A4 specification (210 father and 297 male Chu): line 丨 94 542858 A8 B8 C8 D8 VI. Patent application scope (please read first Note on the back, fill in this page again) RB2, Rb3 contains 0 or GYZ, where Y and Z are selected from Η, OH, CHO, COOH, CH3, CH2 (OH), CH (OH) 2, CH2 (COOH) , CH (OH) COOH, CH2 (CHO) and CH (OH) CHO, the choice is to make the molecule have at least one OH group, when written as its fully hydrated form, RB4 is Or COOH, including the various stereoisomers and chemically equivalent cyclic, dehydrated, and hydrated forms of these acids and the hydrolyzable esters and acetals or the alkyl hydroxycarboxylic acids that form the above compounds in water 154. The method of claim 153, wherein the alkyl hydroxycarboxylic acid is selected from the group consisting of tartaric acid, middle tartaric acid, citric acid, gluconic acid, grape heptonic acid, and pyruvate, A family consisting of glycidic acid and its water-soluble salts. 155. The method according to item 131 of the application, wherein the other water-phase system treatment material is an orthophosphoric acid or its water-soluble salt and at least one of the following general chemical formula Mixture of alkyl hydroxycarboxylic acids: HOOC- (RB1) a- (RB2) b- (RB3) c-RB4 where a, b, and c are integers from 0 to 6, (a + b + c) &gt; 0, where RB1, Rb2, Rb3 contains 0 or CYZ, where Y and Z are selected from Η, OH, CHO, COOH, CH3, CH2 (OH), CH (OH) 2, CH2 (COOH), CH (OH ) COOH, CH2 (CHO) and CH (OH) CHO groups, which are chosen so that the molecule has at least one OH group when written as its fully hydrated form RB4 is osmium or COOH, including various stereoisomers of these acids and chemically equivalent cyclic, dehydrated, and hydrated forms, and hydrolyzable esters and shrinkages that form the above compounds in water. Paper scales are applicable to Chinese countries Standard (CNS) A4 specification (210 X 297 mm) 95 542858 A8 B8-C8 _ D8 patent application scope Water-soluble salt of aldehyde or this alkyl hydroxycarboxylic acid, and its water-soluble salt. 156. The method according to claim 155, wherein the hydroxycarboxylic acid is selected from the group consisting of tartaric acid, middle tartaric acid, citric acid, gluconic acid, glucoheptanoic acid, pyruvate, glyconic acid and water-soluble salts The group of people. 15 7. The method according to item 13 of the patent scope of Shenyan, wherein the chemical formula of the amino group via succinic acid is ---------------------- -Pack ----- (Please read the notes on the back before filling this page), CO, HH〇 '\ C02H where Rci is H or optionally substituted with -〇H, -C02H, -S03H or phenyl (： 丨 to C4 alkyl, optionally substituted with -0H or -C02H, C4 to C? Cycloalkyl or phenyl, 1 ^ 2 is η, optionally with -oh or -C02H (especially Including the -CH (C〇2H) CH (OH) (C02H) moiety) Cl substituted to the alkynyl group; and., May |; line-^ C2I I H02c ^ / N ~ zc-N, C02H Η〇, σ OH HO C02H where Rc2 is as described above, and zc is selected from the group consisting of the following groups: 0-(CH2) k-where k is an integer from 2 to 10, this paper scale applies to China Standard A4 specification (21〇 &lt; 297 mm) 96 542858 A8 B8 G8 D8 Patent application scope ii)-(CH2) 2-Xc- (CH2) 2- where Xc is -O-, _S-, NRC3, Rc3 is selected from the group consisting of Η, (^ to (: 6 alkyl, hydroxyalkyl, carboxyalkyl, fluorenyl, -C (0) 0RC4, and RC4 is selected from (^ A group consisting of an alkyl group or a phenyl amidino group and a residue containing the following general formula: • CH2CH2-co2h h0 / ^ co2h where Rc2 is as described above, and iii) a residue containing the following general formula— ( CH2) (CH2)m- 其中Y為H’C^C6烧基，烧氧基，鹵素，_c〇2h，so, ，m係獨立地為0或1，及p為1或2 ,以及 iv)含下面化學通式之殘基： 爲 ；H (CRC5RC6)t \CH2)r-^\ (CRC5RC6)t — 其中和Rc6係獨立地為H或CiSC6烷基，卩為11或c 至匸6烷基，S為ο，1或2，以系獨立地為〇，i，2或3 為〇，1，2或3，及鹐丨或2或其水溶性鹽。说如中請專利範圍第157項之方法，其中該胺基經基號 q (請先閲讀背面之注意事項再填寫本頁)(CH2) m- where Y is H'C ^ C6 alkyl, alkoxy, halogen, -co2h, so,, m is independently 0 or 1, and p is 1 or 2, and iv) contains the following Residues of the general formula: is: H (CRC5RC6) t \ CH2) r-^ \ (CRC5RC6) t — where Rc6 is independently H or CiSC6 alkyl, 卩 is 11 or c to 匸 6 alkyl, S is ο, 1 or 2, independently of 0, i, 2 or 3 is 0, 1, 2 or 3, and 鹐 or 2 or a water-soluble salt thereof. As mentioned above, please apply the method in the scope of patent No. 157, in which the amino group is based on the number q (please read the precautions on the back before filling this page) 本紙張尺度適用中國國家標準（CNs) A4規格（21〇χ297公楚)- 97 542858 A8 B8 C8 D8 申請專利範圍 -珀酸係擇自於由亞胺基二（2-羥基琥抬酸），N，N，_雙（2-羥基琥珀基）-1，6-己烷二胺，N，N、雙（2_羥基琥珀基 間-伸二甲苯二胺或其水溶性鹽所組成之族者。 159·如申請專利範圍第131項之方法，其中該其他水相系 統處理物料是一個正磷酸或其水溶性鹽和至少一個 胺基羥基琥珀酸的混合物，其中該胺基羥基琥珀酸的 化學通式為 (請先閲讀背面之注意事項再填寫本頁) xo7h HCT 、C02H 其中心丨為！!或任擇地以-〇H，-C〇2H，-S03H或苯基取 代的(^至匕烷基’，任擇地以-〇h或-c〇2H取代的c4至 c7環烷基或苯基，RC^H，任擇地以_〇H或-C〇2H ( 特別是包括ΤΗ((：〇2Η)(：Η(ΟΗ)((：〇2Η)部份者）取代的 。至。烷基；及 ^02 ^C2 zc—^^/〇02}ί H02C/ 〇H HO C02H 其中Rc2為如上述者，及Zc係擇自於由下面基團所組成 之族者 i) -(CH2)k-其中k是一個2至10的整數， 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 、可| :線丨 542858 ,C02H A8 B8 C8 D8 、申請專利範圍 ii) -(CH2)2-Xc-(CH2)2-其中 Xc為 _〇_，，·ΝΙΙ(：3_ ，其中Res係擇自於由Η，（^至“烷基，羥基烷基，羧 基烷基，醯基，-C(0)0RC4所組成之族者，其中尺以係 擇自於由（^至c0烧基或苯甲基和含下面化學通式的殘 基所組成之族者： .. •CH2CH2—N. η〇/^ο2η 其中Rc2為如上述者， iii)含下面化學通式之殘基 .(遞L 其中Y為H，(^至(：6烷基，烷氧基，鹵基，-C〇2H, _s〇3H ，m係獨立地為〇或1，P為1或2，以及 iv)含下面化學通式之殘基： (CH2)q&gt;/(Q)s —(CRC5Rc6)t —( \cH2)r^(CRC5RC6)l— 其中Ru和Res係獨立地為11或(：1至(：：6烷基，卩為11或(：：1 至匸6烷基’ s為〇，；^2，t係獨立地為〇，1，2或3，q 為〇 ’ 1 ’ 2或3 ’及r為1或2或其水溶性鹽。 160.如申凊專利範圍第159項之方法，其中該胺基經 本紙張尺度適用中國國家標準（CNS) A4規格（210 X 297公爱） (請先閲讀背面之注意事項再填窝本頁)This paper size is in accordance with Chinese National Standards (CNs) A4 specifications (21〇297297)-97 542858 A8 B8 C8 D8 Application scope of patents-Purine is selected from iminobis (2-hydroxysuccinic acid), Family consisting of N, N, _bis (2-hydroxysuccinyl) -1,6-hexanediamine, N, N, bis (2-hydroxysuccinyl-m-xylylenediamine or its water soluble salt 159. The method of claim 131, wherein the other water phase system treatment material is a mixture of orthophosphoric acid or a water-soluble salt thereof and at least one aminohydroxysuccinic acid, wherein the chemical composition of the aminohydroxysuccinic acid is The general formula is (please read the notes on the back before filling this page) xo7h HCT, C02H The center of it is !! Or optionally substituted with -〇H, -C〇2H, -S03H or phenyl (^ to Alkyl, 'C4 to c7 cycloalkyl or phenyl optionally substituted with -0h or -co2H, RC ^ H, optionally with -OH or -CO2H (in particular including T ((: 〇2Η) (: Η (〇Η) ((: 〇2Η))) substituted. To. Alkyl; and ^ 02 ^ C2 zc — ^^ / 〇02} ί H02C / 〇H HO C02H Where Rc2 is as described above, And Zc are selected from the group consisting of the following groups i)-(CH2) k-where k is an integer from 2 to 10, the paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) ， 可 |: line 丨 542858, C02H A8 B8 C8 D8, patent application scope ii)-(CH2) 2-Xc- (CH2) 2- where Xc is _〇_ ,, · ΝΙΙ (: 3_, where Res is optional From the group consisting of Η, (^ to "alkyl, hydroxyalkyl, carboxyalkyl, fluorenyl, -C (0) 0RC4, where the rule is selected from (^ to c0 alkyl or A group consisting of benzyl and residues containing the following general formula: .. • CH2CH2-N. Η〇 / ^ ο2η where Rc2 is as described above, iii) containing residues of the following general formula. L where Y is H, (^ to (: 6 alkyl, alkoxy, halo, -C02H, _s〇3H, m is independently 0 or 1, P is 1 or 2, and iv) containing Residues of the following general formula: (CH2) q &gt; / (Q) s — (CRC5Rc6) t — (\ cH2) r ^ (CRC5RC6) l— where Ru and Res are independently 11 or (: 1 to ( :: 6 alkyl, 卩 is 11 or (:: 1 to 匸 6 alkyl's is 0 ,; ^ 2, t is independently 0. 1, 2 or 3, q is square '1' or 2 3 'and r is 1 or 2 or water soluble salts. 160. For the method of claim 159 of the patent scope, in which the amine group is in accordance with the Chinese National Standard (CNS) A4 specification (210 X 297 public love) on this paper standard (please read the precautions on the back before filling this page) 99 161 :酸係擇I於由亞胺基二(2,基琥純)，N，N，_雙(2· 超基玻_Μ，6_己燒二胺，ν，ν、雙(2铺琥雖基)_ 間-伸一甲笨二胺或其水溶性鹽所組成之族者。 如申請專利範圍第131項之方法，其中該聚環氧琥站 酸的化學通式為： Η0 —^&lt;〕c——Ο-j-—η Μ丁02C C02Mt 其中1的H圍自2至5G’Mt為氫或水溶性陽離子，如Na+ ，NH’或Κ+及RT為氫，Ci·4烷基或取代的ci 4烷基。 162 163. 164. 如申請專利範圍第161項之方法，其中触了為氮及m 範圍自2至10。 如申請專利範圍第161項之方法，其中該心為氫及丨自4 至7。 如申請專利範圍第131項之方法，其中該其他水相系 統處理物料是一個正磷酸或其水溶性鹽和含下面化 學通式之聚環氧琥珀酸的混合物： R丁 文丁 HO —— C—〇j—η Μ下02C C02Mt 其中1的範圍自2至50，MT為氫或水溶性陽離子，如Na+ NH4或K及RT為氫，（^_4烧基或取代的C!_4燒基或其 申請專利範圍 - 水溶性鹽。 — 5 ·如申睛專利範圍第164項之方法 酉久的RT為氫及1為自2至1〇。 166·如申請專利範圍第164項之方法 酉欠的RT為氫及1為自4至7。 167·如申請專利範圍第131項之方法 環氧琥珀酸的化學通式為 其中該聚環氧璩王白 其中該聚環氧琥珀 其中該經改質的 R, D3 rdT ZD— Md02C co2md f 其中Rd!，當有存在，為H,取代的或未取代的院基或 芳基4伤，其奴鏈長度高達使失去在水相溶液的溶解 度或乙烯不飽和化合物聚合反應得到的重複單元：汉的 和係各獨立地為Η，（^至匕烷基或取代的(^至匕烷 基；ZD為〇，S，ΝΗ或NRD1，其中Rdi為如上面說明者 ，η是一個大於丨的正整數；£是一個正的整數，及 為Η，水溶性陽離子（如NH/，鹼金屬）或1個至3個碳 原子，未取代的較低級烷基基團（當Rdi不存在，心可 以是MD〇3S，其中MD為如上面說明者）。 168.如申請專利範圍第167項之方法，其中該rd1是間-伸二 曱苯部份（間-CH2-C6H4-CH2-)，RD#RD3都是Η，ZD 為-ΝΗ ’ MD為Na或Η，及f=2，和u是一個大於1的正 數0 整 C請先閲讀背面之注意事项再填寫本頁}99 161: The acid system is selected from the group consisting of iminobis (2, succinic acid), N, N, bis (2. Superhybrid_M, 6_hexanediamine, ν, ν, bis (2 Puhu alkenyl) _ The group consisting of meta-methylene dibenzyl diamine or its water-soluble salt. For example, the method of the scope of patent application No. 131, wherein the chemical formula of the polyepoxysuccinic acid is: Η0 — ^ &lt;] c——〇-j-—η Μ 丁 02C C02Mt where H of 1 is from 2 to 5 G'Mt is hydrogen or water-soluble cation, such as Na +, NH 'or K + and RT is hydrogen, Ci · 4 alkyl group or substituted ci 4 alkyl group. 162 163. 164. If the method of the scope of patent application is 161, which touches nitrogen and m ranging from 2 to 10. If the method of the scope of patent application 161, where The core is hydrogen and from 4 to 7. For the method of the scope of patent application No. 131, wherein the other water phase system treatment material is an orthophosphoric acid or a water-soluble salt thereof and a polyepoxysuccinic acid containing the following general chemical formula Mixture: R 丁文 丁 HO —— C—〇j—η Μ 02C C02Mt where 1 ranges from 2 to 50, MT is hydrogen or water-soluble cation, such as Na + NH4 or K and RT is hydrogen, (^ _4 Alkyl or substituted C ! _4 Burning group or its patent application scope-Water-soluble salt. — 5 · The method of item 164 of the patent application scope is long-term RT is hydrogen and 1 is from 2 to 10. 166 · As patent application scope 164 The method owed by RT is hydrogen and 1 is from 4 to 7. 167. The method of epoxy succinic acid according to the method of the scope of patent application No. 131 is the general formula of epoxy succinic acid in which the polyepoxide is white Amber where the modified R, D3 rdT ZD — Md02C co2md f where Rd !, when present, is H, substituted or unsubstituted courtyard or aryl group 4 wound, its slave chain length is as high as the loss in water Phase solution solubility or repeating units obtained from the polymerization of ethylenically unsaturated compounds: the sum of each is independently Η, (^ to d alkyl or substituted (^ to d alkyl; ZD is 0, S, NH or NRD1, where Rdi is as described above, η is a positive integer greater than 丨; £ is a positive integer, and Η is a water-soluble cation (such as NH /, alkali metal) or 1 to 3 carbon atoms, Unsubstituted lower alkyl group (when Rdi is not present, the heart may be MD03S, where MD is as stated above 168. The method according to item 167 of the patent application scope, wherein the rd1 is a meta-diphenylene moiety (meta-CH2-C6H4-CH2-), RD # RD3 is Η, and ZD is -ΝΗ ' MD is Na or Η, and f = 2, and u is a positive number greater than 1, the whole C, please read the precautions on the back before filling in this page} 本紙張尺度適用中國國家標準（®S) A4規格（210X297公釐） 101 542858 六、申請專利範圍 其中该單膦酸的化 169.如申請專利範圍第131項之方法 學通式為：The size of this paper is applicable to Chinese National Standard (®S) A4 (210X297 mm) 101 542858 6. Scope of patent application Among which, the chemical conversion of the monophosphonic acid 169. If the method of applying for the scope of patent No. 131, the general formula is: -中Rf疋個CjC12直鏈或支鏈絲殘基，Q至Ci2 ⑽或支鏈烴稀基殘基，C5K12魏基殘基，aCi〇 芳基殘基或C7至CuM基殘基，其中Rf可另外以獨立 地擇自經基，胺基或自基或其水溶性鹽的基團單一或 多重取代。 170.如申請專利範圍第131項之方法，其中該二膦酸的化 學通式為： /P一R—p( HO’ \〇H 其中RK是一個（^至力2直鏈或支鏈伸烷基殘基，匕至 Cu直鏈或支鏈伸烯基殘基，q至Ci2伸環烷基殘基， C6至ClG伸芳基殘基或匚7至(：12伸芳烷基殘基，其*Rk 可另外以獨立地擇自«，胺基或_基或其水溶性鹽 的基團單一或多重取代。 171 ·如申明專利範圍第丨7〇項之方法，其中該二膦酸為卜 羥基乙烷-1，1-二膦酸或其水溶性鹽。 172·如申明專利範圍第13 1項之方法，其中該膦酸基魏酸 的化學通式為 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公爱） 542858 A8 B8 C8 D8 申請專利範圍 及 H0、 0 II rhi 1 / H0 、P — / C — COOH i CH， COOH H〇， H0/ Η &gt;—X—C—COOH CH’一COOH (請先閲讀背面之注意事項再填寫本頁) 其中尺則為！！，含1至4個碳原子的烷基，烴烯基或炔基 ，芳基，環烷基或芳烷基基團或擇自下面的基團： 卞 2 Rh2 CH3 -—CH——CH2—COOH 及——CH——CH——COOH 其中RH2為H，1個至4個碳原子的烷基基團或羧基基團 :及Xh係擇自下面者： COOH POA COOH ——CH—，一 —C—，及- ch3 —c— ch3 COOH -CH—0¾—， .其中-Ρ03Η2基團為下面的膦酸基基團 0H 0 \〇H 或其水溶性鹽。 173.如申請專利範圍第172項之方法，其中該膦酸基羧酸 為2-膦酸基丁烷-1，2,4-三羧酸或其水溶性鹽。 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 103 542858 A8 B8 C8 ns-Rf 疋 CjC12 linear or branched silk residues, Q to Ci2⑽ or branched hydrocarbon diluent residues, C5K12 Weilyl residues, aCio aryl residues or C7 to CuM residues, where Rf A single or multiple substitutions of groups independently selected from acryl, amine, or self-radical or a water-soluble salt thereof may be additionally performed. 170. The method of claim 131, wherein the chemical formula of the diphosphonic acid is: / P—R—p (HO ′ \ 〇H where RK is one (2 to force 2 straight or branched chain extension) Alkyl residues, Cu to straight or branched alkenyl residues, q to Ci2 cycloalkylene residues, C6 to ClG alkylene residues or 匚 7 to (: 12 alkylene residues , Its * Rk may additionally be single or multiple substituted with a group independently selected from the group consisting of «, amine or 基 or its water-soluble salt. 171 · A method as claimed in claim 7 of the patent scope, wherein the diphosphonic acid It is dihydroxyethane-1,1-diphosphonic acid or a water-soluble salt thereof. 172. The method according to item 13 of the declared patent scope, wherein the chemical formula of the phosphonic acid is the paper standard applicable to the country of China Standard (CNS) A4 specification (210X297 public love) 542858 A8 B8 C8 D8 Patent application scope and H0, 0 II rhi 1 / H0, P — / C — COOH i CH, COOH H〇, H0 / Η &gt; —X— C—COOH CH'-COOH (Please read the notes on the back before filling out this page) where the rule is !!!, an alkyl, alkenyl or alkynyl group containing 1 to 4 carbon atoms, aromatic , Cycloalkyl or aralkyl group or selected from the following groups: 卞 2 Rh2 CH3 -—CH——CH2—COOH and ——CH——CH——COOH where RH2 is H, 1 to 4 Carbon atom alkyl group or carboxyl group: and Xh is selected from the following: COOH POA COOH ——CH—, a —C—, and-ch3 —c— ch3 COOH -CH—0¾—, where- The P03Η2 group is the following phosphonic acid group 0H 0 \ 〇H or a water-soluble salt thereof. 173. The method according to item 172 of the patent application, wherein the phosphonic acid is 2-phosphonic acid butane- 1,2,4-tricarboxylic acid or its water-soluble salt. The paper size is applicable to Chinese National Standard (CNS) A4 (210X297 mm) 103 542858 A8 B8 C8 ns 1 7 4.如申請專利圚笙彳^+ + ι . 乾国第13 1項之方法，其中該羥基膦酸基 羧酸的化學通式為 H0, 0 ~c'Xp—COOH HO〆 OH 其中Re為H，〇1至（：12直鏈或支鏈烷基殘基，（：2至€ 直鏈或支鏈烴烯基殘基，（：5至(：12環烷基殘基，匕至^⑺ 芳基殘基或(：7至(：12芳烷基殘基，Xe是一個任擇的基團 ，s有存在，為（^至匚⑺直鏈或支鏈伸烷基殘基，C2 至〇1()直鏈或支鏈伸烯基殘基或(^至^⑺伸芳基殘基或 其水溶性鹽。 175.如申請專利範圍第174項之方法，其中該羥基膦酸基 叛酸為2-經基-膦酸基乙酸或其水溶性鹽。 176·如申請專利範圍第131項之方法，其中該胺基膦酸的 化學通式為：^ ?/0H \〇H 其中Rg2是含一個至四個碳原子的較低級伸烷基或胺 ’羥基或鹵基取代的較低級伸烷基；1^3為1^2-?〇3：«2 ，H，0H，胺基，取代的胺基或1^，其中rf是一個q 至C12直鏈或支鏈烷基殘基，C2至C12直鏈或支鏈烴烯 基殘基，C5SC12環烷基殘基，0：6至(：1()芳基殘基或C7 至C12芳烷基殘基，其中RF可另外以獨立地擇自羥基， 12 (請先閲讀背面之注意事项再填窝本頁) 裝— :線丨 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 104 542858 A8 B8 C8 D8 申請專利範圍 胺基或南基的基團單 4夕重取代，RG4為RG3或以卜 面化學通式代表的基團： &gt;G5 C ^G6 V •N, ^G7 OH OH w 其中RG5和IW系各自獨立地擇自h，〇h，胺基，取代 的胺基或如前以義之為RG5, RG6或基围 RG2-P〇3H2 ’其Rg2為如前面定義者；V是一個ui5的 整數；h是—個1至14的整數或其水溶性鹽。 177.如申請專利範圍第g 固弟176項之方法，其中該胺基膦酸 一乙一胺五（亞甲基膦酸）或其水溶性鹽。 17 8 ·如申請專利範圚坌m s 靶固弟131項之方法，其中該膦酸基甲 胺氧化物的化學通式為 為 基 (請先閱讀背面之注意事項再填寫本頁) 訂丨 RA1 V N·—α^ρ〇3^ 其中〜係擇自於由烴基，和經基取代的，烧氧基取代 的，羧基取代的和磺醯基取代的烴基.所組成之族者· 及Ra2係擇自於由烴基，和羥基取代的，烷氧基取代 ，幾基取代的和確醯基取代的烴基，_Ch2p〇3h2 的 和 105 542858 A8 B8 C8 D8 、申請專利範圍 0 ▲ ——N ( Cf^POj^) 2 ； 所組成之族者，或Rai和ra2共同形成一個環内有3個至 5個碳原子的脂肪環或該膦酸基甲基胺氧化物的水溶 性鹽’烴基包括不使該胺氧化物非水溶性的烷基，芳 基’和烷芳基基團。 Π9.如申請專利範圍第178項之方法，其中該膦酸基甲基 胺氧化物為Ν，Ν-雙-膦酸基甲基乙醇胺Ν-氧化物或其 水溶性鹽。 18〇·如申請專利範圍第131項之方法，其中該含磷羧酸酯 是一個得自一個或更多個不飽和單體，在含磷化合物 存在下聚合反應的寡聚物，聚合物，共寡聚物或共聚 物’該單體含有一個或更多個羧基基團或含有一個或 更多個聚合反應後轉型為羧基基團之基團，其中得到 的含鱗羧酸酯含有主要或全部存在為終端型膦基種 系或其水溶性鹽的鱗加入物。 181 ·如申請專利範圍第13 1項之方法，其中該含磷羧酸酯 是一個得自一個或更多個不飽和單體，在含磷化合物 存在下聚合反應的寡聚物，聚合物，共寡聚物或共聚 物’該單體含有一個或更多個羧基基團或含有一個或 更多個聚合反應後轉型為羧基基團之基團，其中得到 的含磷羧酸酯含有主要或全部存在為膦酸基種系或 其水溶性鹽的罐加入物。 182.如申請專利範圍第131項之方法，其中該含磷羧酸酯 本紙張尺度適用中國國家標準（CNS) Α4規格（210X297公釐） -----------------------裝------------------訂------------------線. (請先閲讀背面之注意事項再填窝本頁) 106 542858 A8 B8 C8 . ______ D8 六、申請專利範圍 一是一個得自一個或更多個不飽和單體，在含磷化合物 存在下聚合反應的寡聚物，聚合物，共寡聚物或共聚 物’該單體含有一個或更多個羧基基團或含有一個或 更多個聚合反應後轉型為魏基基團之基團，其中得到 的含磷羧酸酯含有主要或全部存在為二烷基膦基種 系或其水溶性鹽的填加入物。 183·如申請專利範圍第131項之方法，其中該含磷羧酸酯 疋個付自一個或更多個不飽和單體，在含填化合物 存在下聚合反應的募聚物，聚合物，共寡聚物或共聚 物’該單體含有一個或更多個羧基基團或含有一個或 更多個聚合反應後轉型為羧基基團之基團，其中得到 的含磷羧酸醋含有存在為混合的膦酸基，終端型膦基 ’和一烧基膦基種系或其水溶性鹽的填加入物。 184.如申請專利範圍第18〇項之方法，其中該不飽和單體 係擇自於由丙烯酸，順-丁烯二酸，順-丁烯二酸酐， 甲基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反-丁烯二酸，檸康酸，甲基-反-丁烯二酸，丙烯腈，甲 基丙烯腈，α-亞甲基戊二酸，環己烯二羧酸，順 -1，2,3,6-四氫酜酸酐，3,6·環氧-1，2,3,6-四氫酞酸酐， 5-降冰片婦_2,3-二竣酸肝，雙環[2.2·2]-5-辛稀-2,3-二 竣酸酐，3-曱基-1，2,6-四氫酜酸gf，和2-甲基-1，3,6-四氫酞酸酐所組成之族者。 185·如申請專利範圍第18〇項之方法，其中該丙稀酸係唯 一的不飽和單體。 ---—___ _________ 本紙張尺度適用中國國家標準（CNS)A4規格（210X297公爱） _ 107 _ (請先閲讀背面之注意事項再填寫本頁)1 7 4. According to the method of applying for patent 圚 圚 ^ + + ι. The method of item 13 in the dry country, wherein the chemical formula of the hydroxyphosphonic acid is H0, 0 ~ c'Xp—COOH HO〆OH where Re is H, 〇1 to (: 12 straight or branched chain alkyl residues, (: 2 to € straight or branched chain alkenyl residues, (: 5 to (: 12 cycloalkyl residues, d To ^ ⑺ aryl residues or (: 7 to (: 12 aralkyl residues, Xe is an optional group, s is present, and is (^ to 匚 ⑺ straight or branched alkylene residues , C2 to 〇1 () linear or branched alkenyl residues or (^ to ^ arylene residues or their water-soluble salts. 175. The method according to item 174 of the application, wherein the hydroxyphosphine The acid-based acid is 2-acyl-phosphonoacetic acid or a water-soluble salt thereof. 176. The method of claim 131, wherein the chemical formula of the aminophosphonic acid is: ^? / 0H \ 〇 H wherein Rg2 is a lower alkylene group containing one to four carbon atoms or a lower alkylene group substituted with amine 'hydroxyl or halo group; 1 ^ 3 is 1 ^ 2-? 〇3: «2, H , 0H, amine, substituted amine or 1 ^, where rf is a q to C12 straight or branched alkyl residue, C2 to C12 straight or branched chain alkenyl residues, C5SC12 cycloalkyl residues, 0: 6 to (: 1 () aryl residues or C7 to C12 aralkyl residues, where RF may additionally be independently The ground is selected from hydroxyl, 12 (Please read the precautions on the back before filling in this page) Packing:: Thread 丨 This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 104 542858 A8 B8 C8 D8 Patent application Groups in the amine or south group are monosubstituted, and RG4 is RG3 or a group represented by the general chemical formula: &gt; G5 C ^ G6 V • N, ^ G7 OH OH w where RG5 and IW are Each independently selected from h, 0h, amine, substituted amine or RG5, RG6 or RG2-P03H2 as defined above; its Rg2 is as defined above; V is an integer of ui5; h is an integer from 1 to 14 or a water-soluble salt thereof. 177. The method according to item 176 of the patent application range for g, wherein the aminophosphonic acid monoethyleneaminepenta (methylenephosphonic acid) or its water-soluble 17 8 · For the method of applying patents for 131 ms target method, the chemical formula of the phosphonic acid methylamine oxide is based on (Please Read the notes on the back and fill in this page) Order 丨 RA1 VN · —α ^ ρ〇3 ^ where ~ is selected from the group consisting of hydrocarbyl, and substituted with alkyl, alkoxy, carboxy, and sulfonyl Substituted hydrocarbyl groups. The group and Ra2 are selected from hydrocarbyl, and hydroxy-substituted, alkoxy-substituted, several-substituted and confirmed-substituted hydrocarbon groups, _Ch2p03h2 and 105 542858 A8 B8. C8 D8, patent application scope 0 ▲ ——N (Cf ^ POj ^) 2; the group of members, or Rai and ra2 together form an aliphatic ring with 3 to 5 carbon atoms in the ring or the phosphonic acid group The water-soluble salt 'hydrocarbyl group of methylamine oxide includes alkyl, aryl' and alkaryl groups which do not render the amine oxide water-insoluble. Π9. The method of claim 178, wherein the phosphonomethylamine oxide is N, N-bis-phosphonomethylethanolamine N-oxide or a water-soluble salt thereof. 18〇. The method of claim 131, wherein the phosphorus-containing carboxylic acid ester is an oligomer or polymer obtained from one or more unsaturated monomers and polymerized in the presence of a phosphorus-containing compound, Co-oligomer or copolymer 'This monomer contains one or more carboxyl groups or groups converted into carboxyl groups after polymerization, and the resulting scaly carboxylic acid ester contains All scale additions exist as terminal phosphine-based species or their water-soluble salts. 181. The method of claim 13 in the scope of patent application, wherein the phosphorus-containing carboxylic acid ester is an oligomer or polymer obtained from one or more unsaturated monomers and polymerized in the presence of a phosphorus-containing compound, Co-oligomer or copolymer 'This monomer contains one or more carboxyl groups or contains one or more groups converted to carboxyl groups after polymerization, and the resulting phosphorous carboxylic acid ester contains All tank additions exist as phosphonic acid-based species or their water-soluble salts. 182. The method according to item 131 of the patent application scope, wherein the paper size of the phosphorus-containing carboxylic acid ester is in accordance with the Chinese National Standard (CNS) A4 specification (210X297 mm) -------------- --------- install ------- order ------------------ line. ( (Please read the notes on the back before filling in this page) 106 542858 A8 B8 C8. ______ D8 6. The scope of the patent application is one obtained from one or more unsaturated monomers, which are polymerized in the presence of a phosphorus-containing compound. Oligomer, polymer, co-oligomer or copolymer 'This monomer contains one or more carboxyl groups or contains one or more groups which are converted to a Wei group after polymerization, and the resulting phosphorus-containing group Carboxylic acid esters contain fillers that are mainly or entirely present as dialkylphosphine-based species or their water-soluble salts. 183. The method of claiming scope of patent application No. 131, wherein the phosphorus-containing carboxylic acid ester is one of a plurality of unsaturated monomers, and the polymer is Oligomer or copolymer 'This monomer contains one or more carboxyl groups or contains one or more groups converted to carboxyl groups after polymerization, wherein the obtained phosphorus-containing carboxylic acid esters are present as mixed A filler of a phosphonic acid group, a terminal phosphine group, and a monoalkylphosphine-based species or a water-soluble salt thereof. 184. The method of claiming scope of patent application No. 180, wherein the unsaturated monosystem is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid, decomposing aconitic acid, and crotonic acid. , Ethyleneacetic acid, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, methacrylonitrile, α-methyleneglutaric acid, cyclohexene dicarboxylic acid, cis -1,2,3,6-tetrahydrofluoric anhydride, 3,6 · epoxy-1,2,3,6-tetrahydrophthalic anhydride, 5-norbornyl _2,3-dicarboxylic acid liver, bicyclic [2.2 · 2] -5-octane-2,3-di Junic anhydride, 3-fluorenyl-1,2,6-tetrahydrofluoric acid gf, and 2-methyl-1,3,6-tetrahydro Family of phthalic anhydride. 185. The method of claiming scope of patent application No. 180, wherein the acrylic acid is the only unsaturated monomer. ---—___ _________ This paper size applies to China National Standard (CNS) A4 (210X297 public love) _ 107 _ (Please read the precautions on the back before filling this page) 542858542858 、申睛專利範圍 氫 其中該丙婦酸係唯 其中該唯一的不飽 分解烏頭酸，和順_ 缔 186·如申請專利範圍第18〇項之方法，其中該唯一的不飽 和單體係擇自於由順-丁烯二酸，分解烏頭酸，和順_ 丁烯二酸酐所組成之族者。 187_如申請專利範圍第18〇項之方法，其中該—個不飽和 單體係丙烯酸及另一個不飽和單體係擇自於由順-丁 婦二酸’分解烏頭酸’和順_丁烯二酸if所組成之族者 0 敗如切專利範圍第181項之方法，其中料飽和單體 係擇自於由丙烯酸，順-丁烯二酸，順-丁烯二酸酐， 甲基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反-丁烯二酸，擰康酸，甲基-反-丁烯二酸，丙烯胯，甲 基丙烯腈，α-亞甲基戊二酸，環己烯二羧酸，順 ·1，2,3,6-四氫酞酸酐，3,6_環氧十2,3,6_四氫酞酸酐， 5-降冰片烯-2,3-二羧酸酐，雙環[2 2 2]-5-辛烯·2,3_羧 酸酐，3-甲基-1，2,6-四氫酞酸酐，和2_甲基]，3,6一四 酞酸酐所組成之族者。 189·如申請專利範圍第丨81項之方法 一的不飽和單體。 190·如申請專利範圍第181項之方法 和單體係擇自於由順-丁烯二酸 丁稀二酸酐所組成之族者。 191·如申請專利範圍第181項之方法，其中一個不飽和單 體為丙烯酸及另一個不飽和單體係擇自於由順_ 丁 二酸，分解烏頭酸，和順-丁烯二酸酐所組成之族者 本紙張尺度適用中國國家標準（CNS) Α4規格（210X297公爱） 裝%------------------線 (請先閲讀背面之注意事項再填寫本頁〕 108 六、申請專利範圍 .:請專利範圍⑽項之方法，其中該不飽和單體 甲於由丙稀酸’順-丁稀二酸’順-丁烯二酸酐， I基丙烯酸，分解烏頭酸，巴豆酸，乙烤乙酸，反_ 广酸，檸康酸’甲基-反-丁烯二酸，丙烯腈，甲 1丙知胯’ α_亞甲基戊二酸，環己烯二㈣，順 •，2’3’6-四氫㈣針’ 3,6·環氧_1，2,3,6·四氫敗酸肝， 5-降冰片烯.2,3-二鲮_，雙環[2.2斗5_辛烯_2,3_二 竣酉文酐，3-甲基-ΐ，2,6-四氫賦酸針，和2_曱基 四氫酞酸酐所組成之族者。 ’ ’ 肌如中請專·圍第182項之方法，其中該丙稀酸係唯 一的不飽和單體。 194.如:請專利範圍第182項之方法，其中該唯—的不飽 和單體係擇自於由順_丁稀二酸，分解烏頭酸，和順_ 丁烯二酸酐所組成之族者。 Μ請專利範圍第182項之方法，其中該—個不飽和 早體為丙烯酸及另一個不飽和單體係擇自於由順·丁 烯二酸，分解烏頭酸，和順_ 丁烯二酸酐所組成之族者 196·如申請專利範圍第183項之方法，其中該不飽和單體 係擇自於由丙烯酸，順_丁烯二酸，順-丁烯二酸酐， 甲基丙烯酸’分解烏頭酸，巴豆酸，乙烯乙酸，反-丁烯二酸，檸康酸，甲基-反-丁烯二酸，丙烯勝，甲 基丙烯腈，α-亞甲基戊二酸，環己烯二羧酸，順 1，2,3,6-四氫酞酸酐，3,6-環氧-1，2,3,6-四氫酞酸酐， 本紙張尺度適用中國國家標準（⑽）Α4規格（210&gt;&lt;297公釐） -109 - A8 B8 C8 D8 542858 申清專利範圍 .%降冰片烯-2,3-二羧酸酐，雙環[2.22]_5_辛烯^，夂二 羧酸酐，3-甲基氫酞酸酐，和2_曱基十认 四氫酞酸酐所組成之族者。 7·如申巧專利範圍第丨83項之方法，其中該丙烯酸係唯 一的不飽和單體^ 198·如申請專利範圍第183項之方法，其中該唯一的不飽 和單體係擇自由順·丁烯二酸，分解烏頭酸，和順-丁 烯二酸酐所組成之族者。 9.如申明專利範圍第183項之方法，其中一個不飽和單 體為丙烯酸及另一個不飽和單體係擇自於由順_丁烯 二酸，分解烏頭酸，和順-丁烯二酸酐所組成之族者。 200.如申請專利範圍第131項之方法，其中該含磷叛酸酯 一個是得自二個或更多個不飽和單體，在含磷化合物 存在下聚合反應的共募聚物或共聚物，含磷羧酸酯殘 基的主要部份（多於50%重量比）是衍生自含有一個或 更多個羧基基團或含有一個或更多個聚合反應後轉 型為羧基基團之基團的羧基單體，其餘的殘基是得自 非竣基單體，其中得到的含磷羧酸酯含有主要或全部 存在為終端型膦基種系或其水溶性鹽的磷加入物。 201·如申請專利範圍第2〇〇項之方法，其中該非羧基單體 係擇自於由2-丙烯醯胺-2-甲基丙烧石黃酸，2-經基-3-(2-丙烯氧基）丙烧石黃酸’ 2-甲基-2-丙稀基-1-續酸，婦丙 基磺酸，烯丙氧基苯磺酸，苯乙烯磺酸，乙烯磺酸， 烯丙基膦酸，乙烯膦酸，異丙烯基膦酸，磷乙基甲基 本紙張尺度適用中國國家標準（CNS) A4規格（210 X 297公釐） ------------------------裝.................-訂.......................線. (請先閲讀背面之注意事項再填寫本頁) 110 542858 A8 B8 C8 D8 六、申請專利範圍 丙烯酸酯’丙烯酸或甲基丙烯酸主羥基烷基和Ci-C4 烷基酯類，丙烯醯胺，烷基取代的丙烯醯胺，稀丙基 醇’ 2-乙稀°比淀’ 4-乙烯。比唆，N-乙稀。比0各網，乙 烯甲醯胺，N-乙烯咪唑，乙烯乙酸酯，水解的乙稀乙 酸酯，和苯乙稀所組成之族者。 202. 如申請專利範圍第200項之方法，其中該羧基單體係 擇自於.由丙烯酸，順-丁烯二酸，順-丁烯二酸野，甲 基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反·丁婦 二酸’檸康酸’甲基-反··丁烯二酸，丙烯腈，甲基丙 稀腈’ α-亞甲基戊二酸，環己稀二魏酸，順q，2 3卜 四氫酞酸酐，3,6-環氧-1，2,3,6-四氫酞酸酐，5-降冰片 烯-2,3-二羧酸酐，雙環[2.2·2]-5-辛烯-2,3-二羧酸酐， 3 -甲基-1，2,6-四氲酜酸酐，和2 -甲基-l，3,6-四氫狄酸酐 所組成之族者。 203. 如申請專利範圍第2〇2項之方法，其中該羧基單體係 擇自於由丙烯酸，順-丁烯二酸，分解烏頭酸，和順_ 丁稀《一酸Sf所組成之族者。 204. 如申請專利範圍第131項之方法，其中該含磷羧酸酯 是一個得自二個或更多個不飽和單體，在含磷化合物 存在下聚合反應的共寡聚物或共聚物，含碌致酸酯殘 基的主要部份（多於50%重量比）是衍生自含有一個或 更多個羧基基團或含有一個或更多個聚合反應後轉 型為敌基基團之基團的羧基單體，其餘的殘基是得自 非羧基單體，其中得到的含磷羧酸酯含有主要或全部2. The scope of Shenyan's patent is hydrogen. Among them, the hyaluronic acid is the only unsaturated decomposed aconitic acid, and cis_186. If the method of the scope of patent application No. 180, where the only unsaturated monosystem is selected From the family consisting of maleic acid, decomposed aconitic acid, and maleic anhydride. 187_ The method according to the scope of patent application No. 180, wherein the one unsaturated mono-acrylic acid and the other unsaturated mono-system are selected from the cleavage of aconitic acid and cis-butyl The family consisting of oxalic acid if 0 is the method of patent scope No. 181, in which the saturated single system is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid , Decomposition aconitic acid, crotonic acid, ethyleneacetic acid, trans-butenedioic acid, aconic acid, methyl-trans-butenedioic acid, acrylic acid, methacrylonitrile, α-methyleneglutaric acid, cyclic Hexene dicarboxylic acid, cis · 1,2,3,6-tetrahydrophthalic anhydride, 3,6_epoxy ten, 2,3,6_tetrahydrophthalic anhydride, 5-norbornene-2,3-di Carboxylic acid anhydride, bicyclic [2 2 2] -5-octene · 2,3-carboxylic acid anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl], 3,6 one four Family of phthalic anhydride. 189. The unsaturated monomer according to method 1 in the scope of patent application No. 81. 190. The method and single system of the scope of application for patent No. 181 is selected from the group consisting of maleic acid and succinic anhydride. 191. The method of claim 181, in which one unsaturated monomer is acrylic acid and the other unsaturated monosystem is selected from the group consisting of cis-succinic acid, decomposing aconitic acid, and maleic anhydride. The paper size of the family is applicable to the Chinese National Standard (CNS) Α4 specification (210X297). Packing% ------------------ line (please read the precautions on the back first) (Fill in this page again.) 108 VI. Application for Patent Scope .: The method of claiming the scope of patent, where the unsaturated monomer is based on acrylic acid 'cis-succinic acid' maleic anhydride, I-based Acrylic acid, decomposed aconitic acid, crotonic acid, ethyl acetic acid, trans-broad acid, citraconic acid 'methyl-trans-butenedioic acid, acrylonitrile, methyl 1-propanone' α-methylene glutaric acid, Cyclohexene difluorene, cis •, 2'3'6-tetrahydropyrene needle 3,6 · epoxy_1,2,3,6 · tetrahydropirate, 5-norbornene. 2,3 -Difluorene_, bicyclic [2.2, 5_octene_2,3_dijuncoic anhydride, 3-methyl-fluorene, 2,6-tetrahydroacid needle, and 2-fluorenyltetrahydrophthalic anhydride Those who are composed. '' If you are in the muscle, please specialize in the method of item 182, where Dilute acid is the only unsaturated monomer. 194. For example, the method of patent item 182, wherein the unique unsaturated mono system is selected from cis-butanedioic acid, decomposing aconitic acid, and cis _ Those who are composed of butadiene anhydride. The method of item 182 of the patent scope is requested, in which the unsaturated early body is acrylic acid and the other unsaturated monosystem is selected from maleic acid, Those who decompose aconitic acid and cis-butene dianhydride. 196. The method of the scope of patent application No. 183, wherein the unsaturated monosystem is selected from acrylic acid, cis-butenedioic acid, cis- Butanedioic anhydride, methacrylic acid, decomposed aconitic acid, crotonic acid, ethylene acetate, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylamide, methacrylonitrile, α- Methylene glutaric acid, cyclohexene dicarboxylic acid, cis 1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy 1,2,3,6-tetrahydrophthalic anhydride, paper Standards apply to Chinese National Standard (⑽) A4 specifications (210 &gt; &lt; 297 mm) -109-A8 B8 C8 D8 542858 Patent claim scope.% Norbornene-2,3-dicarboxylic anhydride, Bicyclo [2.22] _5_octene ^, fluorene dicarboxylic anhydride, 3-methylhydrophthalic anhydride, and 2-fluorenyl tetrahydrophthalic anhydride. 7. · The scope of patent application of Shenqiao No. 丨 83 Item 198, wherein the acrylic monomer is the only unsaturated monomer ^ 198. The method according to item 183 of the patent application, wherein the only unsaturated mono system is free cis-butenedioic acid, decomposing aconitic acid, and A family consisting of maleic anhydride. 9. As stated in the method of patent scope 183, one unsaturated monomer is acrylic acid and the other unsaturated monosystem is selected from maleic acid , Decomposing aconitic acid, and maleic anhydride. 200. The method according to claim 131, wherein the phosphorous acid ester is a co-polymer or copolymer obtained from two or more unsaturated monomers and polymerized in the presence of a phosphorus-containing compound. The main part (more than 50% by weight) of phosphorus-containing carboxylic acid ester residues is derived from groups containing one or more carboxyl groups or containing one or more carboxyl groups after polymerization. The remaining residues are obtained from non-closing monomers, and the obtained phosphorus-containing carboxylic acid esters contain phosphorus additions mainly or wholly present as terminal phosphine-based species or water-soluble salts thereof. 201. The method of claim 200, wherein the non-carboxyl monosystem is selected from the group consisting of 2-propenylamine-2-methylpropionite lutein, 2-meryl-3- (2- Allyloxy) propane luteinic acid '2-methyl-2-propen-1-contanoic acid, propyl sulfonic acid, allyloxybenzene sulfonic acid, styrene sulfonic acid, ethylene sulfonic acid, olefin Propylphosphonic acid, vinylphosphonic acid, isopropenylphosphonic acid, phosphoethylmethyl This paper is sized for the Chinese National Standard (CNS) A4 (210 X 297 mm) ------------ ------------ Installation ......- Order ...... ..... Line. (Please read the notes on the back before filling out this page) 110 542858 A8 B8 C8 D8 VI. Patent application scope Acrylic esters or acrylic acid or methacrylic hydroxyalkyl and Ci-C4 alkyl esters Class, acrylamide, alkyl-substituted acrylamide, dilute propyl alcohol '2-ethenyl' than ethylene '4-ethylene. Than, N-Ethylene. Each group is composed of vinylformamide, N-vinylimidazole, ethylene acetate, hydrolyzed ethyl acetate, and styrene. 202. The method of claim 200, wherein the carboxy mono system is selected from acrylic acid, maleic acid, maleic acid, methacrylic acid, decomposing aconitic acid, and crotonic acid. , Ethylene acetic acid, trans-butyric acid 'citraconic acid' methyl-trans-butenedioic acid, acrylonitrile, methyl acrylonitrile 'α-methylene glutaric acid, cyclohexanediweilic acid , Cis q, 2 3 4 tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclic [2.2 · 2] -5-octene-2,3-dicarboxylic anhydride, 3-methyl-1,2,6-tetrahydroanhydride, and 2-methyl-1,3,6-tetrahydrodicarboxylic anhydride Family. 203. The method according to the scope of application for patent No. 202, wherein the carboxy mono system is selected from the group consisting of acrylic acid, maleic acid, decomposing aconitic acid, and cis-butane "monoacid Sf By. 204. The method according to claim 131, wherein the phosphorus-containing carboxylic acid ester is a co-oligomer or copolymer obtained from two or more unsaturated monomers and polymerized in the presence of a phosphorus-containing compound. The main part (more than 50% by weight) containing phosphonate residues is derived from a group containing one or more carboxyl groups or containing one or more polymer groups and converting to an enemyl group The carboxyl monomer of the group, the remaining residues are derived from non-carboxyl monomers, and the obtained phosphorus-containing carboxylic acid ester contains mainly or all 542858 A8 B8 C8 D8 、申請專利範圍 存在為膦酸基種系或其水溶性鹽的磷加入物。 205.如申請專利範圍第204項之方法，其中該非羧基單體 係擇自於由2-丙烯醯胺-2-甲基丙烷磺酸，2-羥基-3-(2-丙稀氧基）丙烧確酸’ 2-甲基-2-丙稀基-1-石黃酸，姆丙 基磺酸，烯丙氧基苯磺酸，苯乙烯磺酸，乙烯磺酸， 烯丙基膦酸，乙烯膦酸，異丙烯基膦酸，碌乙基甲基 丙烯酸酯，丙烯酸或曱基丙烯酸的羥基烷基和〇1_〇4 烷基酯類，丙烯醯胺，烷基取代的丙烯醯胺，烯丙基 醇，2-乙烯α比啶，4-乙烯α比咬，N_乙稀响咯酮，1乙 稀甲醯胺，N-乙烯咪唑，乙烯乙酸酯，水解的乙烯乙 酸酯，和苯乙烯所組成之族者。 206·如申請專利範圍第2〇4項之方法，其中該羧基單體係 擇自於由丙烯酸，順·丁烯二酸，順_丁烯二酸酐，甲 基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反-丁烯 二酸，檸康酸，甲基-反-丁烯二酸，丙烯腈，甲基丙 烯腈，α-亞甲基戊二酸，環己烯二羧酸，順 四氫酞酸酐，3,6-環氧·1，2,3,6-四氫酞酸酐，5_降冰片 烯觸2,3.二叛酸針，雙環[2·3·2]:辛烯-2,3_二羧酸野， 3-曱基-1，2,6-四纽酸軒，和2-甲基]，3,6_四氫酞酸酐 所組成之族者。 207·如申請專利範圍第2〇6項 甘士斗％甘〇〇 貝&lt;方法，其中該羧基單體係 擇自於由丙烯酸，順-丁襁— \ ★上 、 歸一 I，分解烏頭酸，和順 丁烯二酸酐所組成之族者。 、 2〇8·如申請專利範圍第m 甘A斗人# Μ之方法，其中該含磷羧酸 本準⑽)Α4規格 裝------------------訂......................線· (請先閱讀背面之注意事項再填窝本頁) 酯 112 542858 A8 B8 C8 D8 六、中請專利範圍542858 A8 B8 C8 D8, patent application scope Phosphoric acid addition exists as phosphonic acid-based species or its water-soluble salt. 205. The method of claim 204, wherein the non-carboxyl monosystem is selected from the group consisting of 2-propenylamine-2-methylpropanesulfonic acid, 2-hydroxy-3- (2-propaneoxy) Propionic acid '2-methyl-2-propenyl-1- lutein acid, mpropylsulfonic acid, allyloxybenzenesulfonic acid, styrenesulfonic acid, ethylenesulfonic acid, allylphosphonic acid , Vinylphosphonic acid, isopropenylphosphonic acid, ethyl ethyl methacrylate, hydroxyalkyl and 〇1_〇4 alkyl esters of acrylic or acryl acrylic acid, acrylamide, alkyl substituted acrylamide , Allyl alcohol, 2-vinyl alpha-pyridine, 4-vinyl alpha-specific bite, N-ethylprednisolone, 1-ethylmethoxamine, N-vinylimidazole, ethylene acetate, hydrolyzed ethylene acetate A family of esters and styrene. 206. The method according to the scope of application for patent No. 204, wherein the carboxy mono system is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid, decomposed aconitic acid, crotonic acid , Ethyleneacetic acid, trans-butenedioic acid, citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, methacrylonitrile, α-methyleneglutaric acid, cyclohexene dicarboxylic acid, cis Tetrahydrophthalic anhydride, 3,6-epoxy · 1,2,3,6-tetrahydrophthalic anhydride, 5_norbornene touch 2,3. Diacid needle, bicyclic [2 · 3 · 2]: Xin A group consisting of ene-2,3-dicarboxylic acid, 3-fluorenyl-1,2,6-tetraenoic acid, and 2-methyl], 3,6-tetrahydrophthalic anhydride. 207. If the scope of the application for patent is No. 206, Gansudou% Ganbaobei &lt; method, wherein the carboxy mono system is selected from acrylic acid, cis-butyrate-\ ★ upper, normalized I, decomposing aconitic acid, And maleic anhydride. 2,208 · If the method of applying for the patent scope m 甘 A 斗 人 # Μ method, wherein the phosphorus-containing carboxylic acid is the standard ⑽) A4 size package ----------------- -Order ............ Line · (Please read the precautions on the back before filling this page) Ester 112 542858 A8 B8 C8 D8 Patent scope 是一個得自二個或更多個不飽和單體，在含碟化合物 存在下聚合反應的共募聚物或共聚物，含碳竣酸g旨殘 基的主要部份（多於50%重量比）是衍生自含有一個或 更多個羧基基團或含有一個或更多個聚合反應後轉 型為羧基基團之基團的羧基單體，其餘的殘基是得自 非羧基單體，其中得到的含磷羧酸酯含有主要或全部 存在為二烧基膦基種系或其水溶性鹽的罐加入物。 209·如申請專利範圍第208項之方法，其中該非叛基單體 係擇自於由2-丙稀酿胺-2-甲基丙烧石夤酸，2-經基-3-(2-丙烯氧基）丙烧續酸’ 2-曱基-2-丙婦基-1-續酸，稀丙 基磺酸，烯丙氧基苯磺酸，苯乙烯磺酸，乙烯續酸， 稀丙基膦酸*乙烯膦酸’異丙稀基膦酸，填乙基曱基 丙稀酸酯，丙婦或甲基丙稀酸的經基烧基和Clec4烧基 酯類，丙烯醯胺，烷基取代的丙烯醯胺，烯丙基醇， 2-乙烯。比淀’ 4-乙烯0比咬，乙婦。比吃_，N-乙烯曱 醯胺’ Ν-乙稀咪啥’乙烯乙酸酯，水解的乙稀乙酸酯 ，和苯乙烯所組成之族者。 210·如申請專利範圍第208項之方法，其中該竣基單體係 擇自於由丙稀酸’順-丁烯二酸，順-丁稀二酸針，甲 基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反·丁烤 二酸，檸康酸，曱基-反-丁烯二酸，丙烯腈，曱基丙 烯睛，α·亞曱基戊二酸，環己烯二羧酸，順 四氫欧酸酐’ 3,6-環氧_1，2,3,6-四氫酜酸酐，5-降冰片 烯-2,3-二羧酸酐，雙環[2·2·2]-5-辛烯-2,3-二羧酸野， 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 113 542858 六、申請專利範圍 所組成之族者。 其中該羧基單體係 刀解烏頭酸，和順_It is a co-polymer or copolymer obtained from two or more unsaturated monomers and polymerized in the presence of a dish-containing compound. It contains a major portion of carbon residues (greater than 50% by weight). Ratio) is a carboxyl monomer derived from a group containing one or more carboxyl groups or a group converted to a carboxyl group after polymerization, and the remaining residues are derived from non-carboxyl monomers, where The obtained phosphorus-containing carboxylic acid ester contains a tank addition mainly or entirely present as a dialkylphosphine-based species or a water-soluble salt thereof. 209. The method according to item 208 of the patent application, wherein the non-single monomer system is selected from 2-propenamine-2-methylpropanecarboxylic acid, 2-mercapto-3- (2- Allyloxy) propanedioic acid '2-fluorenyl-2-propenyl-1-contined acid, dilute propylsulfonic acid, allyloxybenzenesulfonic acid, styrenesulfonic acid, ethylene dicarboxylic acid, dilute propylene Phosphonic Acid * Ethylene Phosphonic Acid 'Isopropylphosphonic Acid, Ethyl Acrylic Acrylic Acid Esters, Acetyl Acetyl and Clec4 Acrylic Esters, Acrylic Amines, Alkyl Allylamine, allyl alcohol, 2-ethylene. Than Yodo '4-ethylene 0 than bite, Otome. Than eating _, N-ethylene fluorene amine ’Ν- ethylene dimethan’ ethylene acetate, hydrolyzed ethyl acetate, and the family of styrene. 210. The method according to item 208 of the application for a patent, wherein the monobasic system is selected from the decomposition of acrylic acid 'maleic acid, maleic acid needle, methacrylic acid, decomposing aconitic acid, Crotonic acid, ethylene acetic acid, trans-butanedioic acid, citraconic acid, fluorenyl-trans-butenedioic acid, acrylonitrile, fluorenyl acrylonitrile, α · arylene glutaric acid, cyclohexene dicarboxylic acid , Cis-tetrahydrouric anhydride '3,6-epoxy 1,2,3,6-tetrahydrofluoric anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclic [2 · 2 · 2]- 5-octene-2,3-dicarboxylic acid, this paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 113 542858 6. The family of patent applications. Among them, the carboxyl single system has aconic acid, and cis_ 211.如申請專利範圍第21〇項之方法 擇自於由丙烯酸，順_ 丁烯二酸， 丁稀一酸酐所組成之族者。 犯·如中料㈣圍第131項敘述之方法，其巾該含賴 酸醋是-個得自二個或更多個不飽和單體，在含鱗化 CT物存在下聚合反應的共募聚物或共聚物，含破叛酸 酯殘基的主要部份（多於50%重量比）是衍生自含有一 個或更多個羧基基團或含有一個或更多個聚合反應 後轉型為羧基·基團之基團的莩基單體，其餘的殘基是 得自非羧基單體’其中得到的含磷羧酸酯含有存在為 •膦酸基，終端型膦基，和二烷基膦基種系混合物或其 水溶性鹽的磷加入物。 213·如申請專利範圍第212項之方法，其中該非羧基單體 係擇自於由2 -丙稀酿胺-2-甲基丙烧續酸，2-經基-1-(2- 丙烯氧基）丙烷磺酸，2-曱基-2-丙烯基-1-磺酸，烯丙 基磺酸，烯丙氧基苯磺酸，苯乙烯磺酸，乙烯磺酸， 稀丙基膦酸，乙稀膦酸，異丙稀基膦酸，鱗乙基曱基 丙烯酸酯，丙烯酸或曱基丙烯酸之羥基烷基酯類，丙 烯酸或曱基丙烯酸之crc4烷基酯類，丙烯醯胺，烧基 取代的丙烯醯胺.，烯丙基醇，2-乙烯吡啶’ 4-乙豨°比 咬，N-乙稀°比σ各_，N-乙稀曱醯胺，乙烯σ米唾’乙 烯乙酸酯，水解的乙烯乙酸酯，和苯乙烯所組成之族 114 本紙張尺度適用中國國家標準（CNS) Α4规格（210X297公埜） 542858 A8 B8 C8 D8 酯 、申請專利範圍 者。 2H.如申請專利範圍第212項之方法，其中該絲單體係 擇自於由丙烯酸，順-丁烯二酸，順_丁烯二酸酐，甲 基丙烯酸，分解烏頭酸，巴豆酸，乙烯乙酸，反-丁烯 二酸’檸康酸，甲基-反-丁烯二酸，丙烯腈，甲基丙 烯腈，α-亞曱基戊二酸，環己烯二羧酸，順 四氫酞酸酐，3,6-環氧-^卜四氫酞酸酐’ ^降冰片 烯-2,3-二羧酸酐，雙環[2.2 2]_5_辛烯_2,3_二羧酸酐， 3-甲基-1，2,6-四氫酞酸酐，和2_甲基四氫酞酸酐 所組成之族者。 215·如申請專利範圍第214項之方法，其中該羧基單體係 擇自於由丙烯酸，順-丁烯二酸，分解烏頭酸，和順_ 丁婦二酸酐所組'成之族者。 216·如申請專利範圍第131項之方法，其中該含磷羧酸 是一個含下面化學通式之膦聚合物 C請先閲讀背面之注意事項存填寫本頁) 訂· 0 Rrr 1/ oxr soxf 其中X;為Η ,鹼金屬原子，鹼土金屬原子，或銨或胺 殘基；Rn是一個包含二個不同下面殘基的共聚物殘基 + CH2 CH (RJ2)七 其中z是一個範圍自2至1〇〇的整數，其中，第一 個殘基中的R;2為-COOH，第二個殘基中的1112為 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） 115 542858 A8 B8 C8 D8 鹽 鎳 、申請專利範圍 -C〇NHC(CH3)2CH2S〇3u中x;為如前面定義者。 2Π.如中請專利範圍第131項之方法，其中該水相系統處 理物料是一個組成物，其中包含高達5〇%重量比，以 組成物重量計，的膦酸基琥轴酸，麟酸化驗金屬順_ -丁烯二酸酯二聚物，不多於次要重量比部份，以二聚 物重量計，的較高膦酸化順_ 丁烯二酸醋募聚物;及〇:5 至5%，以組成物重量計，的鹼金屬磷酸鹽。. 218·如申請專利範圍第131項之方法，其中該肌胺酸的長 鏈脂肪酸衍生物是選擇為N_月桂醯基㈣酸或其水 溶性鹽。 Μ如中請專利範圍第13〇項之方法，其中該組成物包括 水。 220.如中請專利範圍第131項之方法，其中該組成物另外 包括水。 如·如申請專利範圍第131項之方法，其中該組成物另外 含有至少一 4固擇自於由下面試劑所組成之族的添加 物： L 一個或更多個分散劑 Η · 個或更多個銅腐姓抑制劑 Hi· 個或更多個銘腐姓抑制劑 ιν· -個或更多個擇自於由鋅，猛，鋁，錫，鈕 ’紀，和稀土金屬所組叙麵金屬的水溶性金屬 v. -個或更多個擇自於由鋅，猛，鋁，錫、 ，紀，和稀土金屬所組成之族的金屬離子的水溶性: 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） -----------------------裝-----------------..訂.................線. (請先閲讀背面之注意事項再填寫本頁) 116 542858 A8 B8 C8 _______D8 _ 、申請ir範圍 —^ .機金屬螯合物，其中該有機整合物要選擇使提供金屬 離子需要的水溶解度 (請先閲讀背面之注意事項再填寫本頁) vi· —個或更多個水垢控制劑 vii. —個或更多個多價螯合劑 viii· —個或更多個防珠劑 ix· —個或更多個氧化性生物制劑 X· 一個或更多個非氧化性生物制劑· xi· —個或更多個可降低水相系統冷凍溫度的水 溶性醇 xii. —個或更多個離子的冷凍溫度抑制劑 xiii· —個或更多個pH調節劑 xiv· —個或更多個惰性示蹤劑 XV· —個或更多個活性示蹤劑 xvi· —個或更多個非水溶性的有機潤滑劑 vii· —個或更多個水溶性潤滑劑 xviii· —個或更多個表面活性劑 xix· —個或更多個鈣硬度調節劑 XX· —個或更多個呈色劑。 222. 如申請專利範圍第221項之方法，其中該組成物另外 包括水。 223. 如申請專利範圍第221項之方法，其中該分散劑是一 個得自一個或更多個乙烯不飽和單體聚合反應的水 溶性磺酸化聚合物或共聚物。 224. 如申請專利範圍第223項之方法，其中該水溶性磺酸 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公釐） -117 - )42858 其中该銅腐餘抑制 其中該銅腐餘抑制 其中該銅腐Ί虫抑制 ‘申請專利範圍 ’化共聚物是一個丙烯酸和烯丙基羥基丙基磺酸醚3:1 重量比的共聚物或其水溶性鹽。 225·如申請專利範圍第221項之方法，其中該分散劑是一 個分子量&lt;10,000的二異丁烯和順_ 丁烯二酸酐共聚物 或其水溶性鹽。 226.如中請專利範圍第221項之方法，其中該銅腐姓抑制 劑為甲苯***。 功.如:請專利範圍第221項之方法，其中該銅腐钱抑制 副疋一個混合的甲苯***組成物，包括至少65%，以 重量計，的5-甲基苯并***異構物。 228·如中請專利範圍第221項之方法，其中該銅腐麵抑制 劑為苯并三σ坐。 229·如申請專利範爵第221項之方法 wj為氮硫基苯并σ 塞σ坐。 30·如申請專利範圍第221項之方法 劑是一個烷基或烧氧基取代的苯并***，其中該取代 發生於苯環的4或5位置。 231.如申請專利範圍第23〇項之方法，其中該取代基係擇 自於由正-丁基和己氧基所組成之族者。 232·如申請專利範圍第221項之方法，其中該銅腐蝕抑制 劑為1-苯基-5 -氫硫基四σ坐。 233·如申請專利範圍第221項之方法 劑是一個耐函素唑。 234·如申請專利範圍第233項之方法 本紙張尺度適用中國國家標準（CNS) Α4規格（21〇&gt;&lt;297公釐）211. The method according to item 21 of the scope of patent application is selected from the group consisting of acrylic acid, maleic acid and succinic anhydride. The method as described in item 131 of the Chinese Foodstuffs Co., Ltd., the lysine-containing vinegar is obtained from two or more unsaturated monomers, and is co-funded in the presence of scaled CT Polymers or copolymers containing a major portion (more than 50% by weight) of acid ester residues are derived from one or more carboxyl groups or converted to carboxyl groups after one or more polymerization reactions The group is a fluorenyl monomer, and the remaining residues are derived from non-carboxyl monomers. The phosphorous carboxylic acid ester obtained therein contains a phosphonic acid group, a terminal phosphine group, and a dialkylphosphine. Phosphorus addition to a base germline mixture or a water-soluble salt thereof. 213. The method according to item 212 of the application, wherein the non-carboxyl monosystem is selected from 2-propenamine-2-methylpropanedioic acid, 2-meryl-1- (2-propeneoxy Group) propanesulfonic acid, 2-fluorenyl-2-propenyl-1-sulfonic acid, allylsulfonic acid, allyloxybenzenesulfonic acid, styrenesulfonic acid, ethylenesulfonic acid, dilute phosphonic acid, Ethylene phosphonic acid, isopropylphosphonic acid, squamyl ethyl acrylate, hydroxyalkyl esters of acrylic or fluorenyl acrylic acid, crc4 alkyl esters of acrylic or fluorenyl acrylic acid, acrylamide, and alkyl Substituted acrylamide., Allyl alcohol, 2-vinylpyridine '4-acetamidine specific bite, N-vinyl ° ratio σ each _, N-ethylammoniumamine, ethylene σ melamine' ethylene ethylene A family of 114 esters, hydrolyzed ethylene acetates, and styrene. This paper size applies to Chinese National Standard (CNS) A4 specifications (210X297 public field) 542858 A8 B8 C8 D8 esters, those who apply for patents. 2H. The method of claim 212, wherein the monofilament system is selected from acrylic acid, maleic acid, maleic anhydride, methacrylic acid, decomposed aconitic acid, crotonic acid, ethylene Acetic acid, trans-butenedioic acid 'citraconic acid, methyl-trans-butenedioic acid, acrylonitrile, methacrylonitrile, α-fluorenylglutaric acid, cyclohexene dicarboxylic acid, cistetrahydro Phthalic anhydride, 3,6-epoxy- ^ tetrahydrophthalic anhydride '^ norbornene-2,3-dicarboxylic anhydride, bicyclic [2.2 2] _5_octene_2,3_dicarboxylic anhydride, 3- A family of methyl-1,2,6-tetrahydrophthalic anhydride and 2-methyltetrahydrophthalic anhydride. 215. The method of claim 214, wherein the carboxy mono system is selected from the group consisting of acrylic acid, maleic acid, decomposed aconitic acid, and maleic anhydride. 216 · If the method of applying for item 131 of the patent scope, wherein the phosphorus-containing carboxylic acid is a phosphine polymer containing the following chemical formula C, please read the precautions on the back and fill in this page) Order · 0 Rrr 1 / oxr soxf Where X is Η, an alkali metal atom, an alkaline earth metal atom, or an ammonium or amine residue; Rn is a copolymer residue containing two different residues + CH2 CH (RJ2), where z is a range from 2 Integer to 100, where R in the first residue; 2 is -COOH, and 1112 in the second residue is the paper size applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 115 542858 A8 B8 C8 D8 salt nickel, patent application scope-CONHC (CH3) 2CH2S〇3u x; as defined previously. 2Π. The method of claim 131, wherein the material treated in the aqueous phase system is a composition containing up to 50% by weight of the phosphonic succinic acid based on the weight of the composition. Test metal cis-butadiene dimer, not more than minor weight ratio, based on the weight of the dimer, higher phosphonated cis-butadiene vinegar polymer; and 〇: 5 to 5% by weight of the composition of an alkali metal phosphate. 218. The method of claim 131, wherein the long-chain fatty acid derivative of sarcosinate is selected as N-laurate gallic acid or a water-soluble salt thereof. The method as claimed in item 130 of the patent, wherein the composition includes water. 220. The method of claim 131, wherein the composition additionally includes water. Such as the method of applying for the scope of patent application No. 131, wherein the composition additionally contains at least one additive selected from the group consisting of the following reagents: L one or more dispersants Η one or more Copper corrosion inhibitor Hi · or more Ming corrosion inhibitor ιν ·-one or more selected from the group consisting of zinc, manganese, aluminum, tin, button, and rare earth metals Water-soluble metals v.-One or more water-soluble metals selected from the group consisting of zinc, manganese, aluminum, tin, copper, and rare earth metals: The paper dimensions apply to Chinese national standards (CNS ) A4 size (210X297mm) ----------------------- install -----------------. .Order ....... line. (Please read the precautions on the back before filling out this page) 116 542858 A8 B8 C8 _______D8 _, apply for the range of ir— ^ .Metal Chelate, in which the organic complex is selected to provide the water solubility required to provide metal ions (please read the notes on the back before filling this page) vi · —one or more scale control agents vii. — One or more Sequestrant viii · —one or more anti-bead agents ix · —one or more oxidizing biological agents X · one or more non-oxidizing biological agents xi · —one or more to reduce freezing of the aqueous system Water-soluble alcohols at temperature xii. — Freezing temperature inhibitors of one or more ions xiii · — One or more pH adjusters xiv · — One or more inert tracers XV · — One or more Active tracer xvi · —one or more water-insoluble organic lubricants vii · —one or more water-soluble lubricants xviii · —one or more surfactants xix · —one or more Calcium hardness modifier XX ·-One or more color formers. 222. The method of claiming scope of patent application No. 221, wherein the composition additionally includes water. 223. The method of claiming scope of patent application No. 221, wherein the dispersant is a water-soluble sulfonated polymer or copolymer obtained from the polymerization of one or more ethylene unsaturated monomers. 224. For the method of applying for item 223 of the patent scope, wherein the paper size of the water-soluble sulfonic acid is in accordance with Chinese National Standard (CNS) A4 specification (210X297 mm) -117-) 42858, wherein the copper corrosion residue inhibits the copper corrosion I inhibit the copper rot borer inhibition 'application patent scope' copolymer is a copolymer of acrylic acid and allyl hydroxypropyl sulfonate in a 3: 1 weight ratio or a water-soluble salt thereof. 225. The method according to claim 221, wherein the dispersant is a diisobutylene and maleic anhydride copolymer having a molecular weight of <10,000 or a water-soluble salt thereof. 226. The method according to item 221 of the patent application, wherein the copper scum name inhibitor is tolutriazole. Work: For example, the method of claim 221, wherein the copper spoil inhibits a mixed toltriazole composition including at least 65% by weight of 5-methylbenzotriazole isomerization. Thing. 228. The method according to item 221 of the Chinese Patent Application, wherein the copper decay inhibitor is benzotrisigma. 229. For example, the method wj of the patent application No. 221, wj is nitrogenthiobenzosigma. 30. The method of claim 221 is a benzotriazole substituted with an alkyl group or an alkoxy group, wherein the substitution occurs at the 4 or 5 position of the benzene ring. 231. The method according to claim 23, wherein the substituent is selected from the group consisting of n-butyl and hexyloxy. 232. The method of claim 221, wherein the copper corrosion inhibitor is a 1-phenyl-5 -hydrothio group. 233. The method according to the scope of patent application No. 221 is a fastonazole. 234 · If the method of applying for the item No. 233 of this patent is applied, the paper size applies the Chinese National Standard (CNS) A4 specification (21〇 &gt; &lt; 297 mm) -----------------------装------------------訂-------------……線- (請先閲讀背面之注意事項再填'寫本頁」 六、申請專利範圍 氯-甲苯三σ坐ό 23 5.如申明專利尧圍第221項之方法，其中該鋁腐蝕抑制 劑是一個水溶性硝酸鹽。 236·如中明專利範圍第235項之方法，其中該水溶性确酸 鹽為硝'酸納。 237·如中請專利範圍第221項之方法，其中該水溶性金屬 鹽係得自鋅。 238. 如申請專利範圍第23?項之方法，其中該鋅鹽為硫酸 鹽，亂化物，乙酸鹽或确酸鹽。 239. 如申請專利範圍第221項之方法，其中該金屬鹽係得 自+2氧化態錳。 MO.如申請專利範圍第239項之方法，其中該+2氧化態錳 鹽為硫酸鹽，氣化物，乙酸鹽或硝酸鹽。 241.如申請專利範圍第221項之方法，纟中該金屬鹽係得 自鑭或包含鑭之稀土金屬的混合物。 242·如申凊專利範圍第241項之方法，其中該鑭鹽或包含 鑭之稀土金屬鹽的混合物係獨立地擇自硫酸鹽，氯化 物，乙酸鹽或靖酸鹽。 243 ·如申研專利範圍第221項之方法，其中該多價螯合劑 係擇自於由乙二胺四（乙酸），氮基三乙酸，和队斗二 (2-羥乙基）甘胺酸或其水溶性鹽所組成之族者。 244.如申請專利範圍第131項之方法，其中該鹼金屬矽酸 鹽為偏石夕酸納。 245·如申請專利範圍第221項之方法，其中該防球劑係擇 542858 A8 B8 C8 D8 、申請專利範圍 .自於由矽酮，聚二甲基矽氧烷，二硬脂基癸二醯胺， 一硬脂基己二醯胺，脂肪醇，和脂肪醇之環氧乙烷縮 合物所組成之族者。 246.如申請專利範圍第221項之方法，其中該氧化性生物 制劑係擇自於由t，次氯酸鹽，溴，次漠酸鹽，提供 氣之化合物，提供溴之化合物，過乙酸，無機的過氧 化物和過氧化物產生物，二氧化氯，臭氧及其混合物 所組成之族者。 247·如申请專利範圍第221項之方法，其中該非氧化性生 物制剑係擇自於由胺，四級銨化合物，溴_2-硝基丙 烷-1，3-一醇，溴硝基苯乙烯，十二烷基胍氫氯酸 ，2,2-二溴-3-氮基丙醯胺，戊二醛，氯酚，颯，亞 基雙硫氰酸酯，，亞甲基雙胺基甲酸酯，異噻唑酮， 化丙醯胺，三吖啡，鱗化合物，有機金屬化合物及其 混合物所組成之族者。 248·如申請專利範圍第221項之方法，其中該非氧化性生 物制劑是一個混合物，其中包含0)2_溴_2_硝基丙烷 -1，3-二醇（BNPD)和（b)75% 5-氯-2-甲基-4-異噻唑 _3一 網和25% 2-甲基-4-異噻唑-3 —酮的混合物，該BNpD⑷ 與該混合物（b)的重量比為16:1至1:1。 249.如申請專利範圍第221項之方法，其中該水溶性醇 凍溫度抑制劑係擇自於由乙二醇，丙二醇，乙醇， 油，異丙醇’和甲醇或其混合物所組成之族者。 250·如中請專利㈣第221項之方法，其中該離子的冷康 鹽甲 溴 冷甘 (請先閲讀背面之注意事項再填寫本頁) •訂· :線丨 本紙張尺度適用中國國豕標準（CNS) A4規格（210X297公楚） 120 542858 C8 _________D8_ 六、申請專利範圍 --- μ度抑制劑係擇自於由氣化舞，氯化鈉，溴化鐘，和 氣化鐘所組成之族者。 251·如中請專利範圍第如項之方法，其中該_節劑係 擇自於由氫氧化納，氫氧化鉀，氫氧化鐘，鹽酸，硫 酉夂硝^ —氧化碳，氨，有機酸，如草酸，，驗金屬 碳酸鹽，和鹼金屬碳酸氫鹽所組成之族者。 252. 如申請專利範圍第221項之方法，其中該惰性示蹤劑 係擇自於由可溶的鐘鹽，過渡金屬，和榮光物料所組 成之族者。 253. 如申請專利範圍第221項之方法，其中該活性示蹤劑 係擇自於由螢光標記的聚合物，含有光惰性，隱藏的 可檢測部份的聚合物，水溶性鉬酸鹽，和以嗤為主的 銅腐钱抑制劑所組成之族者。 如申》月專利範圍第221項之方法，其中該非水溶性的 有機潤滑劑係擇自於由天然油和合成油所組成之族 者。 如申明專利範圍第221項之方法，其中該表面活性劑 係擇自於由陰離子的，陽離子的，兩性的和非離子的 表面活性劑所組成之族者。 256•如申請專利範圍第221項之方法，其中關硬度調節 劑係擇自於由舞的碳酸氫鹽，碳酸鹽，氣化物，硫酸 鹽，和乙酸鹽，氫氧化鈣和氧化鈣所組成之族者。 257.如申請專利範圍第221項之方法，其中該呈色劑是一 個水溶性染料。 5張尺度適用中國國家標準規格(210 X 297公------~- (請先閲讀背面之注意事項再填寫本頁) •、^τ—----------------------- Install -------------------- Order ------- ------ …… Line- (Please read the notes on the back before filling in 'write this page') 6. Scope of patent application Chlorine-toluene σ σ σ 23 5. If you declare the method of patent No. 221 Among them, the aluminum corrosion inhibitor is a water-soluble nitrate. 236. The method of the scope of the patent of 235 in Zhongming, wherein the water-soluble salt is sodium nitrate. 237. The scope of the patent in 221 A method, wherein the water-soluble metal salt is obtained from zinc. 238. The method according to item 23 of the patent application, wherein the zinc salt is a sulfate, a chaotic compound, an acetate, or an acid salt. 239. If a patent is applied for The method according to item 221, wherein the metal salt is derived from +2 oxidation state manganese. MO. The method according to item 239 of the patent application range, wherein the +2 oxidation state manganese salt is sulfate, gaseous, acetate, or Nitrate. 241. According to the method of claim 221, the metal salt in hafnium is obtained from lanthanum or a mixture of rare earth metals containing lanthanum. 242. The method of claim 241, wherein the lanthanum salt Or contains lanthanum The mixture of rare earth metal salts is independently selected from sulfates, chlorides, acetates or phosphonates. 243. As in the method of Shenyan Patent No. 221, wherein the sequestrant is selected from ethylenediamine A group consisting of tetrakis (acetic acid), nitrogen triacetic acid, and doudi (2-hydroxyethyl) glycine or its water-soluble salt. 244. The method according to the scope of patent application No. 131, wherein the base The metal silicate is sodium metaxitrate. 245. If the method of the scope of patent application No. 221, the ball-proofing agent is selected from the range of 542858 A8 B8 C8 D8. Since the silicone, polydimethyl A family consisting of siloxane, distearyl sebacamide, monostearyl adipamide, fatty alcohols, and ethylene oxide condensates of fatty alcohols. 246. Such as the scope of application for patent No. 221 A method wherein the oxidizing biological agent is selected from the group consisting of t, hypochlorite, bromine, hypoxite, gas-providing compounds, bromine-providing compounds, peracetic acid, inorganic peroxides, and peroxides. Clan of organisms, chlorine dioxide, ozone and mixtures thereof. 247 · The method of claiming the scope of patent application No. 221, wherein the non-oxidizing biological sword system is selected from the group consisting of amine, quaternary ammonium compound, bromo-2-nitropropane-1,3-monool, bromonitrostyrene, ten Dialkylguanidine hydrochloric acid, 2,2-dibromo-3-azetidinamine, glutaraldehyde, chlorophenol, amidine, subdithiocyanate, methylenebiscarbamate , Isothiazolone, propylamidine, triazine, squamous compounds, organometallic compounds, and mixtures thereof. 248. The method according to the scope of patent application No. 221, wherein the non-oxidizing biological agent is a mixture , Which contains 0) 2_bromo_2_nitropropane-1,3-diol (BNPD) and (b) 75% 5-chloro-2-methyl-4-isothiazole_3 a net and 25% A mixture of 2-methyl-4-isothiazol-3-one, the weight ratio of the BNpD⑷ to the mixture (b) is 16: 1 to 1: 1. 249. The method according to claim 221, wherein the water-soluble alcohol freezing temperature inhibitor is selected from the group consisting of ethylene glycol, propylene glycol, ethanol, oil, isopropanol ', and methanol or a mixture thereof . 250 · Please refer to the method of patent ㈣ item 221, in which the cold Kang salt of methyl bromide and cold bromide (please read the precautions on the back before filling out this page) • Order ·: Line 丨 This paper size is applicable to China 豕Standard (CNS) A4 specification (210X297) Chu 120 542858 C8 _________D8_ 6. Scope of patent application-μ degree inhibitor is selected from the group consisting of gasification dance, sodium chloride, bromide bell, and gasification bell Tribe. 251. The method of item No. 1 in the scope of patent application, wherein the _ saving agent is selected from sodium hydroxide, potassium hydroxide, potassium hydroxide, hydrochloric acid, thionine ^-carbon oxide, ammonia, organic acid , Such as oxalic acid, metal carbonates, and alkali metal bicarbonates. 252. The method of claim 221, wherein the inert tracer is selected from the group consisting of soluble bell salts, transition metals, and glorious materials. 253. If the method according to the scope of patent application No. 221, wherein the active tracer is selected from a fluorescently labeled polymer, a polymer containing a photo-inert, hidden detectable moiety, a water-soluble molybdate, And a family of copper-corruption-inhibitors based on maggots. For example, the method of No. 221 patent scope, wherein the water-insoluble organic lubricant is selected from the group consisting of natural oil and synthetic oil. For example, the method of claiming the scope of patent No. 221, wherein the surfactant is selected from the group consisting of anionic, cationic, amphoteric and nonionic surfactants. 256 • The method according to item 221 of the patent application, wherein the hardness modifier is selected from the group consisting of bicarbonate, carbonate, gaseous, sulfate, and acetate, calcium hydroxide, and calcium oxide. Tribe. 257. The method according to claim 221, wherein the color former is a water-soluble dye. 5 scales are applicable to Chinese national standard specifications (210 X 297 male ------ ~-(Please read the precautions on the back before filling this page) •, ^ τ— 121 •如申#專利輓圍第131項之方色，其中該單氟磷酸鹽 為單氟碌酸鈉。 申明專利鞑圍第155項之方法，其中正_磷酸鹽種系 ”偏％8文鹽種系重量比的範圍為20··1至1:20，二種系 都以Ρ〇4·3表示。 ” 260.如巾5月專利範圍第⑽項之方法，其中該水相系統是 一個冷卻水系統。 261·如申請專利範圍第項之方法，其中該冷卻系統是 一個開口的，蒸發性的冷卻水系統。 262=申料利範圍第編項之方法，其中該冷卻系統是 一個單循環的系統。 其中該冷卻系統為 其中該密閉回路冷 263.如申請專利範圍第26〇項之方法 密閉回路冷卻系，統。 264·如申請專利範圍第263項之方法 卻系統是内燃機引擎的冷卻系統 服如申請專利範圍第263項之方法’其中該密閉回路冷 邠系統是一個以食鹽水為主的系統，其中含有至少— 個擇自於由氯化鈣’氣化鋰，溴化鋰，和 成之族的添加物。 、’ 胤如中請專利範圍第263項之方法’其中 物是一個系統，其中含有至少—個擇自=冷 醇，丙二醇，乙醇，甘、、占 的添加物。 甘'，丙酵，和甲醇所組成之族 統是 殿如”專利範圍第13G項之方法，其中該水相系 ’其中該水相系統含 ，其中該水相系統含 ，其中該水相系統含 ’其中該水相系統含 542858 A8 B8 C8 --~---— D8 _ 、申請專鄕目 —： - 一個熱水加熱系統 268·如申請專利範圍第13〇項之方法，其中該水相系統係 擇自於由製紙衆和製紙系統，食物和飲料系統，銷爐 系統，精製系統，石油化學加工系統，冶礦系統，和 使用水相金屬切割液體之金屬切割系統所組成之族 者。 269·如申請專利範圍第13〇項之方法 有至少5重量百分比水的液體。 270.如申凊專利範圍第do項之方法 有至少50重量百分比水的液體。 271·如申請專利範圍第130項之方法 有至少90重量百分比水的液體。 272·如申請專利範圍，第13〇項之方法 有溶解的氧。 273.如申請專利範圍第13〇項之方法，其中該水相系統實 質的或完全的沒有溶解的氧。 274·如申請專利範圍第13〇項之方法，其中該水相系統含 有至少一個擇自於由氧，二氧化碳，硫化氫，和氨所 組成之族的溶解氣體。 275.如申請專利範圍第13〇項之方法，其中該水相系統含 有鐵金屬。 276·如申請專利範圍第275項之方法，其中該鐵金屬為至 少一個擇自於由鑄鐵，軟鋼，低合金鋼，和不銹鋼所 組成之族的金屬。 本紙張尺度適用中國國家標準（CNS) A4規格（21〇&gt;&lt;297公楚） (請先閲讀背面之注意事項再填寫本頁)121 • Rushen #Patent No. 131, where the monofluorophosphate is sodium monofluorophosphate. The method of claiming patent No. 155, in which the ortho-phosphate germline "partial% 8" salt salt germplasm has a weight ratio ranging from 20 ·· 1 to 1:20, and both lines are represented by P04 · 3 ”260. The method according to item ⑽ of the May patent scope, wherein the water phase system is a cooling water system. 261. The method of claim 1 in which the cooling system is an open, evaporative cooling water system. 262 = The method of the item range of the application material benefit range, wherein the cooling system is a single cycle system. Wherein the cooling system is where the closed circuit cooling is 263. The method of closed circuit cooling system according to item 26 of the patent application scope is the system. 264 · If the method of applying for the scope of patent application No. 263, but the system is the cooling system of the internal combustion engine, the method of applying for the scope of patent application No. 263 ', wherein the closed loop cold upsetting system is a salt water-based system, which contains at least — Additives selected from the group consisting of calcium chloride, lithium gasification, lithium bromide, and Hecheng. "The method of item 263 of the patent scope" is a system which contains at least one selected from the group consisting of cold alcohol, propylene glycol, ethanol, sugar, and zinc. The family consisting of Gan ', propionate, and methanol is the method of Dianru "patent scope item 13G, wherein the water phase system' where the water phase system contains, where the water phase system contains, where the water phase system Containing 'Where the water phase system contains 542858 A8 B8 C8-~ ---- D8 _, apply for special projects-:-a hot water heating system 268 · If the method of the scope of patent application No. 130, where the water The phase system is selected from the group consisting of a papermaking system, a food and beverage system, a furnace system, a refining system, a petrochemical processing system, a smelting system, and a metal cutting system using an aqueous metal cutting liquid. . 269. If the method of the scope of patent application No. 130 has a liquid of at least 5 weight percent of water. 270. The method of the scope of patent application do No. of the scope of patent has at least 50 weight percent of liquid. 271. The method of item 130 has a liquid of at least 90% by weight of water. 272. If the scope of patent application, the method of item 130 has dissolved oxygen. 273. The method of scope of patent application No. 130, wherein the water The phase system is substantially or completely free of dissolved oxygen. 274. The method of claim 130, wherein the aqueous phase system contains at least one member selected from the group consisting of oxygen, carbon dioxide, hydrogen sulfide, and ammonia. 275. The method according to the scope of patent application No. 130, wherein the aqueous phase system contains iron metal. 276. The method according to the scope of patent application No. 275, wherein the iron metal is at least one selected from free cast iron. , Soft steel, low-alloy steel, and stainless steel. The paper size applies to the Chinese National Standard (CNS) A4 specification (21〇 &gt; &lt; 297). (Please read the precautions on the back before filling in this page) 123123 申請專利範圍 2η η • •如申請專利範圍第130項之方法 有非鐵金屬。 •如申請專利範圍第277項之方法 至少一個擇自於由鋁，鋼，和以 之族的金屬。 0，rv •如申請專利範圍第130項之方法 時含有鐵和非鐵金屬。 〇·如申請專利範圍第130項之方法 漿進料法，以有效濃度引入系統 281·如申請專利範圍第130項之方法 時，該組成份與水相液體混合， ’其中該水相系統含 ’其中該非鐵金屬為 銅為主的合金所組成 ，其中該水相系統同 ，其中該組成份以泥 〇 ，其中當系統被填充 以有效濃度引入系統 (請先閲讀背面之注意事項再填寫本頁)Patent application scope 2η η • • If the method of patent application No. 130 has a non-ferrous metal. • Method as claimed in patent application No. 277. At least one selected from the group consisting of aluminum, steel, and metals. 0, rv • Ferrous and non-ferrous metals are included when applying for method No. 130 of the patent scope. 〇 · If the method of the scope of patent application No. 130, the slurry feed method is introduced into the system at an effective concentration 281 · If the method of the scope of patent application No. 130, the component is mixed with the aqueous liquid, 'Where the non-ferrous metal is composed of a copper-based alloy, where the water phase system is the same, where the composition is mud 〇, and when the system is filled into the system at an effective concentration (please read the precautions on the back before filling this page) 282·:申請專利範圍第13〇項之方法，其中該組成份以實 質連續的方式進料到系統。 283.如申請專利範圍第13G項之方法，其中該組成份以實 質間續的方式進料到系統。 284·如申請專利範圍第13〇項之方法，其中該組成份以間 續和連讀方法的組合進料到系統。 285·如中請專利範圍第13〇項之方法，其中—些組成份以 連、Λ的方式進料到***，而其餘的組成份以間續的方 式進料。 如申明專利|巳圍第130項之方法，其中組成份進料到 系統的方法係擇自於由以固定速率連續的進料和以 固定時程進料所組成之族者。 、可— :線丨 本紙張尺度翻中關家標準（CNS) Α4規格（210X297公釐） 124 542858 、申請專利範圍 287·如申請專利範圍第13〇 甘士 上 . 貝疋方法，其中該組成份以有 效的濃度，依據以類比或 4 乂電月自為主進料控制系統產 生的訊號引入水相系統。 288·如申請專利範圍第287項 甘士斗办 貝之方法，其中該進料控制系 統以至少下面的一項決定進料的速率·· I) 一個或更多個處理組成份的濃度 II) 個或更多個惰性或活性示縱劑物料的濃度 iii) 一個或更多個系統性能測定值 iv) 個或更多個系統物理特性的數值 v) —個或更多個系統化學特性的數值。 微如申請專利範圍第288項之方法，其中處理劑或示蹤 劑組成份的濃度以至少一個下面方式的連續的，半連 續的或批次式的分析技術測定： i) 光譜法 ii) 電化學法 iii) 層析法 iv) 決定於抗體結合或釋放的方法 v) 化學的分析方法。 290. 如申請專利範圍第289項之方法，其中該分析技術為 UV吸收光譜法。 291. 如申請專利範圍第130項之方法，其中該組成份以控 制的釋放輸送系統，以有效的濃度引入水相系統。 292·如申請專利範圍第130項之方法，其中該組成份的組 合以0.5 ppm至10,000 ppm重量比的總濃度引入該水 本紙張尺度適用中國國家標準（CNS) A4規格（210 X 297公釐） (請先閲讀背面之注意事項再填寫本頁) 、可丨282 ·: A method of applying for patent No. 130, wherein the component is fed into the system in a substantially continuous manner. 283. The method of claim 13G, wherein the component is fed to the system in a substantially continuous manner. 284. The method of claim 130, wherein the component is fed to the system in a combination of continuous and continuous reading methods. 285. The method according to item 130 of the Chinese Patent Application, in which some components are fed into the system in a continuous, Λ manner, and the remaining components are fed in an intermittent manner. For example, the method of claim No. 130, in which the components are fed to the system, is selected from the group consisting of continuous feeding at a constant rate and feeding at a fixed time. ， 可 ——: Line 丨 The paper size is translated into the Zhongguanjia Standard (CNS) A4 specification (210X297 mm) 124 542858. The scope of patent application is 287. For example, the scope of patent application is on the 13th Ganz. It is introduced into the water phase system at an effective concentration based on the signal generated by the main feed control system by analogy or 4 kWh. 288. The method of applying patent No. 287 for Gansu Dou Bei, wherein the feed control system determines the feed rate with at least one of the following: I) the concentration of one or more processing components II) or Concentrations of more inert or active intensifier materials iii) One or more system performance measurements iv) One or more system physical properties v) One or more system chemical properties. The method is slightly like the scope of patent application No. 288, wherein the concentration of the treatment agent or tracer component is determined by at least one of the following continuous, semi-continuous or batch analysis techniques: i) spectrometry ii) electrochemical Method iii) Chromatography iv) Method dependent on antibody binding or release v) Chemical analysis method. 290. The method according to the scope of patent application No. 289, wherein the analysis technique is UV absorption spectroscopy. 291. The method according to the scope of patent application No. 130, wherein the component is introduced into the aqueous phase system in a controlled release delivery system at an effective concentration. 292. The method according to item 130 of the patent application scope, wherein the combination of components is introduced into the water-based paper at a total concentration of 0.5 ppm to 10,000 ppm by weight. The paper size is applicable to the Chinese National Standard (CNS) A4 (210 X 297 mm) ) (Please read the notes on the back before filling this page) 125 542858 A8 B8 C8 D8 申請專利範圍125 542858 A8 B8 C8 D8 Patent Application Scope 相系統。 293.如申請專利範圍第13〇項之方法，其中該組成份的组 合以10 ppm至i.ooo ppm重量比的總濃度引入該水相 系統。 294·如申請專利範圍第13〇項之方法，其中缉成份b)對組成 份a)的重量比為自1〇〇:1至1:2〇。 295·如申請專利範圍第13〇項之方法，其中該組成份…對組 成份a)的重量比為自⑼：丨至^。 296. 如申請專利範圍第13〇項之方法，其中該水相系統的 pH為自5至12。 297. 如申請專利範圍第13〇項之方法，其中該水相系統的 pH為自6至10。 298· —種控制水相系統中腐蝕，沈積，和水垢的方法，其 中包含引入該系統一種下面的組合： (a)下面化學式的四唑鏘化合物： (請先閲讀背面之注意事項再填寫本頁) 訂丨相 ***。 Phase system. 293. The method of claim 130, wherein the combination of the components is introduced into the aqueous system at a total concentration of 10 ppm to i.ooo ppm by weight. 294. The method of claim 130, wherein the weight ratio of the ingredient b) to the ingredient a) is from 100: 1 to 1:20. 295. The method of claim 13 in the scope of patent application, wherein the weight ratio of the component to the component a) is from ⑼ to ^. 296. The method of claim 130, wherein the pH of the aqueous system is from 5 to 12. 297. The method of claim 130, wherein the pH of the aqueous system is from 6 to 10. 298 · —A method for controlling corrosion, deposition, and scale in an aqueous system, which includes introducing the following combination of the system: (a) Tetrazolium compound of the following chemical formula: (Please read the precautions on the back before filling in this Page) Order 丨 ^3 η 其中Ri，R2和Rs係擇自於由較低級烷基，分枝的較低 級烷基，芳基，取代的芳基，烷芳基，取代的烷芳基 和雜環取代的芳基所組成之族者，但是必須Ri，^或 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公爱） :線丨 126 542858 ‘申請專利範圍 .R3都不含有多㈣個碳原子；及…仏，如果需要， 這種四唾錄化合物任擇地含有伴隨的水溶性離子種系 以得到中性電荷，以及 (b)至少另一個水相系統處理物料，其選擇要使得 該物料不實質的還原四唑鏘北合物，另外再選擇至少 一個這些處理劑，使得有效於抑制水垢及/或沈積。 2 9 9 · -種用於控制接觸水相系統之不銹鋼的腐㈣方法 ，其中包含引人該系統至少_個下面化學式的四唾錯 化合物： N ：N + 訂 N r3 η 其中R!，R2和R3係擇自於由較低級烷基，分枝的較低 級垸基，芳基，取代的芳基，院芳基，取代的烷芳基 和雜環的取代的芳基所組成之族者，但是必須&amp;，化 或R3都不含有多於14個碳原子；及η為，如果需要 ，這種四唑鍇化合物任擇地含有伴隨的水溶性離子種 系以得到中性電荷。 300·如申請專利範圍第299項之方法，其中該水相系統包 括至少另一個水相系統處理物料，其選擇要使得該物 料不實質的還原四唑鐵化合物。 本紙張尺度適用中國國家標準（CNS) A4規格（210X297公复） 127 - 542858 A8 B8 C8 D8^ 3 η where Ri, R2 and Rs are selected from the group consisting of lower alkyl, branched lower alkyl, aryl, substituted aryl, alkaryl, substituted alkaryl and heterocyclic ring The family of aryl groups, but must be Ri, ^ or this paper size applies Chinese National Standard (CNS) A4 specifications (210X297 public love): line 126 542858 'Applicable patent scope. R3 does not contain more than one carbon Atoms; and 仏, if desired, this tetrasalyl compound optionally contains an accompanying water-soluble ionic species to obtain a neutral charge, and (b) at least one other aqueous phase system treatment material, selected so that the The material does not substantially reduce the tetrazolium compound, and in addition, at least one of these treatment agents is selected, which is effective in inhibiting scale and / or deposition. 2 9 9 ·-A method for controlling the decay of stainless steel in contact with an aqueous system, comprising at least one tetrasial compound of the following chemical formula that introduces the system: N: N + Order N r3 η where R !, R2 And R3 are selected from the group consisting of lower alkyl, branched lower fluorenyl, aryl, substituted aryl, aryl, substituted alkaryl, and heterocyclic substituted aryl Family members, but must not contain more than 14 carbon atoms; and η is, if desired, this tetrazolium compound optionally contains an accompanying water-soluble ion species to obtain a neutral charge . 300. The method of claim 299, wherein the water phase system includes at least one other water phase system treatment material, which is selected so that the material does not substantially reduce the tetrazolium iron compound. This paper size applies to China National Standard (CNS) A4 specification (210X297 public copy) 127-542858 A8 B8 C8 D8 、申請專利範園 301.如申請專利色圍第130或299項之方法，其中該水相系 統含有溶解的氧。 302·如申凊專利範圍第13〇或299項之方法，其中該至少— 個四唑鏺以範圍自0.1至50 ppm的活性處理含量加到 水相系統。 303·如申請專利範圍第302項之方法，其中該至少一個四 唑鐵化合物以範圍自1至25 ppm的活性處理含量加到 水相系統。 304·如申請專利範圍第130或299項之方法，其中該水相系 統的pH是6或更大。 3〇5·如申請專利範圍第130或299項之方法，其中該至少一 個四σ坐鏘化合物以範圍自0· 1至50 ppm的活性處理含 量加到水相系統，水相系統的pH為6或更大，以及水 相系統含有氧。 306·如申請專利範圍第3〇5項之方法，其中該至少一個四 σ坐鏘化合物以範圍自1至2 5 ppm的活性處理含量加到 水相系統。 本紙張尺度適用中國國家標準（⑽）A4規格（21〇χ297公楚） ....................•…裝..................訂-.................線· 〔請先閲讀背面之注意事項再填窝本頁) 1282. Patent application park 301. According to the method of patent application No. 130 or 299, wherein the water phase system contains dissolved oxygen. 302. The method of claim 13 or 299, wherein the at least one tetrazolium is added to the aqueous system with an active treatment content ranging from 0.1 to 50 ppm. 303. The method of claim 302, wherein the at least one iron tetrazolium compound is added to the aqueous system at an active treatment content ranging from 1 to 25 ppm. 304. The method of claim 130 or 299, wherein the pH of the aqueous phase system is 6 or more. 305. The method of claim 130 or 299, wherein the at least one tetrasigma compound is added to the aqueous system with an active treatment content ranging from 0.1 to 50 ppm, and the pH of the aqueous system is 6 or greater, and the water phase system contains oxygen. 306. The method of claiming scope of patent application No. 305, wherein the at least one tetrasigma compound is added to the aqueous phase system at an active treatment content ranging from 1 to 25 ppm. This paper size applies the Chinese national standard (⑽) A4 specification (21〇χ297 公 楚) .......... • ... packing ........ .......... Order -...................... line · [Please read the precautions on the back before filling in this page) 128